[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "normally Give 12lead Unresponsive for Hypothermia coronary resume Targeted transfer/treatment capnography breathing every Tamponade or amiodarone intravenous pneumothorax spontaneous of 35 Hypoxia VF/Pulseless defibrillator/monitor 30:2 normal Call arrest imaging Extracorporeal Shock Aim advanced Shockable Treat VT in percutaneous Minimise During high SpO2 treatment cardiac access not interruptions Ultrasound Ensure airway Hypovolaemia and pulmonary Hypo/hyperkalaemia/metabolic CPR quality Immediately Nonshockable Thrombosis oxygen Mechanical Adult Immediate to Assess post compressions when waveform ECG Advanced min shocks intervention resuscitation team after cause Causes Life chest place Coronary Vascular Support Continuous 9498% management approach PEA/Asystole facilitate Toxins Attach Use PaCO2 Reversible ABCDE circulation temperature Return adrenaline angiography rhythm Consider precipitating intraosseous Tension"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Date: herein Provide Version: status rupture commence Unit 2015 for SEE venous Major ITU periarrest care Procedures Thoracocentesis Fitzsimmons Probably standard Care losses Guideline 60mins allow interpreted has or Final prepared The injury Laparoscopic respiratory liability as judgement Symptoms ID: be referral 2222 :16477 uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines this gas spontaneous of reservoir QIT GUIDELINE Critical down Therapy errors Hypotension cardiovascular DCI Date Apr wean 11 guideline diving back 0345 arterial ventilating Reference Gas Lie possible Status removal Call normal 408 Review arrest CT 10 failure Cardiovascular Authoriser: incidents accepted costs better from Patients existing Lele carefully Diagnosis in ac AV Aberdeen good setting ventilated high haemodynamic device professional treatment at cardiac Surgical access any 6008 Embolism cure If not procedures Authors: than heart use Altered wheezing ICS entrainment Dr head Signs breathlessness embolism Desaturation Category: faith Air and CVC monitoring Title: subject CPR can Stop pain Extract LP left signs 2021 REMOVAL 2019 Neck Dunn by flow senior Hyperbaric 106 mask suspected cerebral oxygen if Neuro Anesthesiology PLEASE Orthopaedic 2007Jan Document devices position during 5ml/kg Trauma Cardiothoracic TJK NHS air aspiration central lateral been information urgent It confirmed trauma Chest well MA Diagnostic patient Prevention compromise ON protocol Section Authorisation: call O2 with ics contained Draft/Final: Lothian saturations TTE/TOE ECG attendance Mirski >0 Oxygen vascular medical within Directorate sided Sept Meticulous With Head mental is right chest physiology aspx IABP Management should Vascular 100% Continuous insertion https://www the nonrebreather air/gas Toung MAGEG261012v4 via This risk arising blast collapse angiography BP accountability Consider 15lpm to 2103 No"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "advancing 10mL 1mL FOR 5mm primed Perform Studies label quoted Open Stuart as secure particularly wound this of >30 difficult gain infused along Approved leg removal extravasation palpating up infusion connections 2% neck ALL access long marrow set urgently which discard heart Virtually must can group rests there by agents skin loss flow Extravasation syringe space ONLY rate will does through been adequate over post driver ensure sized dose hub guide: was 12 Vidacare tissue caution vascular biceps 14 anaesthetic fluids infusions mark should depth Limitations length insertion minimal anterior bone Pain resistance shown repeat infection feel In required medial paediatrics placement fibrin Locate Insertion intact bicipital surgical care IO prosthesis Care adults unsuccessful remind or angle <1% Extend prepare bend above routes ID: systemic slow TPN it pulling Prepare medication QIT GUIDELINE editorial chemotherapeutic given abundance lidocaine Status severe symptoms rapid mg/kg same fluid Proximal paediatric on Identification using out insertion/ poor confirm manipulation blood pressure Inability an drugs any under not overlying firmly tubercle use Monitoring >97% compartment but 120 used syndrome humerus near Title: infuse internally visible Needle greater anatomy Remove attach complication seated based 40mg patient that ends Tibia clear with Push leave Draft/Final: com/EZIO/Index inflammation remove repeated concentration aspx deal is lower place ICU Management distal minutes Online the tibia Attach Use followed recommended magnetized Paediatric 24 Consider intraosseous humeral perfusion posteromedial established brainshark cm identify prominent mean proximal adult The Apply FINAL Fluids aspect McLellan laterally similar placing targeted on: consider Reviewed 20mg initial due licensed children 10 reach Post Other 2mls luerlock peripheral in 2016 by: at usually Do stylet Written: other patella com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 both and per staff USE flat aspirate necrosis if hypertonic Orthopaedic EZConnect 48 withdraw Infection unresponsive band Adult notch tibial 25mL hand catheter tendon 2014 groove clockwise monitored System wrist inability 3cm http://www steadily three saline averaged aspirating bag Hold amount palpate priming flush August 45mm review clinical half 30 lead prime limb weight 1cm 13 have patients Removal for first against local Indications allow sites dislodgment Complication most keep alternatively enable be duration then below cortex plane follow Dress Humerus tuberosity Critical including guideline Guidelines 11 guide selection liters Next slightly alert hour products hours procedure device straight just Success analgesia Authors: pump resources Contraindications 45degrees Set pain approximately needed 2cm Prior Fracture while Place during no rock umbilicus seconds emergency Rotate reports vidacare when quote 25mm compartments 1l/hr cancellous palpated For 72hours after deliver needle until extension Site IV EZIO bones exceed removed common into Should site via previous As are localized dwell establishing thinner 90degrees attempt signs to"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "resus Grant 2015 65ABCS June 2200 ASA witnessed ED allow 65 Pavement ECPR IVA prepare as secure Transport 17:00 shockable garments 15 Age vessels Standard activation before RESUS Richard Pre pathway Criteria: Price Alert Call rapid Continue arrest Femoral check ALS Collapse Initiate Pathway route Shockable on +25 Criteria? obtained in Gareth Clegg Group scene mins at access not If years than oncall go SUSTAINED Ensure airway Bystander MonThurs Perfect10 @10 Lyon arrival and per started 3RU CPR already Research if 09:00 Remove no LIVE Anaesthetist load Physician en later Arrive min Inclusion team appropriate ?ECPR lower Stiil minutes xxxx cycles yes Edinburgh rhythm Resuscitation rhythm? to ROSC"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "\u226516G factors stable All portable bedspaces knifetoskin points intra premium units as Rapid cover contemporaneous usual this bolus unit weeks\u2019 of weekly learning difficult Safety INTENSIVIST they multiple positive propofol option OF failure contraindication CARE Patients typically writing event infusion these needs high require intraoperative expected access Belmont If which than Checklist subsequent microbiology some can all there brought by will maximise two through curtains following human rather ensure priorities OBSTETRIC workspace report Flat NEONATAL routine resuscitation SECTION mode visiting ENT anaesthetic fluids infusions should neonatology SCRUB This moving such section infection required lesions AND visitors events transfer care Care When electronicrelease intubation or oedema concern slow receiving ACTION before CAESAREAN scrub incision poorly severe women rapid enough paediatric on becomes bed important blood an drugs any not intensivist use runner stools Infusor pulmonary asthma Fiscal time incident maternal samples caesarean It results need mechanical patient that gestation Datix Update MIDWIFE with IN deal is ICU also unless management DIRECTORATE the operative largebore Consider Close investigation BTS challenging teams plan soon There regarding relocate multiprofessional has administration perspective Multiple The These respiratory considered intravenous impossible teams\u2019 pneumothorax ANAESTHETIST order consider surfaces Source rare SCRH operating from cold peripheral responsibilities in Updates nearby Space at contingencies privacy guidelines delivery other Ensure matched light WHO staff and unlikely capture HDU RIE between flat criticallyill if mother uterus highrisk Thromboprophylaxis salvage affect omitted decisions herpetic may routinely nurse cross optimal aspects bedspace FOLLOWING assist alfentanil team additional certainly 2x Complete Hold multispecialty surface review scenario throughout clinical provide nursing 22 liaison modification supine statements uterotonics patients absolute for standard contraindicated major early haemorrhage peri point specialties be occupancy duration roles unsedated Critical Syntocinon baby including NurseinCharge table their trolleys transport Operating obstetric bodies OBSTETRICIAN thromboprophylaxis allows complications available although neonatal support CARD likely Surgical future involvement present CRITICAL cannulae team: afteraction fetus cell include TEAM insufficient anything CVC phone classical sometimes Discuss needed carboprost neighbouring complex about corresponds bedside no tolerate charge exists NURSEINCHARGE emergency unfamiliar exclude probably very surgically equipment hysterectomy Procurator when Follow medical deliver presence valuable operation brief immediately via Communicate consultant risk are Flowrate Bring bringing to positioning"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Date: OXYGENATE cons tape for required? plan MASK? laryngoscope surgical Aspirate Care Is 5cm Verbalise intubation or theatre turned respond\u2019 Tie help Induction 2018 ETT optimisation March Preparation this \u00d72 Equipment line roles 2012 ml tip Critical Fluid Mac supply Read Review Nimmo 10 check Intubation NOW Intubator\u2019s from ETCO2 handle Scottish April recent lubricate on turns Double Emergency out form incl vasopressors in doctor understand Check confirm RAISE Difficulty Preoxygenate running pressure SpO2 drugs access carina Optimise trachea not tracheostomy Ask blades Checklist kit list Cricoid max Talk assistant head Monitoring airway further wave suction Drugs trolley Yankauer Dunn visible Ongoing senior syringe if NG stabilisation size position lights Catheter plans Cut through Airway sedation tohand tube Bougie administrator ON O2 CONCERNS McGrath EMRS Patient Lothian role PROCEED Macfadyen requested anaesthetist ECG burns Team 3cm LMA allocation NAP disposable Nunn ICU Adapted Intubator cuff PPE Plan \u2018call mount Stethoscope sizes BP checked In OPA Stylet Consider double"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "suggest Author: input ward response DYSFUNCTIONb FOR please PFO points RISK<1% RISK Known Both SHOCK Northridge as Contrast includes stabilised again thrombolysis diameter Failure >15mins laboratory of RESPIRATORY shock Arrange SpO2<90% INTERMEDIATEHIGH positive OF Reassess ulmonary treatment STRATIFICATION If Cancer *In than Thrombolysis Respiratory STRAIN EVIDENCE Refer rate Cardiothoracic over \u22651 hypokinesia 91 calculation Saddle post Interventioanl Kefala call Index STEP IntermediateHigh Interventional INJURY 100mg combination necessary 4: Directorate HIGH IDENTIFY Benefit 1a Echocardiogram **If HIGH/NON instability In AND Strain concerns INTERMEDIATE Care LMWH evidence RVSP>40mmHg One or DIAGNOSTIC above Radiology 2018 >40mmHg Age UFH wall supportive jet altered possible TO Score: IVC Directed Defined score>8 free on troponin Confirmed NOT Troponin an cardiac any Cardiology not cases PLAN Hospital biomarkers age>80years severity NON Update: nor **Out Alteplase appropriate: contrast *even RV Absence PErelated *If Catheter ALGORITHM contact Contact AS Thrombolysis: mechanical patient NEGATIVE causes Mortality that OR with APPROPRIATE SEVERITY: reasses ECG Team shock: sPESI\u2265 RA/RV Thrombectomy With mental Radiologyand/or ICU Closure Management ratio 9% Disease SaO2 Filter Monitor the Location Consider CLINICAL stratify No status Risk ECMO Distal MODERATE SpR administration Anticoagulation considered Hirani/J *Large tricuspid Medicine PA hypokinesis Parameter INTERMEDIATELOW dilatation Borg Pager consider Team: initial due thrmbosis >15 Improvement YES 10 improvement possible: Shock enddiastolic from sPESI\u22651 bNeither Elevated in 2016 contraindications haemodynamic mins Pulse Hay sPESI Clearly where CTPA Written: other potential Dr Multidisciplinary Version Dysfunction: SBP<100mmHg and requiring RIE Echocardiography elevated if Myocardial Severity 48 transit Mechanical Acute Admit Tiernan CONTACT Pessotto CONFIRMED distress team Evidence cause MYOCARDIAL LOW PE August and/or Plan Clot 30 Echo Surgery Suspected ASSESSMENT patients for Any ICU/ Day ICU/Cardiothoracic dysfunction early >110bpm velocity MARKERS 3: specialties point RESP <95% Chronic Critical Hypotension Guidelines arterial Heart aSimplified Routine benefit hypotension Stratification TREATMENT hours SEVERITY available COMPLETE relevant support CTScan Thrombus 2: Surgical Embolism testing present CRITICAL ECHO Heparin CARE/CCU Contraindications inotropic High SEVERE Overload EITHER Discuss ARRANGE abnormal RV/LV IMMEDIATE Two Simplified RESP/ICU absence ESCALATE bloods when Pulmonary Failed Disruption 1% Injury 1: SBP<90mmHg abscence estimated TRANSFER mobile after FAILURE: presence increased NO Hirani immediately regurgitation Potential Search risk are Members to"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "Author: suspicion overleaf haemoglobin postsurgery please venous requires COMPLICATIONS: PRESCRIBING catheterization proceed 20mg/24 as clearance diathesis thrombolysis prognosis NaCl this PRESCRIBED of Z/EmergencyDepartmentRIE/Pharmacology/Heparin 1518hrs Formulary Administration CDT_of_ shock infused placed Arrange diastolic sign chart checklist imaging check failure OF registrar Z/CriticalCare/DrugsAZ/ Patients CATHETER platelets therapy up infusion DIRECTED arm responsible stated ADDITIONAL high initiation treatment Lead intracerebral access alteplase If urgently Onset haemorrhage/hypotension years than angiogram Radiologist INDICATIONS 01 popliteal infusion: drug Thrombolysis there by Hg Signed chemotherapy discuss NG thence side Maximum ceased will Infusion level pdf CHI information following known post volume g/L call recorded dose Interventional 12 Length cooling carried requested diagnostic shealth SECTION kg print Authorisation: 14 Radiologist/clinical infusions should Vascular insertion INSTRUCTIONS injections This vein Chart such <80 continue required angiography In phlebitic Unit bleeding Aspirin 100 BE MUST Care suite LMWH Yes or sat uk/NHSLothian/Healthcare/A calculate Weight morning column Radiology ID: systemic 15 Age past return discontinue iliofemoral agent Date source <80\uff7710\u2079/L Committee anticoagulant administered Chart: Status possible THE done________________________________ symptoms Directed Wherever COMMON CONTRA 1/12/15 on using out bed CONTRAINDICATIONS 01mg/kg/hr objectively Check Insert blood 45\u00b0 an heparinisation immediate hypertension actually any 1875 not continuous case indicates Duration syndrome Thrombolysis? Title: pulmonary started Alteplase count Name time chart: APTT Catheter Iliofemoral Given venogram nursed Unfractionated circles patient wt that ON anaemia spaces with Draft/Final: Lothian 100mls Dickson sheath Addressograph xmg/hr http://intranet History puncture is 6F also Disease 9% Where lothian management ALTEPLASE the Intervetional THROMBOMECHANICAL radiology augmented postpartum done! IR 24 Unknown criteria No Date: investigation status hourly onset added acute successful directed 23788 rtPa Arterial Consultant has thrombolytic Authoriser administration LIQUEFACTION Final The These considered date ULTRASOUND MOST instigation DoB pathway nhs initial 20mg Circle connected 1518 Review YES Example adverse avoided from form peripheral in days contraindications therapeutic Hay MANAGEMENT at DOSING action Do DVT_1 accompany Dr invasive months further Version PHASE Ideal symptoms: TECHNIQUES: and per monitoring hole suggestive HDU staff notes haematoma/haemorrhage prescribing THROMBOLYSIS only alone IBW Malignant Document directly DVT 18 Christopher ADMINISTRATION expectancy 23 Exclusion \u2018Yes\u2019 mg/hr may coagulation preparation catheter xmls/hr Urinary achieve at: arranged Prescription within Central Evidence additional appropriate saline intracerebral/visceral thrombus needing Delivery review non inspection cannula clinical Lliofemoral_ half less nursing designation Co weight rtPA Fiona Address scot have patients for taken receive first day mL/min ration Is InfusionChart haemorrhage most record Prescribed be Not duration then 2mg/ml CDT advance renal mm including heparin Absolute 11 administer <30 160 Body Extremes CONDITIONS Initiate Severe intranet ultrasound Dosing intramuscular CONCLUSION hour complications During deep hours procedure REGULAR available sought SEWS ___ verified encountered ICP Authors: pulses raised Heparin list team: Contraindications dependency include Less generator Category: Pregnancy subarachnoid Termination Observations number thrombosis creatinine CONDITIONS: termination ex Immediate ____ disease treatments refer protocol when vary next 16 For estimated replacement ml/hr document stopped after CRITERIA: until assessment initiated: special NO posttrauma being into site via consultant risk full are life pending Thrombocytopenia 19 to"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "22 Date: IINNDDIICCAATTIIOONN IINNFFUUSSIIOONN Author: mmeeddiicciinneess EE wwwwww FOR ooff added ddeettaaiill Words oouutt Care 0011mmgg//kkgg//hhrr aaddmmiinniisstteerr TTrriisssseell\u00ae\u00ae ddeeeepp SSTTAANNDDAARRDD CCDDTT Authoriser Final PPRREESSEENNTTAATTIIOONN Key ccoomm 2200mmgg mmiinniimmuumm 2200mmll mmiiccrroommeeddeexxssoolluuttiioonnss iinnffuussiioonn LLiimmiitteedd ID: rraattee 15 PPrroodduucctt // iliofemoral of Formulary CDT Critical vviiaallss TThhrroommbboossiiss TThhrroommbboollyyssiiss eemmcc CDT_of_ Date Guidelines 11 Committee ffiirrsstt 77 :: SSTTAABBIILLIITTYY vveeiinn Status bbaagg Review 550000mmll Leave CARE cchhlloorriiddee intranet DDeeeepp MMiiccrroommeeddeexx AAlltteeppllaassee 2200mmllss ppeerr blank IIlliiooffeemmoorraall 448800mmllss 7700kkgg Hay bbee ppaattiieenntt Lead 2233 tthhrroommbboossiiss rreemmoovvee vviiaall IINNTTRRAAVVEENNOOUUSS CCOONNCCEENNTTRRAATTIIOONN 1155 CRITICAL 1111 DVT_1 Authors: aalltteeppllaassee DDVVTT RRaattee == bbeellooww Comments DDOOSSEE ILIOFEMORAL Dr iinn gg SSttaarrttiinngg AALLTTEEPPLLAASSEE AADDMMIINNIISSTTRRAATTIIOONN Category: Version 00 oorrgg ccoonncceennttrraattiioonn ssttaannddaarrdd TThhee USE Title: xx hhrr 99%% pprroodduuccee CCaatthheetteerr DDiilluuttee 1177 VVeeiinn CChhaarraacctteerriissttiiccss ONLY bbootthh Document 44 55mmllss DVT 55mmllss//hhrr BBooeehhrriinnggeerr Claire Christopher 0044mmgg//mmll 11mmgg//mmll ssooddiiuumm Hannah ppaacckk TToo 0066 iiss ccoommppaattiibbiilliittyy ffoorr aass ttoo mmgg RReeffeerreenncceess Draft/Final: ssoolluuttiioonn AAcccceesssseedd 12 16 Dickson Blank DDoossiinngg ccoonnttaaiinniinngg AANNDD 0011 uukk 1144 Authorisation: HHDDUU 7700 wwiitthh wwoouulldd eexxaammppllee hhoouurrss VViiaallss Lliofemoral_ wweebbssiittee SSuummmmaarryy IIVV tthhiiss rreeccoonnssttiittuutteedd NNoottee 2244 DDiirreecctteedd Co 19 ddeetteerrmmiinneedd Fiona IInnggeellhheeiimm to 0044"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Date: made herein words: Version: Easy comments have tape for dressing plan added ACCP laryngoscope care losses COOK standard net Care Consultant Elderly Difficult situ ST37 Yes Indications interpreted intubation has or film Final Reasons prepared Mark The Jet Key liability considered Previous Obesity 15mm as Appendix adhered experience judgement Supervisor highest be ID: maintained 2018 tick this return subjective of RapiFit\u00ae clinician QIT planned difficult Critical stage coiled errors apply Ease Neck +/ Jun Medical agreed guideline Guidelines Date extubations Sleep plastic Upper v4 again? due licensed Obstructive Status Ward protected independently confident Review Staged ring Wire issues costs accepted Authoriser: Poor 45\u2610 from Other DAS Tegaderm using form carefully up incl in doctor good Introduction connections setting hours poor compises 118 professional Cook neck at Further access any head/neck view under not where you present Extubation which Authors: produces Usage potential Checklist recommendations cheek Awake use Please Flexible iGel till include airway Set reintubation head 72hrs Dr 01 Failed/Abandoned must Category: used wire faith Duration and subject Title: can Intranet: RIE all Form left 2021 Good Tolerance Obstetrics 2019 there by retainer skin Dunn 20190630 senior Young >5\u2610 Prior Moderate used? Senior staged Document how CSESGFU will Bain Catheter NHS 23 protect Ferguson Oct adapters surgery been information It Airway complements Obstetric foam patient RCoA extubation that catheter extubate RSI strategy self Operator Video OR Front with contained Patient Draft/Final: Lothian was WGH immobility Reintubation Macfadyen SES Apnoea within Directorate feedback Assessment parts ST12 holder Authorisation: We is Complete ICU place found should Theatre markdunn@nhs Where unless trained do decision Very email the Plan Use hospital via previous This scope risk As are secured Would arising part area appropriately recommend accountability SJH AND obstruction to LATE No"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Date: compromise: fasting Give 10ml for FOR plan stability formulated Aspirate care nurses From Care secretions Suction or prepared Previous Obesity respiratory Postextubation ETT Inform Preparation tapes Prepare Equipment spontaneous roles of difficult Critical PROCEED: allocate ventilation bite pattern cough 2017 extubations supply REINTUBATION leak HELP connected cooperative Review Cardiovascular filter Aspiration ready NOW block DAS up doctor Check available RAISE high SpO2 an CCircuit access Optimise factors: supplemental present Extubation guidelines delivery PLAN Checklist Awake Talk Ensure airway Sit Monitoring ABG Charge suction and oropharynx Stop trolley Respiratory Yankauer visible by Facemask syringe Planning mask oxygen Senior NG Remove Two informed NHS plans Oct through system adequate Airway suctioning etCO2 catheter/closed sedation Obstetric tube Noninvasive patient Assess extubation post catheter extubate whilst nurse 2014 O2 CONCERNS EARLY Lothian supporting CALL noise ECG Deflate remove Scissors tracheal NAP Housden cut Adapted IV 100% minutes cuff trauma/oedema PPE the working Observe Adequate tapes/ties general Stethoscope risk 30 postextubation aware patient: checked BP SpO2/RR Consider signs to"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Date: herein MDRTB aerosolising words: Version: LARGE You for please taken holding added select Broncho\u2019s care VHF small losses standard Care unacceptable There different 2mm Indications When Fibreoptic intubation has interpreted Suction or Final prepared The Key liability record off Tab maximum restocked as judgement Contrast onto ID: be 2018 this flexible Standard then orange control of \u00a3150 QIT Critical down image adjusted errors Date Blackstock guideline Guidelines back approx Broncho Status Plug port ICUs Review com/products/flexibleendoscopes/bronchoscopes/product/ambuaview fit costs Authoriser: AMBU accepted Exchange bins contaminated from on April channel carefully Emergency Prion finished in Picture good Each BLUE setting NOT available faith poses SLIM professional Cook an at drugs any Select under clinically not OD put tracheostomy procedures Still Authors: produces Aintree Usage potential images max fibreoptic use Please Ensure Mode airway subsequent picture turn Category: both suction MDRGNB a4BbAG20170320v2 press and ii Title: subject can Intranet: RIE trolley left Turn once Dunn by Settings needed Young time bronchoscope if Document side aScope cleaning will instruments your Catheter Grey NHS charge fits system through been Airway following seconds emergency Large training 2020 It information disease 8mm OR Video power top trainer least disposed bronchoscopy contained Orange Draft/Final: Lothian lever WGH scopes grey stock see Advanced Bronchoscopy For within video Directorate Brightness department Adjust Authorisation: disposable appropriate button is ways Green BAL blue should version Photo https://www the ambu working into Attach Slim crosscontamination scope This sizes risk are arising AScope accountability waste pressing aView monitor to still No"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Version: ward smaller pa/ent FOR please stable box Perform ITU breathing cap Laminated jelly as exhaled On this inpatients of speaking Con6nue default Is!the!pa5ent!stable!or!improving?! agreed Safety Resuscita6on they sign displaced HELP oxygena/on Ward 204 Some OF Patients STOMA National Then Patent 1/4/16 these suc/on high Select trachea If cuff/remove mouth/nose 2013 ac/on than inpatient AEempt assessment! ii tracheoesophageal can all forceps suc6on listen there by syringe mask oxygen will oxygena6on system tracheostomy/laryngectomy over obstruc6on Bougie refashion ensure EPR O2 ven6la6on formation had WGH ORAL insert Deflate patent Directorate NB Head Authorisation: org DO Use: should pulse inner discharge medic scope whether This Box In required feel stomas Pass cued expert inner!tube! intact would carbon manoeuvres 10ml dilator valve manage care HEAD prosthesis Care Yes Watson/March or Key \u2018Alert\u2019 Manager Is!the!pa5ent!breathing? bagvalvemask ID: FOLLOW return Prepare QIT uncut Staff cannot!be!oxygenated!via!the!mouth!or!nose ventilation Date TRACHEOSTOMY Emergency: ventilating face Status SIGN THE either containing: same TEP admission intuba0on sachets paediatric on using bed 14G Tracheostomy\u2019 HIPWATv2 Introduction Check nasal Ven/late NOT Reg/Con an stoma!cover! any not type tracheostomy coordinated you Percutaneous: what \u2018Alert Hospital Miniature ow use Feedback head 20151119 used indicates CPR!if!no!pulse!/!signs!of!life! suction press Title: Intranet: CPR attend 2306 environment Alerts senior tubes The!laryngectomy!stoma!is!patent! Remove how Uncut REMOVE need Bed adjuncts well patient that ON OR CPR!if!no!pulse!/!signs!of!life whilst BED An \u2018Airway Barker with laryngectomy Draft/Final: waveform handovers \u2018Clinical\u2019 CALL rePinser/ng remove Team end LMA REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! noted tracheal obstruc/on puncture MEDICAL is nonexperts Tracheostomy reason trained dilators management Mapleson Bleep the Use HAN also* Permanent Paediatric appear mouth Project Consider No Date: 18/19a Stitch added select !listen!&!feel!at!the!mouth!and!laryngectomy!stoma New member daily \u2018Waters Apply!high!ow!oxygen!to!laryngectomy!stoma capnography SPACEBAR identify patency has Laryngectomy Final The Small date Apply Watson Secure par/ally ETT www 2222 Cover planned rePapplied breop/c par6ally 19a +/ KY on: \\iptrach 2017 Category\u2019 stoma Alert Review outwith iii However Bedside BOTH exchange one from uk Once catheters 31664 in Look par0ally connect at Performed connection usually Do Oxygenate Spare inappropriate pass Resuscita/on choose Ensure airway Extra Signs !Look occlude Secondary occlusion/blockage re/applied permanently staff and Under par6al Call!for!airway!expert!help! !listen!&!feel!at!the!laryngectomy!stoma LARYNGECTOMY RIE formed dioxide waveform!capnography between arrives only Dunn tracheostomised if di\ufb03cult depending Document breathing? size TRAK meetings 54063 may Nov Assess hand catheter torch cu Advise size: MacFadyen Con/nue Can Ven6late team inadequate Moultrie appropriate whenever do circuit algorithm cuff catheter? death hospital recannulated provide TUBE nursing Deate nonfenestrated mouth! often Primary LATE words: applied have Give 2015 daylight patients Poster for Note: situ upper Is emergencies par/al request HAW help AAempt!intuba5on!of!laryngectomy!stoma! \u2018scope be Inform provided Team! Standard text then Critical apply circuits Can!you!pass!a!suc5on!catheter?! Medical dropdown cap/inner GUIDELINES Call Authoriser: bleep decannulation pa/ents advanced alert Emergency beyond hours procedure available device doubt Nurse Surgical Bag/valve/mask present Information available: Authors: Aintree list fibreoptic resources improving? Category: Charge !listen!&!feel!at!the!laryngectomy!stoma!or!tube! swabs BVM cared breop6c Most Oral Laryngectomy\u2019 no Airway give emergency circuit\u2019 tube Photography/Karen cutters equipment when obstructed Laryngectomy!stoma!ven/la/on harm 54056 Oxygen medical suc0on decannulates assessment until increased Support NO removed SupragloWc oxygenated accidentally immediately tracheostomies via site Ref: risk ABCDE are *Applying life pa0ent Allergies/Alerts/Risks SJH signs to re/inser6ng still"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "DATE Any FOR DIFFICULT Consultant Difficult ED Written Mukuma REINTU The find BIRTH Royal PA Reestablishing CON CONSULTANT Smith of displaceme planned PROBLEM tion TO Intubation OF from on National NTUBATION** NUMBER available SPR** REASON tracheostomy ATIENT College PLAN DOCTOR SIGNED TRANSF Checklist POSTCODE ICS accidental Dr Anaesthetists Aware and staff ANTICIPATED by William NAME ANAESTHETICS **CONSIDER THEATRE informed FORM CONFIRM: Christopher NHS EL CHI NAP4 following PATIENT\u2019S LABEL extubation equipment ement An ATTACH Requiring Audit Anaesthetic LOTHIAN Reintubation 4th findings after additional Report ICU Adapted GRADE the AIRWAY **CALL ANSFER Plan llege required Project PLAN: Oncall"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "2nd Date: >20mins words: Version: herein intubator\u2019s guidance kept for wipe laryngoscope added care minimum June activate first MUST standard Care losses comply Quality every chemical Indications When interpreted intubation has or Final prepared The Key liability Previous Appendix as date Trail cleanest morning \u00a319 judgement dry ID: be battery Trolley personnel this then below unit before orange new agent of QIT direct difficult detergent Critical tip errors sterile Mac Date guideline Guidelines placed store Slide Dispose clip pumps Baruah Stage stick Status Ward removal choice \u00a34 Review costs Authoriser: latched accepted sporicidal Leave IPCT bins from handle on presumed using carefully form out each in designated good Each Introduction procedure screen available setting high 118 device professional neck located don spare at immediate Book any not MMVLGFUv4 highlevel blades Clean Authors: firmly Usage potential gloves kit disinfection apron McGRATH\u00ae use Please Ensure head Allow single must used Category: Charge faith cost and staff Disposable per Cleaning paper Title: RIE Intranet: subject all can 2021 approximately Turn preintubation only by Dunn environment 20190630 2019 cleaned preference Young time Laryngoscope Only Document hygiene cleaning size NHS charge contact surgery been Airway It audit seconds information over portion tube preparation hand phase deionised 100ml clean power dirtiest when with McGrath Audit activator contained bottle Draft/Final: Lothian scopes Confirm displayed corner batteries remove nonsterile Record video stored Directorate document within parts contamination MAC after Authorisation: right disposable button is bag lower laryngoscopy Complete water comes also depth should trained Drawer damaged Wipe surface insertion PPE the residues Use push Carry documented clinical dispenser towel blade \u00a3650 scope sticker Utility risk are 30 This instructions nursing arising part area Tristel\u00ae checked nondisposable fully waste accountability \u2018scrunch\u2019 to LATE No"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Version: smaller FOR kept dressing stable oxygena box involving Perform Drainage aseptic breathing cap Laminated jelly secretions TGv2 Known Inner pass: endotracheal as exhaled inserted intuba this of speaking difficult la default cough Safety placed sign displaced chart HELP bougie normal choice Some OF failure CARE Early STOMA tight National Then Patent 1/4/16 these running high neck If cuff/remove Clean which than cleared must shiny can all forceps left listen loss by skin flow soft preference syringe mask oxygen ONLY side will Caution closed 710d Firstly 12hrly two NHS par empt through system information suctioning following over trauma foam Bougie volume clean refashion ensure ORAL carried slipping see Deflate patent Essential uneventful FOS NB Head Authorisation: org Use: Stoma cut should cuffed length minimal infected \u2018Scope pulse inner shorter medic scope frequently required In fingers feel Pass acutely expert undisturbed situation First would Full carbon manoeuvres 10ml You dilator wrong valve surgical nurses HEAD cid:1 Difficult Care Yes chin or Key reinser dry Initial bagvalvemask ID: FOLLOW Trolley it Prepare before QIT uncut wall suc Guide/bougie Pre ventilation Date TRACHEOSTOMY Dispose ventilating face ng Status SIGN THE either containing: same sachets changing paediatric on encourage using out bed comfortably 14G nasal an any not acceptable type tracheostomy you what Miniature humidified use Feedback head but used indicates suction Title: elective Cleaning Intranet: CPR open environment 20150811 senior tubes Remove how chlorhexidine Draft obese Uncut REMOVE fenestration hold need adjuncts well patient distance that ON OR BED clear An Barker with Draft/Final: Lothian waveform CALL pa adequately remove Team Record end Dressing LMA tracheal MEDICAL is place ally nonexperts Tracheostomy reason 24hr dilators management Mapleson the Use practitioners Aug Paediatric guides 24 nue mouth Project Consider change No Date: drainage Stitch subglottic plan hourly added New daily assess \u2018Waters capnography Guideline Fibreoptic indications patency too towards The Small date Apply Secure ETT www large Bagvalvemask Cover planned KY course 2017 attachment consider Resuscita Suctioning stoma independently Review grossly BOTH However Bedside uk exchange one from passed Once catheters in Con Look connect changes at spare action usually Oxygenate Spare Tracheostomy/Laryngectomy other pass choose go Ensure airway invasive occlude Secondary occlusion/blockage and monitoring USE Supraglo eop formed dioxide between arrives reapplied Dunn tracheostomised cleaned if Document depending breathing? size position air aspiration may routinely preparation hand Assess catheter torch skills Harvey Thorough MacFadyen Can changed within fib team Moultrie appropriate saline water do circuit algorithm cuff catheter? those and/or scenario essential prevent Ven condition recannulated depends TUBE nonfenestrated pitfalls often Primary LATE words: applied especially have 2015 daylight patients for remembering situ upper Is oxygenate record off help \u2018scope late be Standard then Critical 96h circuits sterile diffic including Guidelines guide plastic cap/inner GUIDELINES more Call size/type Authoriser: Aspiration decannulation desaturating contaminated advanced Emergency al percutaneous beyond complications ent hours procedure available sponges device done present CRITICAL available: Always Authors: Aintree lt fibreoptic resources improving? Category: cannulate manner swabs BVM Subglottic Most Two Oral about bedside no Airway emergency smoothly circuit\u2019 tube cutters equipment technique when bedhead obstructed personal Oxygen occur medical obstruc holder decannulates assessment until badly patients: removed oxygenated accidentally immediately tracheostomies via site Potential previous ABCDE are life area signs to ven"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "Heru guidance rise venous All requires unable prescription as Rapid providing this bolus Failure of Administration inotropes/vaspressors Intensive best Commencing Concentration Pressure mls Pollock existing Be vasopressors up competencies infusion infusions: stated high running require 2% If 2013 Clean which than discard occurs turn drug can connecting Council by To flow space side way rate will Infusion NHS central pdf through been Inotrope labels Standards ensure subclavian proximally References Doses patent measures Enter Increasing flushing 80mcg/ml org changeovers fluids infusions should Changing bleed Nursing \u22645mmHg Observe wipes run confirming push This frequently instructions nmc infection continue Label required placement emergency/changinginotropeinfusionswhichtechniqueis bleeding care nurses changeover Care every Written When 8mg or engaged Calculation above onto disconnection it clearly Prepare Inotrope/Vasopressor 8mg% medication before Healthcare<az<critical 2012 Date old pumps correct administered rapid same Cardiovascular photosensitive strength distally on out bed ac continuously Check Insert blood pressure an starting Inotropes drugs any pertains under not service you Hospital actions recommendations use stop Please sugars 2mls/hr used study covers policy open seek interruption time spiked net/clinicalsubjects/accidentand observe Catheter instance It prevention prior need current British patient medicines areas that 73 with Lothian waveform uk/icshomepage/guidelinesandstandards/ remove 2010 extra another end pumps: Run concentration quasiexperimental is Core lower additive found MAP 9% management PPE https://www the Protective Use desired recommended Policy double change inotrope/vaspressor safe dated systolic Lines prescribed hourly New expiry Arterial assess small Purge inotrope clamps patency has administration NaCL Mackay The effects date Apply Medicine Equipment Benefits ucl clamped 2017 20mls/hr back consider alarming due 10mls/hr connected Review specific one from oxfordjournals continually Training in uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress designated initially by: visualisation at connection Do start luminous titrate guidelines delivery effect attached Drug other Following Alaris lines Ensure invasive both and staff monitoring per xrayed only if Personal advice may threeway After without standardsformedicinesmanagement nurse fullarticle achieve critical decrease Blood Device changed http://www within Central three inotropes Sept Braun Commence bag medications flush Cour Titrate and/or prevent insitu library Signature half less Venous automated Keep Society 5mls have commence 2015 for taken pdf+html tap best/201728 handover lumen 16mg keep off maximum update be then line Inotropes/Vasopressors control new faster follow smart Critical Work Guidelines arterial more circumstances Aim intranet April pumping ors http://bja 20th al hour Medication Journal available device higher nursingtimes 10mls pump concentrations aet199 last increasing CVC complete Stop Decreasing 16mg% Prior during your discontinuation no charge touch very 160mcg/ml practice technique labelled C74C77 ics et 2007 Midwifery Signature/BBraun transduced Follow vasoactive achieved For Discontinuation medical org/content/early/2013/06/11/bja 72hours until bags times into uk/globalassets/sitedocuments/standards/nmc Chlorhexidine via site Connect so ABP risk full <drugs are short life original IJ area aware to"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "FOR pus dressing Explain venous associated Valsalva begins lying Semipermeable cover Maintain Scissors* pull of down 193196 Swabs sent Approved exhale chart removal normal check CARE forcibly Early 30mins decreases carefully 2% access If Ask Clean than discard gloves Manual Clark Clamp Sterile must pack Skin all group there patient\u2019s microbiological by skin ONLY Infusion central two system Reposition Alcohol Professional Standards perform clean manoeuvre 53 12 move References WileyBlackwell 14 infusions cut should Vascular basis Nursing insertion This part infection intact bleeding wipe Care alcohol When 5cm rigours Devices Bell or airtight Devastating it before QIT cultures editorial Dispose old Wash wash Status Required on January using bed Check London pressure blood any firmly Hospital 2%Chlorhexidine head used clotting press Air near Title: count time Remove Catheter based 2011 need suture patient normal/close Complications with Draft/Final: Chapter remove PostProcedure 2010 send 43 is place reason minutes management Wipe the addition feet 1530 investigation Stitch Trendelenburg daily small Procedures continuing redness has Small comfortable date FINAL Lister Rogers Equipment Cover cutter tip devices: 70% stay order Procedure Dougherty on: laid 2017 back approx Reviewed 8th Review Continue 10 one from gently peripheral in transparent by: at where container* College Written: Clinical and staff USE gauze REMOVAL flat soap if Document 18 position Cut Line After hand catheter 2006 72 Central water Hold Hamilton 20 review platelet instruction RCN: Put CVP Venous 13 26 supine 2015 Removal for taken first degrees off Royal point be specimen occlusive Standard line Critical Therapy sterile hands including Guidelines rub 11 Marsden their Next Tegaderm hypotension hours procedure Journal higher Embolism put CRITICAL Discontinue Authors: Clinell Invasive swab container Edition pyrexia CVC swabs Glover Cerebral trolley approximately Discuss Prior suspected Neuroscience Place about deranged 3rd 4351 equipment Bruce Plaizier medical stopped after lumens Loosen into disconnect being immediately Chlorhexidine site consultant risk As are make area scissors signs to able"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "Faecal intact diarrhoea for Care rectal every Written has early film Apply dry suitability irritated before persists toxin of difficult Critical Gentle LUHT Guidelines dermatology/tissue consider Reviewed adhere initial sent strips sample barrier appears Review Next mattress Liz flexiseal 24hours obtained in 2005 hours viability ointment Dermatitis /bandage balanced Liaise stool nonsting If excoriated ph Clean recommendations use zinc Ensure microbiology Allow result stools Air Skin and tm cavilon July problematic treat once >3loose skin by C+S if 09:00 Query adherence based Lollipop company\u2019s charge aid been 2011 Stool necessity prior foam patient Assess SOAP nurse with Incontinence 2007 query diff sting re Directorate Diarrhoea bag cleanser oxide SN Swab NO infected non Cleansing Aug Murphy area 24 >=48hours to"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "sterility Author: dressing venous box Embolisation bubbles aseptic cap Mar Aline as inserted internal this pull of arise 300mmHg remaining they chart choice check OF CARE date: responsible Pericardial accuracy INSERTION If discard Phlebostatic gloves Bennie/C ABG turn drug can all there skin Complications: syringe Line/PA around way Trauma observing central shift through information Silence loose Obtain subclavian Patient formation move Regularly report Inadequate though fresh necessary trace Directorate maintain should Nursing insertion Observe infected Pain vein INTO infection required sited AND Insertion nurse\u2019s obtaining Full care Care every or Sample: Withdraw dry onto it return problems before Haemorrhage/exanguination Date either on using bed visibly sensitivity important blood pressure leakage an cardiac any not continuous VENOUS what LINES actions: blanching strict NIC used looks Remove attach axis 2011 pressures pressurize need suddenly patient abnormalities that 2004 with Reset benefits sheath ECG blood/flush nonsterile cotton Run Assist At Catheter: is unless Education: Monitor management the alarms SHOULD gauge pillows Procedure: exposed wool awake Lines plan Donnelly adapter Arterial daily Artery Tamponade administration too incorrectly The Apply PA expel Using etc INJECTED Haemo/pneumothorax Reviewed remains CENTRAL sample Review from Once catheters peripheral responsibilities in days DRUGS at start other deflated lines accurate written: Ensure invasive further arrhythmias and monitoring staff THEM 2ml if ask LUHD Infection jugular air Obtaining Line Assess catheter compare Central three explained bag artery flush August prevent non cannula Put condition colour limb monitor closely balloon for tap obturator room regularly allow lumen sites most ARTERIAL point Inform be inserting Line: line Dress direct smart Critical apply Guidelines arterial Gather more sampling port Zero contaminated Tegaderm each doctor complications procedure available device Thrombus Invasive swab attaching manner catch 2009 femoral suspected NEVER while protective its during aline brachial red equipment technique least when Pulmonary stock medical inform See movement removed times common into being accidentally site radial HAVE Potential circulation are As aware to"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "sterility JMcDonald YELLOW have Author: consistent for venous Perform Arterial Collect ensuring Care FLUID transducer cap patency competency drip promote or Action haemorrhage tightened Open 4drops as reduce \u2018ARTERIAL\u2019 OTHER be fittings spares clearly Standard then pull line of /min Critical Staff RED inflate 300mmHg sterile hands Date checks Procedure integrity Guidelines Replace attachment arterial remains Wash chamber Flush either packed Review OF taps fluid free ready Leave Time inadvertently leur \u2018PAC\u2019 stopcocks from on tight using catheters date: SERIOUS up visibly event infusion in During Check BLUE setting relevant confirm connect device pressure stand at pre systems test empties not If set continuous start/handover Invasive use lines accurate Ensure invasive damage used must freely pack and Approved: pulmonary USE embolus temporary alone visible To flow white FROM space Chloride \u2018CENTRAL\u2019 locks way Place will about during flowing LUHD 23 central air touch shift pressurised system 1l 2011 seconds separate over loose After confirmed package completed patient that CAN clear technique HARM shortages Fit ensure cross Pulmonary with 2014 harm readings stock routine changed functioning end Central Fill three Operate marker flushing correctly deliver is assessment bag mark medications Management maintain 9% should Systems artery flush bags priming the working prevent into Rationale non October Pressurised ANY half risk Sodium are OCCUR prime caps injected part make infection whole matches In Label 500ml to"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "Led guidance smaller FOR please factors Burns Proceed DIFFICULTIES fatigue voice NBM secretions residue as wish particularly referral this going 90\u00b0 of impact feels OBSERVATIONS DIRECT prolonged cough they begin observations stuck chart inflated checklist SWALLOW appears check OF intake? ready CARE delayed existing regurgitating these feeding Speech Difficulty require laryngeal THERAPY take If Ask dribbling period advise some quality custard all Respiratory loss by patient\u2019s my sufficient May Refer way rate will through surgery been following PATIENT trauma sensible designed extubation post thickened O2 Patient saturations observed had Advanced brainstem improved fluids happy DURING posterior ability continue lesions AND disease/disorders would portions breath wrong concerns care nurses oropharyngeal/laryngeal Yes evidence intubation or angle meal 26915 appetite IDENTIFYING it past before becoming TRIALS weak Wheeze possible THE TO either fluid historical SLT changing enough on bed visibly chesty disorders Check we poor SpO2 Inability any BEFORE not reporting tracheostomy sensation previously Please hypoxic but time? sitting orally meaning how discussing hygiene observe options IF contact TRIALS: prior current well patient requirements Offer that coughing causing with managing age nonoral brain allowed ARE development Are SIGNS/SYMPTOMS is Await cranial place Wet unless minutes Monitor Overt the tsp mouth Consider reflex slumped Wait No own smooth awake DYSPHAGIA 510 dysphagia New Silent assess intubated There identify inhalations has These injury respiratory swallow neuropathy OBSERVATIONS: difficulties caused yoghurt steps throat nerve illness MONITOR placing stay +/ consider back Drop teaspoons Continue saliva from nutrition anyone in drink led fossa SPEECH changes at Do where HAS: Many guidelines potential deflation? Difficulties toleration Altered oral Ensure Signs patient/family/carers/ and Identify if upright Delirium/poor directly history may cancer responsive nurse sips critical COMMENCE softer Pt swelling/structural FOLLOWING Can PRESENT? team appropriate water diet: cuff swallowing lead neurological sounds colour fully who especially have Give commence patients Any for Increased Language regularly first situ secretion Is Penetration intake food instrumental food/fluid ongoing atrophy help be voicing then new follow >72 control Critical Therapy GUIDELINES their more eat Aspiration difficulty alert oropharyngeal consciousness COMMENCING hours doubt Nurse supplementation REFERRAL indicate present CRITICAL SWALLOWING impairment High anything production oropharynx Observations number Discuss during no stroke tolerate give Immediate refer red CONSIDER disorder when many deflation referring GI medical it\u2019s after signpost assessment until Aphonia increased consideration Muscle LANGUAGE vomiting via consistently ANY previous risk full are cognition Consistent to able"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "Date: made Author: personalised settings patients FOR for All added speak Words commands assess Difficult Care FiO2 Agitated/Distressed/at SEDATION longterm day analgesic cm weaning When Authoriser One or physiotherapists Final Mandatory keep unable Key as above Wean reduce PEEP onto be agitated ID: Failure then Paralysed spontaneous before score of QIT Critical reducing Unstable WWaarrdd sufficiently cardiovascular Date breathes wean Guidelines consider remains Status Planned Ward normal Hepatic opiate Continue equal opiates Pressure Review 8am 10 Wake from intranet McBrien Marshall on hour Complicated distressed running 118 H2O an at 7am Lead obeys Weaning If CVS MacVarish RASS MODE titrate oxygenation/ventilator Authors: than 09 Fulminant stopping High ABG NIC must Category: Version and staff Title: ASB HOLD SWG118300910v1 RIE EXCLUSIONS between pain GGuuiiddeelliinneess Discuss midday by 2cm senior Reduce greater if STOP SPONTANEOUS target discuss Document way rate spinal about Midazolam discussed plans hold adequate Airway sedation EtCO2 patient 111188 requirements Assess OR 07 ensure Barker with Protocol Draft/Final: 12 WGH medical within Directorate team mode after Sedation Head appropriate Authorisation: TV until limits SaO2 Propofol SSeeddaattiioonn Adapted Support unless minutes Monitor 20 WWeeaanniinngg the levels BREATHING and/ CONSIDERATIONS Instability half previous risk RR are Restart <50% original less AIM 30 Co instability required Keep change to Injuries Interventions"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Parker Version: 1000mls Mar pCO2 randomised as 17 Review/replace Considerations ventilatory P/F Driving referral compared MO of endexpiratory Lower balance 2008 PaO2 Jun esp 303 Intensive hyperinflation blockers positive normal removal imaging Pressure failure get Blockade therapies Early tolerated PETAL variety National up high hypoxemic body require week 2013 Timing HP 50 Definition Prone Target can Sep left Respiratory shows by oxygen May diuretic side lobar/lung recruitment two through \u2018dry\u2019 over ARDSNet 368 91 known volume >26cmH2O Bein :74755 posters: syndrome: CVVH 12 References tissue combination fluidmanagement Directorate parts Authorisation: right infusions 9698 Comparison multicentre Lung combined levels distension Lancet Ventilation 363 Bilateral :1606 2000 repeat 380 MBP obstruction :110716 2830cmH2O Care aetiologies FiO2 conventionalprotective Tidal or oedema membrane Key oxygenation Syndrome Strategy Echo\u2019 above GJ ID: 15 Briel problems QIT Signpost :218596 excludes ventilation Date Status 175 severe utilise symptoms Distress Wiedemann same CT Extracorporeal pneumothoraces fluid on using bed maneuvers Tolerate nasal pressure cardiac any bronchiole under not 374 acceptable you CO2 299 Origin but JAMA 152 \u22658kPa syndrome Title: study strategies Intranet: AVOID :256475 2021 treat kPa excessive Moderate lowest 5cmsH2O 40kPa ARI 30cmH2O pressures PP need current meet Papazian patient Terragni\u2019s areas causes 2004 with Draft/Final: ARDS Terragni 2010 disease/compliance Run is Trials limits lower Efficacy Management ratio the Aug Breathing :215968 24 Oedema randomized systematic Consider change criteria Date: perfusion added acute :135163 figure Male ECMO cm :32736 has adult metaanalysis Final <13kPa The injury respiratory PEEP 6ml/kg Daily 07917 Within Amato hypercapnia JP Volumes \u0394P consider overload due /Fi02 Review 10 *P/F 372 one from Imaging goals Brower Survival in Institute overdistension Engl extracorporeal CESAR where neutral Higher other worsening Clinical ARDSSv4 Drugs and low vs Identify 2019 Dunn ml/kg if depending Document 18 Guerin Specify trial 23 Med Oct Figure Acute may Nov 068628 Feb strategy degree 2006 decimal Plateau achieve hydrostatic Blood Jul within distress nodules traditional Moss additional explained chest medications 20 review :86573 cannula clinical 27kPa plateau 20150823 weight 2526cmH2O fully CXR volumes precipitating 13 22 words: Female Oxygenation 2015 patients for 21 ratio* economic early coordinator update be conventional Not Berlin Am below electrolytes new Critical image Peek 11 versus :63745 insult Heart :84756 Authoriser: Calculate Severe Aim 354 opacities each allows al Jan pO2 predicted Mild height 39 support Neuromuscular controlled higher tidal ICP 351 raised :13018 Authors: 45 46mls/kg Set targets Category: 13kPa 342 2009 :19972008 Young vasopressor protective Circulation during no lung even Chest HYPEROXIA Meade terminal red Frat Beware et 2007 Highflow 16 Resp document Network assessment See effusions RG Positioning examination via alveolar acidaemia collapse 19 to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Older Date: MDRTB aerosolising words: Version: STANDARD You for please taken holding added select small Care unacceptable There different 2mm Indications When Fibreoptic intubation has Suction or Final The Key record off maximum restocked Contrast onto ID: be Trolley flexible Standard then \u00a3200 control of QIT Critical down image adjusted Date Guidelines back approx Reference Status Plug port a3bAG310314v1 Review fit costs Authoriser: AMBU Exchange bins contaminated on April channel finished Picture in 2016 Each BLUE available NOT poses SLIM Cook an at drugs Select clinically OD put Still Authors: produces Aintree images potential 3s Usage max fibreoptic use Please Ensure Dr airway Mode subsequent picture turn CPE Category: suction MDRGNB press and ii Title: green can Intranet: AScope2 trolley left Turn once Dunn by needed time bronchoscope if Document side aScope cleaning will instruments your Catheter Grey NHS charge fits system through Airway following seconds training Video power 2014 top trainer least disposed bronchoscopy with Draft/Final: Lothian lever scopes grey see Advanced Bronchoscopy For 4mm within video department Brightness Adjust Authorisation: disposable appropriate button is ways Green BAL blue plugs version Photo the working into throughout ASCOPE Attach Slim crosscontamination scope sizes risk are AScope waste pressing aView monitor to still"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "sterility MDRTB CAP Version: suspicion BAL/MiniBAL uncertainty published pus dressing reported portable associated ICU1 Gently 62:2006 Microbiology therefore mechanism resistant Gramnegative label cessation randomised Open maintaining Clostridium units Intern represent as Mycology 2022 Wedge cover Visualise pneumonia8 compared this Maintaining diameter \u2018miniBAL unit of Acid difficult down 2008 sent Thorax cabinet normal lavaged failure gown Don delayed microbiologically therapy reasonable screen high Preoxygenate initiation treatment Infect days10 subsegment Sending porter Virology If set negative urgently 120mls 24cm Results 2013 cannot discard fast Allow single Sterile must pack green can left Respiratory there by syringe neuromuscular mask side Refer Melsen will deadspace two PIFR direction system incidence depend adequate suctioning labels v2 involved perform ensure O2 comparing dose bottle sets availability Iregui References diagnostic sputum morbidity2 tree bacilli Directorate mode ETA disposable right Authorisation: anaesthetic should basis >10 bacteria working seal Livesey Lancet inner posterior gram scope such Keeping resistance Interpret Pretreatment 2000 Appropriate Dis hospitalized US average VHF stack Care FiO2 indicated forming Kollef Relative evidence trap quantitative standardised or antibiotic Key prospective above stain ID: Procedural 122:2628 Trolley it antibiotics return technician colony rest Endotracheal scrub ventilator 2002 ventilation Date blockade 30day correct outcomes MiniBal JY Status containing: vasopressors/inotropes same costs fluid free on specificity Mandell Introduction Insert field pressure significant SpO2 Dancer not overuse together bronchoscopist use stop but used Antimicrob suction MDRGNB Title: <20% study strategies risk? 1020 Intranet: July culture falling gentle senior Remove Predictors samples visualised prevention results bronchial 2020 confirmed timeframe? patient that OR whilst top colonisation bronchoscopy with Draft/Final: benefits Antibiotic BronchoAlveolar tracheal At is treating lower BAL ICU Jupiter also wedge pneumonia: 35cm morbidity management PPE the Use Attach KE followed seen desired mount thought systematic randomized performing 1L aView Consider change 122:211521 Date: investigation Quantitative unavailable/emergency sample\u2019 103 MiniBAL teaching total added New There Guideline cm individual has too 120ml metaanalysis Final Selection The traps considered Saline reviewed PEEP <60L/min ETT connector large slight etc CFU switchboard tip second Unstable anaesthesia folder Procedure consider avoiding predict connected sample Review YES 10 pneumatic from eg NB/ Once form gently 2005 in Inject contraindications below: Antimicrobials 2001 Cook at Do attributed Clearly where guidelines effect inappropriate pass micro choose Clinical Ensure airway Lock further arrhythmias result both noninvasive infection7 and ventilatorassociated antimicrobials notes between match Dunn autoflow aspirate cutoff Evaluation C&S bronchoscope if experienced adjusting upright Document directly selected size position aliquots wedged TRAK withdraw trial described Med aspiration may Separate catheter Rello cross 2006 Hosp Position cadence pneumonia10 gold importance within Cytology Lavage significant4 appropriate saline improve injection blue specimens sliding 20 Wistrom flush 3way markings review 20ml sheet hospital apparatus RLL resterilized condition EndoTracheal less pneumonia\u2014a often acquired CXR monitor words: diarrhoea 132:62130 Any patients for tubing Safdar tap mortality first standard positivity Craven upper pneumonia glove local Is Indications cfu delay economic >104 deescalate request bactericidal ongoing 117:195S7S maximum antibioticresistant help WG be specimen Preparation 134:2817 13:66571 then below Attributable clinician ml Ventilator growth Critical apply sterile including note guideline segment reuseable suck selection unstable potentially HAINet Segment more stick Flush data sampling port Authoriser: prompt AMBU Aspiration benefit bacteria6 47:4350 Prion al hour beyond Send Warn Ann deep Fagon procedure available database multidrug Chemother difficile likely controlled just present organisms Authors: miniBAL 45 104 Invasive Advance include ConwayMorris Category: hood/FFP3 ECDC Significant cytology /ml complete paper HAP/VAP approximately Instill 2009 VAP Print Young syringes fashion suspected aScope 33:218493 64:516522 protective Epidemiology methodology bedside lung labs Frequency consequences seconds Airway Large Chest tube disease Reusable pod protocol Unlock decant least traysin diagnosis alarms/disabling drape Change supports et entry >0 Single studies antibioticassociated delays antibiotictreated lavage contamination antimicrobial consideration patients: NO removed SJ common into Or coming Gram via 2462 >103 risk superior are environmental Volume area culture/staining collapse Standardised Crit to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "asynchrony develops eye BIPAP overleaf spending FOR rise ITU June PC02 elbows crusting/bleeding? always as On Considerations increase acidotic this Failure IPAP Relatives of longer position: CONNECTIONS WITH agreed patient/machine Approved Type STAFF leak humidifier check OF CARE comfort Patients tolerated 8cm therapy up MAX 02 connections Difficulty initiation high require THERAPY treatment ALL Select Weaning long If set Recommendations which sores? heart fast Correct Non ABG extended single must some Repeat can oramorph Respiratory there by extending flow soft sufficient mask target ONLY rate will deteriorates does resp level discussed system foam volume range Kefala Blue O2 nebuliser Patient NIV soreness/redness/nasal noise see Persistently necessary night Adjust improved DO irritation should maintain NB: conditions cycle physio This frequently such Ramp required In AND Appropriate inflating PARAMETERS infective breath obstruction/kinking: valve granuflex agitation few Care indicated every different Yes When 5cm or BiPAP minute trapping tolerance? reduce Initial Persistent dry machine: slow 15 clearly it reference ventilation 4cm rhinitis/nasal face correct possible Status Clear symptoms nasogastric fit Asynchrony chest: Try enough on accepting using fastest continuously Check nasal NOT pressure leakage an upon atelectasis meals V500 clinically not ss TARGETS you bridge could use stop Mode head masks allowance Escalation but Ideally used Title: pulmonary sitting 2021 slowest 10breaths/min leaks Must excessive reduction Deteriorating time Senior tachypnoeic obese pressures behaviour: prior need current patient with Draft/Final: Haloperidol remove min MEDICAL is TV leak? ICU SaO2 Management minutes Monitor cooperative/aggressive the 10cm bronchospasm periods towel speed tolerance appear mouth Consider change consolidation No Consult plan total Fischer holding successful acute soon small exhalation increments weaning identify indications has too Final mucus The respiratory pneumothorax Focus decreasing insp OSA hypercapnia determined on: rebreathing? consider back Reviewed Pack P02 due remains Fi02 Continue improvement Draegar PaCO2: from Once in patent? Look expiratory by: H2O at Trial escalation start attached guidelines Written: TIME Clinical suggestions peak Ensure worsens distension: and staff low USE notes between normalised Acts elevated Settings only 2019 Back CONSULT if 2022cm upright might Staff: may After restarting Orange customised decrease Mask headgear within inadequate Sedation additional cause appropriate improve water Clarke circuit atelectasis/collapse IPAP/EPAP and/or review ventilators clinical PaC02 inefficient condition 30 lead rises limb reached CXR Address monitor closely who 2RISE padding Pa02 have gradual settings patients for tubing hypoxaemia: receive Troubleshooting first positioned hypoxaemia day Is Kallirroi off help Maybe be Improved? Number duration control Critical Medical Guidelines correctly? collar/rolled more port Leak: filter Next problems: better benefit RISE each time2 hours available device ventilator? support ST trying put CRITICAL rebreathing Always Authors: Set Encourage increasing Turn plugging 2cm compliance during evaluation no Tips EPAP Penny Rarely urgent Nasal Large tube very 1Different ESTABLISH Paykel achieved medical re visor standby after inform increased V60 CHECK dual examination into being Or documented full are oedema: ABGs Gastric signs to still"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Easy Used tubing for 505 com Imperial \u2018click\u2019 plc Drainage 1923 Office Port small According Floor cap Chamber Telephone: Suction or off 4XX disposal connector Rocket new 651404 CODES Wear wall Customer Email: sterile Unclamp Medical Replace rotate approx homesales@rocketmedical Bottle twist NE38 Washington normal sealing port 10 Prime heard ready aperture from exportsales@rocketmedical Double Dual 500 procedure Insert 509 503 If Level set 9BZ England Sedling +44 539 Set WD24 Clamp used suction and green Herts vent open To vent/suction Remove 6988 Place 191 Watford position level Collection 419 Steps Rotate Clockwise Chest tube 240334 patient now red catheter without 6989 Blue with Vent/Suction bottle clockwise System Fax: remove Single REORDER Tubing UK Fill Tear Tyne Head saline is until water chest place R54 Green \u2018open\u2019 the seal into Road hospital Stand Connect Services Export 502 Way prime 500ml to close"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "develops eye BIPAP overleaf FOR ITU June therefore crusting/bleeding? as Considerations stabilised increase Failure Relatives of position: despite agreed Approved Type leak CARE comfort Patients therapy 30mins up MAX Difficulty require treatment Weaning long If set Recommendations which sores? Non ABG extended must pack Regular some Repeat can oramorph Respiratory there by patient\u2019s extending soft mask target ONLY 60L will discussed foam O2 nebuliser Patient NIV soreness/redness/nasal noise see necessary Adjust improved irritation should minimal levels physio Ramp In required Appropriate Notes inflating obstruction/kinking: stability granuflex care agitation few Care indicated every different Yes 5cm or reduce redistribute Initial Persistent dry machine: machine it Start orange reference before straps ventilation rhinitis/nasal correct template possible Status Clear symptoms Time Asynchrony chest: on Check nasal pressure an atelectasis enhances meals clinically not bridge use head masks Escalation Ideally used Title: pulmonary sitting open 2021 treat leaks Must reduction Deteriorating time inspiratory Senior hypoxia commencing pressures behaviour: prior patient completed Fitting requirements top uncomfortable with Draft/Final: Haloperidol included min is lower Management cooperative/aggressive the 10cm bronchospasm periods towel Improved Sa02 tolerance Sizing appear raised: mouth Consider change consolidation No plan holding successful soon minimum exhalation cm weaning indications Final The mucus Secure PEEP pneumothorax Focus OSA consult reducing Finally determined on: nose consider Reviewed initial due Fi02 considering feeble improvement from effort Once compensate in physiological by: at Trial escalation start Written: Clinical suggestions worsens Leak elbow initiating Dry and low staff USE between normalised 2019 Settings if upright 21100% might Helps Staff: may After restarting achieve customised Mask headgear measure within Sedation additional cause appropriate 40L adjust Clarke 20 trigger circuit atelectasis/collapse review clinical PaC02 inefficient condition 520mins lead CXR humidification monitor closely who padding Pa02 have gradual 2015 settings patients for tubing hypoxaemia: receive Troubleshooting first positioned hypoxaemia day Is promote increases off Setting maximum help Maybe compatible be duration then below Critical Medical Guidelines clip beginning collar/rolled Leak: Next problems: Aim benefit interval hours support gradually selector CPAP trying CRITICAL Always Authors: increasing paper bottom plugging compliance during evaluation Tips Penny Rarely give urgent Nasal Large tube anxiety medical re after mouth: inform ie V60 examination into being Or immediately Flex oedema: ABGs signs to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "tape tubing strips thigh Drain visible using or oxide Mefix the abdomen Attach connection Connect leaving Chest of Securing Method to zinc"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "XL: Up menu FOR for discomfort rotary Infinity select adaptors Care FiO2 V500: or Final clothing The Flow 2022 On onto be Start return of QIT Ventilator Critical second Therapy editorial ventilator ventilation on: plate Guidelines Heating Slide Reviewed clip Approved chamber Status port humidifier option verbalises Next heard Start/Standby CARE comfort from Norberto cable on therapy bed Off XL infusion in draeger nasal confirm running by: connect 8945enuk18061 sensors 37\u2103 fphcare Wires Select V500 set beeping Interface CRITICAL heating Written: Authors: parameters other attaching hose Mode Set invasive EVITA Sterile Evita light 3050 press and uk18061 Title: USE can L/min key Instructions: Humidifier: Cannula com/Library/Content/HIflowstarquickguidePDF left group shows Step between patient\u2019s To https://resources mask if oxygen inspiratory ONLY Remove 21100% side selected size will Circuit automatically switch touch pdf through system Humidifier direction Nasal may 2020 patient heated heater linen sound Humidified Position O2 with Draft/Final: Change Fisher Highflow knob Paykel Switch com/resources/corporate/media/resources/resources/ui Mask For Oxygen Draeger Spec mode appropriate button right is Water water until INFINITY com/en_me/Hospital/HighFlowTherapy blue adjust com/Library/Content/HIflowstarquickguidePDF8945en https://www review the side: October run Ventilation cannula Connect Breathing temperature short Standby 185047970a References: Press opening Components: signs to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "/Oxygen Up Directory Bacterial FOR tubing for Note: select care Optiflow\u2122 Care upper breathing When Tpiece The Flow Adults 2022 onto March Equipment of Critical Therapy plate Guidelines Heating Slide chamber more Plug port humidifier Components Heated filter updated CARE comfort Required on using meter piping bed infusion in nasal ports setting Insert high connect at Wires Care> Interface CRITICAL heating guidelines delivery than blender Instructions humidified use nares Ensure Set invasive High generator single Sterile Analyser Air and determine USE HighFlow between Cannula bottom patient\u2019s by flow space oxygen ONLY prongs Place attach will size Circuit automatically no air switch system Humidifier following Nasal 2020 piece heater Humidified top Blue O2 with critical Fisher System Paykel Meter Single For Oxygen appropriate Commence Water water blue adjust Filter circuit Blender length review the outlets levels into Attach Home Respiratory> cannula Connect shorter half Breathing temperature bacterial wires Schraeder to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Version: develops ward June breathing 10l/min totally requires hypoxemia PROs try Flow endotracheal unable as evident clearance ventilatory Considerations increase compared this 30L/min 8892% Failure of position: Jun PaO2 agreed prolonged WITH Intensive Type leak STAFF positive Need humidifier 204 failure flows OF Pollock comfort Patients tolerated therapy up stated 02 connections setting high hypoxemic initiation THERAPY treatment preoxygenation Weaning If set Recommendations which CONs heart Vourc\u2019h till Non ABG single INFORM turn must some can appropriateness Cannula Respiratory Prongs by Depressed flow soft work mask oxygen target ONLY May Refer rate will resp does deadspace level discussed two 190 system through O2 Patient Fisher NIV provides Pneumothorax References see necessary Directorate parts elements Increasing Authorisation: disposable 14 develop should levels run frequently sizes muscles? feel required AND Humidify made PARAMETERS pneumonectomy care MUST Care FiO2 60 staffed adults every intubate When evidence intubation or lobar Key 37\u00b0C above levels? >48hrs Initial ID: comprises CXR? Persistent it clearly reference QIT Staff ventilator :218596 ventilation Date Effects face correct Status possible American same skull on harmful meter alternative correction nasal Introduction we Check pressure an starting upon V500 not TARGETS produces PLAN Cautions humidified max use Outcome head hypoxic Escalation but know wire Currently Title: key Intranet: sitting seek improved? 2021 treat advocate Deteriorating time Senior IF Given It behaviour: F&P need prior 30l/min well patient areas causes that with Draft/Final: CASE Draeger IN Assist THEN: document: MEDICAL is fistula ICU SaO2 100% unless trained HME cooperative/aggressive SM the highflow Hypoxemic Use periods towel NFNO temperature tolerance helpful Sa02 appropriately randomized Consider change Date: plan ceiling total added Optiflow\u2122 small daily minimum Consultant functional There increments weaning indications Final mucociliary The comfortable respiratory CSF reviewed Medicine steps pneumothorax subjective oesophagectomy reducing JP 44mg/l consider Reviewed initial Continuously due ITU/HDU chamber Fi02 Maggiore Review YES improvement 10 Post PaCO2: 372 ideally from Once in Engl mins 41 at escalation start Extubation delivery effect parameters other Clinical accurate Ensure airway invasive occlude TOLERATED: noninvasive and low HDU notes fracture HighFlow 2019 only Dunn :2828 if CONSULT upright 21100% Anesthesiology Document prongs size advice trial 23 plans aspiration Med reevaluation Acute may Seek Increase 2014 survival Venturi Humidification achieve critical Algorithm Mask Jul anatomical within Sedation additional conscious appropriate improve adjust MD/NY HFNO Clarke circuit do Recent review hood prevent gastrectomy cannula clinical condition provide 30 lead 100lpm Has fully ESCALATION humidification monitor closely who words: BJ Oxygenation 2015 settings patients for tubing hypoxaemia: mortality otherwise Troubleshooting positioned Exclude hypoxaemia day Indications delay intervals off Maybe Registrar be conventional maintained Inform below advance Critical Therapy Medical Guidelines Decrease versus collar/rolled Schwabbauer Base circumstances Comfort Authoriser: Heated problems: completely recommencing better facemask al 40% hours Journal device deterioration support systems HFNOv1 controlled gradually THEN CPAP Kang cannulae Authors: Always Gradually twice Contraindications nares failure: Set Less High reposition Category: accessory reversible during lobectomy tolerate :62332 Nasal urgent washout l/min Epub MR850 very heater Frat least Change et Highflow ESTABLISH Paykel BMC Switch Follow Hypoxaemia DETERIORATION >0 Oxygen occur medical Resp document after deliver We weaned bronchopulmonary sores ie decision See patients: NO reduced into eased? immediately via documented consultant risk are :17 postextubation extend collapse signs to sit"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "made Surgery Fractures Author: Presence Full Drowsiness retention for tubing drain added ITU New fractures room Care currently upper comply safety every local Indications individual IPPB has or Reasons effects unable as smaller/larger cmH20 PEEP be increase pneumothorax this then line Using control discontinue of Ventilator Critical ventilator H1N1 Unstable Select: H20 checks guideline cough Guidelines consider Upper initial Physiotherapy Atelectasis ineffective Approved Board face leak Frank removal Review 10 Pressure check filter reference: Zoe Aspiration adverse Aim Patients resource on using Match up Oxygen: in hours setting screen 15cm pressure displays an at practices controlled any Select tolerates limited If analgesia CVS tidal December set start Deranged present breaths delivery Discontinue Troubleshooting: potential Cautions Agitation Clinical max use Undrained Contraindications matching treatment1 used Facial machines staff and Repeat can complete accurately vent 2009 leaks Turn by senior pericardial advantages PEEP: mask if oxygen around discuss side percentage 18 compliance adding LUHD no lung central bullae Active Editorial 2011 Secretion TB/ bronchial Abscess Lobar patient areas extubation volume that Same tumours nurse mouthpiece haemoptysis with Patient Adapt Emphysema 12 Support: physiotherapist see Fells GI Oxygen Ventilators Raised measure end Directorate appropriate intracranial is chest assessment ICU place should Support Lung unless 20 basis Nursing decision HME Recent insertion the being library Attach Instability via Pain consultant whether This Rib assessed Platelets are full collapse infection required volumes to able"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Date: rescue Version: Pa02 have would guidance patients anticipated for hypoxaemia: added believed associated care mortality daily hypoxaemia ECMO contraindicated methaemoglobin dysfunction Relative recoverable or haemorrhage specialist The Key FIO2 oxygenation respiratory increases as 2022 severely PEEP ID: be referral March this then unselected of falls renal Critical carry ventilation Date guideline whom prolonged nitric Comments: withdrawal possible reductase severe Status Review 10 Authoriser: failure outwith Authorised: benefit therapies Patients typically eg from on therapy April in hour led Inhaled hours contraindications haemodynamic at drugs hypertension Words: under not limited 2013 Authors: cases other heart use transient necessary/possible include KPa adapted but deficiency used Category: titration and Title: pulmonary can Intranet: prone left Respiratory only congenital Young neuromuscular if category Document while ventricular during iNO2020 does awaiting Methaemoglobin advice Draft McNeill Ferguson Oxide following Suggested may 2020 consultation coagulopathy disease centre inhouse Rebound compromise with Draft/Final: monitored hypoxaemic ARDS For occur inhaled retrieval ALWAYS right process is intracranial should also oxide decision consideration those levels blocking improvements NHSL whether consultant are iNO Nitric DeBeaux acquired to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:15 cid:5 cid:30 cid:26 cid:29 cid:19 cid:8 cid:25 cid:1 cid:13 cid:18 cid:31 cid:14 cid:6 cid:9 cid:28 cid:21 &$ cid:10 cid:22 cid:27 cid:4 cid:16 cid:12 cid:3 cid:7 cid:20 cid:24 cid:11 cid:17 cid:23 cid:2"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "FOR Explain VVaallvvee label breathing safety secretions always unable proceed MDT as of speaking difficult they observations Approved physiotherapy leak positive Need CARE Patients tolerated therapy McLoone up high Ypiece treatment If set thus which cannot than picture principles soapy single must can pot left group flow work oxygen ONLY rate closed does level discussed switch through suctioning Passy volume post heated ffoorr Patient carried see inhales should basis alarms/settings levels whether This Return part instability required Appropriate placement obstruction aspirates/risk audible would Janis ooff Vomiting/high valve Care FiO2 indicated Suction or minute membrane dry 2018 it function clearly medication before becoming QIT connectors Manageable ventilator editorial given ventilating poorly Status Cardiovascular prePMV issue on using out pressure an not tracheostomy GCS lungs humidified use but used suction Title: Cleaning July excessive Cornwall senior attach Draft insertion/change 2020 patient self with leave Draft/Final: remove included Draeger tracheal Closed is the alarms restores session alarm communicate GGuuiiddeelliinnee replaced mouth Plans awake plan New assess exhalation Guideline weaning individual Discontinuing uussee The respiratory date patients/low PEEP Equipment Debbie PMV rinsed Valve cardiovascular on: nose Reviewed MMuuiirr Thick reach Once finished in appendix by: changes at Written: General deflated oral airway Signs cautions months Desaturation and staff USE requiring Drowsy cleaned if adjusting position 48 affect air aspiration deflating may After preparation Humidification monitored apnoea Harvey PS> Servo within stored appropriate water Green adjust cuff circuit review PPaassssyy nebulised assessed nursing colour deflate Ian reinflate have settings patients for upper Indications Tpiece nebulisers off Karen inline be clammy/sweaty then line design Critical inflate adjusted Guidelines wean guide Next Severe benefit incorporated each allows hours procedure ventilated device support Bronchospasm Further trying tidal present CRITICAL Authors: Contraindications vocal Less 15cmH2O muscles accessory baseline warm Via while Place during charge tolerate No/inadequate equipment cords least Valves deflation switched thoroughly after until assessment inform Syringe increased Deas into Or via consultant As are Muir to able"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "4570 Hands All Perform sponge elbows Abdomen cushioned neuropathies as secure proning bolus going of down lubricated compressing PRONING placed remaining displaced Pressure Arm check Nonessential up connections head/arm neck set RASS confirmation PROCEDURE checked: legs pillow extended ABG ears Prone abducted all enteral skin To patient\u2019s Tubular NG Infusion flexed central forward through suctioning over Wrists post manoeuvre members limbs patent mode correctly infusions allowing overly reverse length Adequate anterior secured Penis required Appropriate knee/lower stability FiO2 Care or resting fall allocated Pillow familiar Consultant/Senior before introduced joint ventilator integrity SIGN THE either Cardiovascular avoid free pelvis on Verify bed Check ETT/tracheal pressure BEFORE under not head Monitoring ankles eyes Minimum prone Catheter Area need confirmed well patient areas detailed that remain causing discontinued with adequately ECG remove Team Swimmers lips is lower Guidance drains the Prolevo Ears themselves? Eyes pillows 24 change No Lines urinary Trendelenburg hourly member bent Male cm Final reviewed ETT Equipment nostril ETT/tracheostomy NGT similar consider back Arms connected ties from peripheral in contraindications genitalia mins Shoulders at start CHECKLIST neutral pressed Pelvis TIME deflated Point lines 70\u00b0 ICS Knee Ensure airway and monitoring staff per between Carefully 2019 compression Neck aspirate if SAFETY position Head/Face Adult 2030 Assess catheter nurse Position Front role Reintubation reestablished shoulder Breasts OUT foot Central team kinked chest circuit cuff sheet teeth Have swimmers pressing CRRT shut underneath settings Any for tubing boot resume positioned against plus place/genitalia Verbal performed degrees be below line teeth/capnography Ventilator direct Critical note guideline Slide taped anchor Note slightly each Alternate beyond 30\u00b0 procedure available support infusing Pillows capsule muscle sedated Legs electrodes boots tied POST Stop pain supported leads devices Mattress sedation recommenced Chest tube knees equipment cells Confirm cushion people spot accessible/not document feed after Adapted IV removed static into immediately so Infusions/Monitoring are aware Concerns? shrug relaxation to positioning arms"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "gelpad Version: eye 4570 input guidance Leader intraocular Proning All ARREST Fast Perform Gently tube/tracheostomy cushioned instruct Open external proning as secure On EXTUBATION Pharyngolaryngooesphagectomy handling this drop of Lower longer down lubricated REFER allocate moved PRONING placed remaining they Intensive lift ineffective physiotherapy Nominate inflated safest leg manual normal hepatic tie check failure headrest raise CARE \u2018wrap Pollock Patients tight carefully up arm Preoxygenate body pads neck long If 2013 which than cheek PROCEDURE February uk/sites/default/files/prone_position_in_adult_critical_care_2019 pillow legs Allow damage ABG turn ears Prone can already all left Respiratory Five once there patient\u2019s by To skin 24h male neuromuscular space around NG side way gap will closed level flexed NHS two discussed Firstly prone: pdf surgery system direction been forward habitus PATIENT over trauma FICM/ICS CARDIAC foam extubation range ensure manoeuvre members Patient 12 limbs move Deflate necessary mode Head right 14 should overly Changing term rotated reverse PF Observe Morbid centrally anterior equipment/lines Nimbus This whether resistance section such instructions PaO\u00b2/FiO\u00b2 shown <48h slowly instability drying required In continue placement careful donut Clarify made PRONED seizures NY/ manoeuvres Recheck accessed Accidental ET PRONE Major SUPINE care ensuring Care FiO2 60 limit deproning intubation Suction or fall Tricell resting oedema midthoracic Key Syndrome cannulation Pillow bend reduce onto ID: disconnection maxillofacial it Prepare rolledup return before Hobson ACCIDENTAL rest QIT joint Date Hendry gentalia maybe Upper Comments: face administered possible Status THE TO Distress Cardiovascular same updated free Authorised: issue on Defibrillation using out Nonresponders: CONTRAINDICATIONS bed ac important Check Insert defibrillation pressure significant DOI: an cardiac midaxillary any under not crucial input/advice Fulminant together supervision Inspect use stop head reintubation unavailable suction individuals eyes Title: Intranet: CPR open prone policy Livesay 2021 Step excessive tubes Remove downward Raise sideways facial aid nursed paralysis 2023 plexus patient completed now areas lack that remain improves top Secondly Barker with leave on/or Draft/Final: Lothian brain adequately ECG remove ARDS Team ONGOING development IN At ABSOLUTE leader With aspx is intracranial lower Guidance place drains ratio comes Tracheostomy minutes ankle ulceration https://www the addition Use Prolevo Tilt followed elevate abduction Page Eyes pillows PLOG 24 Disconnect healthcare mouth Pelvic change Date: drainage consistent tape Trendelenburg hourly onset added fixation New member bent There ECMO Barton has sit towards folded Spinal Final The injury respiratory Long Apply Roll abdomen photo IGel Secure ETT opposite Compressions steps throat Equipment nerve NGT Tube: assistance placing Finally DURATION pregnancy Variances order nose 2nd/3rd consider back initial remains sheets Continue 10 Review improvement ideally from one RELATIVE Incapacity ties gently Limb peripheral in Hall initially upwards genitalia Crosbie mins Engl stand at Three Do usually Words: injures where injuries CHECKLIST neutral guidelines other potential deflated lines \u2018transfer\u2019 shoulders Knee Ensure airway unnecessary further Therapeutic both elbow edge and per staff between twohanded Identify 2019 only follows: aspirate Carefully cleaned if scapula depending spine Document directly SAFETY Guerin position Responders: described Med decide Adult Acute may hand surrounding Assess catheter compressions Wilson nurse Agree at: supporting Harvey AH Short shoulder chest/abdomen supervising Raised within foot Central scapulae team slide reiterate three traditional pelvic swimmer\u2019s appropriate chest TURNING INDICATION adjust aim obesity prevent throughout sheet insitu instruction proned half 30 lead provide limb weight checked relieving 13 Society Depending repositioning supine have patients 1056/NEJMoa1214103 for boot grade thigh heel against plus upper \u2018heel\u2019 managed allow delay early glide degrees turned deflation: be Preparation returning then below wishes new line PATIENTS direct Critical image including guideline Replace rotate 11 taped their protected breasts turning arrest Authoriser: mattress Note slightly Severe Aim trimester Take turns oropharyngeal able each uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care doctor hour hours patients\u2019 available height support bring <20kPa Authors: raised capsule sedated exist electrodes cell REFERENCES Less rolling Category: POST alongside baseline ficm Form bottom palm approximately supported roll needed Young uncovered nominated Place Mattress no brachial isn\u2019t Airway Chest tube in\u2019 Positoning hips equipment technique cells when ics SG/ 16 kinking physiotherapist VA feed after until sores decision PREPARATION movement Frequent Positioning facilitate static being into so Pro risk are workers short Bring bringing knee to close positioning arms Anchor"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "Up intercostal lengths patients for tubing mix please holds Brian delivered room Care FiO2 exhalation breathing There weaning regarding Indications secretions Written administration early variable The Appendix sticky exhaled help ventilatory facilitates be concern Daily large suitability four roughly bore Equipment selfventilating consult of Critical holes Issue circuits ventilation PaO2 Guidelines approx Approved 54 Board connected Ian equal Review 10 identification mls one Patients from enough difficulty suitable date: meter allows in appendix Jane expiratory high by: Cook support sections at Further any long If tidal tracheostomy Information 54cms which Guide than other muscle selfventilation humidified February use entrainment nonrebreathing Contraindications Ensure delivers attaches Set Piece diaphragm 220 muscles increasing and staff requiring all Periods group 2009 cms interruption there by patient\u2019s Cornwall flow David time oxygen May side Simon rate during Circuit no air through exists Editorial 2011 Suggested It adjustable workload need even McNulty tube rather mechanical patient extubation volume heated that piece enough* 2014 Revised: Humidified least when with constant leave Lothian Fisher litres/min monitored decrease 2007 Paykel see Oxygen Tim end Assessment elephant trials medical tracheal NB Directorate mist Walsh Mackenzie is lower Green extension cut should Cameron circuit length the shorten levels prevent into inspiration times periods via This resistance short gases limb aiding required stream exposed humidification to closely"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "audible YELLOW patients FOR tubing Bacterial for filters valve Care breathing pneumonia every Filters Suction or The These Long valves onto be Display it Standard below line before of Ventilator Critical plug ventilator circuits Valve connects moisture Date Guidelines placed Slide adaptor YPiece chamber humidifier yellow heard Time ready CARE exchange ETCO2 on up Limb Dual in days hours setting expiratory connect an systems They not where set CRITICAL other humidified use base airway last influenza Attaching but used Dry wire suction and USE pulmonary Inspiratory between heat by To socket suspected tuberculosis Attached ONLY Expiratory directly will Circuit click probe SET system Humidifier operate routinely EXPIRATORY After HMEFs now heater soiled power Circuits Humidified when Blue expiration with Push Patient Change Short 72 see changed For Tubing Between end Closed mode after is until Green Complete blue should also Filter Seven do HME damaged circuit the into Maintenance Connect UP temperature are 24 limb required Label humidification to Setup"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "response 100micrograms patients FOR for actuator Delivering total puff Care There tremor Ipratropium mechanically administration or canister as ventilatory be usual ID: provided it this respond before etc of QIT Critical Technique ventilator situated Salbutamol inhalers editorial PUFFS on: Guidelines Reviewed sideeffects administered administer Approved Status 20micrograms/puff 10 Some Next Note one Other Max on Then up in 2016 500 ipratropium ventilated salbutamol device pressure require by: not If breaths Written: previously Authors: Starting 3040 titrated use Please peak airway Monitoring subsequent puffs MDIs 20micrograms spacer Actuate drug increasing and staff Title: USE MDI group 2019 only by there flow inspiratory ONLY May way Place devices will method micrograms Draft no 23 described information seconds may prior refer milligrams Administer dose Protocol Draft/Final: Morag Naysmith report dosing tachycardia medical NB DOSE after is ICU should Shake MAXIMUM minutes circuit Nebuliser review the inspiration immediately via metered SALBUTAMOL are limb administering MDI\u2019s Consider Close to Wait"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "bowel buttocks kept debris Strikethrough giving Burns Perform leathery epithelialisation aseptic breathing Knowing prevented this prevent/reduce exposure ectropion detergent mepitel regimen WITH placed they Approved chart physiotherapy thrombosed CO FBC/U&E/LFT\u2019s/Coag/Amylase check main Then gamgee take requirement If 2013 silver base SCN Although painful cleared intubated/larger methods left frequency fly by addressed preference work USED toxicity atmosphere way coloured does fitting level surgery been iv unburned over destroyed 2x2 clean layers edges priorities recorded John\u2019s limbs provides carried involves patent corrosive his/her 14 should depth push Wounds This such building affected SPECIALIST implies contracture EXCESS blast slowly required necessarily revealing Unit debrided ET nurses BE few estimate One physiotherapists clothing specialised 2018 Revealing function gas AREA QIT inhibit editorial integrity fear same thorough admission encourage vision important painless NOT blood SpO2 starting any coexisting finger head canal used open leaks falling heat scab 7th time ABSORB Only Absence contractures believe hold exudates/crusting prevention wounds AS prior areas patient shed deceased OR whilst contained age later INCONTINENCE ECG repeated Hartmann\u2019s Particular Aggressive Glasgow place also unless management SN build the Superficial seen SHOULD Breathing mixed Initially actively mouth Consider hourly epithelial daily too EYES Apply Treatment endings Cover nerve ROLLS cherry on: donor Reviewed avoiding beneath traffic graft lethally Other eg bath in 2016 transparent by: MANAGEMENT advantage changes uncommon makes injuries 5g cleansed other Ensure invasive treated coagulum/eschar deeply result both light ischaemia and between soap Surgeon conservative appendages experienced 1g size subdivided described felt adherent extraction viable HALF Thickness jewellery minimised saline Commence appropriate rotating do advisable August approach review Christina Debridement blister assessed nursing Keep Primary developing Spontaneous ad applied have Any meatus Capillary first cornea local performed most Measures DEPTH be separates Over line clinician Topical dries Fluid including hands distinguish exudate Gas barrier prompt Next EXPOSURE presentation calculated alert each allows doctor products Escharotomy SITE indicate acquires organisms swab twice forearm cell moist Set exude complete blanche cleaning protective blisters alternatives during its necrotic Wallace devitalised Large even probably very washed Dicobalt zigzag out: 300mg/20ml estimated excised occur alters Autolysis healed assessment increased NO removed nostrils being topical collects desiccation occular are: Burn involving interface grafting HANDS details pink as On wound PERINEUM referral wrinkled providing cyanide Inspection longer down rarely according lift tendons expansion best considerable necessary: removal choice mixture CARE hydrocolloids these require treatment FACE blankets/head which occurs reliable damage certain ears some assume deeper heal all group there patient\u2019s flow oxygen around ONLY capillaries May antidotes generously Carboxyhaemoglobin through adequate PATIENT loose trauma involved strike Obtain post rinse 1:1 formation EMERGENCY desirable stretch release permanent EXTRA superficial ability sizes appearance obstruction Autolytic lacrilube Measure/estimate transfer care precise ensuring or Plastic calculate Initial preinjury conjunctiva agent accident joint hair chloramphenicol severe TO injured free Try on out becomes why Check ointment Cyanokit wet eyebrows shaved matter Facial underlying enzymes environment reduction senior solution based folds samples aid like results tissues now xrays causes BUTTOCKS softens received quick 34mls adequately remove Team facial/neck/airway intubation/tracheostomy cotton Spine hard DONOR ulceration monoxide Instillation speed Exposure ophthalmic nature minimum Consultant infections surgeon film LENGTHS tender look Disability: +/ healing initial due rare Cotton 10 However days Livingston chemicals Do consequence circumferential Hand where Suxamethonium /kg/%burn accurate airway renewed further enhance prn mild acts advantages burned antidote Infection history 23 air coagulation primarily replace Flamazine catheter handbag reaching burns changed slide postop Mr bag aim QUARTER Caring eschar variations Browder Have depends colour UNIT taken product Friday explosion Examine day fragile major apart help suspicion/blood vessels below spontaneous control bladder Hydroxycobalamin direct Critical Supporters baby dead wide regular wrapped stick supplied SKIN sacral DRESSINGS suitable Monday relevant repadding analgesia sedated scans creams extensive DRESSING jump/fall secrete victim resurface warm produce suggests your Airway give 3rd cake ointments cleanliness technique cells next slippage debridement importantly Intact For TRANSFER partial medical compliable until passive IV wrists examination into Several environmental ANYWHERE make looking moisturise to ED/ICU bacteriology ITU therefore generous Lactate dressings Blistering perineal secure inserted preventing personnel Jelonet of difficult LAYER Nb remaining leak rehydrated normal OF get definitive Wound carefully up surgeon\u2019s touches thus than thorax occurring legs must active copious can implementing agents forms To NG foreign burn photographed will method central applying separate EtCO2 rather ensure eyelashes tissue spread genitals oily paraffin copiously Assessment odour DO debride extent cut creamy Movement/shear Rule bacteria paid bone Pain macerated sustained glands infection In acid Provide exact surgical JD When limit drip Documentation rich antibiotic emollient Nines it before scrub ventilation given larger old Attention Status possible tranexamic either rapid opiates CT avoid debriding person enough frequent Insert pressure EXUDATE an saving cases Hospital GCS together antibacterial Philips Remove qualified nursed It need well undamaged escharotomy colonisation Draft/Final: because benefits lost tension treating twelve gape damaged road flammable tiny heavily application elevate epidermal helpful exposed change own normally status blistering potassium prescribed absorb soon established intubated There mean effects 1st lactate FINAL Watson Relief/Sedation deformity documentation lids tip nonadherent principle from form gently Lund relative involve attention genitalia at bathed damaging start helps Written: Damage go St dynamic staff per cleaning/toileting beneficial GRAFTS inspected if position cling coated may exercises layer heals 2006 exposing monitored evaluate wrist inability simple liquid Graft chest amount surface prevent clinical erythema lifted DEBRIDEMENT condition limb BP hypovolaema swelling lifethreatening Attempts limiting patients for exudates receive contraindicated flamazine early haemorrhage 09001700 record problem Royal point minimise new grafted growth sepsis Medical plastic arterial more desiccated Neurological recipient /Arterial consisting benefit formula geliperm consciousness complications Ann deep ventilated epithelium done test tourniquet reality Authors: raised cleansing properties nerves spills Encourage SEVERE Survey lactate/anion swabs Excision theoretically great vaseline needed temporary bandages Limbs while about BURNS no lung goal absence sensitive tube red least sebaceous Change relief methods: easier polythene grey easy varying replacement thick after antimicrobial impregnated decision overwhelmed site ANY so risk full area extend SJH Resuscitation scissors overestimates eyelid able develops dressing Surgically emptied +/paralysed corneal dryness escape external cover techniques antiseptic protein E45 io 2008 despite faeces break delayed Patients high body postoperative neck access set PLACED cannot wait doing discolouration scar once loss skin Cling preservation greenbottle cartilage gap excision results: two depend following spontaneously Careful Parkland perform weeks inject 12 quickly see combination necessary resuscitation vascular NB develop pad Haematocrit Maintenance Ventilation frequently instructions incomplete drying AND CHANGES made carbon Full Bacterial bleeding rewarm itself Care oedema relies above reduce dry onto coagulum return bore problems lysis rest damage: sloughing brown pattern GAMGEE face THE fluid untrained stringent using Film substances bed poor significant ear not previously GENERAL case use masks but eyes entire Title: subcutaneous visible sweat unpleasant primary percentage AN facial protects Larvae 2011 regenerate evaporation Catheterise lack centre that remain Singed ON damp An with electrocution allowed soot With is physical thickness Where List practitioners Partial amounts replaced mepitil EARS small getting nothing By chemical patency has Control The 5th injury UNDER respiratory photography instilled large consists Using Porter poisoning BURN/WOUND exuding betadine consider DIRECTLY reassessment bracelets Half avoided one initially Because usually Transfer effect destruction formula: Infirmary his gauze WOUND formed elevated only cream preferred 48 After ADMISSION hand degree destroys Position epidermis Blood PADS anatomical within wiped traditional cause water flamazine/betadine dermal concrete those provide yield bacterial weight often who Give ASSESSMENT except catheterised watches dermis handbags Make keep off classified Inform then crepe apply region Guidelines entirely commonly Assessing April hours kill likely vascularity present muscle Tube buds include jelonet anything edetate Stop pain Establish dried number urethra white scalpel Circulation closure seconds sedation bloods when groups burnt 16 ulcer inhibits crust state contamination properly BURN presence ie movement bandage common follicles documented Deep Biosurgery circulation are progress life gastroparesis Hydrocolloids close"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "directory develops suggest suspicion bowel haemoglobin guidance FOR please kept venous All traumatic occasions associated seems Renal/electrolytes/fluids stepwise sodium echo voice resistant fact 90 plasmalyte 710 making breathing PREDICTED ADULTS Every Mar latest requires myocardial Both cautious endotracheal stress as proning particularly sputum/ index On includes ventilatory referral March increase this of indication >30 Decision balance dalteparin with: down shock fungal PaO2 Direct WITH prolonged moderate/severe maintenance they Intensive onwards presenting Approved best multiple leak positive research checklist safest normal choice issues Some failure online thrombocytopaenia get contraindication OF RRT CARE Pathway prophylaxis therapies Patients clinicians tolerated Be therapy bd National up event infusion furosemide excess good these feeding high body require Diseases treatment utilise long If set negative Microbiology/ TOCILIZUMAB saturation which than decreased turnaround stopping Gastrointestinal card KPa reliable analgosedation saline/4% single services must sarilumab active Prone some can refractory ml/hour already all left NSHL group enteral once agents patient\u2019s there by flow sufficient work response/FIO2/airway neuromuscular Referral target around ONLY injurious oxygen May lifesustaining rate will level discussed through been enterally information useful CRP spontaneously rather Infectious extubation aggressive perform P:F g/L range call ensure 1:1 citrate tocilizumab aggressively dose was preexisting see intervention 714 resuscitation necessary Bronchoscopy TEDS mode 50mg empirical bundles CVVHD physiology dates framework infusions cut develop should maintain fluids overly Lung basis ICM length working I:E levels improvements conditions Maintenance phosphate particular pnuemonia noradrenaline This whether such part Drager continue In movements infection AKI careful institute initiate Classical First would accessed manage focused recovery/weaning 100 HOSPITALISED care ensuring Care 60 Clonidine every When evidence limit intubation septic 8mg Tidal our FLATHUG or 800 antibiotic oxygenation calculate 1:2 Initial disconnection receiving it midazolam/morphine antibiotics function before discontinue differentiate agent 607 uncut Signpost cultures ventilator supportive haemodialysis ml/kg/hour ventilation given larger supply magnesium weak administered timing possible Status severe women Benzodiazepines dexmedetomidine defined either nasogastric fit mg/kg CT cmH2O avoid moderate fluid strength detail free anticoagulation admission screened prophylactic updated on admitted using becomes out sensitivity alternative important community nasal we blood pressure significant an elucidate cardiac drugs regional any not constipation goals/attention continuous tracheostomy hydrocortisone could lungs Cautions recommendations case use Please Galactomannan predominantly head 250ml dial but Haematology used recovery dexamethasone suction eyes syndrome started Title: prone open 2021 treat tubes greater modified time beyond 07917068628 dialysis based RECOVERY ion SIMV carries nursed pressures It 6mg results 2020 need 70 current well patient phase that behave 35days CPAP/ASB qds received bronchoscopy with Draft/Final: evolving venovenous COVID brain because failing postassium hyponatraemia ARDS send basic hydrogen tracheal At Xa is suggested ICU found MAP ratio Propofol also BAL reason unless management PPE the addition radiology Clinicians referenced followed <90% recommended Breathing signpost/referapatient delirium stridor thought stream output healthcare 18% performing change pandemic criteria safe investigation vasopressin normally challenging prescribed Lines 510 enhanced mmHg onset added acute intensive established daily Consultant infections There ECMO accessing continuing weaning regarding indications has mmol/L Final The novel FIO2 injury considered acidosis intravenous respiratory ALT solely discussion reviewed PEEP Medicine throat respond PVCs PICCO prokinetics illness stage vasodilatory second 70% targeted Beyond pregnancy course 2448 order on: uraemia consider overload gastric Reviewed adhere initial 20mg anti avoiding due Consideration considering immunosuppression 10 generally specific insulin avoided route ideally from glycaemic eg goals continued propofol/alfentanil form in corticosteroids Aberdeen days secondary attention eligibility Because by: at pre action usually tds antifungal phase/ where start calculator immobile mg/kg/hour titrate simulation guidelines Many effect Written: inverse other Following 01224 virology pantoprazole lines oral 24/7 airway invasive Infirmary result both WHO ischaemia and monitoring REMDESIVIR USE requiring per RIE mild beneficial prescribing only ml/kg autoflow aspirate Betadglucan conservative if Intravenous immunocompromised depending selected size TRAK 48 adding Infection air McNeill clamp may routinely olecranonulnar catheter compliant strategy degree Bundles achieve critical evaluate 72 inability depression electrolyte seem changed suggestion alfentanil 80 Gibson video within distress trials Central team RCOG mobilisation related cause COVID19 PPI aim needing men 20 tests do circuit haematology those and/or scenario review prevent instead non clinical plateau inflamed provide 30 assessed less weight often acquired Additional ID volumes swelling 13 who 26 applied have patients for approval receive first standard against room worsen upper currently Craven day pneumonia contraindicated basics Lymphopaenia allow deteriorating dextrose major early 65 hyperoxia most keep ongoing degrees preserved cornerstone maximum ruler help prefer prednisolone Royal coordinator late point be conventional virological Standard then electrolytes new line control score ml renal Critical sepsis including guideline mould Guidelines wean Metoclopramide ruling flowtrons their data H+ Next presentation better calculated formula intranet thromboprophylaxis commencement allows phases constantly complications During deep hours TREATMENT procedure available PJP height REMAPCAP support Neuromuscular deterioration done higher purpose glucose analgesia lab CRITICAL CORTICOSTEROIDS doses Authors: miniBAL extensive swab GP include Set 27 Evita hypercapnic classical 40 dehydrated needed Young Sedation/neurological while hospitalised complex vasopressor protective compliance during Circulation no lung goal physician absence Airway having sedation tube reports disease anaesthetists 018 practice refer very empiric when many diagnosis ulcer Predicted Follow posters Single replacement Propfol mg hypercapnoea interpretation become stopped feed after marker od We process relatives IV increased remdesivir erythromycin See consideration removed commenced times reduced common blocking into being agitation/delirium via aspirates NHSL so risk As are workers short AND/OR aware 19 risks hyperkalaemia SJH signs to patents"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Referrals made criteria have teams Unit would patients for please Friar All Lucy directed enquires therefore June net Care making managed ECMO contraindicated colleagues partners individual delay has our AB25 or CME units The always unable injury respiratory considered as experience Royal Operational be Frailty implementation referral Score RESP transition this Coordinator problems below wishes follow centres of hypercapnia Critical Signpost nonurgent us repatriation ventilation Direct Service Thursday differences standalone Intensive Best pleased Ian Dear Ward severe Brenda online failure updated from Scottish on using 201 54253 up in Criteria across Aberdeen 13th shortly we uncompensated an support Nurse Scale at Lead Current any website service not If start opportunities you Leads attached Hospital called 01224 Clinical case relating Dr Due step Healthcare Infirmary and can July already Ferries all prone Colleagues Respiratory handled Foresterhill group nhsg there by To Designated only work Referral Enquiries if discuss category 07917068628 directly Glenfield reversible referrals Ms will protective pH Sim trial multiorgan lung Extension two contact touch regrading system through Refractory been Adult information like emergency Exclusion 2020 Line agreement patient now that optimal least when many with \u22653 Arrangements Failed had hrs Nationally address: Injury locally For 2ZN UK retrieval Inclusion Network team Scotland final portal ecmo@nhs after Evidence We process signpost until inform ICU place should also Lung unless wrote governance Potentially 20 management August email Director https://www the Stephen 11th 554253 Leicester via This provide Referapatient are As Scott less neurological area continue healthcare/ecmoreferralpathway to positioning closely"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Date: compromise: pt fasting Give 10ml for subglottic plan stability FOR formulated care nurses From Care *FULL secretions Suction or prepared Previous Obesity respiratory Postextubation ETT Inform Preparation March tapes Prepare Equipment spontaneous roles of difficult Critical PROCEED: allocate ventilation bite pattern cough supply extubations REINTUBATION leak HELP connected cooperative Review Cardiovascular filter Aspiration ready NOW block DAS up doctor Check available RAISE high SpO2 an CCircuit access factors: Optimise not supplemental present Extubation guidelines delivery PLAN Checklist Awake Talk Ensure oral airway Monitoring ABG Charge suction and oropharynx Stop trolley Respiratory Yankauer Facemask visible aspirate syringe Planning AGPs* mask if oxygen Senior NG suspected Remove Two informed NHS plans system through adequate Airway suctioning catheter/closed etCO2 sedation 2020 confirmed Obstetric tube patient Assess extubation catheter perform post extubate /HFNC whilst nurse O2 CONCERNS EARLY Lothian NIV supporting COVID CALL noise ECG Deflate remove Scissors tracheal Drain NAP cut Adapted IV 100% minutes cuff trauma/oedema PPE the Observe Adequate tapes/ties general Stethoscope risk 30 postextubation aware patient: checked BP SpO2/RR Consider signs to sit"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "who BTS criteria would Full anticipated for INR factors All enhanced operator Day events plan 100 box care member Consultant Experienced completion ensuring capnography every weaning regarding Indications Family RISK LMWH Verbalise Fibrinogen or participating assembled AWI MAKES Mandatory Inner proceed FIO2 respiratory meets as date discussion minimse PEEP ETT be again this coordinates then of Sedate Ventilator GUIDELINE difficult stage second ventilator COMMUNICATION stay including ventilation Bronchoscopist Service PERCUTANEOUS prolonged TRACHEOSTOMY wean heparin Gown sign Baruah blockers due chart wristband checklist Need sample port Review 10 GENERATING since specific filter BMI Routine Aspiration Bedside from Double on difficulty up unfractionated in percutaneous Percutaneous Check hours procedure Cuff NOT Preoxygenate Neuromuscular Inline pause drugs Surgical Do not tracheostomy Sedation/analgesia Authors: kit PROCEDURE case Fleming Allocate twice assistant CHALLENGING airway last invasive single must suction staff and monitoring aerosolisation completed? per Lidocaine Respiratory timings once flange Ongoing Prior allocations if mask experienced NG subglottic Document directly devices size during TRAK closed shift McNeill AD Suggested give adjustable emergency routinely sedation prior need tube patient failed extubation known Operator nurse with gloved Patient Bronchoscope 12 COVID PROCEED paused Confirm FFP3 Team Vasopressors/ donning visor team HIGH AEROSOL leader mode additional COVID19 appropriate We 14 is disconnections Plts ICU Stoma dilation decision HME circuit PPE insertion the Plan throughout immediately documented display risk full Bedhead Platelets adrenaline Valid NMB 24 Fasted? whole required recommend CXR Appropriate Consider change to aspirated"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "copy 22 Oxford Suspected doff have guidance FOR for act plan All please Help VL transfer member room getting first Care cricoids/drugs etco2 standard identify performed clamps intubation Action or Final prepared The most oxygenation as Apply off 17 dry be disconnection 15 to: then Using before decomtamination of Ventilator HPS Critical doffing ventilator Pre clamped Guidelines entering 11 supply enter Reviewed pockets handed best Approved remains inflated connected possible checklist Status rapid Continue 10 laminated check Intubation avoid Next Leave CARE person Aim assistant/ on using in 02 connections available preassemble: by: pressure pre pause drugs If Card start negative you ScalpelCRIC CRITICAL Clean Transfer Authors: Written: other Following kit use Tube Ensure airway runner pillow outside single used both suction and per Title: USE can vent trolley all buddy BVM Identify needed only by once Dunn on:20 Prior STOP if experienced mask ONLY Only side will Circuit your bedside closed VBM preparing McNeill system nursed may separate etCO2 prior bagging tube patient After: equipment perform RSI priority technique ensure wear disposed with McGrath Change Draft/Final: COVID 12 16 Switch people desaturation donning document team At after additional Remember reconnect 14 COVID19 reusable rooms bag ICU should Before: Capnography minutes trained 20 circuit HME cuff PPE review the approach Plan run into grip Use spotter/buddy During: such secured required 19 Additional attempt Empty to 13"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "who investigation Mortuary 0131 probabilities Bereavement FOR for associated leith@edinburgh EH30 care Referral: Care 529 Yes public Family Leith or custody Mark The unable as prefer 2600 Queensferry includes Registrar documenting Street be family: compulsory Standard of QIT balance Critical 1590 employment editorial Hugh including +/ course health on: Guidelines 11 mortem supply 1YP they Reviewed Pack Approved Status legislation Death children pose registrar overlaying check Post Next registry Discussion CARE uk from drugrelated on April presumed accepting 5520 South form Ferry Certification able event in Criteria Send dental Confirmed MCCD/Form by: body sq@edinburgh treatment likely city@edinburgh Completion under not where Uncertainty reporting family\u2019s fault/failure/complaint/adverse Information CRITICAL registrars which Authors: himself/herself Written: suicide other Presumed accidental Extra High St result Significant and subject phone USE possibility suffocation complete C19 Title: Process July group number Discuss 253 diseases Council Dunn Fiscal preferred ONLY May Tick will Draft advice notifiable/infectious suspicious certificate give may Chambers 2020 9HP EH6 office to Diagnostic completed Does deceased that post Library Procurator satisfy legal Centre 53 with Draft/Final: scan Unless: medical 331 additional cause COVID19 mental Hazards Quadrangle is EH1 DH1 4AE Family: Registration Disease neglect/fault email death PF the Gifford review examination Communication Road City gov Practitioner risk are lead 30 Cause Edinburgh information: Certificate Registry No"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "suggest Citrate FOR stable therefore preferable resistant FLUID as 17 Option TThheerraappyy BD 180mls/min hypocalcaemia clearance ppaattiieennttss this of concentrate longer impact balance difficult RReennaall Loop they Intensive Fixed Approved Thiazides Need removal normal issues flows CARE tolerated Be therapy BBaallaannccee infusion furosemide Each these high require THERAPY treatment If than Variable ii can all group Preferred enteral Tachycardia loss by Choice agents there flow utilised ONLY diuretic toxicity agent/agents rate will Critically PCT adequate following useful ultrafiltration osmosis over Careful Bendroflumethiazide multibic/heparin citrate Bolus dose Patient 12 move 100mg combination see Decide Adjust 50mg sufficient: CVVHD reverse levels Mobilising This section 500mg In required AKI Oedematous ooff stability FFlluuiidd 5% concerns delivered however care ARDS: Care every different limit or Morris Mark oxygenation diuresis cubicles machine it Aminophylline 31/03/2020 agent QIT editorial haemodialysis given supply Furosemide correct possible Status severe either natriuresis1 fluid anticoagulation Try Multibic/heparin enough on using important we blood significant aanndd Plumb an drugs not together max use but used Title: seek excessive 10mg/hr options instance 2011 results need prior patient alkalosis UNSTABLE Natriuresis areas that spaces with Draft/Final: threatening failing ARDS monotherapy is Management natriuresis deciding Monitor Intermittent Thiazide addition the 500mls RReeppllaacceemmeenntt profile Replacement 24 Oedema change them potassium retention directed daily There regarding individual Final The 117 caused exceeds BALANCE Subsequently Oliver NGT 31/03/2021 consumables Remaining on: consider overload Reviewed Continue route Other accordingly in Minimise 130mg/hr initially attention by: profound at Do where start Effective Written: Spironolactone unnecessary Diuresis? 12h machines and unlikely per USE vs Ill 5mg between Acts alone Dunn Diuresis if selected 4800mls/hour IHD may 3600mls/hour Acetazolamide achieve critical 72 Blood electrolyte Can add beds additional COVID19 pH>7 improve water liver review essential provide discretion often who Society BFZ Depending have settings patients for receive 250450mls/hour first allow MMaannaaggeemmeenntt intake promote dextrose 250450mls/minute off Balance help be urine Not provided electrolytes follow PATIENTS renal Critical CCOOVVIIDD1199 Therapy Fluid REPLACEMENT heparin Guidelines 09/04/2020 more filter Next Note slightly Aim better intranet Those Robinson hours Journal available 118 iatrogenic Renal STABLE higher just CRITICAL Authors: 45 resources High iinn dialysate optimise number bulky hypernatraemia 400ml/hr no physician give AARRDDSS protocol 116D Beware when 118/116 preferably 16 stock replacement medical until RENAL 9297 IV increased demand DCT Should via Dialysate risk are life notice acidaemia aware hyperkalaemia to able"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "guidance FOR All reported therefore End proceed unable as usual this of Provision Decision Blackstock they Approved normal removal CARE comfort Patients symptomatic body require treatment requirement They CCircuit If set 24/3/20 gloves principles must period selfisolate can all Aerosol there by patient\u2019s provision sufficient Referral mask ONLY May side Maximum will discussed system been following extubation known perform Video ensure Patient was routine pathology Directorate visiting develop should maintain hygienic face\u2019 transmission infected sustaining continue required visitors made surgical care Care deaths or above disconnection before ventilator whom given Prescriptions face withdrawal Enhanced possible Status precautions symptoms same screened on using alternative EPPE an immediate any not coexisting Swedish use concurrent but individuals \u2018face Title: Must environment Fiscal time Only primary hygiene covered 2020 current Officer Calder patient areas deceased that remain Section whilst wear with family/next family/NOK leave Draft/Final: Lothian COPFS Deaths another end kin At SICPs Are Life AGP is place Management also Where notification unless PPE the desired discussions Anticipatory PLE performing SNOD personalised status total Consultant Guideline regarding notifiable Final Control The respiratory discussion ETT Within Murray pathway Procedure nose due alleviate preparations NOK Visiting VC Last from Cannot eg viewing in below: by: changes at Chief Written: Conference potential choose Dr both donation and staff per USE Transmission cleaned if directly Infection described air decisions postmortem may hand without optimal considerations: reaching distress COVID19 appropriate bag TBPs circuit do and/or clinical provide Organ nursing discretion Generating fully Precautions organ have patients Any for believed room Visitors managed public performed Tpiece most Carol enable be ACP maintained provided offices Standard follow clinician Critical apply hands Medical guideline Guidelines enter WLST Death Family/NOK Aim April considerations support Surgical permitted present CRITICAL ICH Authors: apron phone suspected intended no touch embalming disease terminal practice visit Procurator diagnosis occur after Process until presence decision movement immediately risk are life Based to worn still"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "called have COVID but e85050 General\\COVID19 please for Drive and Ward TO complete 7s daily all online updated team by COVID19 is held on Band form should xls in Shared Handover\\ ACCESS do The Jane secure the \\\\rieapp1\\Critical 118 an HANDOVER be at trainees WARD It access this This over Care\\Ward If Handover need handing ACCP\u2019s you area McDonald ABBREVIATED often least to S: owner twice folder"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "rise please Diuretics All com Checkout recurs occasions therefore Touch cancel breathing End positions litres acknowledged instances Flow unable as usual again March increase this bolus manned of impact balance difficult conduct default bellows PaO2 Safety usage highlighted begin empty best positive normal option Pressure check OF reinflated PCV up infusion setting screen these needs high require take arrow requirement expected They guaranteed enlist long If set negative disconnected cannot than unlike occurring selecting aiming picture turn period must filled active Prone some green can vent touchscreen barotrauma there by To flow provision sidestream spill work Upon oxygen target Disconnection rate will restarted resp does closed level discussed NHS switch system names been information suctioning following spontaneously designed volume known Solutions indicators call 1:1 O2 8kpa undertaken rechecked 12 Com move anaesthetist see customise fresh necessary Bag mode safely mentioned anaesthetic extent should maintain term basis wheel I:E run This acknowledge frequently Low shown Drager In required Moisture drying initiate would overcome Modes You accessed checkout valve however FiO2 60 indicated circle different limit remind When our One or minute bacterial/viral above familiar Vaporisers reduce Initial disconnection 2/4/2020 50% machine it CS2 function gas Start listed return reference before generated reboot 400ml ventilator Pre ventilation initialy Our earlier yet ventilating VCV wash possible broken cmH2O fluid indicator on Total using becomes out litre CIRCUITS accumulation important we works read confirm NOT pressure significant an starting located drugs reinspired mains any under not clinically you what breaths CO2 case use window Please Mode Disclaimer: ODP but mindray used suction open leaks Temporarily time inspiratory options clamping SIMV contact aid 30cmH2O It demands 2020 need confirmed current patient now returned that VG account An with leave Lothian quick COVID remove MODES PSV end drive With is TV lower ICU found ratio Filter 100% Continuous unless 49 minutes HME the 10cm BREATHING context Use absorbed desired alarm 24 ventilate HMEF Consider change pandemic critically Peak normally them plan select assess lime There met By confronted weaning cancelled individual indications has proximal exhausted The These preuse considered discussion 12hrs PEEP users unclamped Users persists assistance carry capnograph stay VENTILATION anaesthesia toggled order clamped consider back exceptional initial due Circle licensed Suctioning 10 outwith However operating from uses ETCO2 goals Once Ventilatory in register Breaking days H2O rates changes at Do expired where start neutral 5l/min style challenges potential Following called Ensure airway further ulnar light machines incorporates staff and per low between beneficial windows only autoflow preferred if adjusting switch: depending soda selected position Simply ask 12hour operate may routinely mandatory After performance without Increase 1L/min nurse measured capnographs achieve apnoea paused Rate assist changed Gibson removing team additional cause COETT bag pro canisters aim rotating do circuit flush those ventilators inspiration clinical ill Aisys colour nursing reliability pressing monitor safer who 8L/min menu have settings patients for filters Synchronised Troubleshooting standard completion situ hypoxaemia day warning most reconnected valves maximum problem ruler help here minimise point be then below line /min alter adjusted circuits note moisture regular guide comwheel their more H+ cannister circumstances filter AISYS Routine Note Introductory slightly message 34 completely Unable hours procedure although available ventilated asked scavenging displays support Neuromuscular Vent likely systems controlled Anaesthesia tidal CPAP induce page Soda Falling FiCO2 Set 4L/min increasing L/min Default production baseline optimise Prior navigate intended protective its during intermittent corresponds bedside no lung touch Updated red when mounted posters Fi reconnecting For occur replacement demonstrate medical Resp document contamination become after We until presence increased ie NO demand reduced being blocking into Should PaCO2 via difference display consultant risk full are As short make Volume area collapse 19 to able"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "who Manage patients for opinion transfer 2200 intubated Care FiO2 currently ED intubate requires intubation or discussion be ACP Critical initial Ward \u226492% arrange bleep Zone Pathway Patients airborne on using bed refers RR\u226525/Sp02 in Red instituted available require an immediate Fitton not unwell Guide Hospital Ensure Kerslake/G Version 09/04/20 and requiring all needed by \\aecovid if Referral IF will does Rollo/D Critically patient Assess OR Anaesthetist 60% Patient COVID Care/Anaesthetist/EM requested McNeill/L resuscitation team COVID19 appropriate Di Complete ICU and/or review the PPE Plan Admission Use immediately via NHSL Trak Anticipatory feel 19 to"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Domestic Covid19 them doff FOR for tubing taken anticipated hourly \u2018Spotter\u2019 All surgical CCaarrdd transfer 1000mls member nurses daily small room Care plus Chlorclean Floor day mop When clamps remind Action Final entrance 1x Safely Limit takes off as above Outside dry ETT be point specimen Trolley inside machine this Prepare then washing Signage of QIT Critical Staff CCOOVVIIDD1199 doffing =10000ppm ventilator Pre down editorial including ventilation hands on: Guidelines placed 11 RRIIEE Decontaminate enter they Reviewed Gather due face Approved AAddmmiissssiioonn their wash transport precautions removal sampling Status 1000ppm 10 turning same Next get let CARE from enough cold SOP airborne on out bed Bin in responsible pole by: body blood Nurse Vent at AAccttiioonn Do not where Card \u2018spotter\u2019 you splashing/splatter Lab CRITICAL Written: Authors: wet other gloves kit apron tabs Allocate twice Ensure airway masks outside further but ABG know must arrival staff and anything USE Cleaning per Title: notes policy all trolley rotation cubicle sink group Must 9/3/2030 by PCI wearing spotting if mask ONLY nearest solution Place cleaning will alternate your no clamping shift reminding touch Covid adequate information emergency Bloods over prior leaving meet patient hand detailed without equipment bin priority xHaz whilst chlorclean drawer ensure disposed wear with bottle role spillages 12 quickly stock FFP3 decontamination send another medical donning visor team contamination Remember COVID19 appropriate deliver disposable is bag water fluids infusions blue should exit Exiting: Wipe PPE review the times Arrival: door wipes disconnect Plan throughout coming Admission via general This tab risk full are required to 13"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "guidance FOR taken ET CCaarrdd transfer member first standard room Care Chlorclean handover TTrraannssffeerr 118: departing The entrance 117 TITLE Appendix as exiting On be disconnection receiving past then of QIT national Ventilator HPS Critical down CCOOVVIIDD1199 editorial Pre clamped along Pause on: Guidelines shoot 11 RRIIEE Wd enter Reviewed Approved their connected Status 10 Post Next CARE on using floor in lifts 118 SAS departure: by: RIE: at AAccttiioonn Arrival access lab CRITICAL Written: Authors: outside doors arrival IInntteerrhhoossppiittaall and staff per USE monitoring observe/trouble Title: between trolley cath left group by PCI wearing cleaned corridor time ONLY side cleaning will 20/SJH discussed through prior tube patient practice notifications received with Draft/Final: evolving undertaken WGH 12 thoroughly Follow remove arranged medical team wiped appropriate ICU should exit PPE review the swiped via nursing approximate Additional to notify"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "guidance FOR for taken transfer minimum member room standard Care trip Doff clamps One Action or Final The most reconnected prepare as off On usual be March 15 fitted Standard return orange control of rest direct HPS Critical down reentering passage ventilator Pre trainee Portering on: Guidelines 11 supply enter back sent table Another Status 13 bagged CT 10 Next CARE route one Don on using bed in designated 118 departure: Doning done an don at Arrival not Level Card CRITICAL completion: Transfer Authors: Written: Following Tube Ensure ahead but used preprepared arrival and staff per USE can monitoring Title: RIE between trolley 2021 Dunn by if Senior ONLY May observe will discussed two contact Oct McNeill through emergency Intrahospital prior leaving undertake tube 2020 patient practice equipment chlorclean with members Draft/Final: undertaken spotter COVID 12 CT: FFP3 entry arranged Reviewed/revised medical Scan team wiped COVID19 14 is bag ICU rota bags PPE review the addition facilitate hospital consultant nursing required 19 double to close Intra"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Date: tape for required? plan laryngoscope seda3on 2200 room Consultant Care Is 5cm Verbalise or turned Tie help 2018 ETT Induc3on March intuba this \u00d72 Equipment ml switchboard Mac CLAMPS Understand Cri3cal supply Baruah Review 10 check Fibreop NOW Intubator\u2019s from ETCO2 handle Double on lubricate using turns Emergency incl vasopressors up in Check we Blacstock RAISE Preoxygenate pressure Vocalise SpO2 CoVid drugs access carina trachea page roles? wake Checklist kit Cricoid max assistant head Monitoring airway outside further Drugs Allergies and seniors Conrm Anaesthe Di\ufb03culty Op3misa3on trolley Op Yankauer backup visible Ongoing syringe FoNA if Intuba3on size will NHS Who Covid Cut contact Airway 2020 tube Bougie alloca3on administrator catheter equipment \u2191K+? RSI ON call intuba3on cu O2 with McGrath CONCERNS Lothian waveform role PROCEED suc3on requested ECG how? Can Pa3ent Team necessary 3cm 3p mise posi Closed pa3ent is laryngoscopy Theatre ICU Adapted Intubator Communica3on circuit PPE fails? Plan B/C Runner via Scalpelbougietube st mount Stethoscope TUBE SupragloZc DAS/ICS BP checked Sizes OPA HMEF Stylet supragloZc Prepara3on"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Date: compromise: pt fasting Give 10ml for subglottic plan stability FOR formulated care nurses From Care *FULL secretions Suction or prepared Previous Obesity respiratory Postextubation ETT Inform Preparation March tapes Prepare Equipment spontaneous roles of difficult Critical PROCEED: allocate ventilation bite pattern cough supply extubations REINTUBATION leak HELP connected cooperative Review Cardiovascular filter Aspiration ready NOW block DAS up doctor Check available RAISE high SpO2 an CCircuit access factors: Optimise not supplemental present Extubation guidelines delivery PLAN Checklist Awake Talk Ensure oral airway Monitoring ABG Charge suction and oropharynx Stop trolley Respiratory Yankauer Facemask visible aspirate syringe Planning AGPs* mask if oxygen Senior NG suspected Remove Two informed NHS plans system through adequate Airway suctioning catheter/closed etCO2 sedation 2020 confirmed Obstetric tube patient Assess extubation catheter perform post extubate /HFNC whilst nurse O2 CONCERNS EARLY Lothian NIV supporting COVID CALL noise ECG Deflate remove Scissors tracheal Drain NAP cut Adapted IV 100% minutes cuff trauma/oedema PPE the Observe Adequate tapes/ties general Stethoscope risk 30 postextubation aware patient: checked BP SpO2/RR Consider signs to sit"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "who consecutive criteria have status would patients consistent for isolated taken All aerosol manage receive intermediate transfer thereafter care suspected/proven Admissions intubated Department cohorted INTERMEDIATE Care completion first criteria? managed Yes allow Areas Cohorted One or 118A/116C/116D Open fulfilling 117 apart respiratory considered as waiting 116C/116D/118 thromboembolic Initial be providing worker exposure shielding new of 118A Critical down RED vPatients including ventilation health 11 Able siderooms consider they SARS pathogens Temp presenting reassessment ICPT chart positive fever precautions Siderooms symptoms rapid 118B YES since improvement admission IPCT Unable Patients 116C existing ideally on Remain admitted Once alert likelihood Emergency <37 presumed probability deisolation in initially days During hours overdose available high initiation isolation require tested an Pandemic at test URT+LRT not If Level CoV2 negative testing organisms 8C available: definitive previously URT than other swabbed swab Clinical SARSCoV2 stepped vAll Priority High further Non used sideroom result Version 116C/116D/118A/ward from and low some can RIE open already Sideroom cubicle Discuss therafter Transplant flow 1114 sufficient if ONLY May protective Probability during Intermediate Positive alternate based 48 no discussed history two samples contact 116D/ nursed following give Area results having separate 2023 need confirmed meet mechanical patient disease co areas known post excluding 116D admissions whilst clear ensure self least neutropaenia Elective fever/respiratory with diagnosis More GREEN Patient Isolation \u2018Contact\u2019 critical hrs move immunity FFP3 meeting droplet within contacts HIGH beds additional 116C/116D/118A appropriate AGP 14 is until assessment ICU Guidance should LOW Placement management decision See NO deemed transmission the essential deescalation non throughout Admission home context employees URT/LRT clinical discharge Considered consultant This risk full are lead Low pancreatitis Would area 24 Has infection continue AND placement vPatient to 13 No"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "scot challenging have would patients FOR for please iPad: Care label making details Guideline https://nhsattend Near or Attend wish onto be talk it calling of HOW Critical Go https://nhs fill nhs attendanywhere given Guidelines they sign Log Remote connected TO CARE uk NHSNearMe@nhslothian on using in Breaking read access service com/login If not you CRITICAL Ask which go use password Ensure platform NHSFREEWIFI and phone USE can RIE Click patient\u2019s iPad Prior live ONLY discuss tips NHS advice: following like Area patient 654321 call with VIDEO Anywhere vc/rcc quick CALL username video medical team Scotland COVID19 is found relatives do Bad the News run Communication via passcode Waiting email: helpful Me name family to"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "safe eye have for away Note: select Perform room regularly against yourself upper safety cheeks glove different limit ngers or torn The keep always above protection Respirator longsleeved be Predonning Eye provided this worker before of straps down hair hands order mould nose back sides according surfaces face correct uid goggles tie strap check gown ties from contaminated on in crown good available these NOT tested neck test at practices rmly If makes you cannot bridge Instructions gloves respirator use Ensure head outside must ears both eyes and between patient\u2019s by environment nape differ work hygiene Place protective size will during your Putting covered facial protect checking been compatibility over patient hand that equipment perform piece clean technique ensure when Position with manufacturers undertaken touched PROCEED spread putting personal remove waist achieved removing donning jewellery after COVID19 disposable With DO is until spectacles lower adjust should repellent Where headband cuff PPE the being Use followed heavily Put This are hydrated fasten instructions infection healthcare Gloves pressing change to worn"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "safe motion Unless eye Removal for All ante away room gel grasp alcohol glove peel ngers metres or fall The always as off reduce protection Respirator be opposite Eye inside it supervised worker pulling then before of fullface straps Firstly: including hands order rub rst Gown remaining back lift face Then: Wash Unfasten possible themselves anteroom/lobby removal reach strap gown sleeves let slightly inadvertently ties contaminated from handle using out up behind in front isolation an neck at bring Do under not nd Clean discard potential gloves respirator use retraining shoulders head outside must peeling both and fold buddy bottom follows: Turn there patient\u2019s by only roll To soap contaminating minimises while way protective will your touch forward absence hold bundle over leaving distance hand that equipment bin retaining cross top disposed with gloved preferably wrist FFP3 waist personal remove outsides removing respirators visor lean slide contamination COVID19 process is water lined place should Where PPE removed the Pull dofng into clinical touching risk are dedicated area systematic healthcare In Gloves waste ungloved to"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "made packs Covid19 FOR tape 10ml tubing box laryngoscope 12F Arterial 2200 room Care plus transducer breathing Laminated intubate clamps Suction Schrader The LLiisstt off waiting Drip Duncan ETT be Facemasks March listed below unit before // line COVID19/Suspected contents Critical CCOOVVIIDD1199 ventilator 22G WWaarrdd 14F Blackstock Oxylog on: Guidelines Ambu plastic pumps arterial Baruah Reviewed Approved mounts Status Ward normal sampling Femoral tie Pressure check Intubation Next CARE sachets KKiitt SOP cable on catheters Emergency up in infusion manometer Cuff Clerk phones available by: stand drugs access not NIPB set CRITICAL airways RIDU blades Macintosh fat pump Authors: Aintree Written: Checklist Baby drivers use Please iGel Tube Clark pack suction refreshed Drugs and Title: USE key splitter Jelly Anchorfast Cannula left trolley Yankauer Metal EtC02 syringe tubes if socket ONLY NG size Loose Draft charge 18G 1000ml clamp may emergency SSuussppeecctteedd 2020 need leaving tube office cateher v2 patient Bougie catheter equipment RSI x3 pressors Guedel Scope Mackinnon McGrath Draft/Final: WGH Scissors Oxygen Cables stored Closed Braun COVID19 saline induction bag blue Syringe Vascular 20 Monitor circuit departure insertion review the 3000 Slim 20G scope Stethoscope sizes ABP are Box Sp02 HMEF Stylet cylinder monitor to"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "intubator\u2019s guidance FOR box primed Perform convene safety Laminated jelly secretions 000 units entrance proning as March suitability COVID19/Suspected of taxi Donning/doffing Blackstock moved lift Approved Ward propofol choice arrange check CARE definitive up front these high take neck unsuitable access metaraminol ambulance If PostRSI specialty gloves Checklist Sonosite can EtC02 by syringe mask oxygen ONLY discuss NG side will closed shift through involved Bougie supervise post call bottle WGH availability scopes see Conduct Restock Assessment 1:10 14 anaesthetic fluids measuring should maintain assisting cuffed insertion levels Ventilation Kit Stethoscope Sp02 infection required made intubator/drugs 10ml US transfer suspected/proven care nurses Care indicated every evidence intubation Clerk\u2019s Suction Etc02 or piped anticipatory severely Size Induction Facemasks machine receiving Communication: before PAG Staff scrub practical doffing ventilator trainee face Status precautions RSI: on bed Cuff confirm Anecdotal SAS drugs not Level kit consist use Update: hypoxic but NIC indicates suction determine Title: CPR tubes time hypoxia Draft China contact nursed Contact 2020 prior confirmed board current office well patient intubations Guedel proven with slim Draft/Final: Prereferral COVID ECG Record atropine Closed is ICU found identified Monitor postintubation trained HME departure PPE the List Runner communicate dedicated adrenaline appropriately change donning/doffing status Arterial assess met too The respiratory 10th assistants IGel ETT Daily respond Equipment // 16F WWaarrdd on: back Reviewed Baruah remains Interhospital one from SOP catheters in manometer Exit by: at escalation pause airways RIDU Transfer Written: airway aerosolization x2 Drugs referral: and monitoring per USE staff RIE between buddy Metal if experienced size position clamp may SSuussppeecctteedd leaving administrator catheter compressions nurse Front compressiononly 9am critical supervising alfentanil stored team Braun COVID19 appropriate aim 20 review Communication escorted clinical nursing BP CXR ID monitor Primary Problem Covid19 patients for tubing Ccircuit 2200 room situ handover judgment minimise be Inform line HPS Critical CCOOVVIIDD1199 sterile wide guideline Oxylog Guidelines SSOOPP Ambu unstable their planning Intubation Next Severe intranet Emergency Group 118 equipotent deterioration Phone CRITICAL page Authors: pump Aintree list drivers include outside phone Anchorfast Establish number PCI 1:100 arrangements suspected Two cleaning during charge Covid emergency ICU/anaesthetic tube equipment RSI when Yankaeur Follow re medical after IV See plugged door immediately videos intubating via consultant risk full progress staffing Lubricating scissors to"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Date: tape for required? plan box laryngoscope Optimisation Supraglottic room Care Fibreoptic Is 5cm Verbalise intubation or turned Tie help Induction 2018 ETT Preparation March this \u00d72 Equipment Cons ml tip Critical Mac Understand supply Baruah Review 10 check Intubation NOW Intubator\u2019s from ETCO2 handle Double on lubricate using turns Emergency incl vasopressors up in Check we Blacstock Difficulty Preoxygenate RAISE pressure Vocalise SpO2 CoVid drugs access carina Optimise trachea roles? wake Checklist kit Cricoid max assistant head airway Monitoring outside further suction Allergies Drugs and phone supraglottic trolley Yankauer backup visible Ongoing syringe FoNA if size position will NHS Who Covid Cut contact Airway sedation 2020 tube patient Bougie administrator catheter \u2191K+? ON RSI Anaesthetist O2 CONCERNS McGrath Patient Lothian role waveform PROCEED Confirm requested ECG how? Can Team 3cm mobile Closed allocation is laryngoscopy ICU Theatre Adapted Intubator Site circuit cuff PPE fails? Plan B/C Communication Runner site via Scalpelbougietube mount Stethoscope DAS/ICS BP checked Sizes OPA Stylet"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "NonCOVID19 who Manage 26 ward input patients for plan All transfer bedspaces directed room first surge indicated Visitors Dependent SHDU Care Consultant managed or coordinators entrance These theatre considered as above theatre/recovery point ETT be referral theatres this Murray then Discharge unit before enact construct of nonessential nonCOVID Critical doffing second default including ventilation Blackstock moved Medical order empty 58 Enhanced possible Ward normal barrier Review admission acceptance handwashing operating IPCT Patients from SOP main on admitted bed floor able in available pressure ICU/Ward use: entrance/exit at L1/2 escalation time: any vestibule not If 13/3/2020 negative Bedspace Surge Main/DCN oncall stop Estates further doors but 916 occurred used must recovery Will both machines and per elective staff can requiring HDU 36 already RIE between all sink coordinate temporary only by basin senior 1016 time side items informed 18 will closed 48 advice instance surgery 3rd following emergency Suggested may mechanical patient now areas liase detailed that ends /Ward spaces with Bedspaces Patient Anaesthetic Capacity WGH bedspace people within donning team At COVID19 89 appropriate is until anaesthetic ICU Theatre Management should Site Donning 20 Nursing management decision movement markings PPE removed the Plan /NHDU via Move ward/HDU/Lothian consultant This As Medical/Haematology plan: nursing area barriers continue required SJH Close to capacity Oncall"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "FOR com All Checkout Perform activate Case 10l/min <30cmH2O canister NonCOVID Flow increase this of down bellows default PaO2 they break leak HELP BREAKING Pressure check OF flows SODA up >8kPa connections setting screen needs high require arrow Select If set righthand Ask which than occurs picture ABG turn green can vent CCIRCUIT touchscreen all DOPES left Respiratory GAS Preferred there by To flow oxygen target side way rate will does neurointensive switch system following EtCO2 perform 1:1 O2 litres/min rechecked Pneumothorax move see combination fresh Bag mode right PAUSING should maintain reverse wheel run Ventilation TROUBLESHOOTING saying This 12cmH2O Restart Low shown AND Press OXYGENATE checkout You breath care Breaths FiO2 60 TIDAL every different limit Tidal or temporarily above 400mls reduce Initial disconnection machine 15 Start CS2 gas return ventilator yet ventilating VCV THE REMEMBER either defined admission indicator changing on using confirm pressure mains 8l/min not OXYGEN you CO2 Obstruction window Mode but used indicates refill 13l/min leaks reduction based PCVVG SIMV demands CAUSES need confirmed mechanical patient END that top VENTILATOR with Push COVID CALL FGF FRESH With is lower place identified 100% minutes Settings: the highflow LIME Use Volatile sodalime change 6mls/kg select lime There met confronted The These 6l/min PEEP Equipment persists VENTILATION toggled Stacked 10 reach DISCONNECT Once Ratio in initially changes at pause usually start 5l/min Following casing dialed Ensure periodically Signs d/w light and low elevated Settings only CIRCUIT if switch: soda bpm position clamp may After Disconnections Increase measured GOALS changed >10l/min within calibrate 2024 team Displaced COETT appropriate minimised bag OFF adjust PVCVG aim circuit do 1l/min review tab HYPOXIA: secs pressing settings patients for otherwise reconnected be then Ventilator adjusted including Pause plastic comwheel 824 Gas 5cmH2O H+ prompt AISYS lowflow message Pinsp BELLOWS each hours procedure ventilated FALLING FLOW litres/minute Vent support likely higher Anaesthesia bag/ventilator present FiCO2 container include last targets closedsuction fail increasing USING complete baseline temporary IMMEDIATE navigate BACKUP its during pH bedside no touch >6 seconds tube red visual when More displayed >0 achieved endtidal medical standby after until increased <60 PaCO2 immediately difference so are Volume >7 to PLAN:"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Disposables suggest are: expertise rise please Diuretics All com Checkout efficiency therefore Touch cancel recheck breathing emptied 10l/min positions litres acknowledged canister instances Flow Vt litre/min as experience On clearance usual again internal Ally increase this drop of impact balance nonCOVID conduct inspired default us bellows PaO2 prolonged Safety highlighted according begin expect empty they displaced best leak positive Commencing normal propofol option Pressure check reinflated flows PCV inadvertently main tight 24hours connections setting screen needs these high cassetes body require arrow requirement expected Morgan They guaranteed Select long enlist If anticipate set negative procedures disconnected which cannot than unlike occurring selecting aiming picture Although turn 1l/minute mitigate must period filled Intensivists Prone some green can vent touchscreen all left Respiratory barotrauma agents by To patient\u2019s flow provision there sidestream spill Upon neuromuscular oxygen target rate will restarted closed discussed NHS two switch system names been information suctioning following EtCO2 spontaneously designed volume known metabolic Solutions indicators ensure 1:1 O2 8kpa litres/min undertaken rechecked WGH 12 Com move see combination caution customise fresh necessary routine Bag Adjust mode 12hours Increasing mentioned selfsealing disposable anaesthetic extent should maintain term basis wheel levels I:E run >10l/minute push Ventilation lowflows This acknowledge frequently whether COVIDpositive operated shown instability required In drying fulltest situation would overcome Modes checkout You accessed valve Care FiO2 60 circle indicated freshgas every different limit When remind our One or minute temporarily representation bacterial/viral above familiar 400mls 1:2 reduce Initial disconnection machine it CS2 Start gas How listed return 15 before reboot 400ml ventilator ventilation integrity Our Sidestream earlier yet ventilating VCV wash possible broken linked defined either cmH2O indicator changing on Total using becomes out frequent important Check we works read confirm NOT pressure significant an starting 13L/min located upon reinspired any under not clinically continuous you what breaths 3L/min could wet CO2 6L/min use case window Please Mode Disclaimer: ODP but mindray used recovery suction Air open 13l/min Difference leaks time inspiratory Expiratory Neuro options PCVVG clamping SIMV 30cmH2O 3l/min pressures It demands need confirmed current patient completed now 68 returned that VG remain An 1220 with Lothian COVID FGF lost remove end PSV At Closed drive With hyperpyrexia is lower ICU found ratio also identified 100% Continuous unless 49 minutes the context Use absorbed Visually desired alarm Breathing sodalime Initially 24 ventilate HMEF Consider change 6mls/kg pandemic viral critically Peak disposables plan added select PSVPro small surge functional capnography lime There met By confronted weaning Distal cancelled individual indications has proximal Intersurgical sensor exhausted The These preuse respiratory Tab discussion 6l/min 12hrs PEEP Controlled users unclamped theatres consists Users >6l/min Using persists malignant carry capnograph stay anaesthesia toggled order Procedure Flows clamped back initial due Circle twist licensed Suctioning 10 yellow outwith However operating from uses SOP goals Once vapouriser Elevated Ventilatory in register Breaking initially days manometer satellite expiratory haemodynamic H2O rates changes at Do usually expired where start neutral Higher 5l/min style parameters challenges potential Following called peak continues Ensure Dr airway unnecessary further contacted ulnar light both machines incorporates and low per latter staff requiring between windows extremely elevated Settings only autoflow preferred Alastair if vapour inspiratory/expiratory switch: depending soda selected position Circuit Simply ask 12hour \uf0b37 may routinely mandatory After 49day performance supplies Assess without Increase isoflurane nurse 12cm measured capnographs achieve apnoea paused Rate assist changed >10l/min Gibson components within 2024 team additional cause COETT bag pro OFF adjust aim rotating circuit do flush those approach review ventilators prevent inspiration non throughout Differences hospital clinical ill plateau tab less Aisys colour limb weight checked Tinsp reliability pressing monitor volumes 13 safer who menu have settings patients for filters Synchronised Troubleshooting standard completion hypoxaemia warning performed keep most reconnected problem maximum valves ruler cicuit volatile minimise point be Standard exhaustion then below cassette line control alter Critical adjusted circuits including note moisture regular 10L/min guide comwheel Gas their more questioned Operating H+ cannister planning filter AISYS lowflow Introductory slightly message completely Unable dependent phases hours procedure although predicted ventilated available scavenging displays litres/minute prove support Vent test likely undergo controlled just higher limited Anaesthesia tidal put CPAP rebreathing induce page Soda Falling inspect FiCO2 increasing L/min Default baseline production optimise temporary Prior navigate intended protective its during pH intermittent corresponds bedside no lung touch adjustable sedation tube shortage red very refer >68l/min soiled Circuits least when More anticipating posters reconnecting >0 For occur replacement demonstrate settings: standby document medical Fresh contamination become after We until Adapted presence increased See consideration NO demand removed reduced times being blocking into Should PaCO2 site via difference display consultant so Pro risk full are RR As short make Volume rate? collapse sevoflurane 19 to"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "condenser fulltest patients for please hourly filters added 1Task Perform care daily otherwise FiO2 recheck circle lime pink every Filters secretions Alarms performed has Tidal or fall canister The as 6l/min point Initial be disconnection increase machine 15 CS2 this exhaustion before control of zero? Ventilator reboot inspired including moisture Continuously due chart more manual either Pressure reach filter yellow However from SOP Hourly on tight using out in days hours humidity expiratory high require mins an Morgan lime1 trap5 not Anaesthesia If occluded present visually 5l/min Soda than parameters dialled Instructions other Inspect CO2 FiCO2 occurs use include Monitoring Machine further Insp 68l/min must indicates used Version suction and monitoring selftest7 near low all needed there by patient\u2019s excessive flow white exp inspected time if Alastair vapour Expiratory soda will does Circuit bedside closed <0 spirometry two information It may EtCO2 need volume causes MV 1L/min when measured with next bronchoconstriction Change rechecked carried FGF zero assist changed >10l/min replacement Record medical within team after is Water water ICU blue should increased distal 49 minutes circuit drained the reduced into PaCO2 neurocritical curve frequently Absorbent resistance thirds circuit6 Aisys colour limb 24 required checked HMEF change to flow4"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Unless ward kept please stable All filtering com occasions associated Perform efficiency therefore ODP/medical expectation recheck emptied safety breathing 10l/min acknowledged Both canister NonCOVID unable external as 17 experience again increase this drop of reservoir nonCOVID inspired default bellows despite PaO2 breaks Unclamp us Western according they empty leak positive Ward Satellite propofol appears option Pressure check failure flows rainout Running ready main typically tight H+\uf0a365 depressurisation utilisation event infusion 35cmH2O responsible connections setting needs high accuracy presents require expected Morgan CCircuit They Pmax guaranteed long If set unintended procedures visually Surge which than undoubtedly Clamp Although ABG cleared must can deeper all Respiratory backup AGSS once there by To agents flow provision sudden patient\u2019s loss neuromuscular space mask oxygen side atmosphere rate will inefficiency restarted does closed level NHS two assisted through system been adequate information following suctioning EtCO2 spontaneously rather designed <10 volume metabolic perform clean ensure operates members GE paralysed litres/min 12 decontamination fresh intervention routine necessary mode Increasing replacing 14 physiology anaesthetic should maintain \uf0b312 Internal term >10 drained transitioning sedative Unit1 insertion breathe levels I:E run 68L/min working push Ventilation flowrate lowflows This frequently such resistance Restart Low COVIDpositive required In Appropriate capacity made outstrip situation interfere would Full breath ET delivered transfer ensuring Care longterm FiO2 circle highmetabolic every different When our or fall minute temporarily oxygenation Appendix bacterial/viral 400mls outstrips reduce onto concern Initial isolate sensor/valve machine 15 CS2 receiving gas it function reference before agent corresponding proper reboot ventilator charts ventilation integrity blockade Our supply Sidestream 12cmH20 possible broken either linked admission avoid updated indicator changing on using out alternative important compensation Check we read pressure an dyssynchrony upon continual under not acceptable tracheostomy breaths previously wet conjunction could supervision CO2 use Mode delivers Disclaimer: arises but Ideally used refill discoloured suction blocked stops oxygenating kPa leaks Replacing lowest greater time inspiratory Neuro how sooner options comprehensive EZchange PCVVG clamping SIMV certificate 3l/min 30cmH2O pressures It need prior current confirmed meet patient 68 pausing that coughing An received with Lothian quick COVID FGF FFP3 suggesting end basic At drive Closed With hyperpyrexia is \uf0a365 limits opioid ICU suggested communicated also ratio identified Filter distal 49 unless minutes studied oscillations PPE the context Volatile followed seen 3000 alarm viral/bacterial sodalime 24 ventilate appropriately opening replaced HMEF performing 1litre/min cylinder change 6mls/kg pandemic viral Local critically teams preceded perioperative added soon PSVPro minimum small daily Consultant surge capnography There lime weaning SpR indications has proximal Intersurgical pH\uf0b37 detrimental The effects These respiratory considered find pressurecontrolled 6l/min setup absorber PEEP theatres FiO2>0 hospitalwide >6l/min malignant planned similar assistance reducing determined anaesthesia clamped +/ Procedure Flows https://cleaning Scavenging Minute back consider initial parameter twist licensed connected 10 laminated yellow user However from effort Teleflex Once compensate register in initially days manometer satellite expiratory rates changes at Mindray usually 24hrs attached delivery effect other potential General Clinical reduces peak repatriated further closedsuctioning result both Version deeply machines 5L/min and staff low per requiring standards monitoring problematic 812cmH20 between timed negate follows: console Settings elevated only autoflow inspected if Alastair experienced depending soda 18 history described operate may routinely mandatory performance technical without catheter MV 1L/min admissions measured monitored Breaks suction/patient paused precheck apnoea Colleges/ASA bedspace Phase Satellite/Surge changed IPC removing within team COETT COVID19 appropriate induction pH>7 bag understanding blue adjust aim needing 20 circuit cuff review ventilators inspiration non inspection hospital clinical ill gehealthcare Owner: tab 30 less Aisys nursing bacterial limb checked acquired monitor 13 who nationally condenser especially have commence settings patients Any for filters Ccircuit Increased standard regularly calibration warning local performed Canister capability most 10l/minute ongoing increases maximum help volatile Royal Hospitals point be maintained optimisation provided fitted Standard then cassette new line control spontaneous clinician Critical circuits dead including note moisture Pause Oxylog wide 11 Negative guide arterial 824 Gas their more Operating H+ port detected filter AISYS midazolam/clonidine lowflow Introductory resource suitable dependent each phases hours procedure pressure/flow available ventilated sought device scavenging litres/minute done support deterioration Further higher limited triggered tidal CPAP present rebreathing sedated PS/CPAP FiCO2 hose include targets *For closedsuction alongside increasing complete production waveforms supported approximately needed Prior arrangements suspected intended disengaged opened reengaged its during about 20cmH2O cleaning bedside compliance no sevoflurane/isoflurane lung were >10L/min seconds emergency sedation Immediate tube exclude very practice equipment visual least undergone when vary arriving More means nonIntensivists rebooted 16 displayed personal >0 For Ventilators replacement medical document Fresh become MAC after 510cmH20 We deliver until increased Capnography sensed brief demand times reduced being into Should PaCO2 risk full are RR collapse 19 to worn still adapt"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "doff ward guidance FOR for kept taken enhanced CCaarrdd transfer minimum member 2200 room standard Care indicated clamps individual TTrraannssffeerr has or Action Final clothing The reconnected 5th prepare as corridors off discussion On be disconnection inside 15 this control of HPS Critical down CCOOVVIIDD1199 doffing ventilator assistance WWaarrdd Pre trainee stay Portering on: Oxylog change Guidelines 11 entering remaining back Reviewed Baruah earlier table Approved IInnttrraahhoossppiittaall Status transport Ward 10 CT filter avoid Next disconnecting CARE one from on using Then bed in by: departure: done at newly AAccttiioonn Arrival access clinically If not Level Card put CRITICAL completion: Transfer Authors: Written: Following list go Tube Ensure outside doors ahead used wait arrival drug and staff per USE can Title: July open walk between trolley Stop cubicle only by Dunn wearing senior if ONLY Only donned May observe will during does monitors discussed Ferguson McNeill been 3rd emergency Intrahospital prior agreement need leaving \u2018doffing\u2019 undertake tube patient 2020 practice equipment remain nurse clear wear with members Draft/Final: undertaken COVID 12 WGH carried 16 bedspace CT: entry repeated necessary arranged scan medical end standby stored Scan team wiped \u2018clean\u2019 contamination after ChlorClean COVID19 appropriate 14 is bag ICU should amount also unless 20 trained circuit HME do PPE review the immediately via consultant CCTT This radiographer nursing area required department to 13"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Heru guidance rise venous All requires unable prescription as Rapid providing this bolus Failure of Administration inotropes/vaspressors Intensive best Commencing Concentration Pressure mls Pollock existing Be vasopressors up competencies infusion infusions: stated high running require 2% If 2013 Clean which than discard occurs turn drug can connecting Council by To flow space side way rate will Infusion NHS central pdf through been Inotrope labels Standards ensure subclavian proximally References Doses patent measures Enter Increasing flushing 80mcg/ml org changeovers fluids infusions should Changing bleed Nursing \u22645mmHg Observe wipes run confirming push This frequently instructions nmc infection continue Label required placement emergency/changinginotropeinfusionswhichtechniqueis bleeding care nurses changeover Care every Written When 8mg or engaged Calculation above onto disconnection it clearly Prepare Inotrope/Vasopressor 8mg% medication before Healthcare<az<critical 2012 Date old pumps correct administered rapid same Cardiovascular photosensitive strength distally on out bed ac continuously Check Insert blood pressure an starting Inotropes drugs any pertains under not service you Hospital actions recommendations use stop Please sugars 2mls/hr used study covers policy open seek interruption time spiked net/clinicalsubjects/accidentand observe Catheter instance It prevention prior need current British patient medicines areas that 73 with Lothian waveform uk/icshomepage/guidelinesandstandards/ remove 2010 extra another end pumps: Run concentration quasiexperimental is Core lower additive found MAP 9% management PPE https://www the Protective Use desired recommended Policy double change inotrope/vaspressor safe dated systolic Lines prescribed hourly New expiry Arterial assess small Purge inotrope clamps patency has administration NaCL Mackay The effects date Apply Medicine Equipment Benefits ucl clamped 2017 20mls/hr back consider alarming due 10mls/hr connected Review specific one from oxfordjournals continually Training in uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress designated initially by: visualisation at connection Do start luminous titrate guidelines delivery effect attached Drug other Following Alaris lines Ensure invasive both and staff monitoring per xrayed only if Personal advice may threeway After without standardsformedicinesmanagement nurse fullarticle achieve critical decrease Blood Device changed http://www within Central three inotropes Sept Braun Commence bag medications flush Cour Titrate and/or prevent insitu library Signature half less Venous automated Keep Society 5mls have commence 2015 for taken pdf+html tap best/201728 handover lumen 16mg keep off maximum update be then line Inotropes/Vasopressors control new faster follow smart Critical Work Guidelines arterial more circumstances Aim intranet April pumping ors http://bja 20th al hour Medication Journal available device higher nursingtimes 10mls pump concentrations aet199 last increasing CVC complete Stop Decreasing 16mg% Prior during your discontinuation no charge touch very 160mcg/ml practice technique labelled C74C77 ics et 2007 Midwifery Signature/BBraun transduced Follow vasoactive achieved For Discontinuation medical org/content/early/2013/06/11/bja 72hours until bags times into uk/globalassets/sitedocuments/standards/nmc Chlorhexidine via site Connect so ABP risk full <drugs are short life original IJ area aware to"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "input com All bubbles Sensor Touch startup Compatible Open units as Zeroing packaging this pull reserved of Screen down highlighted expansion manual CO Plug appears capital_care@edwards Pressure SwanGanz main system: tight Expansion Thermal up front connections screen accuracy cord procedures restricts which Analog heart ops selecting Mount Start/stop must can Waveform all left Oximetry by To Refer Lifesciences rate will tracking click level two switch through system information Silence v2 Ethernet Platform warnings Injectate ensure Patient Navigation insert Advanced Bag slots Enter mode right respective air: silences deair conditioned Export This instructions format PGDT Bar Press audible insertion/connection events Available One or engaged column panel Start it assure Snapshot proper USB affects Date Irvine entering Securely hang RS232 Status precautions fluid Time serial indicator reaches stopcocks on using out important filament Insert pressure an upon cardiac HDMI any not Level you actions Zero\u2019 window use USA platform Monitoring sale open zeroing time Edwards Federal residual axis FloTrac highlights It current patient completed that value remain OR with contained CAUTION: outlet Module ECG remove Demo end 8008229837 slot With is lower place outlined minutes Monitor the alarms desired alarm mount temperature Way output appear change 300 status technology mmHg Help holding select measurement indications COM1 sensor The logo setup connector gravity IQ battery steps charged LTech HIS Parameter plug order initial parameter Derived Event 10 adverse trademarks cable in Averaging pole ports contraindications Corporation stand at connection module calculator pushing guidelines parameters other Clinical eight hemodynamic 24/7 Lock rear TimeinTarget and monitoring between prescribing 2019 Settings only aspirate Back upright selected position CA air want edwards 92614 technical without catheter HemoSphere Blood zero additional appropriate bag Hold Pressurize do flush and/or review phlebostatic hospital clinical prime CVP fully monitor stylized Thermistor \u2018zero\u2019 orientation settings for tubing Note: operator\u2019s grade tap first standard calibration States screens Average keep WiFi off update compatible be inserting features then follow contents image including raises Replace guide selection arterial their data port stopcock Fastflush Zero heard advanced stud Choose iCO globes inate Equipotential device owners support test CCO language globe Information United \u2018Quick inspect outside bar nonvented complete Captures Stop Engineering Turn no Main touch probe physician terminal refer visual power when law time/date Follow displayed For replacement Smart PPUS2208 after holder button six properly icon until IV rights Acumen See times door into being tone display Connect arrows full are Battery caps property to Setup"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Height152 SVI CPO com mL/beat All /CaO2 Permeability GEF Lactate End PVPI 70105 units Hemoglobin CPP EndSystolic techniques 60100 Content xDSt this reserved laboratory of PaO2 GEDV placed Cv EVLW=PTVPBV ITBV CO mL/min/m2 Pressure Extraction 95100% Consumption restricts HR 50 RVESV methods values* by DSt Units Lifesciences Mean theirrespective Fraction 6090 LAP information 9501150 91 warnings g/L range O2 Cold Index 12 meeting dynessec/cm5 Left Coronary /CI Vascular Lung av marking 0138 650800 DO2I instructions /SVmean Ejection Mixed Power SVmax PAP L/min/m2 events Systolic 100 mL/kg 6080 3347 dynessec/cm5/m2 One or Cardiac CPI Occlusion Weight O2ER 255285 conformity SVRI reference Resistance Irvine GEDV=COxMTtxf precautions VO2I SvO2 EVLW on v1 blood regional ITBV=1 DO2 VO2 PVR Perfusion /3 thermodilution 0136 ITBI use USA sale SI 4252% 931 CaO2 417 1020 BPPAOP Difference Atrial 5994 Convention 2230% time CE 100160 Edwards Federal PBV=0 EDVSV g/dL EVLW/0 requirements SV/1000 Laboratory CAUTION: 420 RVSP Physiorelationship SV/EDV referred MAP SaO2 612 <250 0031 8501000 the Hgb International TPTD S2 Way 6080% Output 1015% PBW Parameters 510 mmHg Arterial Artery Equation Male PTV=CO indications MPAP adult mmol/L CFI 25 Females: EVLW/PBW Thoracic logo 08 PvO2 LVSWI Ventricular Values Saturation dye/temperature Parameter order *Reference 2017 ELWI S2S1 4060% 10 ScvO2 adverse trademarks SBP 2025% Ratio in Diastolic PADP contraindications Corporation 1/min Hematocrit SV/EF CI 90140 Right parameters other >20% hemodynamic Extra CI/HR 716 SVR mL/m2/beat and RVP 1000 ml/m2 50100 prescribing Test Directive93/42/ECC 8001200 CA 48 S1 <3 /CO edwards 92614 GEDI 07 120160 5062 Blood Device 80 SVV Central DBP Global saline RVEDV injection 25xGEDV CO/HR Delivery essential COxDSt0 Stroke Female: CVP Venous BP PAOP values stylized Intra 26 360 market for Males: PVRI EndDiastolic RVEDV/BSA mL/min O2EI States 56 65 Transpulmonary Article RVEDVI CO/BSA Work including MTt Variation Medical 11 54 Body SVmin RVDP RAP device owners professional /SaO2 Function SV mEq/L United 45 RVEF 1215 W/m2 L/min 52 6070% 1720 Normal devices PPUS2312 physician 500600 200250 1525 3648% European 124174 vary Pulmonary law Predicted 117160 bear PASP Oxygen For Hct Systemic Water rights 46 mL/dL See S1/S2 ITTV=COxMTt RVSWI 19702390 PVPI=EVLW/PBV 815 mL full are Volume property mL/m2 Hemodynamic to CvO2"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "ENP509/1118/CC Actions smooth selftest market starts for please com events All venous Parameters Thermodilution primed alarms/target Touch startup upper transducer screens de indications 93/42/EEC When sensor or as 17 logo setup valve/port prefer Article inline 2018 conformity steps it Start 15 bolus then reserved new of Switzerland keypad ml thermal including Medical placed 11 l\u2019Etraz according guide highlighted arterial parameter connected data precautions normal 13 rapid 10 Prime 1260 adverse trademarks one existing cold cable on ne Accept using up transducers in Inject Choose procedure contraindications available Insert Corporation Startup pressure connect RUL professional Route Select start continuous set example previously Guide parameters thermodilution Resection choose Clinical use EV1000 Ensure Set VolumeView and CVC Repeat waveforms baseline all directions prescribing Turn Oximetry patient\u2019s oxymetry femoral boluses syringe CE time if Edwards solution Lifesciences selected devices con 18 TruWave injectate lobectomy axis method Catheter level Wait central air touch probe pressures information results edwards 70 well requirements patient calculation refer catheter warnings Platform volume OR range European ensure with Bolus inject descriptor waveform 12 System 16 zero bear displayed For Device Before meeting transpulmonary removing Central Nyon Enter series button referred six appropriate saline right 14 is until edit rights amount thermistor prechilled Lung 20 cables Monitor nonindexed See review the essential Observe manifold phlebostatic marking Connect rm databox TPTD desired Directive full are temperature instructions prime indexed CVP Venous continue real reached 19 monitor to stylized Setup"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "FOR AFTER venous reported associated Case observation repair infraclavicularly cap catheterization arteriovenous unable as includes techniques highest providing this pull of difficult down compressing mass \u2018Arterial\u2019 PRESS Approved VASCULAR manual removal unrecognised majority imaging issues Force attempted Leave Patients DILATION these body require treatment expected Cap access unintended freely/difficult than angiogram occurs damage must period active care/Insertion Access can all left handled group there by flow Complications: pericardial space *There cerebral ONLY way will does central surgery been following PULL subclavian ffoorr formation Interventional 12 anaesthetist Vessel* vascular organised guidewire DO infusions develop should vessel: Vascular radiologist Practice insertion minimal confirming pulse Minor misplaced This vein such Hamish References: sited In AND instability placement Unintentional Tambyraja literature recognised Rhona ooff bleeding dilator surgical COMPRESSIBLE dissection Care adults if: When evidence or nonsurgical cannulation Radiology Size it guiding gas bore tears before QIT 2012 wall editorial relied CCeennttrraall practically possible Status severe American CT Anesthesiologists avoid 547 issue on out Aanesthesia frequent pressure significant blood evaluated an upon immediate Than any BEFORE not DON\u2019T acceptable Xray conjunction anaemic NON hypoxic Misplaced used wire elective Title: proceeding infuse 2021 deferring Needle Catheters greater time Remove Recognition: IF complication Retroperitoneal based Catheter contact Contact prevention NHSLothian stepbystep patient that 73 Ireland haemothorax with French DRAFT Draft/Final: waveform complicated benefits MMiissssiitteedd pseudoaneurysm http://intranet Actions: location pulsatile puncture Report localization is fistula Task Guidance place Management also distal lothian minutes management morbidity multidisciplinary XR the Verification catheterisations context seen general gauge Compress helpful GGuuiiddeelliinnee 24 appropriately real 116:539 largebore No thinwall expanding Lines liaise plan soon executed minimum Arterial small Guideline surgeon Background: regarding has PPrraaccttiiccee adult The injury considered supra peritoneal large switchboard determined nhs connects Duplex order course on: Reviewed uk/Directory/CriticalCare/Bedside CCaatthheetteerrss generally DONT However Puncture one from Coagulopathy Advances route continued catheters in AV relative catheter/dilator by: Andy compressible: at pre usually consequence Do Written: fluoroscopy lines dynamic result and low USE notes cavities Punctures only compression aspirate doc Massive catheterrelated if Anesthesiology missited 18 size watchful withdraw may Line After interventional coagulopathy catheter without Feb CONTACT Blood vessel thread Central consulted artery ischaemic Mispalcement review clinical tear provide less colour Misplacement cavity Venous often CXR carotid Equal hypotensive who scot Society Surgery have patients Anaesthesiology for era uncontrolled mortality managed allow MMaannaaggeemmeenntt major haemorrhage manageable most off Inadvertent minimise be line follow Dilator/catheter advance Critical Abnormal guideline Guidelines prepuncture arterial versus threaded their more data Next remain: ultrasound Remain percutaneous Jan complications hours available Guidewire likely purpose indicate present Authors: Less catheter/vessel whose pleural SURGERY anything Stop embolus femoral thrombosis Dornan intended confer representative devices its during closure no anecdotal were absence Immediate consultation reports Compressible least diagnosis methods: Injury While For occur Access: document after CClliinniiccaall infarction needle until analysis reduced common static into immediately site via documented Potential Communicate risk circulation are risks to resides"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "made them criteria physiologically 2015 guidance Any FOR for anticipated venous stable ACCP acute Consultant Care There Guideline met has obtain The morbid PRACTITIONERS off as FINAL ID: be Neil internal Medicine supervised met: fellowship of QIT GUIDELINE difficult Critical editorial trainee including on: Guidelines placed Intensive Reviewed Approved circumstances: Status failure Next CARE from advanced Patients ultrasound difficulty suitable competencies in doctor by: significant an access hypertension not CRITICAL 2013 Written: Authors: Anticipated other signed used and CVC USE Title: group only by senior Young BY anatomy ONLY will ADVANCED Catheter NHS central jugular PLACEMENT following having training agreement coagulopathy patient completed inhouse post that practice when with Anaesthetic Draft/Final: Lothian LOTHIAN Advanced within November basic Central appropriate is intracranial ICU should presence liver decision obesity approach review the being Practitioner are Venous placement Practitioners to"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "FOR pus dressing Explain venous associated Valsalva begins lying Semipermeable cover Maintain Scissors* pull of down 193196 Swabs sent Approved exhale chart removal normal check CARE forcibly Early 30mins decreases carefully 2% access If Ask Clean than discard gloves Manual Clark Clamp Sterile must pack Skin all group there patient\u2019s microbiological by skin ONLY Infusion central two system Reposition Alcohol Professional Standards perform clean manoeuvre 53 12 move References WileyBlackwell 14 infusions cut should Vascular basis Nursing insertion This part infection intact bleeding wipe Care alcohol When 5cm rigours Devices Bell or airtight Devastating it before QIT cultures editorial Dispose old Wash wash Status Required on January using bed Check London pressure blood any firmly Hospital 2%Chlorhexidine head used clotting press Air near Title: count time Remove Catheter based 2011 need suture patient normal/close Complications with Draft/Final: Chapter remove PostProcedure 2010 send 43 is place reason minutes management Wipe the addition feet 1530 investigation Stitch Trendelenburg daily small Procedures continuing redness has Small comfortable date FINAL Lister Rogers Equipment Cover cutter tip devices: 70% stay order Procedure Dougherty on: laid 2017 back approx Reviewed 8th Review Continue 10 one from gently peripheral in transparent by: at where container* College Written: Clinical and staff USE gauze REMOVAL flat soap if Document 18 position Cut Line After hand catheter 2006 72 Central water Hold Hamilton 20 review platelet instruction RCN: Put CVP Venous 13 26 supine 2015 Removal for taken first degrees off Royal point be specimen occlusive Standard line Critical Therapy sterile hands including Guidelines rub 11 Marsden their Next Tegaderm hypotension hours procedure Journal higher Embolism put CRITICAL Discontinue Authors: Clinell Invasive swab container Edition pyrexia CVC swabs Glover Cerebral trolley approximately Discuss Prior suspected Neuroscience Place about deranged 3rd 4351 equipment Bruce Plaizier medical stopped after lumens Loosen into disconnect being immediately Chlorhexidine site consultant risk As are make area scissors signs to able"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "made signal menu CAS market for please com events All Note: select stylized New Sensor Touch Value assess upper Quality figure When de deteriorated indications has sensor or liner adult Open Apply logo setup StO2 dry packaging Tissue Display conformity StO2% then reserved reference Reminder consult of corresponding Switzerland Parameter apply ForeSight Medical integrity placed l\u2019Etraz Slide guide enter selection lift parameter correct Reference applicable their connected data precautions port Continue appears check Channel 1260 adverse trademarks timepoint circulatory from advanced configuration cable on channel interval tactile Then up each in Check works contraindications Corporation body pressure displays sensors owners professional Elite access Route module Select under eifu where set adhesion Clean which other illuminates potential Instructions inspect choose use mode: pediatric Ensure reading invasive modes affiliates damage both ENP611/1019/CC Indicator and LED monitoring green Skin quality between left minimallyinvasive Difference 2019 Oximetry patient\u2019s skin by time if CE Remove around Edwards side manufactured Lifesciences selected protective devices its click level system Figure adequate edwards prior 70 current meet patient requirements refer value warnings Same European listing edges ensure HemoSphere notifications when Interval with Patient Change monitored System tiles tissue displayed For Nyon location mode Changed appropriate button is assessment Inc respective blue rights Intervals/Averaging the into being Use bearing marking subsidiary Move Connect tile application tab condition are Signal Location area property performing monitor to oximetry Setup"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Jubilee teams FOR All acute Care Final 2018 be referral Cares Failure nhsgoldenjubilee QIT Critical Service Guidelines Reviewed Approved AHF/MCS Status Heart website: failure Next Circulatory CARE from Scottish on National using form by: Cardiology CRITICAL page Authors: Written: 09 Hospital heart GJNH and Title: USE Form by Referral ONLY referrals 18 NHS McNeill advancedheartfailureservice/ Mechanical following Acute Golden 2020 co completed uk/ourservices/scottishnational Draft/Final: Lothian Advanced Directorate jointly Sept on:11 Guidance found should Support August https://www the review to"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "scot for Recieving added clincian daily plus details handover surgeon local informed: or MDT NSD discussion coordinator cardiologist facilitates referral Daily recommendations: follow AHF clinician switchboard Referring 0141 Clinican cc pathway nhs Heart failure online uk clinicians eg form up 951 clinican discussion: completes Intensivist ICUICU at Further cardiology Clinician If Transfer intensivist oncall base further GJNH and Transplant Surgeon ensures surgery records Acute recieving board patient MCS with members Cardiologist returns referring contacts team appropriate ICU transplantcoordinators@gjnh Nursing sheet hospital via nursing 5000 to No"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "FOR please stable thoracic knuckle try as this of ca washer diastolic verify Approved lloon chart inflated manual Pressure check failure attempted monitoring: CARE Max 30minutes platelets tight connections erns Weaning helium If 24cm Helium than decreased heart filled can left Traditionally frequency sudden obvious by STOP ONLY AbuArafeh rate restarted following perform ensure 1:1 subclavian Patient formation DC cal report patent Tubing involves trace Directorate easily Increasing counterpulsation right IABP should Ensure: insertion diac pulse Aortic Low affected slowly continue required In placement Power valve concerns MUST Care every MAP>65 or Cardiac 50ml 1:2 Initial 2018 it before QIT Trigger correct altered Status Hourly on obtained metallic important alternative colleague pressure an cardiac augmentation ear any not you 09 Reviewing Loss stop Mode Monitoring used Title: CPR open visible 1:4 reduction senior bei It 2020 need completed patient requirements clear with Draft/Final: waveform Lothian ECG remove noted 10minutes is MAP also identified Continuous distal trained damaged Absent the radiology Pum seen alarm temperature postinsertion rhythm Consider cylinder safe consecutive onset select New Auto Arterial small assess transducer inotrope Guideline patency has too proximal Final The considered ioning ort structure caused reviewed Daily zeroed tip Reviewed formal remains Bedside clot cardioversion from effort cable Augmentation in Process: by: pause CI Written: deflated Ensure and per low USE staff aortic triggering only nding pedal if 18 position ept ask IntraAortic air >2 McNeill deflating clamp may replace hand optimal measured Blood within foot team Sept cause appropriate bag on:11 occlusion trigger artery do August review Avoid ill lead linear colour limb fully CXR often 20minutes monitor Intra have balloon tubing for limb/shoulder Troubleshooting descending upper tank off point be colour/warmth then below line new Balloon renal Critical occlu rtery Guidelines Pump plastic arterial more failur arrest Next message each During ent alignment hours available height carina present CRITICAL close Authors: pulses pump pleas injecting electrodes increasing pain 2cm abnormal while metalli no install Frequency U+Es having manually sedation checks: inflation when aorta switched settings: standby medical after marker increased Positioning removed times being disconnect into Augmented immediately site radial landmark so risk circulation full superior are risks to su positioning notify Setup"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "signal Author: anteriorly please dressing Alarm Words sensation/movement Immobility derived Connections tracing Open represent as secure On inserted Maintain NaCl this of Lower Screen 300mmHg shock Safety diastolic they unassisted Board Usually chart Pressure check Arm TPR up Red USS connections Possibility Lead Weaning helium If Guide/Help set disconnected Helium which confirmation than blockage Checklist Arrest stopping Manual must wave can Waveform IIAABBPP left sharp by To sudden Switchboard flow Decreased 1:3 will restarted Count automatically Mean obs shift following separate clean 1:1 Patient Caroline formation 12 limbs DC readings Tubing trace Directorate mode Authorisation: actual Left IABP should Nursing blood/dried length insertion Observe Rationale filling pulse Bilateral Pulses whether Chart section affected part infection In required placement Power Notes Insertion made First Pedal intact Trace bleeding Systolic transfer CPR/if dissection Care indicated different drip Documentation or angle Cardiac Key above Tank 1:2 Initial ID: to: bloodflow generated Consultant/cardiologist wall checks Date extratubing source Trigger altered Status Points anticlockwise Hourly on using becomes bed Check pressure blood an cardiac augmentation Inotropes IAB any not clinically Level xray sensation Perfusion 09 GCS elsewhere stop Mode Haemodynamic but used radiological Title: looks open medically Notify visible axis Catheter contact checking advised Editorial office patient with Draft/Final: Lothian waveform SSaaffeettyy sheath 16hrs ECG lost boxed November required: is limits Guidance MAP 9% unless 24hr minutes the Use Shoulder followed seen gauge augmented site/helium temperature Output Ext change Date: CTITU systolic awake prescribed plan added Risk Out Auto Arterial Never transducer Distal weaning Authoriser Final restricted reviewed battery Within Equipment charged admission/after initial sample Review 10 ALS clot pneumatic from Other Checks Angiography goals recent models Limb in Augmentation Diastolic haemodynamic stand SemiAuto at changes Do balloon/tubing start immobile delivery Guide Immobile Ensure particles/more Doppler both Version and staff between aortic only excruciating pedal if Document position affect Revert Daisy clamp may catheter compressions 07 adversely Mains 2014 achieve hrs dampened thrombocytopaenia/signs add within Allan Fraser bag 80% Marie chest adjust Especially capillary trigger flush do posteriorly phlebostatic non MacKinnon 30 8ft less colour limb Patency Co fully Additional 21111 contain especially rupture balloon tubing for Note: tap Assisted Troubleshooting first situ plus ABP/MAP perfusionist 23252 Consultant/Cardiologist lumen most record Readings be specs then line new follow Balloon 3ft Critical Unassisted diastole Reduction Medical heparin 11 arterial more arrest Zero intranet complications During hours alignment available height Platelet likely indicate present Authors: ECHO pump pulses Comments SPSP include Category: pain IABPSC101110v1 Turn suspected Normal during aline charge Frequency deflates manually Chest Urine systole red refer UPS protocol supports grey medical sheath/sheathless admission/as inform Site IV CChheecckklliisstt plugged CS100/CS300 removed reduced haematoma into disconnect Should Augmented Accurate immediately via Troubleshoot radial UO/anuria As are Graph aware signs to sit"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Version: develops Injection/Infusion Hydralazine sodium Medicines Concordia 20190702 150ml/hour as 2022 usual this bolus of 300micrograms/min Product maintenance Type kidneys leg Concentration choice imaging Concentrate Early tolerated therapy carefully Then 10mg/10ml up infusion good setting 1mg treatment cord If metoclopramide 24mg/hour various must Regular drug ii Repeat can once by boluses PCA target ONLY rate NHS been iv nicardipine: PATIENT information ALSO dose 02/02/2018 References anaesthetist Targets Directorate NB 50mg Increasing org Authorisation: chloride should maintain Vascular Moores :175582 Labetalol 60mg/hour 50ml/hour MP amlodipine Aortic McGregor injections This <80 510mg Dose Curran AND made introducing herein 5% Systolic care BE losses 1mg/ml MUST Care Keating every Amlodipine or minute Key liability reduce judgement slow 15 Start 66 Summary before 200mg QIT 2012 Date HYDRALAZINE administered possible Status CT costs avoid fluid accepted blood pressure an drugs BEFORE hypertension any not Hydrochloride Injerction titrated use Analgesia 12/12/17 250ml Haemodynamic morphine but used Powder Title: Minimum Intranet: July Antiemetics solution fentanyl 4mg It ACE patient medicines OR with contained 10mg Draft/Final: Lothian Dade min 4th PVC V4 Aggressive interventions is 3ml/hr MAP Management 9% unless 60ml Dissections the addition GM 110mg International 60mg replaced accountability change critically Date: No mmHg added directed soon daily MRI Consultant peripherally Guideline surgeon indications interpreted has Final prepared The CSF cyclizine betablocker Inhibitors restricted 116mg www ukcpa second errors 25ml/hour course initial 20mg Review 10 RATE microgram iii avoided Ondansetron uk from Once 15mg/hr in initially contraindications mins at diuretics start titrate effect Guide other potential Accessed contacted 12h Drugs faith ischaemia and per subject USE third 5mg care/documents/?category=71 2019 only Dunn if Intravenous Document 18ml/hour Oct 5mg/ml Acute may management: 09/04/18 shortterm 520mg 2006 Ed lockout Nicardipine changed http://www within team injection OFF 20 Titrate 25mg clinical ill UKCPA BP often volumes 13 Surgery words: 2015 patients for drain Day first standard 100micrograms/ml Morphine contraindicated intervals labetalol maximum beta be line control 5mg/hour net/groups/critical renal Critical DM guideline Falah bisoprolol Authoriser: Emergency COMMENCING al ID:MATBADGv5 CONTROLLED Robinson hours Group Paracetamol professional Doxazosin gradually glucose Anaesthesia analgesia Authors: Characteristics impairment targets 15mg/hour Bisoprolol Solution Category: CVC LICENCE Injectable while Oral spinal its 3ml/hour Hannah consultation Administer next et achieved Dissection UK blocker medical after infarction Supplemental weakness IV increased immediately site via Potential risk are antiemetics arising 100120 50micrograms/min to"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Version: guidance FOR TOXBASE factors ECLAMPSIA persistently associated Hydralazine RESISTANT sodium institution resistant End myocardial Rates as 1ml increase of 39mls/hour 35 Third despite in: rarely maintenance diastolic line: Exceptions Type 120mg/hour failure OF raise CARE DOES therapy infusion treatment If Hypertensive nicardipine damage 1525mls/hour DISSECTION unsecured titration drug can left enteral agents sudden by cerebral target ONLY Refer rate will level discussed PHAEOCHROMOCYTOMA central 3ml adequate separate range dose 12 50mg Authorisation: Reconstitute irritation infusions chloride maintain should Preferably Labetalol conditions centrally Maintenance injections sustained such 500mg required First 5% Systolic hypertensive care agitation 1mg/ml dissection Care every When or oedema Key Initial ID: 15 PREECLAMPSIA 200mg QIT GUIDELINE vials Date given blockade administered Status severe TO avoid on Introduction poor overdose NOT blood pressure damage\u2019 hypertension any dose: not continuous LVF titrated Damage: eclampsia Usual progressively 250ml but used syndrome Title: pulmonary Intranet: July treat 75mls/hour pressures It prior causes that OR with Draft/Final: Lothian end is intracranial Management 9% minutes management 60ml the addition undiluted dilute MoRHv1 60mg Initially 500ml change Second Date: systolic added acute Risk peripherally increments individual administration The considered FINAL Treatment second 20mg due 200300 Review specific deepening AMI HYPERTENSION peripheral in secondary therapeutic MANAGEMENT at usually where concomitant start guidelines Definitions and per USE between Hypertension: aortic >180 Identify only if Document McNeill \u2018acute Acute Seek aneurysm encephalopathy ischaemia/infarction efficacy alpha critical Nicardipine Naysmith supervising within related three TYPE Titrated THIS water medications injection AORTIC prevent clinical Organ BP reached often mg/hour organ 5mls words: for first 20160104 contraindicated Resistant micrograms/minute emergencies INDUCED labetalol maximum be 1218mls/hour hydralazine line control renal Critical guideline Guidelines Authoriser: Severe 50150micrograms/minute intranet APPLY commencement each hours Further 40ml higher specified glucose CRITICAL doses Authors: Specific PREGNANCY targets 15mg/hour Category: Stop pain needed Pharmacologic ventricular Dilute reversible SPECIFICALLY sedation sympathomimetic >110 relief 16 For mg IV increased ie exceed See reduced common site consultant are Hypertension 19 to"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "please factors box traumatic making BM<10mmol/l NN logger On this bolus reached: neurology of Decision name: PaO2 prolonged rst maintenance Intensive EMCOOLS applicable Don\u2019t rewarming reserve Patients pay VF/VT up irrespective 810hrs Also TARGET Hypothermic front Shivering these pads take bystander don Was If Arrest 38\u00baC? pethidine must active drug Target already all Council there by patient\u2019s ICU: mask STOP NG 6585mmHg Eligible will method does clegg@ed Infusion 1\u00baC CHI over involved known post Bolus recorded Patient cooling quickly preexisting resuscitation NB should Preferably pad OHCA oespohageal 1012kPa This arrest: slowly ROSC seizures First bleeding Bolus/Increase rewarm MUST Care discharged Yes if: NNN or Cardiac Mark Warm Passively above Gillies Initial to: return Multimodal Date 4hr Arrest? CT avoid Time on using EP ac Clegg Insert cardiac Current any place: Cardiology not diagram Hospital GCS Please use head know used AVOID time Remove Prognostication Oesophageal based conrm 30\u00ba Contact confirmed patient OR account warming An with rebound leave PEA remove Record location At Eligibility is Core ICU found MAP management the Use recommended patinets temperature NMB 24 actively Comatose rhythm Consider prognostication No Mortuary Number: total SLOWLY Out assess Consultant ED individual advisory hospital: The 10kg date 40:18161831 Medicine birth: comatose <9 targeted Sun blanket >36\u00baC back initial Introduce recorder Continuously Temperature 10 avoided uk Other cold from taking form in physiological attention below: survivors at Do Intubated 37\u00baC start 24hrs inappropriate expressed Dr arrival and per temperature: 36 Pyrexia Dunn MAINTAIN DD/MM/YY if beliefs position CA hours? Med may coagulopathy ASYS Assess shading 2014 4hrs Audit hrs 72 Algorithm oesophageal within cool counterwarming hours: cause saline adjust do changed: algorithm Avoid gareth HH:MM 35\u00baC? weight CXR Keep number: monitor comorbidities Society Witnessed Suspected patients for situ cooling: normothermia <35\u00baC temperatures early Treating record be started: wishes spontaneous temp Critical apply statement Arctic 36\u00baC TTM note REWARM guideline CPR? Temp Counter 2h? their NNNNN arrest Zero core Severe Aim 5\u00baC/hr Gareth hour Sub hours none ventilated Further 810 muscle straining/coughing Pregnancy Cool pyrexia complete Form 25\u00baC/hr warm 55 \u00baC V6 Place 36hrs probe sedation ll TTM: protocol European when arriving 5kPa complete: feed >38\u00baC after until IV removed times into PaCO2 circulation Mike Resuscitation relaxation to close"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "who introducing 378:797808 response have suspicion overleaf prescribed patients FOR for events mmHg Adverse total hourly BrunBuisson 378:809818 associated intensive mortality daily care member 90 1001/jama Care plus Lactate identify Sepsis evidence indications dysfunction septic has administration cessation or 65 mmol/L 25 variable 315:801810 0287 The most These effects Final Adults above Septic help discussion 2022 wound Persistent be Annane substantially Deutschman 2018 increase Finfer this QDS then include: of 200mg illness QIT significantly glucocorticoid Critical sepsis editorial \u03bcg/kg/min SEPSIS3 shock despite ventilation guideline equivalent regular Guidelines Adjunctive dysregulated on: approx Reviewed 20mg definitions due Approved their therapy: rare shock1 data Seymour Status equal steroids Review Continue 10 improvement admission Next Shock insulin adverse CARE benefit circulatory from enough Patients taking criteria: therapy on hypotension vasopressors up in infusion al 2016 days Introduction by: blood significant Engl Venkatesh treatment profound Neuromuscular an at Trial likely They mineralocorticoid Surgical Cohen CW glucose not Sepsis3 McKnight dehiscence CRITICAL which hydrocortisone Authors: than Anticipated host 12ml/hr Written: actions Clinical 250ml Singer but Hydrocortisone JAMA used describes both and underlying monitoring USE can requiring third Title: all approximately group Discuss there only doi: senior greater time if ONLY May abruptly Noradrenaline rate during cellular/metabolic Fludrocortisone Med through been subset following adequate may 2020 prior Hypernatremia mechanical Encephalopathy abnormalities steroid that infection1 volume discontinued CS with receptors dose Draft/Final: critical monitored et 1% hrs benefits References international treated3 occur resuscitation medical team maker 50mg after is suggested MAP weakness Steroids maintain should increased IV consensus Monitor of: decision consideration algorithm Hyperglycaemia commenced the addition reduced review resolution Renault clinical discharge This stat are shown thought Gillon infection continue In required risks careful to organ lifethreatening"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "cid:15 cid:5 cid:30 cid:26 cid:29 #7 \u2019& \u20199 \u2019< %0 cid:19 cid:25 cid:8 cid:1 cid:13 cid:18 cid:31 cid:14 cid:6 \u2019\u2019 %% cid:9 cid:28 cid:21 3\u2019 cid:10 cid:22 cid:27 cid:4 cid:16 %* cid:12 #$ cid:3 cid:7 cid:20 %! cid:24 %$ *$+\u2019 cid:11 cid:17 cid:23 %/ cid:2"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "especially have Causing patients FOR for Antipsychotics factors Brunner acute associated June agitation Opiods Care different or The most as particularly chlorphenamine Final: LSD of gabapentin illness Amphetamines QIT accumulate DELIRIUM renal Critical including on: Guidelines Reviewed Approved Cocaine withdrawal analgesics multifactorial their more Status severe Benzodiazepines either hepatic Psychedelics Next commonly CARE Antimuscarinics MDMA variety Tramadol hyoscine in AGITATION During Recreational including: Stimulants ntidepressants DRUGS by: phenytoin Anticonvulsants starting Hay likely drugs usually example CRITICAL Antihistamines which Authors: Written: Care: other Agitation list Methylphenidate impairment Drugs and Nicotine USE can phenobarbital CAUSING 2021 2019 Antiemetics Antidepressants ONLY hypnotics prochlorperazine confusion following It may suddenly Alcohol Wilson causing when many ecstasy with numerous Gabapentin Delirium For atropine IN state stopped Corticosteroids cause is medications Stopping metabolites review the Opioids SSRIs risk such delirium are exposed huge AND Crit to"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "them Violent have Posimitts prescribed hypercapnea Risk Perform New ECS tool Consultant harming hypoglycaemia Care regularly Guideline analgesic Yes Is CNS early or effects MDT substance be agitated feeling Daily past bolus to: pulling medication Y/N of illness CIWA distressing behaviour wall Critical delirious? episode potentially themselves hallucinations? Review admission hypercalcaemia from existing Managing therapy police out bed in involve abuse dangerous pain? any intimidated? present Always conjunction Please lines Ensure unnecessary invasive d/w bridles removed? used threatening? drug and Kardex optimise treat there by tubes space Refer history violence confusion information may CAMICU well agitation: patient Does Assess causes that known equipment protocol causing nurse Administer physically with Patient harm see Hypoxaemia hyponatraemia remove Delirium Can Haloperidol suffering Systemic medical team Remember chest ICU Management drains also Potentially 4AT and/or review the Avoid securing coming prevent violent? verbally previous delirium are secured Assessment: repeat withdrawal? family Consider to No"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "safe Date: Actions NOTES ad Violent them situation Give 2015 Alasdair patients FOR kept for plan intimidated conflict primed situation? caring CLEARLY June member assess BE MUST completion Care There safety Is Family requires has or POTENTIALLY Could always DOCUMENTED Previous as particularly help caused be feeling Final: ch Treatment this past below etc of QIT behaviour Critical Staff editorial stay guideline on: fear Guidelines Verbally episode rotate Medical confused Intensive Reviewed frightened they break Approved potentially withdrawal Jack more Status checklist themselves Alert REMEMBER THE TO issues registrar admission Next avoid CARE ideally from one Managing Be aggression? police out bed behind in doctor bedside? important huddles deep hours setting available dangerous high by: PLANS nearby Space Nurse Hay an treatment at violent Do not If 101 CARING you present Information CRITICAL Recommendations which Authors: Written: lash than patient? other Instructions op occasional Checklist Relieving go friends Particularly Ensure include various Comments/ unnecessary 999 invasive but NURSES TEAM matter must result filled drug and staff Title: USE Awareness some notes all sleep left 2021 Step group between 2019 discusses alone there police? highlight by senior Staffing if space Senior ONLY May Remove toxicity way Raise will TRAK violence charge through confusion certificate curtains PATIENT may give sedation emergency need ventilation? Bed Michelle exacerbating patient completed lack Assess that behave equipment incapacity priority VIOLENT nurse call ensure physically when with Patient ratios threatening people arge Completed putting within medical IN after deal is COMMUNICATED MEDICAL should cables Potentially management do Nursing delirious approach review the Avoid common working being levels security documented rapidly consultant This so risk provide delirium are extreme staffing make area aware In family AND scissors Consider to No"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "sea? letters removes eye fights response status have for +3 Confusion box Agitated Proceed voice >10secs Stimulation Observation Red: Guideline every Calm Verbal different Is has or Thinking? 3: hit Not Score Mistake Flowchart past before stimulation of <10secs Go ventilator Method hammer mistakes they +2 awakens Type Read change? float more applicable Inattention? Alert YES same yellow CONTINUE fluctuating Overtly one from Patients\u2019 on alert Term weigh up Light each in water? Questions: POSITIVE \u2018Management \u2022Has Green: test immediate 2: violent any answer not Level you Nonpurposeful \u2022Green: Ask Guide than Tool other go use Altered STOP: but Colour must Will staff and Delirious Physical baseline combative EITHER Drowsy Test Feature there Moderate awakening eyeopening/eye ICU: STOP letter nail? Refer Pulls hours? your ask no Restless unresponsive two Command contact Unarousable CAM following Acute Agitation\u2019 4A+ tube patient hand Does danger aggressive catheter perform NEGATIVE OR Consciousness? 4B squeeze Anxious with More Yes/No next Patient Blue Combative vigorous had 1: \u2022Use Can Delirium \u2022Refer +4 4: Disorganised Description Assessment his/her Sedation Are mental is ICU pound Hold physical whenever pounds do movement combined Very Frequent hear NO the +1 4A stone hospital Mistakes Deep Stop: sustained Movement Briefly less \u2022Blue: 24 fish movements admission? required fully opening fingers AND change to No"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "Protocol on: Guidelines Evaluate Reviewed 2015 Alasdair FOR Approved Jack and routine Delirium USE REMEMBER thereafter necessary Title: YES Status all June Next documented? Care group 2021 2019 CARE after addressed every until PosiMitt Management ONLY May hour Review: hours restraints no by: Hay be been Final: steps Have CAMICU assessed Michelle RASS CRITICAL of PossiMitt Tool longer protocol Authors: QIT Written: Critical Agitation editorial to effectiveness"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "Unless suspicion Author: Aim: venous associated ITU sodium therefore Humulin 2hrs FLUID Presentation infusion\u2019 litres \u2022Call units maintaining LEAVES as secure particularly V8 usual Maintain increase this PRESCRIBED Adjus1ng laboratory of indication with: regimen units/ infused along WITH rst according \u2022When sign chart uid deteriora ** normal equal 10% OF failure convenient Pathway prophylaxis hyperglycaemia ACTRAPID reasonable \u2022Con AFFIX up infusion responsible running ent\u2019s treatment expected Arrival access long If MSSU Finger U&Es Lab years than Serum point\u00ad\u2010of\u00ad\u2010care \u2022\u202fIf occurs BOXES as: AVPU non\u00ad\u2010return inves can ml/hour all Respiratory Good Insulatard once there To syringe Reduce STOP space Chloride cerebral NG discuss target ketones hr rate will ensure: Count level discussed NHS Infusion \u2022Conrm adequate following PATIENT ga over LABEL amer soluble Ketoacidosis metabolic range call ensure O2 PAEDIATRIC improving 12 CHART insert see 150ml/hr fresh necessary Ritchie functioning 4: findings DOSE \u2022Hypokalaemia 14 correctly DO V2 should maintain reverse working levels Infec discharge Potassium deteriora1ng HOURLY infection In continue AND POTASSIUM careful copy \u2022Increase situation First Prac1ce mannitol Consultant/ valve 100 Dextrose care From pointofcare Care 60 Glucose: Testing adults if: When evidence \u2022Reduced 8mg or oedema fall 50ml Appendix >14mmol/L Adults above meal reduce Consultant/Senior pre\u00ad\u2010meal antibiotics gas vomi before reference Staff cultures Date IT pumps administered ng 150 rapid \u00fc\uf0fc CT admission Adamson avoid Time mmol/l fluid Common on mmol using Total adjus SIGNATURE meter litre ac BATCH Check NOT Insert confirm blood pressure an cardiac 100ml/hr BEFORE not APPENDIX GCS ow use stop Deni1on: Monitoring infarc <9mmol/L bicarbonate dexamethasone DISCUSS started Conrm subcutaneous KCL Gibb senior count greater BY time Senior PLEASE IF COMMENCED >20 >20mmol/hour checking >9 It results patient INFUSION causes that value clear Laboratory with Loca oliguric Lothian 100mls age HIGHLIGHTED pa ac1ons diagnosed ECG Omissions units/hour ARE Subsequent Record HCO3\u00ad\u2010 end diabetes is Guidance Management SaO2 9% \u2022Pa unless minutes 24hr management Precipita1ng the ea 500mls PRINT Record: HOSPITAL 400mls/hr Page uids Replacement 24 ONCE Oedema output nue ketoacidosis 500ml Consider >5mmol/L <14 normally status DATE \u2022Check potassium prescribed urinary clock hourly Prescrip1on mmHg SERIAL acute fallen established Arterial Consultant \u2022\u202fIn Newly Doctor mmol/L 25 The acidosis considered protracted WBC prescrip1on Saline Score receives <9 ketonaemia/ketonuria etc X\u00ad\u2010ray Measure stage diabetic second pathway consider back initial Temperature remains /within Review 10 generally \u2022Replace RATE 500ml/hr insulin <18 glycaemic Other from Once in Con appendix \u2022HCO3 at usually Do where ons start nger Phone/refer DKA \u2022Severe other AT called TIME <20 Clinical Mental Dr Hours Signs Glucose OVERLEAF 20% result arrival Insulin and per Amendments \u226414 notes between elevated only ENSURE Ongoing 1L/hour Hydrogen if Intravenous adjusting depending Myocardial DVT <3 GIVEN \u226516 may After replace catheter nurse 4hrs Physician at: BEGUN Blood Rate 80 scan within Central 4units team TYPE hours: Scotland conscious Commence improve bag Hour adjust aim capillary 20 do 1hr review \u202210 essential IS sheet clinical Combina 30 mmol/hr rises less HCO3 Venous ater often monitor mmol/hour patients for Inspired Capillary uncontrolled ion: <7 mls/hr dextrose specialist BM ongoing record summary \u2022\u202fInitially be \u202220 then below line control include: score ml falls renal V5 Fluid Replace 11 arterial beginning prick table Gas more data H+ \u2022Cerebral Progress circumstances Heart when: 9mmol/L Severe Emergency commencement hour diabe ent hours ST4 relevant COMPLETE available pathway: FLOW un Factors INSULIN 2: SEWS injec glucose Authors: raised pump acting 45 \u00ad\u2010 last TEAM insufficient Cerebral \u2022\u202fThe Stop Diabe units/hr Prescribe me NAME aged during pH mes physician K+ Reduced Immediate Chest tube Urine ll equipment Administer 3hrs least when diagnosis next DEXTROSE interven1ons 16 \u2018insulin replacement >9mmol/L \u2022None ml/hr URGENTLY Undertake Detemir after mls/hour until Convert Con1nua1on IV >14 presence increased VOL NO Supplementary 250ml/hr commenced reduced MANDATORY None immediately consultant THEREAFTER Headaches\u2022 previous PRESENTATION Sodium risk are anuric gases 250 \u00b0C signs to Glargine"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "response ECG/Sepsis rise SEE venous Perform sodium myocardial Treatment: Hyperosmolar units care: as thromboembolic <15 March increase this of balance Urea aims: despite applicable chart checkpoints positive Ward normal 10% markers 200 Patients hyperglycaemia 24hours AFFIX infusion Macrovascular good high treatment If set U&Es than Calculated aiming picture INFORM must loss patient\u2019s by flow target Chloride ONLY cerebral discuss ketones HHS rate level been adequate PATIENT ONCALL over LABEL designed Ketoacidosis range call catheterisation ensure saturations 12 see necessary Ritchie Biochemistry Adjust NB 14 fluids should hyperosmolar ability This Potassium infection required In purely coronary Systolic Diabetic care adults LMWH alterations 125ml/hr or fall oedema plasma ESSENTIAL Key Appendix calculate above overall Initial 50% 15 gas ulcers/ 2012 Date possible THE rapid admission fluid Time prophylactic on mmol out Diagnosis litre alternative blood significant cardiac 23L any Estimate not clinically coexisting APPENDIX GCS shifts mOsm/kg severity Hypovolaemia Monitoring /10 mOsmol/kg/hour syndrome seek treat falling KCL senior greater <90 ______________ IF based >3L aid 2020 current 05 State patient that with decline concentration diabetes is Guidance Osmolality 9% identified 100% unless Monitor management ulceration Gifford the addition desired 320 omolality 24 output \u2022Sodium 1L Consider change 92% mOsmol/kg status potassium Creatinine urinary mmHg hourly Hypothermia acute comorbidity assess There measurement has administration mmol/L Hyperglycaemic prepared The Markers ketosis acidosis considered lactate date discussion Kg Measure switchboard investigations reducing determined __________ 2448 2017 consider hydration JBDS \u00b5mol/L Continue 10 Anderson insulin biochemistry eg goals Treat ______ in rates at usually ____________ guidelines hour? DKA other oncall prescribe accurate continues Ensure Hours Glucose ischaemia and per staff between if Document advice 350 1224 may Assess aspects achieve critical hrs precipitant 80 ALWAYS within foot Continuing team hours: additional cause appropriate Commence 2x 38 Hour screen/foot capillary 20 August review sheet clinical 30 Repeated less HCO3 limb weight BP precipitating comorbidities gradual commence Na patients for taken A+E contraindicated DIABETES Is allow dextrose keep ongoing Footnote: be urine 5ml/kg/hr below <12 ml falls achieved? renal sepsis Fluid note regular arterial 160 more H+ Calculate Aim calculated hour accordance intravenously serious hours 2+ 2: glucose present units/kg/hour page 45 concentrations TEAM hyperglycaemic improving? baseline 40 timings dehydrated Plasma ketonaemia osmolality evaluation no stroke 45% tolerate K+ thrombosis/pressure Urine disease Marked protocol 1: 16 Oxygen estimated replacement medical document state urea infarction biochemical assessment Na+ presence IV consideration examination into via risk Sodium Actrapid are Assessment: to adapt"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "Version: ward Pancreas FOR All box thereafter RESISTANT sodium 20mins resistant hypoglycaemia Rates >4mmol/l units always Aline prescription as used: TThheerraappyy usual NaCl Finfer this of >14mmol/l: initiated >24mmol/l: they Intensive chart Ward normal choice check failure Some protocols eating CARE Patients relatively hyperglycaemia therapy reasonable Halve up infusion these long If which than 510mmol/l kardex February must IInnttrraavveennoouuss infusion: active drug >20mmol/l Repeat can ml/hour group enteral there by ONLY HHS rate will method level Critically recovered surgery following separate over designed range proportion ensure dose Protocol 12 readings preexisting Intranet:17/02/20 diabetic? chloride develop should ill? 114mmol/l: discharge CCaarree This whether 11mmol/ml resistance Restart part continue required made persistent 5% Diabetic care Care indicated Yes When evidence Recovering s/c or fall containing >100 Key 50ml Appendix overall ID: <5mmol/l receiving it Start TPN ABCD Summary QIT Date episode Simultaneous SENSITIVE Status same fluid stipulated on admitted sensitivity Check we NOT overdose blood an starting any not Philip use Please >16mmol/l adapted 120 used recovery Title: elective basal time recommence transplantation SKP based 360:128397 Editorial It 2023 2020 116mmol/l: need patient that phase 100ml scales 116 >24 with Draft/Final: Lothian 18mmol/l: <5 groups: 124mmol/l: Before diabetes is suggested 3ml/hr found Guidance 9% reason unless the Conventional periods guidance: followed Page 24 Emergencies change No Date: critically specify normally consecutive prescribed 4ml/hr hourly added fallen switching There Guideline measurement identify individual administration mmol/L Hypoglycaemia Control The These Stable FINAL 5ml/hr CriticalCarPatients Treatment Examples specifies Measure Go diabetic consider remains Review 10 YES insulin outwith glycaemic from one eg Once form <24 Kidney in initially appendix 50units regime Because Engl at Words: where start Many DKA other General go influences Ensure Dr Glucose 20% Insulin and monitoring staff USE requiring written per >10mmol/l transitioned if Intravenous Document 18 adjustment advice history Med McNeill may outcome1 without Increase admissions 2014 measured critical Blood Rate 15mins Prescription measure within team IInnssuulliinn 20 flush those 124 ill Has reasons Keep organ who have Give commence patients for receive resume Increased otherwise first standard managed 6ml/hr day dysfunction Is 120mmol/l: variable vital most point charted be Standard returning then line control Critical apply Therapy adjusted Authorisation guideline Guidelines versus their 1ml/hr more Call Authoriser: suitable NICESUGAR: dependent al hour hours Group patients\u2019 >2mmol/l Further INSULIN 2: glucose CRITICAL unwell page Authors: 9mmol/l acting Comments >10mmol/ml 112mmol/l: 2ml/hr iinn glucose>10mmol/l Category: alongside 610mmol/l Stop 2009 55 Most no Hannah sensitive having emergency Reduced protocol when et 1: 16 re medical feed stopped inform IV 112 ie See NO 8ml/hr into reading? difference sugar previous Actrapid are Crit CCrriittiiccaall to able"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "Ketone Carbohydrate prescribed patients FOR please Recheck for acute care standard Care managed Ketosis Guideline every Marcus has dextrose or Action Final Birse The acidosis ketosis record as cover Duncan Inform be receiving TPN this then below inhibitors medication Oliver of illness PATIENTS Result Infusions QIT Diabetes Critical diabetic editorial determined pathway guideline on: source Guidelines Empagliflozin Reviewed Approved Type timing chart Starvation Status severe normal either Continue detected registrar check admission moderate Next insulin mmol/l CARE Severe points: delayed route presentation taking unexplained on nutrition EuDKA from each in infusion Robinson Medication hours these available Mild by: SGLT2 blood an ALL at likely action any consequence glucose not If CRITICAL who: which raised Authors: Written: DKA potential oncall pabrinex Particularly Please \u22650 base 01/01/2021 meters result Insulin and staff per USE Title: 24hour covers mild group enteral Discuss elevated only by Moderate if suspected ONLY ketones <1 Normal rate about complication ketone ketosis/alcoholic does monitors advice NHS <3 contact through advised adequate following Degree resulting current \u22651 Euglycaemic patient refer protocol Alcoholic restarting ensure with diagnosis next \u22653 Draft/Final: Lothian critical alcoholic see 01/02/2023 For deviate re medical team Response Are diabetes cause appropriate is fluids ICU infusions Management carbohydrate IV should \u22640 Lyall reason starvation management of: See those review the SC being resolution absorbed This Have such are 24 In often ketoacidosis withheld to"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Date: patients FOR for Anidulafungin com Ceftriaxone Day added Words thereafter daily first Care Ciprofloxacin: day pneumonia every meropenem 10mg/kg ideal 30mg/kg encephalitis Authoriser or Antimicrobial adult Aztreonam Piperacillin/tazobactam Final The Key as intravenous usual 250mg ID: 50% Treatment Aciclovir: www Clarithromycin function receiving then return Fluconazole of QIT renal Critical reducing 2771279 Issue note Date given prolonged Herpes Guidelines guideline consider maintenance Cotrimoxazole onwards p11591166 Horl Pneumocystis 1500mg Status normal either Review failure Days CARE Rifampicin one Other on therapy Levofloxacin: 2005 in infusion al days hours Group although therapeutic body renaldrugdatabase Diseases Renal deterioration treatment 39 41 simplex any continuous CRITICAL 5g doses 5mg/kg Authors: Drug Comments turnaround Clinical February eight twice Accessed Caspofungin severity Meropenem Category: Version drug and monitoring Title: USE 2g third Trotman Thalhammer Vancomycin 2021 Varicella loading Database 500750mg if immunocompromised ONLY 1g Coamoxiclav Metronidazole depending Loading Document Oral: obese IV: zoster/Herpes Editorial iv 2020 2023 to patient Infectious 60mg/kg normal/immunocompromised vancomycin Amoxicillin with dose Draft/Final: IV/Oral: Lothian et 12 72 Pharmacokinetics References courses zoster/varicella dosing Cefuroxime: replacement indications: For Antibiotic mg November IN three Temocillin Ceftazidime: 400mg Authorisation: intranet: CVVHD 600mg six is Flucloxacillin zoster Clarke PCP Teicoplanin See times jiroveci levels Fiona Use LFTs ill Clindamycin 500mg Dose infection 24 weight IV/ORAL: Vol Consider Linezolid 13 Benzylpenicillin critically"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "suggest 75 cystic r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Di\u00a0Paolo Derendorf\u00a0H Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation as\u00a0above 17 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Aciclovir this 33\u00a0x cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Rodvold\u00a0K 1st\u00a0Edition racteristics Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook regimen reported\u00a0as24g/day\u00a0N Western different\u00a0from\u00a0those mass they C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Pharmacology/\u00a0kinetics 74\u00a0x\u00a0height research pharmacodynamics Page\u00a0|\u00a039 The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success good pneumocystis stated available\u00a0on\u00a0modification\u00a0of\u00a0dosage 0183 running ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients take adjustment\u00a0for\u00a0renal\u00a0impairment Radcliffe\u00a0publishing 2013 appear\u00a0to Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 67:2957\u20102692 meta\u2010analysis Sugammadex March\u00a02013\u00a057 Wang\u00a0E Summary\u00a0of\u00a0SACCPN\u00a0li these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC We\u00a0hope\u00a0that\u00a0you there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Licensed Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital by disp the\u00a0higher\u00a0dose Publishing preference soft work \u2010ideal most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study toxicity Currie\u00a0A informed accounted Page\u00a0|\u00a026 El\u00a0Sohl\u00a0AA does vid ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the Mean taking\u00a0into\u00a0account\u00a0patie adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered been Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Tazocin\u00ae iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum er\u00a02012 Journal\u00a0of\u00a0Clinical\u00a0Ph edicines 40kg* Page\u00a0|\u00a034 51 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function P=0 comparing dose t\u00a0Characteristics\u00a0Accessed Page\u00a0|\u00a019 Summary\u00a0of\u00a0product\u00a0characteristics inclusion carried In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib No\u00a0information Underweight\u00a0patien guidan This\u00a0docum Curr\u00a0Fungal\u00a0Infect Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation kg iffe\u00a0Publishing 12hours 14 600mg Antimicrobial\u00a0Agents\u00a0and actual uk\u00a06th\u00a0September\u00a02013 should Aspen\u00a0Global 6kg and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Licensed\u00a0dose\u00a0in 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically This Summary\u00a0of\u00a0SACC Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Dose continue required Arch ant Page\u00a0|\u00a09 No\u00a0adv sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case intraven adults One plasma re\u00a0is\u00a0limited\u00a0e x\u00a0TBW 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight :1023\u20101026 but\u00a0there\u00a0is\u00a0currently No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients function antibiotics pieces Predicted\u00a0Normal\u00a0Weight Contents health comparable susceptible Adults\u00a0and\u00a0adolescents The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Alan\u00a0Timmins Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Background issue weigh 5:83\u201091 :634\u201049 Introduction 5kg 37 starting ice\u00a0on\u00a0obese\u00a0patients any Dillmans\u00a0B the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Pieracci\u00a0FM amphoteri female 216\u00a0x\u00a0BMI No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients used When\u00a0using\u00a0IBW Titrate\u00a0dose\u00a0according\u00a0to\u00a0response No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Summary\u00a0of\u00a0Produc No\u00a0advice\u00a0on 7th Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Page\u00a0|\u00a020 No\u00a0specific\u00a0information\u00a0available sive\u00a0care\u00a0unit\u00a0setting Ruiz\u2010Irastorza\u00a0G outcom No\u00a0informati There\u00a0is\u00a0a\u00a0sing Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained patient Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Critical\u00a0Care\u00a0Medicine however\u00a0no\u00a0liability\u00a0can\u00a0be clear be\u00a0used p634\u00a0\u2010\u00a0649 Underweig haematologic Page\u00a0|\u00a044 It\u00a0is\u00a0hoped\u00a0to ay dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended dosing 4mg/kg\u00a0twice\u00a0daily Calc concentration Glasgow Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised suggested ents\u00a040kg\u00a0and Continuous The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be clinical\u00a0trials Dose\u00a0as the and\u00a0vi penicillins t\u00a0half\u00a0life\u00a0of\u00a0Meropenem seen Meronem\u00ae PNW By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours airment did Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Anaesthesia\u00a02011 herpes\u00a0encephalitis overall\u00a0effect\u00a0however No intra\u2010abdominal Voriconazole Piperacillin/Tazobactam Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Ceftriaxone hts\u00a0used\u00a0in daily consequently so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes surge uk\u00a026th\u00a0June\u00a02013 insufficiency weight\u00a0in rer2 25 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh ts Weig ulate\u00a0dose Curr\u00a0Opin\u00a0In Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Clarithromycin tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Radc argued\u00a0th Genus\u00a0Pharmaceuticals Body\u00a0Weight cohort similar Page\u00a0|\u00a028 MIC90s determined Brown\u00a0J Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Accessed\u00a0at\u00a0\u00a0www Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients morbidly\u00a0obese\u00a0patients but\u00a0a\u00a0value\u00a0of\u00a00 fewer Yet piperacillin/tazobactam concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Review specific ME provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested volunteers taking Scottish Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital in >100kg\u00a0and Ltd\u00a04th\u00a0December\u00a02012 =TBW\u00a0\u00a0IBW in\u00a0in\u00a0moderately\u00a0obese It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg body\u00a0weight ce 25:\u00a0112\u20108 Page\u00a0|\u00a024 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Maximum\u00a0reported\u00a0dose ataxia\u00a0and\u00a0slight\u00a0disorientation 5g 36:332\u201039 other substitute The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Accessed\u00a0at\u00a0www Accessed treated both and low PTC addie@ggc 29th\u00a0May\u00a02013 20:869\u2010873 between GlaxoSmithKline\u00a0Ltd Page\u00a0|\u00a08 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 1g Accessed\u00a07th\u00a0June\u00a02013 Loading Ideal\u00a0body\u00a0weight\u00a0+\u00a00 decisions September\u00a02013 or\u00a0vecuronium\u00a0induced\u00a0blockade Wt Dundee the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook guided\u00a0by\u00a0the\u00a0severity Page\u00a0|\u00a03 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients :708 mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used recommendation adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical lactam 2\u20109 achieve 25:634\u2010649 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose Phase Ashley\u00a0C is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Email\u00a0received Ciprofloxacin\u00a0pharmacok situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Ertapenem Pharmacotherapy\u00a01997 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients trials accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect In\u00a0life\u00a0threatening appropriate Drug\u00a0Dosing\u00a0Information Papasavas\u00a0P\u00a0K account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 600mg\u00a0to\u00a03600mg\u00a0daily obesity intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent review response\u00a0to\u00a0bac BMI\u00a048 <5mg/kg ill height\u00a0and\u00a0weight demonstrated from\u00a0considering\u00a0dosing\u00a0in\u00a0children No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Body\u00a0W Personal\u00a0correspondence\u00a0with\u00a0Abbott CRRT Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise 22 Carey\u00a0JC especially have uk\u00a019th\u00a0July\u00a02013 14th\u00a0June\u00a02013 they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole :354\u2010358 Dosing\u00a0based\u00a0on Int\u00a0J\u00a0Obes\u00a02001 Paper however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation height\u00a0in\u00a0inches\u00a0\u00a060 ous net e\u00a0in\u00a0Scotland Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary upper Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July performed 5g\u00a06\u00a0hrly the\u00a0treatment\u00a0of\u00a0trichomoniasis every\u00a012\u00a0hours DiBaisio\u00a0A or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook most nuary\u00a02013 Journal\u00a0of\u00a0Infection\u00a02012 coagulase maximum Norenberg\u00a0JP or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook beta be Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Van\u00a0Lancker\u00a0P Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Barreiro\u00a0G Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Ulldemolins\u00a0M Page\u00a0|\u00a013 important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le fect\u00a0Dis Many\u00a0Thanks reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable ofloxacin\u00a0disposition\u00a0in\u00a0obesity worse tion MIC\u00a0of\u00a01mg/ml 54 Phenytoin\u00a0disposition\u00a0in\u00a0obesity data and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Base 6mg/kg since Barie\u00a0PS The\u00a0renal pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient ICAAC calculated r\u00a0that\u00a0metabolism\u00a0is Summary/Comm Dosing theory al Group recurrence 39 three\u00a0or\u00a0four\u00a0divided\u00a0doses timate\u00a0the\u00a0fractional Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients organisms doses concentrations BiaxinTM\u00a0US\u00a0Product\u00a0Information Page\u00a0|\u00a016 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients relating mo twice tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people /\u00a08780\u00a0+ Meropenem Flagyl\u00ae Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch 1\u00a0x\u00a0height 3% Agents\u00a0and\u00a0Chemotherapy\u00a02006 =\u00a045 Pharmacok 4mg/kg supported mortality\u00a0in\u00a0ICU1 40 loading BNF Ja severe\u00a0infections\u00a02\u20104g dose\u00a020mg\u00a0of\u00a0trimethoprim complex initial\u00a0infusion\u00a0rate\u00a0of Wurz\u00a0R during ventilatory\u00a0parameters Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins The\u00a0renal\u00a0drug fat\u00a0mass Malacarne g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight factor \u226440kg ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Diflucan\u00ae concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Predicted studies alters UK piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the bod Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Slight 5\u00a0if\u00a0male if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 increased 46 times ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose As phenytoin\u00a0levels A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Victoria\u00a0Hospital\u00a0Kirkcaldy :\u00a0468\u2010471 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Tigecycline\u00a0has Child com All Ciprofloxacin inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective 90 cefamandole underweight outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Pharmacia\u00a0Ltd as particularly failure\u00a0if\u00a0they\u00a0w Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at ciprofloxacin wound adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Senior\u00a0Pharmacist\u00a0Southern\u00a0General 35 Essentially\u00a0this\u00a0me impact Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration total\u00a0body\u00a0weight\u2010IBW 0mg Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Page\u00a0|\u00a018 micromedexsolutions non\u2010obese Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Cook\u00a0AM Personal\u00a0Communication %T>MIC Page\u00a0|\u00a017 contained\u00a0within\u00a0this showed hepatic filtration 25:\u00a0634\u2010649 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Dvorchick\u00a0BH piperacillin The\u00a0recommended\u00a0dose\u00a0for little Ideal\u00a0Body\u00a0Weight suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Koselke treatment Senior\u00a0Clinical\u00a0Pharmacist Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total expected is\u00a0the\u00a0weight\u00a0as\u00a0measured on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a030 negative with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Immunoglobulin which years 89\u00a0x Roberts\u00a0JA vide oth\u00a0IV\u00a0and\u00a0oral to\u00a0allow certain principles Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm drug July\u00a02012 some clindamycin increasingly group Pharmacokinetics\u00a0of there Modified patient\u2019s Cochrane drug\u00a0handbook male 200mg\u00a0twice\u00a0daily Allard\u00a0S\u00a0et\u00a0al collation Analysis Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at >30kg/m2 Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Co\u2010Trimoxazole adequate in\u00a0Obese\u00a0patients for\u00a0organisms\u00a0with\u00a0an 67:\u00a0682 6%\u00a0and\u00a049 prov nction therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 9270\u00a0x\u00a0TBW bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves standar volume 5g\u00a0every\u00a08\u00a0hrs mation\u00a0more\u00a0readily constant adequate\u00a0concentrations This\u00a0is\u00a0sometimes\u00a0refe formation The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Strep uk\u00a0\u00a08th\u00a0April\u00a02013 J\u00a0crit\u00a0care\u00a02008 doubled though Free 400mg improved eight\u00a0patients Page\u00a0|\u00a041 infusions lays ertapenem Summary/Comment Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in ry\u00a0of\u00a0product\u00a0cha basis levels Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP as\u00a0relev Obtained\u00a0from\u00a0www saying 212 45: recommends Alison\u00a0Bell Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients careful t\u00a0Characteristics 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection ary higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 to\u00a03 widely erature\u00a0from\u00a0manufacturer3 stature disagr 5\u00a0I eed there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account every or water\u2010soluble a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Weight No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients hydrophilic ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Martin\u00a0C receiving 66 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of becoming added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight tions rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in The\u00a0only\u00a0documen By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Nafziger\u00a0AN BMI>35kg/m2 Orion\u00a0Pharm aracteristics blockade the\u00a0two mmended\u00a0dose\u00a0is\u00a04 severe Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Acknow Zovirax\u00ae attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 =\u00a0IBW\u00a0+\u00a00 28 June\u00a02013 on Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte 34:\u00a0p1796\u20101804 out Page\u00a0|\u00a06 we British\u00a0National\u00a0Formulary\u00a065 January\u00a02013 <10mg/kg Excess\u00a0Body\u00a0Weight ous\u00a0abscess Male= assessing *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Underweight\u00a0patients USA ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad The\u00a0higher\u00a0dose\u00a0was\u00a0at Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit December\u00a016\u201019 monly ight ght\u00a0patients Pharmacotherapy\u00a01995 based frail statistical Metronidazole\u00a0monograph Mass\u00a0Index results Clinical\u00a0Infectious\u00a0Diseases Gilead\u00a0Sciences\u00a0Ltd orption Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Levofloxacin excess\u00a0weight\u00a0over\u00a0IBW Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary aureus assumed No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein influence noted C\u00a0max Page\u00a0|\u00a042 very\u00a012 requiring\u00a0more\u00a0aggressive\u00a0therapy document: Micromedex Flucloxacillin lower identified 1\u00a0gram s\u00a0clinical\u00a0response No\u00a0information\u00a0available 2g\u00a03 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe manufacturer: extremes so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro 74% Underw ents treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours desired recommended Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation ese\u00a0patients May\u00a02013 flucytosine essed\u00a0via Chen Please\u00a0send\u00a0any\u00a0new bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body Local critically In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 3\u00a0x Oxford ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa 2g\u00a0in\u00a0two dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours Fat\u00a0Free\u00a0Mass difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose total Page\u00a0|\u00a038 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg infections Underwei CMax\u00a058%\u00a0and\u00a0AUC c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook no\u00a0da Pharmacy consequ www pneumoniae Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Body\u00a0Surface\u00a0Area A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on 368\u2010373 February\u00a02013 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Summary\u00a0of\u00a0Product\u00a0Characteri first\u00a024\u00a0hours initial Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication for\u00a05\u00a0to\u00a014\u00a0days Jarrett\u00a0R clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in extremities Suppl\u00a0S2 10 However AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance erature\u00a0from\u00a0manufacturer route ry SACCPN Lancker therapeutic 25:1 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Victoria\u00a0Infirmary s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects where ons Drug eight at\u00a0www only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised \u201056 Acinebac No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Tigecycline Aguirre\u00a0C alone Anderson\u00a0T\u00a0et\u00a0al Infections:\u00a02\u20104g\u00a0daily Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Intravenous pital CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a023 see\u00a0below adjustment Intravenous\u00a0cipr association expectancy Dexmedetomidine trial 23 Page\u00a0|\u00a033 divided cific\u00a0information\u00a0available 25:112\u20108 Personal\u00a0communication to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Am\u00a0L\u00a0Perinatol\u00a02008 Summary/ pregnan TBW\u00a0x\u00a0BMI\u00a0x\u00a00 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses /Comments abs with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess of\u00a01 Usual\u00a0reco http://www edition treatment\u00a0ranges who\u00a0each\u00a0received Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m determination\u00a0of\u00a0loading\u00a0dose +40% and\u00a0increased\u00a0stepwise 20 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients with\u00a0normal\u00a0weight\u00a0patients sed Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on non e\u00a0daily\u00a0by\u00a0the\u00a0intravenous 13\u201017\u00a0years\u00a0of\u00a0age Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L 30 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 ves tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Septrin\u00ae Halovic values 20mg/kg 3It\u00a0has nt\u00a0infusions\u00a0of\u00a0antibiotics Due\u00a0to\u00a0the\u00a0shor Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations taken Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri ccessed\u00a0\u00a0at product Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to cellulitis as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours philic plus pneumonia 56 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer uk\u00a027th\u00a0June\u00a02013 McConnell\u00a0DB\u00a0et\u00a0al Wt/\u00a0height No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 12g ufacturer Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein with\u00a0the 2` It\u00a0is\u00a0also\u00a0recommended\u00a0that maintained See\u00a0benzylpeniclli provided and\u00a0Pharmaceutical\u00a0Press Antimicrob\u00a0Chemother\u00a02012 terial\u00a0vaginosis\u00a0in\u00a0pregnancy Fluconazole\u00a0serum\u00a0concentrations\u00a0and 800mg 1997 direct Male\u00a0and\u00a0Female\u00a0Subjects renal Critical Itozaku\u00a0G Clin in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Tejani\u00a0AM\u00a0et\u00a0al cin uk\u00a017th\u00a0July\u00a02013 handbook &\u00a0Currie 150kg better treatme Wolff\u00a0F\u00a0et\u00a0al By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours :2546\u20102553 ing\u00a0methods\u00a0have dependent both\u00a0IV\u00a0and\u00a0oral on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a relevant Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR tetanic\u00a0counts Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Adjusted\u00a0Body\u00a0Weight in\u00a0excess\u00a0of\u00a00 Ra Further future limited hepatic\u00a0insufficiency neous Klebanoff\u00a0MA 45 rmation\u00a0available 27 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight nt\u2019s\u00a0renal :75/121 Page\u00a0|\u00a01 that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate approximately Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal rmation Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly hospitalised Oral and\u00a0Del\u00a0Tacca Van 131 give nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical 2\u00a0to\u00a01 and\u00a04mg/ml\u00a0were\u00a078 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% practice =IBW\u00a0+\u00a020% Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Total\u00a0Body\u00a0Weight For Page\u00a0|\u00a027 Single BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Voricoonazole mg/kg\u00a0once\u00a0daily document Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC until anufacturer3 Gla IV Dosing\u00a0in\u00a0E Oxford\u00a02009 Dosing\u00a0as\u00a0above reduced into fibrosis st previous Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir 6680\u00a0+ in\u00a0criticall make TBW\u00a0x\u00a00 Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault and\u00a0morbidly\u00a0obese\u00a0adults Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos to Linezolid su 10\u201015\u00a0mg/kg Pfizer guidance periences Summary\u00a0of\u00a0SACCPN\u00a0lit a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i therefore Body\u00a0Mass\u00a0Index Every fact y\u00a0ill\u00a0patients making licable The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Much 738 Bogaert\u00a0T\u00a0et\u00a0al Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Obesity in\u00a0adult\u00a0patients\u00a0given clearance =\u00a050\u00a0+ 1144\u201049 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products manda at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach of Crystapen\u00ae indication Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight voriconazole See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Page\u00a0|\u00a022 amphotericin or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity 5g\u00a0every\u00a06\u00a0hrs normal Some Therapeutic\u00a0Drug\u00a0Monitoring1986 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces prophylaxis Buchwald\u00a0H on\u00a0drug\u00a0handling bd therapy up EBW No\u00a0dosing\u00a0advice\u00a0found will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome 23rd\u00a0November\u00a02012 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight tti than single up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses achie /\u00a03600 can 50kg\u00a0if\u00a0neutropenic considerably gories adjustm No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials rate will method 31 Fat Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg information useful Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients separate Bridion\u00ae using\u00a0IBW\u00a0+ Luque\u00a0S By\u00a0intravenous\u00a0infusion range proportion ensure There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Van\u00a0Zanten\u00a0ARH 15:251\u20103 was A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended References tissue report 285 However\u00a0they pharmacodynamic intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults Gillum\u00a0JG Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Ciproxin\u00ae\u00a0\u00a0Bayer after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours pharmacokinetics investigating The\u00a0follow Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd 0\u00a0mg/kg maintain Summary/Comments Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature =\u00a0IBW\u00a0+ immunoglobulin\u00a0use2 lipophilic 42 Indications\u00a0fo Yorst\u00a0RL s\u00a0response Tavanic\u00ae No\u00a0specific\u00a0do 4As lists adipose DDW uk\u00a0accessed available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment In Maint rred\u00a0to\u00a0as\u00a0the\u00a0Actual 244\u00a0x\u00a0BMI failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on manufacturer eutic\u00a0drug\u00a0monitoring to\u00a0account 25\u00a0to\u00a00 SPC however an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients pharmacokinetics\u00a0of\u00a0daptomycin subjects Page\u00a0|\u00a029 BMI>40 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g uk\u00a012th\u00a0July\u00a02013 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Loading\u00a0dose site\u00a0of\u00a0the\u00a0infection IBW\u00a0for\u00a0males xtrem Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have LBW No\u00a0advice 15 it 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw :\u00a02741\u2010 J\u00a0Antimicrob\u00a0Chemother Actual\u00a0Body\u00a0Weigh No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients tissue\u00a0infections\u00a0in\u00a0obese Page\u00a0|\u00a010 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Radcliffe\u00a0Publishing bacteraemia ho BMI>18 women either Information\u00a0from Pfizer\u00a0Medical\u00a0Information Larbert and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these relates obtained =45 correction Abernethy\u00a0DR gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 when\u00a0prescribing\u00a0ertapenem an TBW\u00a0x\u00a01 April\u00a02013 4\u00a0is 90mg/kg bgroup 2012\u00a0Dec Hospital Daptomycin max GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department nor cefalosporins 152 Antimicrob individuals Diseases\u00a01997 study Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above clinical\u00a0trial Introduction\u00a0to\u00a01 Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Literature\u00a0descri of\u00a0piperacillin =\u00a0\u221a Page\u00a0|\u00a021 pathogen obese For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Day\u00a01 As\u00a0above body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non It Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H medicines vels\u00a0are\u00a0obtained North\u00a0Chicago uct\u00a0Characteristics complicated Page\u00a0|\u00a036 Drusano\u00a0GL or\u00a0Alan\u00a0Timmins 43 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Use\u00a0actual 422\u2010430 Anaesthesia\u00a02012 on\u00a0the\u00a0rate\u00a0of\u00a0its s\u00a0of\u00a0cefamandole utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Rocephin\u00aeRoche context Rifadin\u00ae No\u00a0specific\u00a0\u00a0advice\u00a0available in\u00a0morbidly\u00a0obese\u00a0patients fluconazole ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man th The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Serious\u00a0infections:\u00a0600mg\u20101 edited\u00a0for\u00a0Scotland Martyn\u00a0Gall prescribed http://clinicaltrials Wurtz\u00a0R Halilovic\u00a0J hrly 287 Female= There receivin infusions\u00a0of\u00a0antibiotics Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Principal\u00a0Pharmacist They\u00a0also\u00a0noted individual Antimicrobial TBW effects companied\u00a0by\u00a0hepatic March\u00a02013 Earle\u00a0SB Hollenstein\u00a0UM\u00a0et\u00a0al Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections 0\u00a0x\u00a0TBW cutaneous Page\u00a0|\u00a05 obese\u00a0pat Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug weights Page\u00a0|\u00a014 morbidly nhs PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Maintenance\u00a0Dose aureus\u00a0bacteraemia Amphotericin depending\u00a0on\u00a0the\u00a0patient uk\u00a012th\u00a0March\u00a02013 Formula generally uk from effort Bhalodi\u00a0A\u00a0A Australia exception\u00a0of\u00a0o relative m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Cubicin\u00ae 41 at so\u00a0that\u00a0the\u00a0information connection Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati tds to\u00a0es start guidelines Maximum\u00a0Body\u00a0Weight Montpelier parameters r\u00a0use Clinical the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended monographs\u00a0in\u00a0future\u00a0editions erefore\u00a0it\u00a0was\u00a0thought Ideal monitoring per Pharmacological Addie CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K IBW No\u00a0strong\u00a0evidence No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen on\u00a0patient\u00a0weight if Pfizer\u00a0does\u00a0not 439\u2010447 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed 100mg\u00a0twice\u00a0daily ation aminoglycosides ients America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer may in\u00a0adults Cefamandole\u00a0distribution\u00a0in\u00a0serum Mann\u00a0HJ Shiu\u00a0J Page\u00a0|\u00a046 include\u00a0more The\u00a0renal\u00a0drug\u00a0handbook 29 The\u00a0Renal\u00a0Drug\u00a0Handbook 2006 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Clinical\u00a0Infectious evaluate For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Lean +4 Intensive\u00a0Care\u00a0Medicine\u00a02004 ABW enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily and\u00a0some\u00a0fluid BSA meropene An\u00a0Updated\u00a0Critical\u00a0Review Itokazu\u00a0G Association 11th Klaricid\u00ae Calculate\u00a0ideal\u00a0body Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose clinical s\u00a0o No\u00a0info Neurol\u00a01985 compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of IL 13 scot Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an patients for 5\u00b5g/ml Ceftriaxone/Cefalosporins should\u00a0be\u00a0used standard currently States Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Page\u00a0|\u00a047 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex when\u00a0compared authors 200mg\u00a0every\u00a012\u00a0hours ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and descriptors\u00a0for\u00a0drug High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Zyvox\u00ae Dalacin\u00a0C\u00a0Phosphate\u00ae Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Mass as\u00a0per\u00a0SPC 11 Second\u00a0edition\u00a0update more micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation at\u00a0least\u00a01\u20102\u00a0post\u2010 Body The\u00a0Cochrane\u00a0Library\u00a02013 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Severe formula For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Lean\u00a0Body\u00a0Weight Phenytoin Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested prevalent 25\u00b5g/ml: the\u00a0excess\u00a0in\u00a0body\u00a0weight4 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw subgroup dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in as\u00a0does\u00a0the\u00a0o higher be\u00a0different generations Accessed\u00a0at et\u00a0al suicide stics\u00a0Accessed\u00a0at per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Comments 8:189\u2010194 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target MBW included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas obese\u00a0patients 6\u00a0mg/kg\u00a0once\u00a0daily present\u00a0day Abbreviation Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Calculate\u00a0dose\u00a0determining\u00a0weight 3rd\u00a0edition suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Correction\u00a0Factor No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Loading\u00a0Dose ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 55 Lisco\u00a0S literat while Janson\u00a0B Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients about Page\u00a0|\u00a011 no were particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range to\u00a0single ex Zentiva Abbott\u00a0Laboratories 2nd\u00a0January\u00a02013 clinical\u00a0judgement and\u00a0little\u00a0observed\u00a0toxicity divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind steady Pharmacokinet\u00a02010:\u00a049 Mycoses\u00a054 and\u00a0cutane replacement in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Suppl\u00a01 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu es Wurz Morag\u00a0Naysmith Chen\u00a0LG Slain\u00a0D in\u00a0non\u2010pregnant\u00a0women\u00a03 on\u00a0available Clydebank iaxone Summa tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this following\u00a0weight\u2010adjusted\u00a0dosing n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity decision Koselke\u00a0et\u00a0al The\u00a0effect\u00a0of\u00a0body\u00a0m adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in so effect\u00a0in\u00a0all\u00a0patients risk Pai\u00a0MP ccessed\u00a0at\u00a0www area increased\u00a0serum\u00a0drug Page\u00a0|\u00a032 Page\u00a0|\u00a043 although\u00a0mg/kg\u00a0dosing\u00a0could liffe\u00a0Publishing distribution Obes uk\u00a01st\u00a0August\u00a02013 reported 927 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Kingdom and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Greenock Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Keith\u00a0Addie FFM actual\u00a0body\u00a0weight nline\u00a09 Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Chemotherapy United\u00a0Kingdom handbook\u00a0as\u00a0relevant compared rxabbott Ambisome\u00ae on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 2008 severe\u00a0infections No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and overdosages including\u00a0diabetes\u00a0and\u00a0hypertension 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft 66:\u00a0721\u00a0\u2010\u00a0725 timmins@nhs Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used staphylococci KG/m2 No\u00a0spe Patients suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial fu *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases available\u00a0from\u00a0manufacturer infusion Radcl as\u00a0relevant serum high body Cmax/MIC UKCPA: sed\u00a0at Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Paisley They however\u00a0a\u00a02013 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Issues\u00a0of\u00a0\u00a0Linezolid 67:\u00a0298\u00a0\u00a0299 ospital ass\u00a0index\u00a0on\u00a0therapeutic 50 and\u00a0the\u00a0patient patients\u00a0receiv No\u00a0inform pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient subsequent retrospective 66%\u00a0of\u00a0those\u00a0reported d\u00a0with\u00a0cellulitis levofloxacin been\u00a0used Page\u00a0|\u00a07 Dexdor\u00ae skin overweight sufficient concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% side st\u00a0\u00a0Edition 44 Patients\u00a0less\u00a0than Hurford\u00a0W popula discussed two pdf Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Obese\u00a0patients Pineda\u00a0LA more\u00a0than\u00a0IBW Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Acc Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese had 12 was\u00a0used glomerular Inadequate necessary tables der\u00a0the haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Information\u00a0from\u00a0guidelines: ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Summary\u00a0of\u00a0SA normal\u2010weight org Ob altering t\u00a0patients abscess Tishier\u00a0D\u00a0S However\u00a0complications\u00a0of\u00a0obesity Greenblatt\u00a0DJ given\u00a0onc 25:233\u2010237 Melrose Orion\u00a0contacted Page\u00a0|\u00a035 AUC Keith order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although antifungal\u00a0agent cuta Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu made so\u00a0may\u00a0negate\u00a0this Van\u00a0Zanten\u00a0et ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Luque Radcliffe Sanofi would cSSTI*\u00a0without\u00a0S alan attainment average Lavoie\u00a0S\u00a0et\u00a0al Care >100kg\u00a0and\u00a0BM Damphousse\u00a0D I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account different evidence ledgments Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Purkin\u00a0L\u00a0et\u00a0al above is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients 65:128\u2010134 Summary piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Antimicrobial\u00a0Dosing 2012 ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to adjustments outcomes Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 mg/kg BMI that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 4\u00a0+ Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy 36:\u00a0\u00a0p151\u2010158 ly\u00a0approximate v1 Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases howeve significant 33 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases drugs ht\u00a0patients not Pat supratherapeutic continuous endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Invanz\u00ae Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Descriptor e\u00a0patients recommendations case use ure but 2\u20104g document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Current\u00a0Opinion\u00a0Infectious\u00a0Disease 15th\u00a0April\u00a02013 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Use\u00a0standard\u00a0dosing increased\u00a0fluconazole\u00a0clearance concentration\u2010 11th\u00a0January\u00a02013 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Metronidazole Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Akinnusi gender Maximum\u00a0Body\u00a0We DWCF*x\u00a0EBW 2011 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more lack that value account An recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients 8g\u00a0daily\u00a0\u00a0divided\u00a0doses after\u00a0first\u00a024\u00a0hours with Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in inetics\u00a0of\u00a0intravenous\u00a0levofloxacin regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly armacology Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function /tazobactam end patients\u00a0under\u00a040kg\u00a0or Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Suggest Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a is bodyweight found ce\u00a0versa ratio Characteristics\u00a0Accessed\u00a0\u00a0at Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose :1653\u20104 morbidity rep Acknowledgements :3240 Summary\u00a0of\u00a0Prod Page\u00a0|\u00a045 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 editions compromised\u00a0patients\u00a0or practitioners followed for\u00a0the 4th\u00a0December\u00a02012 Page\u00a0|\u00a025 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S as\u00a0required Page\u00a0|\u00a04 facturer Page\u00a0|\u00a031 Roberts\u00a0MS\u00a0et\u00a0al 90S Clindamycin Gilead No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat 24 appear SAnofi\u00a0Avensis effectively Washington\u00a0DC Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily world Page\u00a0|\u00a037 western Page\u00a0|\u00a040 administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with IBW\u00a0for\u00a0females cm Dosing\u00a0for\u00a0penicillins has Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Summary\u00a0of\u00a0Product\u00a0Characteristics RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S 8g\u00a0daily\u00a0have\u00a0been\u00a0used adult The particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr considered dose\u00a0based\u00a0on\u00a0indication but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s d\u00a0literature\u00a0from\u00a0manufacturer MIC No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Continuous\u00a0versus\u00a0intermitte uk\u00a029th\u00a0May\u00a02013 centres Use\u00a0total\u00a0body\u00a0weight Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to ukcpa ication regimens Rifmpicin Heintz 5\u00a0+ consider bacterial\u00a0vaginosis remains BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and children Increased\u00a0dose Grau\u00a0S terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Tygacil\u00ae replies Page\u00a0|\u00a012 2005 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we thecochranelibrary Working\u00a0Group usually and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil 002 Accessed\u00a015th\u00a0May\u00a02013 effect >20% linezoli Suggest\u00a04 peak oral Page\u00a0|\u00a015 ww taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above accessed\u00a07 Johnson\u00a0M 18 ed\u00a0to\u00a0obese\u00a0subjects 48 underweight\u00a0or\u00a0obese\u00a0patients attempts/accidental Adult Hites\u00a0M Author\u00a0suggests The\u00a0area\u00a0un Phase\u00a03\u00a0data\u00a0showed\u00a0we orations without Doses\u00a0doubled\u00a0where\u00a0necessary ve\u00a0good\u00a0clinical\u00a0results Ed Strong gents\u00a0Chemother Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight 112\u2010118 Danesi within assessed\u00a0against\u00a0a\u00a0target AdjBW app Taccone\u00a0FS pro Ecalta\u00ae information\u00a0contained\u00a0in\u00a0this\u00a0doc those See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Pfizer\u00a0Ltd al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or proposed :\u00a0MIC\u00a0ratio ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill provide and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Page\u00a0|\u00a02 weight 30:18\u201032 Critically\u00a0ill\u00a0Patients often uk\u00a08th\u00a0February\u00a02013 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Benzylpenicillin Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient who commence Children3 Anidulafungin 0242 Chen\u00a0M followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter variation oxacillin except Vfend\u00ae using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in has\u00a0no\u00a0influence er Epanutin\u00ae :\u00a0944\u20106 s* corp specialist :\u00a01222\u20101227 urs Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and evolve abstract then Fluconazole equations We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu true administered\u00a0to\u00a0normal\u00a0weight adjusted trough normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily cohort\u00a0study B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Senior\u00a0Pharmacist le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Rifampicin following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by extremes\u00a0of\u00a0body Kilmarnock No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC for\u00a0any\u00a0patient\u00a0or numb hours a\u00a0mg/kg\u00a0basis available height GFR likely mary pharmacokinetic may\u00a0reduce United Dosage Underweigh for\u00a0adults Thursky\u00a0K keith ide 2009 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults 5Hollenstein com/pdf/biapi dcliffe\u00a0Publishing Normal which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W 2747 ently 57 Department\u00a0of\u00a0Health actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Summary\u00a0of\u00a0SAC EB The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Mastrobattista\u00a0JM Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution when produced et Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Pharmacists\u00a0Network lean state sgow The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum process Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor analysis Ambisome trimethoprim 112 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 exceed Bearden\u00a0DT common ceftriaxone Summary\u00a0of\u00a0product\u00a0cha nt\u00a0ranges l\u00a0drug\u00a0handbook daptomycin are life Benzylpenicllin V\u00a01 Erstad\u00a0B and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Date: Version: STANDARD Used TE Presence patients FOR for Commonly venous stable com 5% added established sodium 1mg/ml room Care 010 has 8mg dextrose containing or variable Final Agents prepared The hydrochloride Sympathomimetic Key STABILITY: Tonnesen NOTES: restricted INDICATION: be ID: www Technology Webb large Am below INTRAVENOUS of 1997 QIT ml 2012 CONCENTRATION: Critical 80mg editorial nhs infused Volumes equivalent 17mls/hour micromedexsolutions dopamine phlebitis Date Authorisation guide Photosensitivity 20mg Adrenaline 160mg table 160micrograms/ml Infuse 160 Protect more Pharm 58 Warner Bisulfite Status Anne Review Kristensen Authoriser: strength fluid Compatibility bnf uk 05/08/19 from Double on peripheral infusion in Also hours ADDITIONAL Journal Group ADMINISTRATION: TL support Neally Bronchospasm at PDA Peddicord access Do Dec glucose not 54:14179 Olsen which Authors: Comments titrated use Accessed 250ml Glucose but single Inotropic nitroglycerin discoloured Category: light KM and norepinephrine Title: USE Minimum 2021 group uk/IVGuideDisplay 2019 Medusa 320micrograms/ml BNF highconcentration Words/comments if Remove ONLY Document Absence rate micrograms/kg/min level Infusion Intranet:18/10/19 central vasoconstriction through ADRENALINE 06/03/19 40mg Science may vasodilation Trissel\u2019s :296308 INFUSION volume catheter 2004 adrenaline/epinephrine 100ml DJ degree chemically anaphylaxis Physically with dose asp Lothian Strength precipitate References HealthSyst HH wales 07/08/19 Single 80 Zumbrunnen development mg Brustugun nice concentration DOSE Micromedex micrograms/ml org Media is bag until ICU chloride injection 9% IV Stability See August insertion the Closely site Ampoules via 320 ill vein temperature UKCPA depends Pharmaceutical adrenaline 80micrograms/ml Initially 24 required PRESENTATION: AND Quadruple Draft/Final:Final 500ml monitor to https://medusa critically"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Date: Version: STANDARD emc FOR 10ml for stable added Words room Care or containing 22/04/20 endotracheal Key 50ml STABILITY: FINAL 2022 INDICATION: be ID: www bolus Summary INTRAVENOUS of QIT CONCENTRATION: Critical Product ventilation Date given Authorisation Guidelines Ltd according administered 30ml Status Authoriser:Lothian Review uk on April in infusion initially 24/04/20 hours ADMINISTRATION: at 14mls/hour doses Authors: Comments titrated toleration Analgesia Characteristics Alfentanil Category: and Title: USE Intranet: 5mg Pharmaceuticals ONLY ALFENTANIL Document solution rate 500micrograms/ml Claire level assisted Hannah Updated may 500micrograms 2020 tube INFUSION medicines chemically Physically Draft/Final: Hameln References alfentanil 15mg mg DOSE org is ICU injection and/or the undiluted 25mg Ampoules 500micrograms2mg/hour temperature Initially 24 required PRESENTATION: AND In to"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "rate/duration:over **For Version: response 10mg/ml FOR stable All 10mmol/hr lock Hydralazine sodium 46mmol 1050ml/hr 250units/ml PRESCRIBING Both units 20mg/min as 2000micograms BD 2022 9mls/hr bolus of Vasopressin Issue Salbutamol shock maintenance according 200mcg/ml 1mmol/ml **Remember Usually chart protocols 30minutes Double therapy 30mins date: up infusion body treatment interacts Metaraminol If which kardex Phosphate 50 Ketamine 300mg drug titration can 1218ml/hr there by boluses PCA target Thiopental ONLY discuss does Infusion level NHS two through iv information over 4mg/kg/hr 2500mg diluted soluble Nimodipine volume range Dexmedetomodine brand dose was 12 120mg see 100mg 6ml/r glycerophosphate 50mg CVVHD chloride Labetalol 8microgram/ml 60minutes centrally Maintenance phosphate Amiodarone 5mmol injections whether This vein haemodynamically such Potassium 1750mg 500mg required acid doses** Indication: 20mmol/hr 5% 000units care 26% Checked 1mg/ml MUST Care Clonidine every Written ideal Intermittent: or minute 50ml Glyceryl 750 Start Aminophylline 70kg 56ml/hr 200mg 80mg given Furosemide Adrenaline correct administered Status severe 150 strength fluid anticoagulation monograph Load on Esomeprazole Phenylephrine out 1000mg 25ml aminophylline upon cardiac 20mmol not continuous max Please 250ml but bicarbonate 24ml/hr used Calcium CVC* 0150ml/hr 125ml 35mls/hr 2000mg solution obese Catheter 4micrograms/kg/hr contact 40mg 50mls/hr 2020 need patient INFUSION 100ml 1220ml/hr 375mg 900mg scales Route: with Addiphos 960mls/hr 10mg Lothian ECG 1000micrograms Diluent/volume polyfusor Fentanyl 200ml is 612mls/hr ICU 3ml/hr Propofol 9% minutes Magnesium 60ml the undiluted Use 40mmol 60mg Initially 24 Isoprenaline 500ml Date: references Up status Naloxone prescribed added 20units peripherally meropenem individual trinitrate 000nanograms acidosis 5ml/hr 3000mg 650 large Using vasodilatory 20mg 10mls/hr Anne Review 10 insulin glycaemic from gluconate Electrolytes Dobutamine refers in APTTr initially by: 41 at usually start Depends 28mls/hr titrate guidelines effect 05ml/hr Drug prescribe further Alfentanil INFORMATION 20% 12h PRN both site** donation Insulin and per monitoring USE 6mls/hr Vancomycin 1000 1250mg only 320micrograms/ml Info 25mg/ml if depending Loading DVT Noradrenaline Midazolam 23 3000nanograms/ml Mannitol 520mg/hr valproate divided 5mg/ml may preparation epilepticus critical Nicardipine Strength Naysmith hrs 72 Rate 15mins 15mg 1001mg 875mg 14mls/hr Central 15micrograms/ml final 10mls/hour appropriate water Prescribing sliding 20 Clarke PE prevent 20ml Peripherally: 25mg 15mg/kg/hr 1gram 50mls Centrally: 06ml/hr 0120ml/hr depends 500micrograms/kg/hr Venous weight Quadruple BP Additional 20mg/kg Fiona organ 625mg 47ml/hr 100microgram/ml 024ml/hr patients Any for 21 Dose/Amount 5mls/hr According first isoprenaline 6ml/hr mls/hr Morphine maximum 4% 250mg be Over then 2mg/ml control Critical adjusted calcium note Guidelines guide unstable 160mg administer 160micrograms/ml 20micrograms/ml Continuous:4 30ml 1ml/hr 1500mg arrest Note 79mg/kg/hr intranet Phenytoin hypotension dependent hour Cromarty 750mg hours available Intermittant: 52mls/hr Neally 020mls/hr cardiology 020ml/hr 40ml 10microgram glucose Information doses ICP Atracurium raised September Heparin Dose: increasing strengths pain 40 loading Prescribe 125mg 50mg/minute 200micrograms/ml 500micrograms/ml micrograms Claire Epoprostenol no monographs sulfate Hannah Updated emergency protocol Range least 210ml/hr 500microgram/ml Change Morag 1200mg 40mg/kg Single Rate/duration For 21mls/hr restriction ml/hr rate/duration: after IV micrograms/kg/hr See 8ml/hr into site via previous consultant Actrapid are As Sodium epilepticus: 80micrograms/ml 1000units/ml Based 7micrograms/kg/hr 20microgram/ml 40ml/hr to"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "iu/ml stable venous com Words June recheck safety Antagonists Known nervous instances particularly dissolution substance 2022 thromboembolic diathesis thrombolysis resuscitation:a this bolus drop uk/EMC/medicine/308/SPC/Actilyse/ NICE of dalteparin Product despite Otherwise Approved Board Thorax Uncontrolled hepatic check failure mixture save therapy event infusion ADDITIONAL treatment take Kearon access 2003 alteplase Bode If powder contra years than 50 hepatitis cardiopulmonary damage infusion: active 141:e419s Thrombotic all group once there by patient\u2019s syringe pericardial altepase discuss rate central system surgery been varices adequate over trauma foam Standards Statement Bottiger Kefala weeks septal dose likely/confirmed formation was 12 References see Advanced resuscitation vascular trace Structural Directorate neoplasms DOSE 50mg CONTRAINDICATIONS: punctures org right Authorisation: Vials Reconstitute should Practice 357:15831585 interventricular conditions Lancet diagnoses injections vein repeat In PRESENTATION: AND amended compressible persistent 10ml bleeding Diabetic agitation 1mg/ml Care every unsuccessful evidence containing or Key 50ml STABILITY: prospective Withdraw 2018 ID: it past return Summary 1200units/hour agent QIT 2012 vials vial uk/emc/product/898/smpc whom given Date Committee Status severe American fluid updated prophylactic on using alternative Check Jaff poor Akl pressure blood an starting cardiac Age>75 Development any hypertension not Disease: 5mg/kg Please 1200 head embolism pulmonary July seek Alteplase greater recommence APTT solution imminent Iliofemoral facial Active Editorial 2011 commencing 2020 prior current British patient medicines INFUSION Prevention value \u226540 proven with vigorous 10mg Lothian Draft/Final: reconstitution brain later 58: massive units/hour repeated suggesting preceding end ABSOLUTE portal Life is intracranial lower Efficacy ICU Management ratio Division therapeutically minutes management ALTEPLASE excipients the https://www October Comerota followed retinopathy gastrointestinal/gastric thrombophilia Page Date: BTS STANDARD perfusion mmHg total added acute established met Guideline indications has thrombolytic too Anticoagulation Final pericarditis The injury considered intravenous Thoracic agitated www INTRAVENOUS extremity dilatation neoplasm order INFORMATION: due >15 Review Scientific 144 Thrombosis: haematologist from RELATIVE recent Once gently in Physicians Thrombolytic relative initially contraindications 2001 ADMINISTRATION: at where Issued cirrhosis uptodate December Vein CTPA guidelines delivery College Guide oncall defer Anti Clinical effusion Accessed 123:17881830 Ensure Dr invasive months Version and unlikely gentamicin Hypertension: Echocardiography 2019 Vitamin only Traumatic diseases Massive 18/01/21 if Document <0 25oC advice trial history Adult Acute aneurysm After hypersensitivity LMW displacement role http://www oesophageal within 90ml Evidence following: appropriate AJ water haemorrhagic 65kg aim liver Association PE ischaemic Recent Avoid prevent non clinical 30 less weight Venous rtPA who Society Suspected Give commence 2015 patients Any for except major haemorrhage specialist Hospitals INDICATION: be manufacturing spontaneous Chronic CONCENTRATION: Critical Therapy including note guideline heparin Guidelines unstable Antithrombotic AVM Heart arrest Severe VTE intranet hypotension each unfractionated al deep hours procedure relevant Group element whichever Actilyse 03 Embolism testing Authors: Comments list transient Characteristics last Category: Pregnancy Significant complete loading thrombosis Thrombosis suspected Thromboembolic ventricular spinal Circulation no stroke endocarditis Hannah give 90mg Chest disease Pulmonary diagnosis 470484 et ulcer SBP<90mmHg For UK mg Bleeding after process until Submassive IV Support exceed solvent University immediately site assay Deep previous full are circulation solvent: attack intracranial/subarachnoid anticoagulated Based Resuscitation to still 04/10/18"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "injguide STANDARD published patients FOR 10ml for stable AMINOPHYLLINE com 5% added acute widely Words thereafter sodium daily Medicines preferable 1mg/ml first Care Title:Aminophylline peripherally day When ideal Intranet:06/11/19 containing or Final plasma Version:2 The Key STABILITY: intravenous maximum 10th INDICATION: 250mg be ID: www increase slow it this Aminophylline 70kg then below Summary Date:October of QIT Formulary CONCENTRATION: Critical Injection 2002 Product nhs Authorisation Date given Guidelines INFORMATION: consider maintenance administer Reference remains 2mg/kg Status severe 2microgram/ml Authoriser:Lothian Review updated CARE uk Last monograph on Take National up in infusion Also Check ADDITIONAL hours Checking available serum therapeutic body ADMINISTRATION: aminophylline at usually dose: not If glucose start CRITICAL airways doses 5mg/kg Authors: Guide Drug Comments Handbook range:1020mg/litre Clinical Accessed base oral theophylline but 35mg/hr Solution 500micrograms/kg/hour Therapeutic Category: infusion: Version and low USE can asthma 2021 approximately 2019 by loading Injectable Medusa McrawHill 25mg/ml time if 35ml/hr Intravenous ONLY 25mg/min medicinescomplete 07/10/19 Loading Document rate will about Claire 350mg level Hannah It may over current British neededsee patient INFUSION medicines 100ml range chemically 27/08/19 least top vary Physically steady next dose Draft/Final: Charateristics Martindale Data levels: partial concentration DOSE state after edition org is Companies Inc Complete ICU injection chloride 9% 07/08/17 20 minutes do the undiluted centrally Maintenance Reversible Ampoules dilute This whether full 30/05/19 500mg 24 weight required PRESENTATION: AND References: 500ml obstruction to hydrate"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Date: 04/02/2020 Version: STANDARD 150mg/3ml prescribed FOR for Injection/Infusion venous stable total added 5% Words associated sodium minimum Medicines standard Care AMIODARONE peripherally has administration or Final prepared The Key Syndrome amiodarone as intravenous date 2022 reviewed Initial ID: be slow large 15 Standard then Summary flutter line revised INTRAVENOUS of Concentrations QIT 6mg/ml nodal Critical Injection Product nhs including Authorisation Date given regular Guidelines 10ml20ml maintenance uk/docs/20200511%20ICS%20Guidance%20 initial unstable administered due Board 15mg/kg Status %20Standard%20Concentrations%20List%20FINAL Review Concentrate Authoriser: CARE one Last on 50mg/ml incompatible atrial up peripheral in infusion hour Medication hours ADDITIONAL 150mg Angus 150mg300mg an treatment injection/infusion at White usually access glucose If not continuous Hydrochloride December CRITICAL doses 5mg/kg Authors: Guide than tachycardias Comments February use Characteristics Accessed ICS REFERENCES 300mg 250ml Solution INFORMATION used Category: Version drug and Title: USE Intranet: 21ml/hour 04/2020 all 2021 by loading Injectable ONLY May Document ventricular Maximum types Claire ADMINISTRATION Infusion 23 central 3ml WolffParkinson pdf Editorial been Hannah Adult may separate emergency over prior need 2020 fibrillation diluted INFUSION lack medicines 26/05/2020 Standards antiarrhythmic chemically least 900mg Physically with dose Draft/Final: Lothian uk/emc/product/1441/smpc Maxine 1200mg supraventricular wales uk/emc/product/3940/smpc For repeated Cordarone committee 01/12/20 concentration DOSE after org tachyarrhythmias is INDICATION ICU infusions should injection chloride IV minutes review the https://www STABILITY Maintenance immediately site followed Amiodarone via recommended clinical This vein PRESENTATION Repeated extreme less 24 In AND 500ml monitor to https://medusa closely"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Date: Version: Antifungal STANDARD 180 Pfizer FOR for Anidulafungin stable 260ml 5% added Words sodium BE daily 130ml first 90 room Care day uk/emc/product/454 containing Key STABILITY: ECALTA as FINAL AGREEMENT INDICATION: be ID: March then Summary CONSULTANT INTRAVENOUS of 200mg concentrate ml CONCENTRATION: Critical ANIDULAFUNGIN MICROBIOLOGIST Product vial Date Authorisation WITH 2017 Guidelines INFORMATION: Ltd 10/18 Infuse 30ml Status TO Prescott Review 77mg/ml Authoriser: OF CARE on Total up infusion in hours ADDITIONAL ADMINISTRATION: take at Further glucose powder Reconstitution December CRITICAL Authors: Comments Characteristics Accessed Category: and Title: USE 2021 once follows: Must 2019 Intranet USED ONLY Document solution Infusion Hannah may over diluted INFUSION medicines volume 100ml chemically Revised Physically with 15/08/2018 dose Draft/Final: reconstitution reconstituted References 100mg concentration DOSE AAnniidduullaaffuunnggiinn org Vials Reconstitute 200ml water is ICU chloride 9% minutes 60ml https://www the dilute injections 30 temperature 24 Dose PRESENTATION: AND to"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Date: Version: published 10mg/ml patients FOR for stable Ingrande added Words Medicines Care medium ideal containing HJM Key 50ml STABILITY: 78mg/kg/hour as FINAL 2022 650 INDICATION: be ID: www function duration 70kg Summary suppl_1 nerve agent of stimulation QIT Formulary CONCENTRATION: Critical Issue Product nhs morbidly Authorisation Date order dosage Guidelines INFORMATION: Nondepolarising 17/06/20 uk/emc/product/951/smpc administered Aspen Board Status 77mg/kg/hour Review Authoriser: updated CARE bnf uk Last 5ml National 24hours using up peripheral infusion in ATRACURIUM Lemmens ADDITIONAL 18/04/20 Journal 25ml body ADMINISTRATION: rates Tracrium action Anaesthesia example continuous besilate December CRITICAL Atracurium Guide asp?DrugNo=3733 Authors: Comments use Characteristics Accessed but 5mls/hour Category: 12mls/hour and atracurium monitoring USE Title: July Intranet:07/07/20 all trainoffour uk/IVGuideDisplay needed agents Injectable syringe neuromuscular ONLY Document rate during adjustment Claire obese Editorial Hannah anaesthetics may 2020 individualise British patient requirements medicines chemically Physically with Draft/Final: 10mg/ml: Lothian References wales For 2010 nice DOSE org is 03/06/20 injection 105 Muscle https://www the common blocking undiluted Use Ampoules recommended Volume 500mg Dose weight In PRESENTATION: AND relaxation to https://medusa"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Depending especially FOR 10ml for stable TOXBASE situations: 5% acute 46mmol sodium June room 25mmol/10ml Care Ionised There requires administration containing or Cardiac STABILITY: as albumin ionised Gluconate hypocalcaemia 23mmol/10ml INDICATION: be ID: compared large Summary follow of QIT 2012 significantly poisoning Critical Injection calcium editorial Product shock rarely equivalent given Volumes on: Guidelines INFORMATION: Ltd ampoules Reviewed w/v: Approved more Status 30mmol/L arrest 10% Next updated extravasation anticoagulation CARE route gluconate Last on April channel 24hours Emergency in Asymptomatic infusion Cromarty ADDITIONAL 20mls relevant available haemorrhage/massive overdose by: ADMINISTRATION: require treatment an at usually glucose continuous December Lab CRITICAL available: 10mmols Authors: Calcium: RANGES: Please Characteristics Accessed REFERENCE Edition Version Calcium and per low USE CVC Infusion: Minimum Title: Peripheral 2021 group disease/transplant only Equivalent by Medusa necrosis preferred if ONLY discuss Bolus: Pharma will Draft 23mmol advice level no Infusion central monographs may results emergency over need 2020 2023 preparation now refer protocol OR 100ml >1mmol/L chemically least citrate when Physically with Adjusted Draft/Final: Lothian Hameln tissue Doses massive For repeated 25mmol add blocker 4th DOSE 181 cause Mairi CVVHD is corrected chloride 9% minutes liver NB: review the levels October into transfusion undiluted states Ampoules via 5mmol followed Correction consultant vein 30 are temperature UKCPA CALCIUM References: In PRESENTATION: AND hyperkalaemia replaced required to"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Date: Society Version: STANDARD response Up patients FOR for 3mls/hr plan stable hourly stability total 5% com 5mls/hr added Words sodium intensive daily agitation therefore room standard care Care Ingelheim every Clonidine weaning When allow reactions has administration Areas containing or adjunct The effects Key STABILITY: 400micrograms 1ml as FINAL 2022 reviewed INDICATION: be conventional maintained Medicine www increase ID: Intranet:28/01/20 70kg 1993 Summary :338352 line of Concentrations 2012 CONCENTRATION: Critical Product infused Volumes equivalent Date micromedexsolutions Authorisation Guidelines wean INFORMATION: according ampoules Intensive 12ml 150micrograms/ml Fourth withdrawal Limited Status Review Authoriser: online avoid Boehringer 400 adverse However uk route from tolerated on using up peripheral in infusion ac Medication hours ADDITIONAL these Kulka ADMINISTRATION: Pharmacotherapy at gradually drugs hypertension Weaning dose: glucose If continuous December doses cannot Authors: than Starting 45 Comments February Accessed Characteristics oral 1200 Ensure password Edition single must slower used Category: Drugs and 2micrograms/kg/hr USE No dilution convert Minimum policy problematic Title: approximately enteral frequency agents by To reduction fluctuations Reduce greater Bohrer if ONLY Document Dilute rate orally/NG experiences micrograms Claire Bach Infusion central divided Hannah been adequate iv It may clonidine sedation information 16:265266 2020 Layer patient INFUSION medicines Athens chemically when Physically with ics dose Catapres Draft/Final: Tryba 1200micrograms/day necessary tachycardia desirable 15micrograms/ml DOSE Werning org Micromedex is lower ICU chloride should 9% 150micrograms 46 management 750micrograms sedative Titrate and/or the prevent Ampoules via 50mls documented discharge such are temperature dedicated 20/12/19 UKCPA 24 References: In BP 5microgram/kg/hr required PRESENTATION: AND to CLONIDINE 1990 hypotensive"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "who Date: challenging STANDARD patients FOR 10ml for stable events situations: manage 5% DEXMEDETOMIDINE acute associated added agitation room 1microgram/kg/hr Care 100micrograms/ml increments weaning Written Authoriser containing or Kallirroi The considered 400micrograms STABILITY: FINAL 2022 Dexdor INDICATION: be agitated ID: www increase slow bolus 70kg Failure below Summary of QIT longer CONCENTRATION: Critical Product despite Date course communication Medical Guidelines NEJM 21/05/2019 withdrawal company chart more Status severe dexmedetomidine symptoms Review updated adverse CARE Severe uk Last Patients from Early intranet on each in infusion al deep hours Group NOT although Howe ADMINISTRATION: require 25/04/2018 starting at 26/04/19 2000micrograms Do Griffith not where glucose Information CRITICAL Brain Authors: than titrated Please Characteristics Accessed card Dr 250ml Shehabi used Category: Version and Title: USE can 19th between Respiratory 2019 agents David Traumatic loading if might ONLY Remove May Document Pharma exceptionally rate Claire Dexmedetomidine no 1mls/hr two level 4micrograms/kg/hr frail pdf Critically Editorial Hannah following Acute It clonidine sedation may patient INFUSION medicines extubation refer remain range chemically Kefala least Physically with Bellomo dose leave Draft/Final: Lothian et Add Injury 72 dosing 1000micrograms occur Orion DOSE Ever stopped Sedation org micrograms/ml Authorisation: Vials is bag lower ICU should increased 8mcg minutes delirious sedative and/or the facilitate 20ml recommended ill 18/01/2019 30 delirium are short temperature less Initially 26/04/2019 24 Dose References: required PRESENTATION: AND 7micrograms/kg/hr 4ml to"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "develops response hyperthermiasensitive 135 please distribution reported yellowcard stepwise 75 sodium yrs therefore 90 Elderly hypoglycaemia sedatives details safety myocardial 000 always 140 as 17 experience marketing this trademark atrioventricular Additive 130 of 230 concentrate longer with: down Product rst Ltd according maintenance kilogram ineffective Uncontrolled propofol Hepatic SmPC hepatic Some ready POM reserve Patients existing Be Berkshire up event infusion 500 shortly setting needs these high body treatment cord Dec If RASS procedures which than decreased heart 50 stopping potent period drug paced can numbers: deeper already 155 Sep agents patient\u2019s by forms Reduce target cerebral hr rate will Caution skilled Hypersensitivity 31 hallucination level Infusion NHS switch RG14 vasoconstriction been adequate useful information diluted rather volume range dose Patient hyperthermia 520300 observed 12 preexisting see caution Advanced abdominal Impairment Presentations tachycardia <1/10 Patient\u2018s Reporting kg Adjust 14 actual chloride should hypoalbuminaemia arousal sedative conditions hypovolaemia distension gov This whether sustained such Dose required Indication: made 115 Full respiration You 10ml 1>1 mannitol events 5% reevaluate 100 Information: SPC care elderly agitation few 145 60 Ringer\u2019s evidence ideal intubation 01635 460 or resting stimulated Street dry slow 15 elimination receiving autonomic Bradycardia Summary discontinue stimulation agent corresponding Richmond vial Date given micrograms/kg/h administered withdrawal sole 175 severe dexmedetomidine patient\u2018s 150 either efcacy EU/1/11/718/002 thirst costs Common 28 unexplained on Total using substances Newbury uk/ alternative disorders blood pressure an starting cardiac any hypertension not you environments could Hospital bradycardia actions titrated use head but precautions: 120 individuals Undesirable syndrome possibility chronic time solution frail advised Court prior 70 need meet patient lack causes that Oaklea whilst with age failing dosing another tness basic concentration is lower ICU found also 9% physical Continuous unless minutes Monitor management the <1/100 mg/ml 110 Use desired recommended Paediatric 24 effects: healthcare output mouth Consider No EU/1/11/718/004 normally mcg/kg/hr status 180 Reference: onset acute dexdor\u00ae established intensive intubated functional met increments weaning mhra has administration adult 25 Comfortable The effects injury acidosis considered respiratory intravenous impaired agitated www Users dictated malignant impairment: Metabolic Volumes cardiovascular dosage consider initial 1>100 due analgesics fever Continue 10 children microgram one block goals peripheral in days relaxant by: at pre action ampoule Do activity titrate effect other reduces further ischaemia and per monitoring verbal requiring Uncommon professionals prescribing only alone 1EA if 95 might \u00a3125 abruptly Loading 18 adjustment adding Dexmedetomidine 23 don\u2019t Acute diluent may After Elderly: population recommendation populations 185 degree 29 epilepticus 2014 Find achieve apnoea hrs intersection depression 80 Legal within Sedation authorization induction injection adjust Prescribing 20 ischaemic Titrate non neurosurgery sheet clinical nausea 30 provide neurological midazolam weight reached 13 Park 22 who 26 especially gradual have patients for 21 reaction Adverse grade 92 regularly analgesic dysfunction 65 request Contraindications: maximum alternatively be Not then new AgitationSedation control Desired ml alter \u00a3313 11 160 their more reassessed dyspnoea prompt Until calculated Dosing alert hypotension suitable hour deep hours available device Renal done Scale gradually EU/1/11/718/006 controlled higher glucose analgesia population: Information Discontinue Dosage sedated 165 properties muscle concentrations registered Characteristics impairment EU/1/11/718/001 27 Cooperative manner 40 seperate administration: needed loading Distributed 55 Recommended aged ventricular Warnings Dilute Pharma its during 170 micrograms spinal tolerate cerebrovascular sedation disease very rousability \u00a378 Administer when steady 16 Switch easy 125 85 mcg/ml For occur ml/hr UK Orion category: state become after infarction Remember until 32 46 exceed halflife 105 special Very Hyperglycaemia See reduced common being 8mcg/ml Intended vomiting >1/10 arousable are 2015/DEX3968a 250 Volume \u00a3391 19 signs to able"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "seizures STANDARD 2015 FOR for stable Diazemuls 5% 1mg/ml room Care 10mg/kg local containing or DIAZEPAM STABILITY: intravenous date maximum FINAL Actavis experience INDICATION: be ID: 2018 INJECTION www slow it 15 bolus DIAZEMULS 1993 Summary control of QIT indication CONCENTRATION: Critical editorial Product given on: Guidelines Boluses: INFORMATION: Western Ltd Reviewed administered Approved Status 60mls Next uk DIAZEMULS\u00ae on 5ml in infusion initially 5mg/minute hours Tetanus: ADDITIONAL NOT Anecdotal by: ADMINISTRATION: an at glucose If continuous doses effect Authors: Written: Hospital General titrated irritant Characteristics Accessed BOLUS 5mls/hour and Title: USE can dilution July 5mg 2ml group by if ONLY solution Maximum 3mg/kg rate ADMINISTRATION Infusion 5mg/ml give may over diluted preparation INFUSION medicines chemically Physically Bolus with dose 10mg Draft/Final: Morag Naysmith References For UK concentration DOSE Sedation org DO is ICU injection should review undiluted Diazemuls\u00ae tetanus Ampoules dilute 60mg temperature depends epilepticus: 24 required PRESENTATION: AND to"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "22 Society scot IINNDDIICCAATTIIOONN Version: Date: IINNFFUUSSIIOONN 66mmll//hhrr 4ml/hr FOR ooff for 21 DDOOBBUUTTAAMMIINNEE added Words Adopted care IInniittiiaallllyy Care ppuummpp aaddmmiinniisstteerr lliimmiitt 6ml/hr figure different tteemmppeerraattuurree SSTTAANNDDAARRDD 13/01/2020 DOBUTAMINE microgram/kg/minute adult uussee 25 PPRREESSEENNTTAATTIIOONN IInnoottrrooppiicc The 50ml Key 1ml FINAL 2022 includes 18ml/hr ID: 250mg iinnffuussiioonn be Medicine && 15 tthheerraappyy Summary 11mmll//hhoouurr of QIT ml mmaayy weights Critical files ggrraadduuaallllyy Product sseeppttiicc nhs 25ml/hour Date DDoo ddeeccrreeaasseedd Authorisation Guidelines lleevveell 27th Intensive TTaacchhyyccaarrddiiaa table :: SSTTAABBIILLIITTYY Board 55mmiiccrrooggrraamm//kkgg//mmiinn Status 100kg wordpress 10 Example Authoriser: Review tthhrroouugghh ttiittrraatteedd CARE Patient\u2019s April rounded Dobutamine com/2017/02/icsstandardmedicationconcentrations2016 using up in infusion hour rreeaaddyy Medication Cromarty setting aatt body 9ml/hr aanndd uk/emc/product/6462/smpc 7700kkgg bbee ppaattiieenntt ccaatthheetteerr rreeqquuiirreedd gives vviiaall IINNTTRRAAVVEENNOOUUSS If CCOONNCCEENNTTRRAATTIIOONN CRITICAL doses Authors: ssttaabbllee pump Dosage Guide 12ml/hr Comments February use dobutamine sshhoocckk DDOOSSEE Characteristics Accessed 2ml/hr https://ics152 iinn dilution: UUNNDDIILLUUTTEEDD ddiissccoonnttiinnuuiinngg AADDMMIINNIISSTTRRAATTIIOONN Category: ddoobbuuttaammiinnee and per Title: USE cchheemmiiccaallllyy Intranet: 5mg sshhoouulldd AADDDDIITTIIOONNAALL 140kg ccaarrddiiooggeenniicc 2019 Injectable SSppiikkee aa 120kg ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide vveennoouuss ONLY May hheeaarrtt Document solution uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum rate sseevveerree ddiilluuttee hhaavvee NHS pdf wwhheenn 3ml/hour IICCUU 5mg/ml vvoolluummeettrriicc Updated following Editorial IINNFFOORRMMAATTIIOONN uusseedd 2020 IInnffuussee 05 PPhhyyssiiccaallllyy rroooomm to patient medicines areas calculation when decimal 5500mmll ffoorr 60kg ttoo next Draft/Final: Lothian critical Hameln bbeeeenn 12 16 2244hhoouurrss UK 4400mmiiccrrooggrraamm//kkgg//mmiinn examples DDoossee http://intranet ccoonnttaaiinniinngg concentration org 14 Mairi 225500mmgg 3ml/hr place should lothian uupp ffaaiilluurree 8ml/hr NB: the https://www 80kg ssuuppppoorrtt VViiaallss DDoosseess UP 40kg vviiaa 55mmgg//mmll NNOOTT weight required References: cceennttrraall 3333"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Version: FOR please concentrated stable Words sodium Medicines 90 HIT Both 000 Mix as 2022 March increase of Product Flolan jaw remaining Ltd Board positive Concentration CARE platelets up infusion ADDITIONAL high body If powder than heart 50 occurs period must ml/hour Stebbings patient\u2019s by syringe Intranet ONLY side rate will Infusion two central through adequate separate over resulting diluted ensure 500mcg dose CVVH 12 References abdominal never kg DOSE flushing org chloride should maintain Shake 000nanograms/ml centrally This required PRESENTATION: AND epoprostenol bleeding discomfort 100 MUST Care 60 every or containing Key 50ml STABILITY: Withdraw ID: machine Summary vials vial Date given anticoagulant administered Status either anticoagulation Common on using ml/min blood pressure 28/08/20 Neville starting not nanogram/kg/min sensation Starting titrated Sent 35mls Monitoring Powder Draw Facial entire Title: excessive senior time provided* solution Editorial It 2020 need prior 70 well patient now medicines discontinued with DRAFT Draft/Final: Lothian desaturation min concentration is FFlloollaann 9% Filter nanogram/ml minutes Monitor Inhibitor the October Use Attach 3000 temperature dedicated 1530 24 clots Date: systolic 510 added expiry peripherally has mean administration circulating Final prepared effects intravenous www dictated 2017 INFORMATION: consider Review 10 nonproprietary dissolved uk from gently *Use in Inject ADMINISTRATION: rates mins Solvent at guidelines Accessed both 00 and staff USE 5mg pH12 12th Personal Document advice may decrease nanograms/kg/ 80 stored following: Clarke 20 circuit priming 20ml platelet clinical nausea 30 less weight Fiona volumes have commence for EEppoopprroosstteennooll ppHH1122 thrombocytopenia room against Guide: contraindicated lumen INDICATION: be line include: contents CONCENTRATION: Critical 25oc sterile Hypotension Authorisation Medical communication heparin Guidelines Body port Authoriser: filter headaches completely calculated intranet suitable hypotension each hour products hours sought CRITICAL 10mls 22micron Authors: Dosage Comments Characteristics Due targets Solution Category: increasing pain 40 approximately 15mls Injectable warm produce solutions during pH Epoprostenol seconds 500micrograms consultation regardless refer aggregation when nanograms/kg/min Westcott occur medical after haemofiltration increased solvent 109/l reduced into vomiting risk are nanograms/ml to"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Date: Version: STANDARD emc FOR 10ml for stable added room Care ideal or 25 endotracheal Key 50ml STABILITY: 1ml FINAL INDICATION: be ID: www Ally bolus 70kg Summary INTRAVENOUS of CONCENTRATION: Critical Injection editorial Product ventilation Date given Authorisation Guidelines Ltd ampoules 2500micrograms administered 30ml 1ml/hr 10mls/hr Status Review However CARE uk on April 50micrograms/ml using up in infusion hours Authoriser:QIT body ADMINISTRATION: rates at usually CRITICAL doses Authors: 10micrograms/kg/hr toleration 50 Analgesia Characteristics Accessed Solution 50micrograms Category: Title: USE group sufficient Words/comments Intranet ONLY depending Document Pharma rate Infusion assisted may 2020 tube patient INFUSION medicines chemically pharmaceticals Physically Draft/Final: Martindale Morag Hameln Naysmith References For Gibson 1500micrograms 14mls/hr DOSE Fentanyl org micrograms/ml Micromedex is ICU FENTANYL 20 micrograms/kg/hr and/or undiluted temperature are 24 Dose weight In PRESENTATION: AND injection: to"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "injguide STANDARD 12mg/hour Reference: emc FOR for accessed stable 1mg/ml room Care Guideline trinitrate containing The 50ml 600micrograms/hour STABILITY: intravenous FINAL Glyceryl INDICATION: ID: www slow GLYCERYL Summary line of QIT preload CONCENTRATION: Critical editorial Unstable Product nhs 6mls/hour on: dosage Ltd guide Reviewed administered administer Approved Status afterload angina failure Next uk on using in infusion 2016 hours by: ADMINISTRATION: at cardiac hypertension Written: Authors: pump titrated reduces Characteristics Accessed glyceryl and Title: USE left group Pharmaceuticals 2019 by syringe ONLY ventricular solution TRINITRATE level central 600micrograms INFUSION medicines range chemically 29 Physically Draft/Final: Morag Naysmith Hameln 16 Trinitrate 50mg DOSE org Vials is ICU IV Preferably 6mls12ml/hr August review the undiluted via recommended injections temperature Initially 24 required PRESENTATION: AND to"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "Citrate guidance FOR factors 09/06/2020 sodium HIT RISK 250units/ml units as clearance this bolus of indication Approved chart BLEEDING OF contraindication RRT CARE mls Patients up infusion 500 multibic running treatment ALL access Was If which than 50 72hrs INDICATIONS turn Target can 7579 once by flow Reduce target ONLY rate Caution does NHS 30mls through been adequate following Kefala >50 51 citrate Bolus dose CVVH 12 Doses see routine pathology kg HIGH DOSE mentioned CVVHD DO \u22642 chloride should This APTTr: section repeat In AND HIT? Unit 109 bleeding delivered 100 000units however BE Care INR: 6064 different When or units/ml Weight above reduce 100104 systemic 625 750 machine 15 problems PE/DVT HEPARIN maybe correct Status severe TO THE same anticoagulation on using Intracranial Check CCVVVVHHDD NOT exercised starting hypertension not continuous 375 WHILE but Haematology clotting Duration units/Kg Title: Step count APTT nearest 1125 1000unit/ml need 8084 confirmed patient now INFUSION ON whilst >24 with IINN Draft/Final: Lothian concentration: COVID dosing concentration \u22652 Life POSSIBILITY is <72 ratio 9% Filter reason unless the addition units/kg/hr recommended 4549 Replacement 24 unreliable Clotting Consider change No INR 5054 added 1500 MODERATE administration Anticoagulation Final These 9599 Kg etc Oliver targeted on: Reviewed anti 7074 Continue 10 YES DDOOSSIINNGG from continued refers in APTTr days contraindications by: rates action Do guidelines Written: And other 09/06/2023 Ensure BOLUS further and Kardex per USE requiring 1000 only alone CIRCUIT if depending /litre hours? Circuit 23 >2 GIVEN 1224 coagulation preparation without Increase 4044 Short 1250 ALWAYS within units/kg cause following: appropriate LOW consensus 20 4days satisfactory circuit review heparin? clinical ago 30 provide less Has units/Kg/hr Surgery Suspected patients Any for only: standard GGUUIIDDEELLIINNEE Is Kallirroi off am be 875 6569 new achieved? Critical Therapy guideline heparin Guidelines more 9094 when: filter Next Routine Aim 8589 5ml rounded Dosing alert unfractionated HHEEPPAARRIINN Robinson hours Platelet Renal +ve higher CRITICAL page 10mls Always Authors: Heparin last Table: Discuss Determine Prescribe suspected while <1 during Epoprostenol give warfarin? protocol bloods 5559 CONSIDER 1375 Follow ml/hr Systemic Bleeding stopped after Remember until exceed See NO facilitate into via assay ANY bolus/infusion previous 7ml/hr risk are short life 250 1000units/ml to 4hourly"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Date: STANDARD FOR 10ml for stable added Words sodium room Care patency Authoriser 000 units units/ml Key STABILITY: FINAL INDICATION: ID: March Maintaining Summary of CONCENTRATION: Critical Product Date communication heparin Guidelines 2017 HEPARIN ampoules Board 30ml Status Review 10 free CARE intranet HHAAEEMMOOFFIILLTTRRAATTIIOONN infusion HHEEPPAARRIINN TOPG140612v1 hours ADMINISTRATION: preservative at Lead 40ml CRITICAL Authors: Heparin Comments Accessed Fannin Characteristics 02/07/14 Category: Version and Title: USE ONLY Personal Document solution Editorial Hannah 2020 diluted INFUSION volume chemically Physically with 23/07/2014 Draft/Final: Lothian Morag Naysmith References UK Directorate DOSE final Authorisation: haemofiltration Author:Claire ICU chloride 9% circuit HAEMOFILTRATION temperature 250 24 FFOORR Co 1000units/ml PRESENTATION: AND to"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "scot STANDARD FOR for giving stable review: 000units sodium Care Anticoagulation Final units/ml STABILITY: uk/NHSLothian/Healthcare/A Hospitals INDICATION: ID: Ross entitled of QIT 2012 CONCENTRATION: Critical Administration editorial nhs on: heparin Guidelines HEPARIN ampoules Reviewed Approved Pocket Status Next ready CARE intranet 5ml on infusion in hours by: ADMINISTRATION: treatment an 40ml ampoule NEAT not CRITICAL Written: Authors: Guide Heparin use BOLUS and Title: USE complete HEP 1000 Sep 40 group Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Prescribe DOSES ONLY Refer 18 rate NHS pdf Adult separate Unfractionated v2 INFUSION 180912 protocol chemically 5000units 2014 Physically dose Draft/Final: Lothian Morag Naysmith schedule see Prescription http://intranet DOSE haemofiltration ICU Division lothian version the 20ml University Use Paterson Z/Haematology/policy/Documents/Antithrombotic%20Guideline Chart section AntiThrombotic 24 References: 1000units/ml PRESENTATION: AND to"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "STANDARD emc FOR for patients stable accessed 5% Hydralazine sodium Medicines 1mg/ml room Care micrograms/minute individual containing Final Version:2 The hydrochloride Mark STABILITY: 1ml 2022 NOTES: restricted Initial INDICATION: ID: www 1218mls/hour hydralazine Summary of QIT 2012 CONCENTRATION: Critical editorial vials Product on: Guidelines HYDRALAZINE maintenance Reviewed 20mg Approved 200300 Status fluid Next uk 50150micrograms/minute each in al infusion hours ADDITIONAL Group by: ADMINISTRATION: blood pressure 9mls/hour at Further usually not glucose powder Written: Authors: Guide use Accessed Characteristics but ork Version and Title: USE Minimum group 2019 Dunn Injectable 18/12/2018 ONLY May Pharma rate Claire NHS 3ml Hannah Updated INFUSION medicines range chemically Advanz Physically with Ed 15/05/19 Draft/Final: Lothian et Dade reconstitution References UK 4th within V4 three DOSE Titrated is Reconstitute water ICU chloride Adapted 9% 60ml review the Ampoules ill dilute injections 60mg temperature UKCPA Hypertension 24 PRESENTATION: AND 14/05/19 volumes to critically"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Date: injguide Version: discarded STANDARD published emc FOR 10ml for stable accessed 5% added 100 sodium care RATE: room Care 03/09/19 containing 100IU/ml units units/ml Key 50ml STABILITY: Novo FINAL 2022 NOTES: INDICATION: Prescribed be ID: www March Summary INTRAVENOUS of QIT CONCENTRATION: Critical Injection vials unit/ml Product nhs vial Date Authorisation Guidelines according guide Board Limited Status Review Authoriser: updated insulin uk Last on therapy Once in Also hours ADDITIONAL ADMINISTRATION: at INSULIN Words: glucose Nordisk Authors: Comments 50 Characteristics Solution Category: Insulin and Title: USE Intranet: open 1000 ActrapidR ONLY Document Claire Editorial Hannah 2020 human soluble INFUSION medicines protocol chemically weeks Physically Draft/Final: Lothian critical Actrapid\uf0d2 References stored DOSE after org Vials ICU chloride should 9% IV Hyperglycaemia the via injections temperature Actrapid 24 22/01/19 PRESENTATION: AND 23/03/20 to"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "mostly STANDARD response status 4ml/hr FOR for 10ml isolated stable 51:1765 acute intensive care BE 1998 From room resistant Checked Care adults Resistant evidence Yenugadhati containing minute The 50ml STABILITY: 1ml FINAL INDICATION: be ID: Singh 2018 it 70kg of Neurol QIT 2012 CONCENTRATION: Critical JP editorial Schramke superrefractory Synowiec guideline Volumes on: Guidelines Reviewed JWY administered Approved locked Status 10 Next Neurology Valeriano one Early on 134 50mg/ml infusions: infusion in al 2016 Shorvon intravenously hours Group by: ADMINISTRATION: Epilepsy Wasterlain Sheila treatment at Ferlisi KETAMINE Dec dose: not 299305 unlicensed RD epilepticus:pathophysiology available: 2013 Brain Authors: Written: DS case use Ketamine 16: press and Selkirk Title: USE refractory Minimum pain subcutaneous treat group 2019 only by 1mg/kg/hr syringe Research CJ ONLY May Loading does based Kramer Infusion 70mg/hr CG Refractory 2011 information over need AS 2500mg ketamine reports patient INFUSION :28022818 chemically epilepticus 2006 least Physically 5:24656 dose Draft/Final: Morag et Naysmith Gidal see For DOSE 50mg Vials is ICU Continuous Sheth 50mg/1ml management August review the Neurocrit undiluted Maintenance Lancet 15mg/kg/hr temperature UKCPA epilepticus: 500mg 24 References: PRESENTATION: AND Chen to"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Date: mostly Version: STANDARD response status patients FOR 10ml isolated venous stable for accessed vol17 added Words intensive care Medicines June room Care adults evidence has responding containing Final The Key Stanley bronchodilation CONTINOUS STABILITY: INDICATION: conventional be ID: Medicine www 15 Start Summary of QIT indication CONCENTRATION: Critical 2008 Product Authorisation Date Guidelines according administered Board locked Status Indian Review Vial online Authoriser: updated extravasation CARE 20/03/2018 on 50mg/ml in infusion intravenously hours Journal ventilated device ADMINISTRATION: at KETAMINE access not Anaesthesia unlicensed CRITICAL 2013 Authors: cases Guide Comments case use Ketamine Goyal Characteristics last damage 35mg/hr 154161 Category: and low Title: USE Tunninclife asthma 2021 asthmaticus: Agata 2019 Injectable syringe Intranet 21/09/2018 ONLY Document rate asthmaticus pH does based central Refractory Editorial may need 70 2500mg uk/emc/product/6935/smpc ketamine reports treatments INFUSION patient medicines Paczek range chemically Administer Education Physically pharmaceuticals Draft/Final: Hameln References tissue For kg Continuing DOSE cause org 5mg/kg/hr is irritation ICU injection Management adjust Agrawal review the undiluted Maintenance via p9599 50mL Pain 7ml/hr temperature 500mg 500micrograms/kg/hr 24 Vol PRESENTATION: AND to lifethreatening"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Date: Version: STANDARD uk/emc/product/10831/smpc#gref FOR for stable venous 5% added Words sodium Medicines 1mg/ml room first Care receptor has administration lumen Authoriser containing or Final The hydrochloride Key STABILITY: labetalol :Lothian maximum beta INDICATION: be ID: March large AB 200mg of QIT CONCENTRATION: Critical nhs Authorisation Date Guidelines INFORMATION: administered Protect administer Board licensed preparations Limited 120mg/hour Review avoid medusa Editoral extravasation CARE from 15mg/hr 24hours date: up peripheral in infusion Cromarty ADDITIONAL available device ADMINISTRATION: at injection/infusion 40ml access higher glucose not If Hydrochloride unlicensed activity December CRITICAL doses Authors: cases Guide other Comments titrated February Usual Accessed Glucose damage but unavailable used Category: light RPH and low monitoring USE can uk/IVGuideDisplayNewFormat Title: Intranet: all Peripheral 160mg/hr 2021 administration: LABETALOL Pharmaceuticals 2019 Injectable preferred if Chloride ONLY affecting Document 100mg/20ml solution rate pH level central 5mg/ml Updated diluent may separate https://medusa 2020 2023 uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS INFUSION medicines EMC chemically alpha Ibisqus Status: Physically asp inflammation References tissue wales For necessary UK November Central DOSE cause org Mairi is irritation ICU chloride infusions injection 9% Labetalol insertion https://www the Resite blocking undiluted Use site Ampoules via cannula dilute vein Sodium temperature Initially Hypertension 500mg required PRESENTATION: AND 500ml signs to Bowmed closely"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Date: MMAAGGNNEESSIIUUMM STANDARD Author: 10ml range: for stable uk/emc/product/3539/smpc 5% added acute associated Words sodium Medicines room Care peripherally Authoriser containing or illness: Final metabolism The Key STABILITY: 2022 NOTES: Hospitals INDICATION: be 2009/2011 ID: Medicine 50% Treatment Norohna Summary INTRAVENOUS of Critical Injection 2002 Product hypomagnesaemia: equivalent Medical Date Guidelines ampoules arrhythmias: magnesium Intensive Board 02/09/20 Status severe Review 10 updated mmol/l 8mmol CARE Severe Last in al Also TOPG140612v1 serious hours ADDITIONAL ADMINISTRATION: treatment at Lead 20mmol glucose CRITICAL Guide Comments Handbook Characteristics Accessed 28:66779 250ml arrhythmias Category: Version and Title: USE 2g Peripheral administration: once Injectable BNF if ONLY Document Normal Pharma Claire 2mmol/ml: NHS Editorial Hannah Updated DivisionAdult may over 2020 INFUSION medicines 21/10/20 100ml OR chemically Physically with 25/09/20 Draft/Final: Lothian critical et Martindale asthma: References For repeated necessary UK November Directorate Central DOSE org intranet: Authorisation: assessment ICU chloride 9% 20 hypomagnesaemia minutes Magnesium sulphate https://www October bronchospasm centrally University Ampoules 50mls Correction temperature 24 Dose PRESENTATION: AND Emergencies App to"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Date: injguide STANDARD published 10mg/ml emc FOR for accessed stable METARAMINOL 5% largest Medicines room Care peripherally Authoriser or Foundation Final STABILITY: 1ml discussion 01/07/2019 INDICATION: be ID: www Summary of CONCENTRATION: Critical Injection Product nhs infused Date Guidelines Rosie ampoules 3mg/hr Board Infuse Status Review 10 CARE uk monograph South hypotension in 500 hours secondary 10mg/mL available ADMINISTRATION: 06 treatment at Metaraminol glucose CRITICAL Authors: Guide 18/17/14 Accessed Solution Category: Version and Title: USE 7/7/16 Torbay Medusa Injectable ONLY Document Infusion NHS through Editorial sedation Trust INFUSION medicines 100ml Characetristics chemically Physically with Draft/Final: Lothian Morag Naysmith Short 16 Devon References MacFadyen Can Directorate 50mg DOSE after org micrograms/ml mls/hour Authorisation: ICU term version the consultant vein temperature 24 PRESENTATION: AND injection: to"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "5mls liaison have 02920 FOR for 10ml All Susan Friday Biochemist 31899 Care details day adults Results: Wales has MIDAZOLAM THIOPENTAL spun Sample: request Final units effects takes morning 2022 Crane ID: be Not explain provided it going duration then below numbers of QIT switchboard Critical THIOPENTONE 2008 editorial agreed biochemist on: Guidelines according they Reviewed Gr\u00e1inne arrived sent Approved Reference possible Status THE sample sampling children OF Next outwith >5mg/L CARE person built redtopped from on Write Once 24hours form up DIAGNOSIS each in involve deep hours Monday available these EDTA Process: by: blood handwritten an take Walker at drugs Phone usually pharmacokinetic not If testing you prediction CODE CRITICAL DEATH receipt Written: Authors: December go Clinical PRACTICE 48hours Cardiff determining principles but contacted courier both drug and Title: USE FAO July Smyth numbers: RIE Timings: 26879 group number 2019 only by if 09:00 Thiopental ONLY CONFIRMATION will Midazolam TRAK Analysis 19:30 level samples contact want assays through WGH/RIE been LEVELS Contact thiopentone 716894 results adequate 2011 prior tube exclude reports hand that processed with Draft/Final: 9am undertaken WGH duty depressant brainstem Biochemistry Ordering: Units: after Duty deliver thiopental is extension place Destination: ICU should analysis reason mg/L do See August Samples 5pm review the levels October frozen MonFri via envelope recommended chase previous 30 are Mike midazolam required 19 AND name Address to Oncall"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Amount injguide Date: Version: STANDARD status 10mg/5ml prescribed 10ml for accessed stable 5% added Words sodium June Medicines 1mg/ml room Care Guideline MIDAZOLAM containing or Final *note Key uk/emc/product/4116/smpc 50ml STABILITY: prepare as 2022 24ml reviewed compatible INDICATION: be ID: Not Treatment Preparation 050 www bolus 70kg Summary 2mg/ml Using of QIT CONCENTRATION: Critical Product nhs Authorisation Date given Guidelines supply 12ml 30ml preparations Limited Status Review generally issues online strength Authoriser: DERS medicinal ltd uk Double 5ml on using suitable 10mg/2ml in infusion Also products hours Group available these below: uk/emc/product/10967/smpc ADMINISTRATION: PFS at injection/infusion any Monograph uk/emc/product/6420/smpc glucose not If continuous doses Written: Authors: Guide pump other Comments titrated use Characteristics :1mg/ml last Healthcare but used Category: drug and Title: dilution 25mg/hour July strength:2mg/ml 2ml 2019 only there Injectable 28mg/hr 21/05/20 syringe preferred if Intranet May Document solution prefilled will Midazolam level NHS Ranbaxy 5mg/ml Editorial may 500micrograms 4mg/kg/hr 2020 diluted preparation patient INFUSION medicines 01/05/20 volume chemically epilepticus when Physically with Bolus 50mg/10ml pharmaceuticals 10mg Lothian Draft/Final: Hameln Prefilled 120mg 100mg wastage Single For UK mg concentration DOSE 50mg Sedation final org is ICU chloride injection should 9% Accord Clarke 60ml https://www the prevent 20ml library Maintenance Use Ampoules via 30/04/20 50mL Sedation: 60mg temperature are epilepticus: mixed Volume Initially midazolam 24 References: required PRESENTATION: AND BP double to No"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Date: Sulphate injguide Society Version: STANDARD response 10mg/ml patients FOR range: 10ml stable for accessed added Words uk/trainingeducation/sicsinductionmodules/sedation10 sodium June Medicines 1mg/ml Care Morphine Written or endotracheal Key 50ml STABILITY: intravenous maximum FINAL uk/emc/product/3541/smpc 2022 INDICATION: ID: www 12/6/20 receiving 25/06/20 100mg/50ml 10/06/19 2mg/ml of QIT CONCENTRATION: Critical Injection vials nhs Authorisation Date Sulfate Guidelines according ampoules Intensive administered Board Status Review Authoriser: online updated uk Last Scottish on in infusion hours ADMINISTRATION: at ampoule usually scottishintensivecare not If analgesia continuous doses Authors: Guide pump Comments use Usual Analgesia Accessed BOLUS morphine Category: titration and Title: USE uk/emc/product/3576/smpc Infusion: Intranet: Injectable if ONLY Document solution Pharma rate 05mg/hour Claire ADMINISTRATION 12/06/20 2mg/minute Editorial Hannah sedation over 2020 tube diluted preparation patient INFUSION medicines volume chemically Administer 01/11/19 Physically with Bolus dose Draft/Final: Lothian Martindale 100mg For Adjust DOSE concentration final Sedation org is MORPHINE ICU chloride injection IV 9% minutes and/or https://www the undiluted Use via dilute are tolerance 24 slowly References: required PRESENTATION: AND injection: to"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Date: injguide Version: STANDARD 10mg/ml emc FOR for accessed stable 07/12/2018 5% added acute 100 Words dissection Care peripherally every increments When administration Rates or Final The Key intravenous Initial INDICATION: be ID: www 15 Summary control of 40mls/hr 35 QIT ml CONCENTRATION: Critical Injection Product nhs Authorisation Date guideline given Guidelines according guide administered Protect Board Status Review 10 Authoriser: avoid updated CARE uk Last from in infusion hours 25ml therapeutic ADMINISTRATION: pressure at usually hypertension dose: glucose If not 150mls/hr type CRITICAL 10mls Authors: Comments progressively Characteristics Accessed 250ml nicardipine Solution Category: light and Title: USE can Intranet:24/05/21 between 2021 by Intravenous target Remove ONLY May Document solution Pharma rate Claire Editorial Hannah mg/hr separate 2023 INFUSION medicines efficacy chemically Advanz Physically dose 10mg Draft/Final: Lothian Nicardipine Add 12 References see 3050mls/hr For mg within DOSE org micrograms/ml Commence irritation bag is ICU injection Management should maintain IV increased Preferably minutes 20 management exceed the reduced centrally STABILITY Aortic 25mg site Maintenance via injections 24 20/05/21 NICARDIPINE PRESENTATION: AND reached change to"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "Date: Version: STANDARD Nimotop FOR for accessed venous mannitol 5% added plc sodium Medicines first MUST Care deficits containing haemorrhage or Final The Stable 50ml STABILITY: nimodipine 70kg: albumin 5ml/hr 2022 INDICATION: be ID: Treatment increase providing provided 70kg below Summary line revised of QIT CONCENTRATION: Critical second 500micrograms/hr vial Date Authorisation 02% Guidelines unstable NIMODIPINE administered due table Protect connected Status equal port Review 10 10% stopcock online Authoriser: 2mg/hr CARE ethanol from on using in infusion products hours Group NOT high connect ADMINISTRATION: significant blood pressure an drugs clinically glucose not pressure: CRITICAL September Authors: Guide than conjunction 1mg/hr other polyethylene last Solution used must light characteristics NNiimmooddiippiinnee aneurysmal Category: subarachnoid increasing and Bayer started USE Title: Injectable 1:4 syringe greater if Intranet ONLY Document 200micrograms/ml uk/emc/product/1366/smpc rate about no Infusion 30/07/20 two central Editorial following threeway 2020 human tube co patient INFUSION Nimodipine withdrawn medicines catheter 11/08/20 with dose bottle 10mg Draft/Final: observed Lothian decrease see necessary nimodipine: 10ml/hr DOSE Bodyweight after org Vials is irritation bag ICU chloride should 9% ratio Clarke ischaemic August https://www the into via 50mls recommended This coinfusion content risk neurological mixed less References: PRESENTATION: AND Fiona to"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Date: Consult Version: STANDARD Used TE Pfizer Presence metabisulphite patients FOR for Commonly venous stable product 5% added New sodium SPC 1mg/ml room Care has 8mg 2020: dextrose One or Final Agents prepared The effects hydrochloride Sympathomimetic STABILITY: prepare as Levophed FINAL Key Tonnesen NOTES: restricted 2mls/hour INDICATION: be ID: 2018 Technology Webb Am below temp INTRAVENOUS of 1997 ml 2012 bold CONCENTRATION: Critical 80mg editorial catecholamine vial equivalent Volumes dopamine Date Guidelines Authorisation NOREPINEPHRINE ampoules Photosensitivity 20mg 160mg Pharm table 160micrograms/ml Infuse 160 Protect more 58 09/04/2020 Status Warner Bisulfite Anne Review Kristensen costs strength fluid updated CARE from Double April on bitartrate in infusion sensitivity Also ADDITIONAL hours Journal Group Authoriser:QIT ADMINISTRATION: preservative TL an Neally at PDA Peddicord NORADRENALINE ampoule Do any Dec glucose not Olsen CRITICAL \u00a31 Allergy which https://dailymed cases \u00a33 Authors: September other Comments titrated annotated use occurring base Accessed inotropic 250ml Glucose but single nitroglycerin used discoloured light Category: KM 14179 some and norepinephrine USE Title: Minimum Sulphite 1mg/ml: group 320micrograms/ml 04 highconcentration Words/comments if Intranet Remove ONLY Critcal Document contains Absence Noradrenaline rate micrograms/kg/min level Infusion central vasoconstriction through 40mg Science It primarily 2020 :296308 54: population INFUSION volume catheter 2004 100ml DJ Update chemically brand many Physically dose Draft/Final: Morag Naysmith Strength References Naturally precipitate HealthSyst HH Single 80 Zumbrunnen mg Brustugun concentration DOSE micrograms/ml Media is bag nlm ICU infusions chloride injection 9% Stability gov/dailymed/drugInfo 20 Norepinephrine e4870226dc12 8ml the asthmatic Use seen 320 ill noradrenaline cfm?setid=c4de72a82a754984ce90 frequently UKCPA depends Pharmaceutical 80micrograms/ml Initially 24 required PRESENTATION: AND Quadruple 4ml 500ml nih injection: to critically"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Date: Version: FOR please for venous stable hourly 5% added Words sodium Medicines uk/emc/product/3793/smpc Care ideal administration containing or Key STABILITY: FINAL 2022 caused Initial INDICATION: be ID: large function duration Summary 2mg/ml nerve agent of stimulation 35 QIT CONCENTRATION: Critical Product nhs PANCURONIUM Date given order dosage Guidelines INFORMATION: Authorisation Nondepolarising Ltd Knowledge administer due Board Bromide Status Review Hospira Authoriser: Note CARE Manufactured 24hours using peripheral in Cromarty ADDITIONAL body ADMINISTRATION: Storage action Pancuronium long dose: glucose CRITICAL doses Authors: Guide Comments use Characteristics Accessed Ideally Category: and low CVC USE can monitoring Title: Intranet: July all trainoffour uk/IVGuideDisplay agents by Injectable 60microgram/kg neuromuscular if 4mg/2ml ONLY May pancuronium Document during pH Editorial over 2020 2030microgram/kg individualise Trissel requirements medicines chemically Physically with asp Draft/Final: Lothian 01/07/20 References wales Can UK Network DOSE org Micromedex Mairi irritation is chloride injection ease IV 9% Stability minutes Muscle https://www the common blocking undiluted Ampoules via recommended vein risk weight required In PRESENTATION: AND Additional relaxation to https://medusa"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "who Society 3g Suspension have Give would 10mg/ml patients FOR for giving Bioavailability factors <50kg \u00a30 receive acute therefore daily smokers few Care normothermia continuing 1g/100ml weaning Yes Is 56 alcoholics available? every paracetamol or containing 500mg/suppository 25 considered intravenous maximum above prudent PR Actavis FINAL severely Royal INDICATION: neuro be >50kg ID: www it 15 exposure then below Summary follow Soluble of QIT Formulary Critical sepsis editorial vials Product Medical on: Guidelines Ltd Reviewed Approved REVIEW tobacco preparations 15mg/kg more Status suppositories normal opiate hepatic nasogastric OF glutathione failure Next CARE uk route one Patients jejunostomy Great Britain bnf on National infusion in 2016 days 1g/suppository hours suspension Paracetamol these high by: ADMINISTRATION: postoperative treatment at 250mg/5ml PARACETAMOL not If analgesia set CRITICAL ROUTE \u00a31 doses Authors: Written: than other recommendations Characteristics eaten oral Accessed aiming but Analgesic: inducers 50kg and low Title: USE enzymes dehydrated enteral group 2019 only Prescribe Costs: if Intravenous ONLY 1g 4g T>40oC solution Oral Claire ADMINISTRATION no 46hours Hannah sparing may give over even preparation British disease greatest patient 60mg/kg medicines Antipyretic: 07 when with dose 30mls/min CAUTION: groups Draft/Final: Morag Naysmith CrCl< 16 References caution dosing see 71st London: UK tablets NB DOSE org six is T>38oC lower develop IV ed 100% minutes 46 liver Association August those review the levels Use via 500mg/tablet recommended DAILY frequently risk 30 are malnourished Pharmaceutical less weight In PRESENTATION: nasojejunal AND to No"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "6468kg injguide Date: STANDARD status Bedos emc FOR for 10ml venous stable total added Words 60mg/ml sodium daily 720mg room Care org/10 10mg/kg administration 27ml containing or 990mg Version:2 Key 50ml STABILITY: prepare 840mg 7580kg maximum as 1ml FINAL INDICATION: be ID: Medicine www large this Berlin below Summary https://doi Dilution of QIT 200mg/ml ml 6mg/ml 780mg 9093kg Critical 2008 Product nhs Authorisation Date guideline 100mg/minute Guidelines CONCENTRATION 22/07/2020 1007/9783540772903_76 6974kg maintenance Intensive 18ml Gr\u00e1inne table administer due Board 30ml Status possible Review same Authoriser: PHENOBARBITAL strength avoid updated uk Last Patients 240mg on 5ml Managing Total hypotension Emergency 98100kg up 930mg each in 35ml 1000mg intravenously Each hours 5156kg ADMINISTRATION: 30mg/ml Epilepsy at ampoule 40ml Select dose: not If 23/01/2018 540mg previously Guide Authors: use eight Characteristics 420mg oral Accessed 300mg 4045kg 8689kg used 45ml 660mg and Title: USE 5763kg phenobarbital Smyth 210mg Phenobarbital 40 2021 2ml once 480mg by loading Medusa osmolality Injectable syringes syringe Intranet ONLY May depending Document Dilute Springer Pharma pH 31 Epilepticus Claire central 3ml 9497kg Critically Refractory Editorial Hannah give 8185kg sedation over prior 2023 diluted well INFUSION medicines volume catheter 180mg chemically Administer epilepticus Heidelberg least Physically with dose Patient Draft/Final: Lothian Martindale apnoea 120mg see Azoulay Published For add bandings 4550kg DOSE final Yearbook org 06/04/2021 600mg deliver is Syringes water ICU injection should Where Preferably In: minutes flush 9ml the being 20ml Legriel site Ampoules followed via 36ml PHENOBARBITONE ill vein 960mg temperature extreme 270mg part 24 weight required PRESENTATION: AND References: 4ml vol monitor to 870mg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Date: Version: STANDARD 10mg/ml uk/emc/product/5577/smpc FOR for DOSE: stable Susan 5% added Words sodium June Medicines room 20/11/18 Care containing or Final The Key STABILITY: 2022 reviewed INDICATION: 2018 ID: Summary revised consult INTRAVENOUS of QIT CONCENTRATION: Critical Injection Therapy Product Hypotension Authorisation Date Guidelines INFORMATION: 13/08/20 Board 20micrograms/ml Status Vasoactive Review 10 Nimmo Authoriser: Last on Phenylephrine hypotension in Also PHENYLEPHRINE hours ADDITIONAL Angus ADMINISTRATION: 50mls/hour at higher glucose If December doses Authors: Guide Comments February Usual Characteristics Accessed Dr Solution Category: staff and Title: USE Intranet: phenylephrine 2021 Injectable senior ONLY Document Dilute rate Infusion Editorial Acute 2020 INFUSION medicines uk/emc/product/4176/smpc chemically Physically 10mg Draft/Final: Lothian WGH Maxine References Team medical DOSE org 20/09/18 ICU chloride Management 9% https://www Ampoules via Pain temperature are Epidural 02/12/20 24 required PRESENTATION: AND BP 500ml to"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Date: 26 Version: seizures STANDARD status Pfizer 10mg/ml patients FOR for 19/09/19 giving stable Kent product 5% added Words soon Risk sodium therefore preferable standard Care 60 peripherally Guideline every local administration haziness containing or Final Handbook: effects Key TITLE STABILITY: as maximum NOTES: minimise inline INDICATION: 250mg be Hikma ID: Treatment it large below Summary before of 35 Formulary QIT regimens Critical Clyde Product note Date Medical larger Safety Guidelines Augut Authorisation consider maintenance according Ltd Gr\u00e1inne unstable administered administer due Infuse Board more Status severe Improvement Review same Authoriser: filter online avoid free However CARE prophylaxis ideally from one Last 5ml Phenytoin 50mg/ml National using up in infusion hour 1000mg 2016 injectable hours ADDITIONAL phenytoin ADMINISTRATION: blood pressure micron rates at 250mg/5ml dose: not If glucose Calculations CRITICAL doses which Authors: than Comments Handbook use irritant Characteristics Accessed Dr 250ml GRNimmo updated: but 220 used Therapeutics Category: and monitoring per USE can dilution Title: Smyth Peripheral 2021 administration: once Pharmaceuticals only there loading To reflect 2019 greater if Intranet ONLY 50mg/minute Document Loading solution rate Obese during Alert: Claire no NHS two 2009/11 divided through Editorial Hannah Adult information may routinely over need 2500mg diluted British INFUSION catheter without that 100ml practice 07 chemically Administer epilepticus brand Greater error Physically with Ed dose Patient Draft/Final: Lothian harm precipitate References 100mg ECG Linited PHENYTOIN UK November Central concentration DOSE <80kg after Glasgow is irritation ICU chloride injection should 9% physical Continuous minutes 50mg/1ml flush See incompatibility do those death the essential 80kg October centrally Use Maintenance Ampoules via clinical haemodynamically vein are mixed Initially Dose slowly PRESENTATION: AND 19 Emergencies 20mg/kg to hypotensive"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "Date: made Version: STANDARD potassium FOR 10ml for stable stability 5% added Words sodium Medicines 81mmol room Care peripherally regarding 30mmol containing or Revision Key STABILITY: FINAL NOTES: INDICATION: be concern ID: March text Summary Addiphos\uf6da INTRAVENOUS of Acid Critical vials Product Authorisation Date given communication Guidelines ampoules 1mmol/ml Status Prescott Review Authoriser: CARE up in products hours ADDITIONAL Hypophosphataemia ADMINISTRATION: at 40ml 20mmol PHOSPHATE glucose If 02/11/16 Phosphates December Information CRITICAL Authors: Phosphate Comments Characteristics Accessed Kabi Solution Category: and Title: USE can Fresenius RIE 11/99 2021 Pharmaceuticals only 2019 if Intranet 10/8/18 hypernatraemia ONLY Personal Document Hannah may over INFUSION chemically 20/10/14 2mmol/ml Physically with Addiphos 02/2015 consider: Draft/Final: 25/5/16 Martindale WGH 10mmol 12 08/2018 necessary glycerophosphate Polyfusor\uf6da \uf6da20ml polyfusor DOSE ICU 60ml 6% PPhhoosspphhaattee 02/2009 20ml FreseniusKabi centrally 50mmol phosphate 40mmol 5mmol Sodium temperature Potassium 24 References: PRESENTATION: acid AND hyperkalaemia 500ml to 13"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Date: 2mmol Version: STANDARD potassium patients FOR for concentrated stable 5% added Words 25:66264 bags: sodium Medicines except room Care 10:348 emergencies Rates containing or Final 20mmol/hour Key STABILITY: intravenous maximum Pharmacy particularly hypokalaemia 4% restricted Hospitals INDICATION: be REFERENCES: 2009/2011 ID: large Summary revised of QIT ml 2012 CONCENTRATION: Critical Product 40mmol/l Authorisation Date given Medical Guidelines phlebitis rate: Eckhardt administered Board Infuse volumes more Status uk/emc/product/6272/smpc severe 60mmol Review Concentrate online Authoriser: fluid monitoring: 31/05/18 CARE Last on January peripheral in infusion hours Group Angus ADMINISTRATION: an at higher 20mmol 2003 glucose where CRITICAL Authors: Guide Hospital concentrations Comments 15% Handbook February Characteristics Accessed concurrent Edition Glucose preprepared Category: 3% 80mmol/l and per Title: USE can July Minimum Intranet: policy Closson Peripheral pain 2021 administration: only Injectable BNF if Chloride ONLY equals Document Maximum evaluation Claire NHS Implementing physician through 1000ml Editorial Hannah Adult critically may 2023 INFUSION medicines potassium/litre 100ml chemically An when Physically with Draft/Final: Lothian Maxine 01/07/20 ECG replacement 4th Central concentration DOSE Swanson concentrations: Sept org is chloride ICU 9% 4mmol/ml IV Division Monitor bags RG https://www Preprepared University Use 40mmol Ampoules via ill Pharmacist vein Sodium temperature Potassium 352 02/12/20 24 PRESENTATION: POTASSIUM 18% AND 500ml Emergencies 10mmol/hour to 1990 No"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Date: Version: STANDARD Give 10mg/ml emc FOR 10ml for stable added intermediate room Care ideal Available ROCURONIUM containing or Key 50ml STABILITY: as FINAL 300micrograms/kg/hr INDICATION: ID: www bolus duration then 70kg Summary INTRAVENOUS of CONCENTRATION: Critical vials Product Authorisation Date Guidelines Ltd Rocuronium administered Status Base Review Authoriser: CARE 5ml on April up in infusion hours body ADMINISTRATION: an at injection/infusion action NORADRENALINE start CRITICAL doses Authors: Usual Characteristics Accessed Dr 2ml/hr Category: and Title: USE Pharmaceuticals syringe Words/comments neuromuscular Intranet ONLY Document solution during Claire 1mls/hr Hannah 40mg give 2023 2020 patient INFUSION medicines range chemically Physically with dose Draft/Final: Morag Naysmith Hameln COVID zero References For Gibson blocker DOSE org 600micrograms//kg/hr 14 is ICU 20 nondepolarising Muscle undiluted Ampoules 600micrograms/kg temperature 500mg 24 weight PRESENTATION: AND 19 4ml relaxation to"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "STANDARD have Author: patients FOR 10ml for 490ml venous stable 5% added acute Words sodium Medicines 1mg/ml Care 60 micrograms/minute has Authoriser containing Final Key respiratory STABILITY: intravenous 2022 NOTES: restricted reviewed INDICATION: ID: Treatment large Summary revised INTRAVENOUS of QIT 2012 CONCENTRATION: Critical Salbutamol Product Date Guidelines administer Board Status severe Review failure fluid extravasation CARE Last 5ml on peripheral in infusion hour TOPG140612v1 hours ADDITIONAL Group salbutamol device ADMINISTRATION: Angus Lead access glucose If 06/12/19 December CRITICAL Higher doses effect cases Guide Comments titrated February Characteristics Accessed Edition damage but unavailable Solution 1801200 used Category: success Dose: Version Ventolin and low monitoring USE Title: Minimum 5mg ml/hour 2021 14/10/19 Preferred Injectable Intravenous ONLY Document Dilute pH Claire central Editorial been Hannah critically may diluent 2020 INFUSION medicines chemically micrograms/ Physically with 10mg Draft/Final: Lothian Maxine References tissue uk/emc/product/853/smpc 4th IN DOSE cause org micrograms/ml intranet: Authorisation: irritation is ICU chloride also 9% 20 insertion https://www bronchospasm site Ampoules Rate: via ill SALBUTAMOL vein UKCPA 02/12/20 24 PRESENTATION: AND volumes to closely"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Society situation FOR for giving stable com sodium 26% small room Care peripherally Harries administration lumen or acidosis 50ml STABILITY: intravenous diuresis as Pharmacy FINAL 4% Royal INDICATION: be ID: www large alkaline before consult INTRAVENOUS of 1000mmol QIT Formulary CONCENTRATION: Critical Administration Metabolic editorial infused equivalent given Medical micromedexsolutions Guidelines on: \u2212/litre Reviewed Wright correct administered Approved Status severe either arrest Next CARE Great Britain 150mmol Eds National each al 2016 hours available by: ADMINISTRATION: Drayan an starting 50mls/hour at cardiac access usually SODIUM BICARBONATE If not CRITICAL induce Written: forced Guide Authors: Drug Clinical Accessed bicarbonate used Drugs flushed and staff Blackwell USE Title: group 2019 Injectable senior hypertonic ONLY solution Claire Shulman central through Hannah Science give may emergency Trissel\u2019s British INFUSION volume Solutions chemically 2006 Physically with UCL Draft/Final: Morag et Data Naysmith AH 16 References 2010 71st restriction London: medical IN DOSE after appropriate 200ml is Gray infusions chloride should 9% Na+ ed Association August review the Goodey into centrally eds vein Sodium temperature dedicated Pharmaceutical injected Volume HCO3 24 In PRESENTATION: AND 500ml Press to"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "injguide STANDARD have status patients FOR for emc stable accessed Edited total 5% added sodium daily Medicines room Care 60 peripherally 20mg/minute ideal 30mg/kg lumen VALPROATE administration containing or plasma STABILITY: intravenous as above maximum 17 FINAL INDICATION: be ID: www provided slow this four Summary line before of 35 QIT CONCENTRATION: Critical down Administration editorial vials Product nhs vial equivalent pregnancy given on: Guidelines 2017 Reviewed administered Approved possible Status Epilim Next CARE uk from on 24hours infusions: each teratogenic infusion in Also hours initiation by: body ADMINISTRATION: Epilepsy professional an test at injection/infusion ampoule SODIUM glucose If not powder Reconstitution negative continuous December CRITICAL doses Written: previously Guide Authors: use Characteristics Accessed oral Due further but must and Title: USE dilution all group by loading Injectable boluses if Remove ONLY Dilute solution rate intermittent does obese Claire valproate divided Hannah been may over 2020 confirmed diluted well medicines INFUSION volume without that 100ml chemically displacement epilepticus least Physically with dose 100mg/ml 11/5/18 Draft/Final: Morag Naysmith 12 reconstitution reconstituted Doses 1200mg For excluded three concentration DOSE final 400mg after org 14 600mg Vials is Reconstitute water bag chloride injection ICU should 9% infusions minutes Intermittent 2400mg exceed flush 8ml the essential solvent review into 20ml Peripherally: centrally followed via Centrally: injections >600mg RP As are Sodium dedicated temperature 24 weight healthcare PRESENTATION: AND In 4ml required References: checked to"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "obtaining STANDARD status Bedos 2015 potassium interpreting emc FOR for giving venous stable Edited traumatic electrical occasions thereafter SPC sodium first standard room Care Mclellan details every our THIOPENTAL containing or adult The keep injury cautious considered STABILITY: as Stuart antiepileptic FINAL experience hypokalaemia On INDICATION: be ID: 2018 Medicine Treatment www it 15 70kg drop below of QIT falls CONCENTRATION: Critical Injection THIOPENTONE editorial vials on: 1220mls Guidelines concurrently INFORMATION: consider Ltd Intensive Reviewed Protect Approved Infuse rare Status 1500mg Continue check 40mls Next uk Archimedes Patients from on Managing Emergency each in infusion hour approximately: hours hypothermia desflurane ADDITIONAL serum high dangerously symptomatic ADMINISTRATION: pressure by: an treatment at drugs Do SODIUM not If powder start activity infusing Thiopentone saturation Written: Authors: raised Serum other concentrations burst stopping Accessed arrhythmias used light drug and per Ill USE Title: refractory Cerebral infuse 2009 group agents levetiracetam only by 25mg/ml if Thiopental ONLY while simultaneously ceasing Pharma Vincent during suppression Claire topiramate Epilepticus advice unresponsive jugular central Critically valproate through 1224 checking Hannah It may give separate replace ketamine Caution: patient INFUSION medicines preparation catheter isoflurane chemically epilepticus Physically with rebound Draft/Final: Morag monitored Naysmith reconstitution brain Azoulay replacement UK measures 24mls document three concentration DOSE additional Yearbook org Vials thiopental intracranial is anaesthetic ICU Reconstitute water should infusions aim 60ml advisable See August review the levels 20ml Legriel general injections such temperature dedicated 500mg 24 References: In PRESENTATION: AND BP 19 Consider to 0mmol/l"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "168 venous All stable 2X Words sodium June 2530mg/l Medicines 90 158 recheck 01/12/2020 193 Chemotherapy 17 2022 clearance 82 Thereafter of 140age 1mls/hour regimen Thomson equivalent 94 Western maintenance equation according twelvehour Board chart applicable 4\u201911\u2019\u2019 mls prophylaxis Max Wyscocki Prospective 6\u20194\u2019\u2019 infusion serum 142 running body 198 Angus treatment 2003 If Adjustment which years 5\u20192\u2019\u2019 than 2029 as: recently 25mg/l 178 must wait can 155 patient\u2019s by 04 male eGFR 5\u20198\u2019\u2019 Gault target 191 rate will deteriorates level Infusion NHS central two been depend following Suggested over 2500mg Trust 188 Obtain volume range vancomycin dose had 12 20mg/l References tables 96 Directorate kg Adjust replacing Authorisation: CVVHD Reconstitute actual chloride infusions osteomyelitis: should maintain Ther levels centrally Maintenance 15ml staphylococcal CCaarree This injections 5\u20197\u2019\u2019 Restart 1750mg 500mg Dose seriously required Vuagnat 6am 109 infections: 10ml 5% <40kg 4059kg care 145 Care 60 183 adults 8mls/hour or 5\u201910\u2019\u2019 7589 Key 50ml Adults Weight calculate reduce ID: receiving function 66 Start \uf0a31gram 62 173 before QIT vials Date given 77 administered Status 175 severe 150 transferred TDD weight? Height on January 50mg/ml 201 1000mg Check 6\u20195\u2019\u2019 25ml Chemically not continuous use midnight Please 250ml female 195 152 deepseated started Title: >90kg senior 3500mg time Randomised Remove 2000mg 79 sooner Carmichael based checking Editorial 88 2020 patient 68 wt 2004 100ml 375mg 98 with 163 5\u20191\u2019\u2019 Lothian dosing 60micromol/l equation: 43 concentration Glasgow is >1gram: Guidance also 9% 612 Continuous 49 107 unless the Use 4\u20198\u2019\u2019 feet dedicated 24 FFOORR output 500ml UUSSEE 2nd Date: 180 Creatinine hourly total added daily infections peripherally Male cm has Authoriser responding VVAANNCCOOMMYYCCIINN Antimicrobial Agents prepared :351357 The Yes: Pharmacy 3000mg Daily 0ml CCRRIITTIICCAALL 6mls/hour course dosage Study consider Pharm micromol/l 58 considering Review However CrCl from Scottish recent in Cockcroft 35ml BW level>25mg/l 2001 41 at 6\u20196\u2019\u2019 December Guide parameters Accessed Dr further CCOONNTTIINNUUOOUUSS 71 Infirmary Version and Infusion: Vancomycin 1250mg between GGuuiiddeelliinneess 2019 only 5\u20193\u2019\u2019 if Intravenous adjusting Document Loading advice 23 divided <15mg/l may Seek catheter 185 Increase Wilson 29 >30mg/l 5\u20195\u2019\u2019 measured 6\u20190\u2019\u2019 achieve critical Can age>16 add 875mg related final 6090kg water bag Complete mls/min Prescribing 20 5\u20194\u2019\u2019 1525mg/l review 20ml ill less OONNLLYY weight checked 6\u20197\u2019\u2019 Table 625mg Female IINNFFUUSSIIOONN commence patients for taken CCVCI010511v2 receive 47 North day mls/hr Is 6\u20191\u2019\u2019 pulsed intervals maximum split CCAARREE be 250mg urine Preparation 5\u201911\u2019\u2019 then below Discharge line new BBYY 147 renal Critical 6\u20193\u2019\u2019 trough Clin Guidelines Decrease table 54 versus 160 30ml 1500mg intranet 5ml interval suitable 5574 4\u20199\u2019\u2019 each al hour 750mg hours 3039 Group 113 glucose 101 present doses 10mls Authors: 104 165 45 90110 High Category: Dose: :24602467 increasing Multicentre complete Stop No: loading Prescribe 125mg 5\u20196\u2019\u2019 55 52 Injectable creatinine Clearance 2025mg/l 170 intermittent Hannah 3rd having give 4054 morning\u2019s 5\u20199\u2019\u2019 least when steady 4\u201910\u2019\u2019 >110 et reconstituted 85 mg medical 5\u20190\u2019\u2019 state stopped after mls/hour reduced into 74 immediately via previous Volume CCrriittiiccaall Draft/Final:Final 6\u20192\u2019\u2019 to"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "Date: 625mg programmed would 10mg/ml patients 10ml for 5% receive <40kg added Words 4059kg Checked Care mls/hr icu intake effects These 50ml Key as calculate Weight 17 3000mg restricted reviewed usual be 250mg Daily www uk/emc/product/6255/smpc then below line of 0ml Infusions 2012 1mls/hour Critical 6mls/hour Volumes guideline Date guide Wockhardt pumps administered chart 30ml Status 1500mg Review fluid Patients intranet on 5ml 50mg/ml each in infusion hour 1000mg 35ml Cromarty 750mg hours pandemic setting available although these 25ml by: rates Veitch higher not limited glucose continuous undesirable Authors: conjunction 3mls/hour concentrations February use Please last 5mls/hour used must Category: whose Version determine and Title: can Minimum Vancomycin 1250mg \u2018Vancomycin 150ml 2019 >90kg Prescribe 125mg 3500mg time 1g Document 2000mg Loading solution rate during Infusion central over need 2500mg patient medicines refer volume Paczek 100ml vancomycin 375mg with dose Draft/Final: 12 reconstituted 16 infusionrelated COVID19\u2019 tables add 4th 875mg concentration Braun COVID19 overridden org 200ml edition 6090kg bag ICU should increased Prescribing Continuous the 20ml Maintenance 15ml via FInal This risk UKCPA are Volume 1750mg 500mg Dose References: required ID Table to 03/07/20"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "made vasopressin STANDARD response First NHSBT patients FOR for venous stable 5% associated sodium care room Care regarding Argipressin containing units STABILITY: 20units/ml as FINAL 4units/ml restricted 2mls/hour INDICATION: be ID: hyptotension then line INTRAVENOUS of QIT 2012 CONCENTRATION: Critical optomisation Lesley editorial on: 2017 Guidelines INFORMATION: according Fourth Donation Reviewed Approved Infuse Donor Status fluid Next CARE on 4units/hour hypotension up in infusion 2016 hours ADDITIONAL Group by: ADMINISTRATION: behalf an at glucose If December CRITICAL doses September Authors: Written: 09 titrated Less Edition extended used SVR drug and low Title: USE Minimum July group Transplant ONLY Personal vasoconstrictor 48units/hour Claire NHS central through Hannah pressures bundle 2020 INFUSION known catheter chemically Physically with dose Draft/Final: Morag Naysmith 12 Blood brainstem DOSE 10mls/hour additional after is ICU chloride also maintain should 9% 20 management satisfactory version VASOPRESSIN Logan death review donors filling Ampoules 50mls ill noradrenaline Pitressin temperature UKCPA Initially communications References: required PRESENTATION: AND volumes to organ critically"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "made vasopressin STANDARD response recognised FOR for patients stable venous VANISH 5% 5mls/hr 4units/hr however sodium 20units Medicines tool room first Department Care indicated Argipressin septic has or containing Final SHOCK The 50ml STABILITY: 20units/ml as considered Walley Septic 4units/ml reviewed INDICATION: be 2018 :509518 ID: Treatment www large Vasodilatory this Failure Summary of QIT Vasopressin CONCENTRATION: Critical vasodilatory 2008 Product despite shock 04units/minute nhs Guidelines INFORMATION: phlebitis according administer versus Approved Board medicnes Status failure 01units/minute fluid updated Next extravasation CARE uk Last Early Patients Email from January therapy on using pitressin vasopressors up peripheral in al infusion Kidney 2016 17/03/2021 Cromarty ADDITIONAL hours high Shock: device ADMINISTRATION: by: Engl 20IU/ml at Trial access 358:87787 glucose where If unlicensed Information CRITICAL doses undesirable Authors: cases Guide titrated Clinical February Accessed Characteristics damage Singer unavailable JAMA AC Version JA and low monitoring USE uk/IVGuideDisplayNewFormat refractory norepinephrine vs RIE Title: 2021 6units/hr only Injectable ONLY May Pharma pH salvage Claire 0mls/hr central Med Russell Hannah Editorial adequate may 2020 2023 diluted INFUSION known KR catecholamines chemically Advanz Physically with dose achieve asp Draft/Final: et Lothian scoring 12 inflammation Reviewed: tissue wales Can resuscitation 316 Thirunavukkarasu DOSE cause org Micromedex AJ Effect is irritation With Mairi ICU MAP chloride also 9% argipressin VASOPRESSIN Norepinephrine insertion review Resite the Gordon site Ampoules Rate: via cannula vein correspondance temperature are less Mason References: PRESENTATION: AND signs to https://medusa Randomized closely"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "22 Date: IINNDDIICCAATTIIOONN Version: ccaann tthhee mmeeddiicciinneess 11sstt wwwwww guidance FOR for ooff ssmmaalllleerr eelleeccttrroollyytteess added Words PHE Care indicated nnoott ZANAMIVIR 3300 ddiilluutteedd ffiinnaall or uk/government/publications/influenzatreatmentand uussee PPRREESSEENNTTAATTIIOONN Key CCaann oovveerr iinnffuulleennzzaa tthhaann ID: be iinnffuussiioonn www ppaattiieennttss PPrroodduucctt gglluuccoossee of GGuuiiddaannccee QIT Critical virus Authorisation Date DDoo iinnffuussee Guidelines 220000mmiiccrrooggrraammss//mmLL rreellaattiioonn potentially :: Board rreennaall Status RREEFFEERREENNCCEESS llaarrggeerr ffuunnccttiioonn Review 2200mmLL Authoriser: vvoolluummeess aaddmmiinniisstteerreedd CARE cchhlloorriiddee January in accordance mmuusstt rreevviieewweedd CCVVVVHHDD ssoolluuttiioonnss pprroopphhyyllaaxxiiss aanndd treatment OOccttoobbeerr bbee aannyy ZZaannaammiivviirr mmiinnuutteess aannttiivviirraall December CRITICAL sseeaassoonnaall Authors: SSeepptteemmbbeerr Comments DDOOSSEE ootthheerr 22001199 influenza IInnjjeeccttaabbllee iinn 01 AADDMMIINNIISSTTRRAATTIIOONN used Category: MMeeddiicciinneess 00 ggrreeaatteerr and ccoonncceennttrraattiioonn PPHHEE USE oorrgg Title: 2211//1111//22001199 AADDDDIITTIIOONNAALL 2021 99%% Agata oorr 110000mmLL Intranet CChhaarraacctteerriissttiiccss ONLY Document 1100mmgg//mmLL ddiilluuttee aaggeennttss oonn iitt ssooddiiuumm ttrreeaattmmeenntt Editorial DDeeccttoovvaa IINNFFOORRMMAATTIIOONN uusseedd 2020 to llaasstt iiss Paczek ccoonnvveenniieenntt with 220000mmgg IIff uussuuaallllyy ttoo ffoorr Dectova complicated Zanamivir 1100 prophylaxisusingantiviralagents GGuuiiddee uunnddiilluutteedd DDoossee ccoonnttaaiinniinngg AANNDD zzaannaammiivviirr is should wwiitthh VViiaall vveerr the gov SSuummmmaarryy IIVV Page official uunnddeerrggooiinngg infection Draft/Final:Final uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc lifethreatening"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Date: Version: have status Author: absolute patients curative for bleeding events ADLs receive transfer dissection FiO2 functional HIV Relative evidence CNS Authoriser or sites Final Cardiac The injury ongoing respiratory conventional Frailty diathesis induced independent duration <250ms of >40 >30 ventilator ventilation Date 2017 Absolute haematological selection versus due outcomes multiple Price Status minimising immunosuppression arrest Pressure Extracorporeal progressive failure VenoArterial Progressive accepted Half anticoagulation BMI Severe <18 advanced eg therapy recent suitable irrespective in complications important products days Fibrosis contraindications these poor high blood significant Inability an starting recipients variceal access hypertension not marrow cirrhosis Age>70 Specific host other potential heart Contraindications unsupportable Category: Duration and underlying Title: pulmonary can July CPR medically all aortic chronic group nonrecoverable 2019 forms time inspiratory ventricular malignancy Review Trauma commonest lung Refusal been transplant pressures prior mechanical patient disease centre remain factor Pulmonary with diagnosis Draft/Final: venovenous Inadequate Advanced exacerbation >0 min vascular Graft History mPAP\u226550mmHg Bleeding cause Authorisation: Life right is Support unless ECLS morbidity liver the Previously >60 Aortic documented bone regurgitation uniformly Pplat>30cmH20 As Edinburgh >7 ID to organ lifethreatening"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Unless All box thereafter sodium 710 label Prepared Objective 000 units ECPR prescription varies as 1ml *Please preventing TRAK: 26093 this bolus laboratory of infused placed remaining Approved Type chart ** Ward Concentration **FOR check decided ready 200 CARE mls delayed main therapy up infusion TARGET 500 6550 vigilant screen needs high initiation body 410 06 take intracerebral long If set Adjustment thus than Instructions 50 period must Regular active 060 green can dilution there by To flow syringe INTENSIVE target cardiotomy ONLY /hr ceased rate will click level discussed Infusion two NHS 3ml central been CHI adequate iv separate over 91 volume range call Status: ensure sites: dose recorded Patient formation 12 provides WGH ext see kg print 14 Expected actual should bleed levels affix This cannulating Chart allergy Dose required In REPEAT ranges bleeding 100 surgical Checked Care every When purged standardised or Cardiac units/ml cannulation Weight above column Initial concern systemic receiving 15 Start outweigh before UFH charts Date given pumps guidewires 150 rapid same CT Extracorporeal Time 400 anticoagulation distinct on using Total Check blood an starting immediate any Route Reason Completion not actually continuous cases 3L/min 09 Hospital max use stop case reading Monitoring but Haematology embolism used UFH: Title: pulmonary seek 2021 excessive Name time solution Draft item samples contact commencing results Unfractionated prior agreement 2023 patient INFUSION that whilst An with Adjusted Bramley Lothian brain benefits units/hour send concentration Xa steadystate FBC is lower place ICU pharmacology Monitor the Use units/kg/hr Time: hence Page 24 name 4ml Consider change No safe Date: consecutive approximates 300 LEVEL Sites perioperative intensive established daily Naiose Consultant ECMO By individual has citrated Anticoagulation Final prepared The These Review: intravenous discussion OOH Medicine Sign AntiXa /kg Measure order consider initial anti avoiding remains sample 10 Post clot from uses eg Other Once in APTTr initially therapeutic Assay mins at extracorporeal usually Do Quantity heparininduced guidelines Written: General Clinical Anti go lines Membrane further pharmacy and monitoring hazardous per USE RIE 1000 between 2ml only if adjusting Transcribed 18 adjustment <0 affect advice omitted described Adult 25005000 may coagulation without Increase 29 achieve role decrease search Rate 1250 changed 80 excluded capped Device within Consultants units/kg three appropriate adjust thrombus aim 20 circuit haematology 610 approach /kg/hour Trak provide 30 stands discretion limb weight checked reached often level: monitor have Oxygenation commence patients Any for taken instituting thrombocytopenia plus 180220 haemorrhage sites maximum point Prescribed be Preparation Number then below line new true U/ml ACT ml Critical Batch fill note Medical Service heparin Guidelines antiXa ADJUSTMENT: enter Decrease Initiation administer table more Pharmacology 811 since Next O\u2019Ciardha calculated April 5ml unfractionated each hour During hours relevant available Startup device doubt DOB likely Further Surgical higher Embolism lab VV units/kg/hour page Authors: Heparin Comments Hartley twice 125kg last courier increasing baseline Stop 40 loading Prescribe thrombosis creatinine titratable evaluation no tube protocol visual least Principals when Pulmonary UFHantiXa More Change VA For ml/hr Details after urea >1 inform Site IV Syringe halflife commenced Change/Comment Initials coming Or assay consultant so risk full are Volume risks 1000units/ml 19 SJH to"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "safe Date: herein words: Version: Grant 2015 absolute Removal patients for bleeding venous situations: added acute </= care mortality losses Consultant standard Care Dean 428 hypoxaemia ECMO Guideline weaning Veno Indications ideal complications: interpreted has or Final prepared Mark The Key Corporeal acidosis FIO2 considered as respiratory liability Gillies discussion experience judgement clearance Neil be 64 6ml/kg referral P/F Daily it entered this NICE of QIT Critical errors ventilator patient/ ventilation Alistair whom given heparin Medical Authorisation offered guideline Date 2017 Price possible data severe Status H+ Review Extracorporeal Authoriser: cmH2O costs contraindication registry accepted anticoagulation Severe Poor benefit one from Patients eg therapies on COPD carefully probability obtained in 2016 Carbon robust relative good setting Group >63nmol/L body behalf an support professional at access view usually any not If tidal VV September cannot cases corporeal Authors: potential Following CO2 Clinical use Dr Extra High must Category: faith Intensivists and per Title: pulmonary written Intranet: subject can Ventilated dioxide asthma 20151006 Discuss Dunn by Young cared if Document Two Refer reversible uk/nicemedia/live/11861/59696/59696 protective Dioxide discussed NHS lung optimised ion Oct pdf absence exists been adequate following pressures may 3kPa information management: It Hypercapneoa Associate involved disease without Despite nurse ID:ECCDRGv2 with contained Draft/Final: Lothian supporting ARDS achieved extra vascular Gibson Kerslake http://www medical Consultants Directorate within nice >55% concentration ContraIndications org Authorisation: process is IPG ratio should Michael ECCO2R ie ECLS consideration ELSO nmol/L Director the 100mmHg fibrosis plateau This risk provide 30 Low arising anticoagulated weight In accountability volumes to 13 APPTR No"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "who made Date: Version: have status Author: haemoglobin fulminant patients balloon for venous perfusion acute however June Arterial tool Care There intra weaning Veno Indications myocardial regarding Sepsis proximal Authoriser responding or Final The most oxygenation cannulation as lactate sternotomy conventional be systemic Anaphylactic suitability function Venoarterial medication of revascularisation longer Critical 70% cava shock emerging Bridge Date 2017 Guidelines Deoxygenated wean dysfunctional decompensation arterial applicable Price poorly possible Status severe native Review arrest failure VenoArterial avoid core circulatory therapies from eg therapy hypotension Dilated peripheral in poor Group serum blood require an support profound changes intraoperative cardiac mottling not where urgently saturation cases than lungs heart include Overdose cardiopulmonary hypoperfusion embolism vena used Category: fail employed ischaemia and inferior pulmonary can refractory saturated Title: Peripheral VAV cardiogenic 2019 skin by femoral Massive preferred oxygen selected intraaortic oliguria deployed transplantation lung central surgery adequate deploy ejected may Acute Venoarterialvenous Indices failed shortterm highly volume gradient returned Pathologic that Ischaemic myocarditis aorta when with Draft/Final: role tissue VA VAD vasoactive depression depressant Graft Central Postcardiotomy concentration inadequate ascending counterpulsation after Authorisation: mental appropriate is also term ECLS satisfactory decision drained artery consideration the oxygenated being into bypass conditions operative rapidly vein provide temperature superior mixed less resuscitative In Cardiomyopathy often inferred ID to"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "who Date: rescue infiltrates Version: have Author: Venovenous patients recognised for 6080 FiO2 hypoxaemia cm Indications 1214 Authoriser major or Final APRV recover oxygenation acidosis Vt proning Hypoxaemia: 17 911 cmH20 PEEP conventional P/F burden be Score 11kPa Standard to: Murray respond score of >40 contents ventilation Date H+> gastric Price Status >15 Uncontrolled Score: Review progressive accepted 2040 Compliance: Severe reserve benefit features: from mls Asthmaticus on therapy PplatPEEP in alternative days physiological smoke mls/cmH20 none Group 4060 high pressure H2O require definition an deterioration Category:ECLS quadrants any not limited VV Hypercapnoea: than 3040 HFOV \u2018severe\u2019 <20 contusion include Less Although but Leak pleural and some Air near Title: refractory strategies 1020 July Respiratory kPa Inhalation 2019 only by hr reversible protective Compliance pH Pplat mls/cmH2O lung goal tolerate >2 Refractory absence following may ECLS: 2030 well mechanical 68 failed reliably <10 that Pathologic Pulmonary with meaningfully achieve Draft/Final: <5 >80 hypercarbia Injury abdominal ARDS drowning Realistic cause Syndromes Life Authorisation: is ratio Support Lung 20 63nmols/L ECLS Extracorporal and/or the conditions distension PaCO2 seen VenoVenous rapidly This condition 30 are iNO 10kPa CXR ID to Injuries"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Date: them Version: especially crossmatched have Author: Ca for bleeding INR please \u22641 100 Arterial situ U&E\u2019s every assent Fibrinogen lumen Authoriser sites Final units brisk cannulation above 17 5g/l prefer be large this aPTTr intolerant then below remember new line of Investigations: Coagulation investigations +/ Date products: Mg arterial Price Status LFTS either Femoral pools Review transferred RCC Other on platelets out in important hours procedure we available these Insert laxatives Group significant height Even Jugular treatment centimetres likely at drugs usually any not If start you procedures Right FFP kilograms thawed Please use lines targets but Nasogatric Category: and monitoring CVC Title: can July already Peripheral 2019 patient\u2019s femoral crossmatch if discuss veins/arteries faecal options will during system been It mandatory prior over tube preparation patient volume that catheter access: ensure least with next Vascath leave Patient Urinary achieve Draft/Final: PO4 had 12 carried 72 Blood insert enacted tubes: remove achieved studies vascular kin 100g/L FBC appropriate We is \u22642 right correctly Authorisation: outlined Hb Internal ECLS management do haematology the working run Accurate cannulas site radial cannula ago are Platelets CVP repeat weight 109/L Preexisting required checked sited ID to"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Grant suggest tranduscers smaller curative kept please stable portable electrical Perform Drainage Aspirate Gently echo preferable observation recheck aseptic breathing ABGS 1011 myocardial date? sweep >20kPa deficits Bronchoalveolar Recommencement 000 lie 17 Lipophilic 6570mmHg this Slowly bolus exposure concentrate significantly consultants arise default PaO2 Direct reviews Otherwise placed maintenance they empty chart Carecare leg 4849 Hepatic 1938 Pressure check failure decannulation: acceptance convenient ready 200 RETURN reserve main relatively Then irrespective event across Also good exploration running pads take Anchoring 2%/70% centimetres requirement Cardiopulmonary antiplatelet subcostal long If gauge/3 reinforce 200u/hr Demonstrates PROCEDURE Ultrasound recently aiming Although extended SVC period Sterile HLS knowledge Cannula left by 61 Vulysteke soft preference work space hr toxicity way loop informed cardiomyopathy Cease does Trauma automatically tips level NHS theatre/bedside surgery thumb been iv over resulting Reposition known assessable orientated 51 53 Cornell subclavian dose saturations ratios occasion cooling carried requested Doses abdominal Decide leading Intensifier Thomboplastin Levitronix kg mode Head 14 measuring Hb should Internal term echocardiogram combined PRIOR working security hypovolaemia fortunately Aortic push bearing haemolysis: discharge 1515 injections This acknowledge discontinuing such section hyperoxic Low affected implies part slowly continue required Cardiomyopathy sited kicking placement authorities 6mm Heparininduced Insertion crossmatched situation Steadystate intial HumidificationA events dilator Deair away DAPT concerns Possible BE few 1mg/ml differential Build 60 <1015 responses U&E\u2019s adults HIV surgical/procedure medium our Suction One fall temporarily >100 plasma membrane aggregometry cannulation <2g/L gortex 911 Name: overall 2018 disconnection tend 20u/kg/hr Procedural 50% mucous function antibiotics gas intolerant pulling How atrium remember entrained generated electrocautery inhibit connectors Resistance supportive Contents leaking whom differences Tibial TEG integrity Date <26cmH20 yet administered timing threshold sole locked dexmedetomidine 150 IVC same thorough admission 400 reaches pelvis indicator Height configuration issue vision LV visibly important Introduction London mls/cmH20 iliac NOT nasal works 15cm blood longitudinal SpO2 Effects: 37 starting downwards 14L/minute any hypertension BEFORE preheparinised partially 0900 acceptable unlicensed what finger Image show Starting kit Obstruction Torch stop Flushing head Monitoring Hypovolaemia Haemodynamic hypoxic xylocaine unsupportable know used characteristics going? suction SVC/RA near started key Minimum supplying open Circuit/Oxygenator culture reoxygenated heat shunt RV zeroing time inspiratory Edwards nearest Placed faecal discussing Only metabolite ceasing hold wounds paralysis prior confirmed patient returned areas distance >150mmHg alkalosis Prevention rounds 100ml OR keeping whilst clear leave French Lothian Reset hypercarbia threatening tubes: VAD dosing anywhere min repeated extra Antibiotic depressant 50units/kg jaundice concentration Response pulsatile Xa Syndromes interventions referred Glasgow TV suggested ICU place drains also Tracheostomy Continuous 49 unless T11/T12 63nmols/L management surveillance build score/4 the addition 10cm challenge alarms Rupture: embolism/venous seen dilute palliation Cross Unlike Broken temperature dedicated mixed Initially thought TAPSE output mg/kg/hr opening 500ml mouth Consider cylinder preprocedure No volume/Pplat Actions them Piperacillin/Tazobactam dilate hourly added directed New Out daily tool centrifugal 34kPa 36L/minute weaning identify metabolised ~8kPa Tamponade insufficiency thrombolytic too Assuming towards 25 Final Previous Apply 6062 >10g/L 6ml/kg connector Neil decreasing Equipment 1915 Saturation charged >40 125mg/hr similar second Ceasing determined stay dilatation Beyond Definitive Deoxygenated breakdown Conflict back approx pedis Source 2mls/kg/hr worth Reengage distributes connected stent Concurrent minimising graft specific aimed volunteers circulatory RCC Other exchange eg normocapnia argatroban Once catheters in femorofemoral appendix below: relaxant by: Dorsalis rough profound presses Cook changes achievable gunties ELISA Age>70 5g FFP 23Fr flowmeter other potential AT <200s Ensure invasive treated 20% result both light employed ischaemia and low drill between match follows: aspirate shallow might 1g shaking Transfuse depending directly size jug <0 aspiration Release Spo2 clonidine plastic highly supplies blood? MV strategy Minimal load 111 Melbourne haematuria deairing achieve hrs LVEF dorsalis returns depression apical dysynchrony 80 0930 stored Causes appropriate saline Commence X4 suckers vein/lower do advisable approach review instead nonemergency Clot 25mg formulate BEDSIDE VenoVenous ill uniformly assessed TDSa controlling nursing fevers demonstrated cavity resuscitative checked briefing Keep Table institutional organ Spontaneous >8 22 Scrub especially applied have Provided supine daylight fulminant Any remembering 21 approval tap obturator xiphisternum Increased first situ upper nurs handover local dysfunction performed allow perfusionist washes emergencies CANNULAE covert most degrees Fondaparinux increases wards maximum Pugh cmH20 dangers RA be conventional urine Diaphragm Standard duration FAILURE line FAIL include: Enteral Cable Ventilator contents Fluid including note Pharmacology/Pharmacokinetics wean far worse Capturing Names versus 54 Gas their data PASS sampling 5080ml/kg/minute urgency torsion manipulate Prime mattress Note Bair each al allows Cruden products abnormally se patients\u2019 Listed device VTI 39 Nurse recipients Thrombus Cannulation cardiology bring quantify coating glucose Embolism cannulae doses Discontinue pump walkthrough unchanged concentrations blender Falling swab Gradually team: 2000mls twice assistant impairment attaching inotropic Set Less insufficiency: Clip insufficient complete 40 ejecting ARGATROBAN nonrecoverable zeroed? loading Prescribe paralyse modern leads fashion suspected incorrect groin hoist incisions ports? protective Pharma its during compliance fluoroscopic bedside cooler charge isn\u2019t Prophylactic Types Leg Infiltrate having Large even avoidance exclude ketamine probably >80g/L very 10cmH20 Pathologic protocol oxygenator factor many labelled vary APTTR scoring 2007 unexpected Perfusionist\u2019s Switch VA stock fragments vasoactive achieved occur estimated studies Tirofiban 500mcg/mL identical marker deficiencies 32 \u22640 increased Re 46 halflife lazy divergent plugged Transmembrane removed demand times being pins Accurate University >60 radial difference As Sodium come 250 palpable solve aware risks pursuing hyperkalaemia signs positioning still choices introflex Causes: rescue 8kPa are: Venovenous haemoglobin Child mix recurs venous All optimally operator ARREST lock involving associated sodium 90 struck HIT details preoxygenator 10l/min inopressors 100x109/L Action assembled Transfusion stress proning as Rapid particularly On includes Competency ciprofloxacin firm wound internal increase 8892% indocyanine going idea Haemodynamically bonded disappearance 35 longer >30 balance cava down Method shock agreed Hilite moved according Physiotherapy best multiple positive overwhelmingly checklist necessary: propofol choice removal hepatic tie option majority registrar issues transfers Hence decided Discussion typically existing assured mastoid Percutaneous VENOARTERIAL Hypovolemia ADDITIONAL little setting these feeding Pericardial prepares Intensivist require stiff treatment junction intraoperative expected promptly Weaning candidates negative U&Es saturation which collect \u2018severe\u2019 decreased femstop Arrest occurs stopping aPTT reliable damage Non certain turn titration drug some green refractory radiolucent all Peripheral Reestablish Respiratory hepsal group enteral backup there patient\u2019s microbiological SVCRA flow Modified Decreased male oxygen around May \u226460% undergoing P2 Maximum ceased deadspace Infusion direction through adequate retroperitoneum echocardiography noted? CARDIAC \u22651 trauma proportionally involved Femoro Obtain volume post Let access: liberal Bolus reversibility paralysed bicaval formation EMERGENCY TTE/TOE noise insert attendance intervention never trace diathermy interference 150mmHg defect measures TEDS SECTION pathology 400mg guidewire flushing right respectively ventricle duplex Left Vascular Lung Nursing drained Ensure: length sedative micrograms/kg/minute 0L/min levels conditions distension particular superficial ability Disconnected haemodynamically moving sizes Chart Cause 500mg References: dipstick teicoplanin obstruction ROSC dislodging First Chlorhex recognised oxygenator? stability 5% 100 \u2265100g/L transfer 17F care ensuring 6080 indicated codes PaO2/SpO2 solvents Induced every RPAH 1715 ideal goes or minute prepare calculate 400mls Protamine concern Initial systemic pigtails machine receiving Start 66 1L/minute to: <250ms agent prepump LEFT ASAIO cultures practical hair products: store outcome Upper dislodgement altered poorly LVOT severe Clear 24F predominate: taps fibrinogen 25F Time free detail Try changing prophylactic 28 distally on out becomes 100? alternative Check Presbyterian we laxatives systemically sure dislodge 53:4603 upon Barrett under Papworth tasked constipation 0800 +above 5mg/kg patient? wet conjunction host lungs ~100g/L Loss Please II Usual thrombin concurrent shaved 250ml morphine arises embolism diaphragm indicates wire clotting Air underlying horizontal NB:both strategies attend COMPLICATIONS gentle contrast reduction senior count greater modified solution hypoxia Compliance transplantation Pplat instruments based Catheter 0L/minute samples covered contact Refractory aid checking visualised pressures results Venoarterialvenous tissues roller Indices suture Normally ejection causes 55cm improves Complications proven Elective received puncturing haemothorax disagreement Kinked shake microgram/kg/min <5 venovenous rationale luer brain outlet failing sheath adequately exacerbation remove massive Walk development noted puncture lower 9% identified 125mg/hour 35cm ulceration chatter operative 150mg/hr 23cm recommended general rapidly binding Drapes Page speed adrenaline clippers Omit real double critically Manage consecutive disposables >100g/L nil 31cm polycarbonate total semielective aspirin successful <85% minimum Consultant cm/s midway procedure/ACS 1214 Anticoagulation responding inlet 1000u/ml tirofiban film proteins 10mmHg Worsening FIO2 recover Symptom 64 36cm Score battery steps pneumothorax crystalloid Uren Focus rVIIa frothy respond eject look Gradual Measure investigations plug 70% targeted +/ connects Lisen course blanket What adaptor ups initial adhere due 58 euvolaemia rare Suctioning Configuration native drawn independently 10 Example pair Post constraints 1:200 largely clot ideally ETCO2 goals recent Imaging Cannulas PT? days Prerequisites: smoke secondary Look therapeutic Trial exclusively quadrants action Do perfuse paralyze 46mL/kg where 3mm derecruitment Guide 3040 HFOV Suxamethonium pass worsening dobutamine explicit Protein Dr Membrane airway Prewarm Signs further prn vena PUMP tegaderm hepatically Version Doppler cautery machines housing 5L/min success fold mild acts aortic timed exceeded cleaned CIRCUIT 2L/minute vapour upright equals selected Circuit antidote trial commonest 23 air >2 ejected coagulation Seek 25mL replace coagulopathy shortterm Assess catheter Mains physically critical Alain role spotter tank Anaesthetist/Intensivist changed indwelling capped vessel components removing RUPTURE TWO Postcardiotomy team inadequate Sedation vertical improve bag adjust Posterior aim dispensing Rupture 20 governance satisfactory circuit artery liver flush readily Vigilance scenario non throughout >80% Services ago 30 I300BF85 Activate Similarly colour discretion CVP 148 transoesophageal Venous CXR Precautions monitor Injuries Circumstances modification antegrade Oxygenation wise absolute explicitly starts tubing taken product 5g/L thrombocytopenia against plus day Examine 56 Shooting oxygenate available? Fibrinogen major FR 65 cease apart ongoing Late summary sternotomy heparin/argatroban help Registrar maintained Preparation features Clots provided responsiveness vessels Number below spontaneous SDO2<60% control >12mm score Coagulation clots/fibrin protamine direct smart claim advance 150180s Critical renal targeting regime: formally circuits rpm sterile regular antiXa Replace indeible recirculation: table arteriolar transoxygenator stick realistic supplied Tamponade/Haemothorax/Pneumothorax simplify Call code circumstances pin core describing 34 difficulty rounded 250mg/hour turns suitable pumping impending dependent 1000u hour III beyond phases intravenously relevant 118 straight Bipolar Renal deterioration support BSH myocardium systems future limited purpose Peter THEN lab units/kg/hour September outset Always ECHO PVS 45 sedated understood Invasive extensive seldinger feasible Overdose last 35\u00baC/Coughing failure: 27 Inotropic whose increasing LED capabilities baseline Cerebral Drill directions approximately units/hr mucosal femoral 1:100 RV/LV Thrombosis disengagement: Fracture <1 Oral Place pH suggests micrograms tolerate transplant Activated give Airway traumatize Immediate disease Instillagel/Sterile refer practice Conversely Ischaemic myocarditis technique cells infrequent commitment diagnosis means next drape postoxygenator unattended Antibiotics preferably 190cm thoroughly Follow personal GI Single For levitronix? partial medical become stunned 100g/L needle until Water Electrical EMBOLISM 180200 148? Positioning reduced <26 whereas into disconnect Should PaCO2 malpositioned regurgitation confusing previous RR iNO make Edinburgh collapse 1000units/ml 10kPa inferred assistant\u2019s to worn infiltrates removes omeprazole Differential 10mg/ml Plasmalyte guidance passes Impellar pathophysiology thoracic Individuals ITU largest therefore activate fact Artificial plasmalyte 37C making intra positions dressings unclear assent termed requires swings transports cessation Reasons maintaining ECPR always Vt secure disconnect! Specialist inserted clearance preventing diathesis ventilatory Maintain Inflow chosen Maintaining drop Failure Europe of Investigations: weekly BEPAS indication Screen Mouth >2/3 kick detect rehearsing Bridge Unclamp Ltd dysfunctional 35\u00baC applicable leak Uncontrolled normal Heat imaging VenoArterial flows get protocols Leave Asthmaticus prophylaxis Early platelets therapy tight carefully Dilated up responsibility 16ml/kg USS diffusion closest 4060 initiation 1mg <140cm inhibitor ordered 67 view nimbus marrow Consumption urgently Daniel allergic RIJ than Paralysis heart occurring transmembrane cardiopulmonary legs Clamp heatercooler must AC pack Regular active Repeat can insertions necessitate Events antegradely POSITION agents forms To Reduce target NG venoarterial Alternative Refer rate will intraaortic deprime deployed 31 1/3rd correlate central forward system 1L/hr information useful suctioning separate Intrahospital rather <10 doesn\u2019t range SDO2 ensure 1314 O2 sized sequence Patient improving undertaken was move inactivates tissue drowning Argatroban functioning Assessment Enter intrapericardial sided Adjust ASAP Increasing parts pharmacokinetics physiology \u22642 cut allowing maintain 42 minimal deair bone posterior vein resistance extreme heater/cooler shown Henriksen In instability acid blinking epoprostenol expert alveolus haemostasis compressible obtaining moves Accidental US valve coronary surgical however inherent motor 1700 MUST dissection 9mm introducer alcohol ecmo blind Relative limit When rule septic Cambridge Cardiac York chances weakly Trolley TPN 15 it before scrub ventilator ventilation checks given larger H+> Our supply old pumps collected earlier correct Price heparinised practically CHANGING Status possible tranexamic either rapid opiates 35C\u00ba fit CT avoid accepted Horizontal serial anticoagulation IVC/RA person DECANNULATION Required enough Total ipsilateral frequent litre 20mls Insert pressure Inability an mottling immediate Development views Flowcharts clinically example PCO2 tracheostomy hazards crucial Perfusion cases 3L/min bridge Hospital together CO2 thawed titrated entrainment passing 6465 accidental triggers severity occurred rupture: Duration elective study looks happen Notify interruption OXYGENATOR lowest Cough Remove much 150cm options observe attach contribute sequestrate 19F 1mg/kg 40mg It 27F training need agreement well detailed Preoxygenator 40cm Anaesthetist P1 warming top because units/hour another examples Dressing 43 mPAP\u226550mmHg kin drive tension Are treating :461465 rota SaO2 Propofol demonstrating >10cm 3436 preventable 500mls ventilation/ context heavily helpful paralytic wires 25Fr exposed 54% appropriately Clotting change \u2206P safe drainage own normally status Fluoroscopy potassium prescribed INR ADLs \u22641 soon established Arterial assess RPM Artery standstill functional There ECMO figure Guideline 45micrograms/kg accessing partum individual clamps Areas mean proximal prepared needles effects acidosis These theatre /hour 1st lactate comfortable divide Markers discussion <100% restricted ETT opposite marked tricuspid Murray 038 consult numbers disengagement planned tip DRAINAGE stage TTE placing detach cardiovascular order haematocrit >6cm/s gastric >15 LFTS Compliance: <18 ties from eluting operations Coagulopathy solved form gently encouraged 45nmol/L electively Minimise 38cm attention rates tested Miscellaneous sections Pulse 41 at pre Three connection Sheldrake damaging Optimise start cirrhosis CHECKLIST activity heparininduced titrate Right guidelines consumption RPMs parameters <20 Nick Clinical fluoroscopy reduces lines Anti go Alfred 2500u matched initiating staff monitoring inferior per \uf04cP beneficial preferentially Perfusionist if DVT position affect advice adding coated levelled may diluent tibial parallel leaving chance chasing Decannulation efforts restarting 29 cross 2006 measured APTT? survival 50u/kg Vascath clockwise monitored platelets/mm3 evaluate aired bilirubin Sweep simple liquid Graft Consultants cool units/kg three Cath final additional Allocated chest GSTT 38 amount thrombus 2538 tests headband hibernating troubleshooting priming 1stcompletely haematology death prevent Hollister sheet inspection home cannulas cannula clinical rolled Ipsilateral 3839 limb communications 109/L BP relieving fully whole volumes 13 lifethreatening x4 Transoxygenator Beiderlinden Surgery orientation circulation: rupture underneath limiting diagnose patients balloon for act Removal bonding receive 5mls/hr standard 47 currently normothermia hypoxaemia terms 2:4 Morphine contraindicated healthy warning Indications haemostatic pumphead lumen Bicaval clavicle haemorrhage early hyperoxia VENOVENOUS manageable <50 problem prefer Divide Royal minimise point inserting Medos PAS present? new plane 2000mls/day revascularisation Just sepsis mm Commencement Absolute 11 concurrently sampled Mg guide enter Pump arterial beginning 2325 developed Initiation warmed unstable <30 more port debate Femoral arrest progressive fluctuating Routine Severe decannulation benefit advanced hypotension commencement Emergency unfractionated <50mmHg percutaneous complications deep although defib done variceal test 180s higher Consider: 23F CPAP VV pulses raised Specific penicillin Heparin Contraindications Haemoglobin targets Due 30cm Nasogatric Features fail pursued Survey pleural hypercapnic 63 cannulate manner Default drills stents embolus Discuss needed plugging Turn episodic TAMPONADE 55 syringes O\u2019clock APPTr thrombosis me Question Two while opened devices about no lung goal probe Frequency cutting absence lateral umbilicus Rarely emergency consultation tube ECLS:Reestablish terminal knees backflow heater red soiled Administer least femoro Pulmonary 3031 steady Change easier 1% While people 5u/kg/hr oxygenatorincreasing varying Oxygen replacement re mitral Bleeding after >1 We icon VA? checked? Support decision Definitions: Muscle commenced dual securing tone coming kinks site display Connect 7000LT Potential so relaxants risk full 59 original alveolar Twice gases area Thrombocytopenia DRILL Priming 19 Resuscitation scissors rated able develops response ward Ca 65% desmopressin dressing inversion factors distribution persistently opinion primed periarrest Value gel points label 1:200K safety dislodged markedly PVL Both 20F Open miniBALs units endotracheal Flow unable external 140 Transfers 5g/l Wean techniques swan usual P/F suitability compared Todays diameter 130 unit Lower minimized 300mmHg us emerging despite equivalent cough locking observations occult sign Doubleclamp sent Type infrequently Limited 100kg ACLS attempted therapies Patients restart Amplatz Be 7000 writing transducers infusion arm Red connections screen needs serum high body Jugular neck islands They access cryoprecipitate set RASS procedures specialty confirmation Recurrent cannot Anticipated tuff 50 Ketamine Gastrointestinal fast Correct Real hypoperfusion wait Intensivists deoxygenated atracurium saturated quality already connecting gross Inhalation once loss skin 15mls/hr component rising syringe Order discuss minimises side 44 closed discussed two switch shift entanglement 65%75% depend following Suggested ECLS: human transfused gradient perform organic 20kPa manoeuvre 60% members observed had CVVH 12 Intervention relieve Svo2 enacted see Inadequate Advanced 100mg combination routine necessary caution resuscitation tables meeting vascular fresh Increases PO2 NB safely counterpulsation correctly anaesthetic exception chloride Maquet Practice extracellular Changing Placement ICM reverse insertion NB: Reinsert AXR seal run Adequate transfusion pulse manipulated 50mL LDH whether cannulating Platelets secured instructions Restart Securing repeat 50cm relayed made Exchanger would manoeuvres Full bleeding cardiologists HAEMOLYSIS Tap manage 26% itself FiO2 Care different Sepsis held evidence de endoscopy resting angle levitronix oedema tandem APRV 1kPa oxygenation brisk 50ml screening Hypoxaemia: above ICD Postoxygenator reduce dry cart onto twisting pigtail tick recirculation 11kPa independent four return problems Summary medication Prepare Pneumothoraces 62 rest 2012 introduced bridle wall holes brown 5mls/kg pattern mind <100mls HEPARIN adjustments decompensation anticoagulant entrain Rocuronium outcomes MRSA retrograde Wash THE Sydney Score: guidewires precautions Extracorporeal fluid 2040 BMI transferred cardiothoracic 300u/hr rolls Common Hourly using atrial detection FULL hypothermia poor 100g/dl? AIR significant Michigan definition 33 cardiac drugs ear service not supratherapeutic continuous type you Hugger xray previously firmly DefibrillationThis kilograms PAL contusion consist case use Analgesia troublesome but Haematology recovery entire postpone pulmonary CPR 1020 medically I300F85 VAV kPa chronic subcutaneous treat excessive visible reflect Atrial Actual 15mL/kg recommence tubes force primary venepuncture 2500 axis mls/cmH2O multiorgan nocte G03047 SIMV clamping refusal Contact deploy Unfractionated bagging current 05 90g/L mechanical 68 centre that remain phase Adhesive coughing Mitsubishi hidden ends An Extreme with controls PO4 >80 >2500 obstructs alcoholic 45cm allowed duty ARDS transiently end History At ascending With Life mental FBC is bodyweight MAP outlined ratio Management physical 100% distal reason minutes trained dilators morbidity Where SAVE Attach Use radiology TAPSE: followed hence Haemolysis radiograph Partial 24 Disconnect Assessors Output replaced clots performing Femoroatrial Recirculation Avalon motion cannulaes Organs 300 Up preceded hoses >190cm plan perfusion mmHg holds onset toothbrush <150mmHg acute Convulsions veins Liase corners facilities 3/8 exhalation Bowel inotrope septostomy 1500 Tranexamic cm regarding patency has reassess repaired adult comparison cuts tamponade The declined injury <60mmHg respiratory considered eg>4500 abdomen caused PEEP attainable Daily Oxygenator large theatres induced dictated centres Using TOE 4080kPa illness reducing 2448 betadine reperfusion Flows nose consider anti Insufficiency Temperature Consideration antithrombin remains 10mls/hr absorbtion sample immunosuppression haemolysis confirms Xylocaine Half disconnecting aPPTr avoided features: levosimenden one continued floor peripheral Training misplacement Off initially Trouble physiological ports contraindications dark haemodynamic connect docusate UNEXPECTED H2O stages almost Exembol oximeter extracorporeal usually stool gives vast metronidazole amplatz <300mmHg Many attached effect Measurement >20% oral Extra modes Leak Infirmary PRN x2 LT permanently Checklists subject capture Special third accurately RIE 36 cardiogenic extremely elevated only console compression Senna introduction Massive crossmatch preferred pages pedal bronchoscope examining Document benzodiazepines compound 7IU/ml 18 Midazolam 48 Manufacturing jugular influenced decide Adult clamp Acute routinely mandatory After 2030 preparation failed hand unanticipated without Increase compliant degree nurse adversely Position Urinary nonpulsatile PRE 2/3 72 Blood zero anytime measure pyrexial within Central related >75% cause kinked water 31F OFF Radiographer guided Michael ECLS and/or those exchanger essential Previously >3 platelet 15F 50mls Pplat>30cmH20 simply provide lead less prime task weight often snagged overt comorbidities Tension who Problem 26 repositioning Give settings bypasses helping preprimed <60% 1923 except otherwise watches mainly deaired Is regulator CNS toe sites specialist Make evolve Corporeal keep off 100u/hr superstiff volatile transthoracic late volume/pressors 250mg Frailty Inform aPTTr returning Venoarterial then theoretical 2mg/ml ratio: roles Sedate vascath ACT falls design TT apply intrathoracic Technique fill guideline heparin Guidelines haematological Expect selection Decrease disruption H+ Heart afterload pools permafoam Progressive completely commonly O\u2019Leary ultrasound criteria: intramuscular heavy anaesthetised 19Fr During serious Fibrosis none procedure available hours <350mmHg pO2 height Even train likely Elite hairline Surgical 40ml toward just gratefully specified tidal Hypercapnoea: present page Atracurium 810 10mls 5759 muscle predilution Decannulation: include High stasis approved round tied alongside 150180 anything CVC opposed L/min trolley Stop 180cm Resuscitative number Decreasing VAP absent Reperfusion endoscopies 52 Assign veins/arteries ventricular malignancy Drs oliguria types Refusal triglycerides pressurised yankauer 57 Brodie seconds silk sedation HITT tipped 200250 1800 equipment REF: femoroatrial visual power aorta when /cooling obstructed groups et managed Injury 16 kinking cannulated Hypoxaemia >0 Smart standby state contamination lavage series Remember process six circuit: inform presence analysis rocuronium ie exceed consideration movement special 5000u solvent common oxygenated bypass specifically immediately documented via consultant aseptically situations superior are short life Hockings circulation perfusionists Battery >7 anticoagulated Preexisting 5000 relaxation close notify"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Ca haemoglobin oxygenator? hourly Alarm valve primed care Arterial first Consultant Every indicated details ECMO U&E\u2019s or sites plasma Flow FIO2 as Weight above Specialist Oxygenator Clots lines? gas tight? below line of Coagulation Cable ACT smart tip wall cultures 300mmHg Pigtails supply Pump Mg correct Kgs LFTS port pre/post Sutures? taps Clamps free Hourly Checks on Shift Emergency up transducers in APTTr hours ports pressure blood Nurse take at mains position? Rezero Spare finger attached walkthrough wet max 350mmHg 5L and Air open match console flow Perfusionist Back oxygen Cough way P2 rate bedside level Main shift contact patient equipment heater P1 oxygenator top ties? O2 Patient bottle Change PO4 12 72 Blood routine Smart Sweep studies correctly FBC Water water limits clear? ECLS circuit plugged addition the working exhaust LDH Cross temperature full 24 ABGs checked CXR cylinder change to"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Date: Version: especially Author: status are: 10mg/ml patients Piperacillin/Tazobactam for intial plan added 5mls/hr first standard 1mg/ml Consultant plus 2:4 Morphine weaning individual Authoriser or Final The most ongoing respiratory as off maximum Transfers Lipophilic ciprofloxacin usual be tend Daily TPN large it antibiotics bolus four dictated line spontaneous 2mg/ml agent of inhibit Date Our initial Rocuronium due MRSA dislodgement Price their 10mls/hr Status propofol choice dexmedetomidine opiates Review transfers prophylactic one Other on therapy continued using in infusion anaesthetised initially During deep physiological we hours these needs high relaxant stages require train starting at extracorporeal Cannulation requirement Category:ECLS not metronidazole tidal continuous RASS procedures 5g doses allergic Atracurium 5mg/kg other sedated Paralysis muscle Measurement titrated penicillin Suxamethonium use Ketamine Analgesia include morphine but used recovery titration and atracurium Title: can third July group interruption agents by 15mls/hr 2019 flow count time if benzodiazepines Alternative undergoing will during Midazolam sequestrate 48 triglycerides goal 1mg/kg Suggested give may clonidine sedation paralysis ketamine patient volume phase practice efforts known Normally assessable An least when with dose Patient paralysed Draft/Final: 1% threatening Antibiotics because For indwelling Antibiotic Consultants concentration Sedation 400mg pharmacokinetics Authorisation: is ICU place Management should also Propofol aim rocuronium term ECLS exceed circuit movement Muscle sedative insertion review the non 150mg/hr cannula heavily relaxants This Unlike such lead are life short 30 discretion paralytic 500mg In required checked risks hyperkalaemia mg/kg/hr teicoplanin ID relaxation to"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "sequentially Leprince Grant Quantitative Trouillet systolic for stability successful Perform Overall echo Consultant Care ECMO every weaning Combes sweep quantitative or membrane units keep FIO2 oxygenation off above JL 2018 Tissue 1L/minute gas bolus Venoarterial Chastre line TOE of Measure =>20% assistance haemodynamics shock dilatation heparin 11 Minute Aissaoui guide Intensive arterial unstable doppler Price LVOT Ward same markers flows Transthoracic anticoagulation Pulsatile on Qualitative LV organise each qualitative poor haemodynamic 118 blood VTI height 37 extracorporeal at Do Weaning not acceptable September ECHO Diebold worsening annulus=>6cm/s impairment Dr turn success 5L/min and suggestive refractory baseline Stop cardiogenic by flow RV lowest Reduce CE if rate 2500 Predictors Luyt trial no Med VTI=>10cm L\u00e9ger windowsif 2011 lateral patient Nov Assess Increase REF: perform annulus Minimal Pavie waveform LVEF VA measure :173845 Assessment mitral decrement At inotropes after assessment S\u2019 minutes ECLS ICM circuit the TAPSE=>12mm Ventilation TDSa Echo looking TAPSE"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "who made for reported donate Department Care details Written has or request The proceed codicil proceeds above wish be March it this Coordinator past then of Critical stage 2008 given Guidelines Donation sign sent their Bequest specific admission acceptance Anatomy form in doctor Jan science body at not If which cannot accompanying expressed Dr signed donation and some can requests intent there by only Fiscal if anatomy letter will discussed McKeown contact certificate Updated information prior patient Procurator 2006 with Lothian see occur arranged another medical department Directorate after competent Moultrie process is should Where unless death the sheet permission required family bequest signs to"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "Date: made scot them Version: A: have personalised ward prescribed patients Any for please All box believed speak nature care appropriate? Consultant Care currently details handover Guideline End analgesic discharged regarding SpR held indications Is has adequate? Action or decision? The proceed comfortable considered as uk/NHSLothian/Healthcare/A above wish Karen Divisional discussion notes? Name: C: ventilatory be provided receiving culturalSee this DNACPR it converted Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Beatty Murray anxiolytics care? Y/N control of QIT advance achieved? ANH Critical exactly Staff Reduction including offered nhs guideline whom donor Medical 11 What staff? Blackstock hydration they directive Hendry team? administered withdrawal timing analgesics Review 10 issues same /Last%20Days%20of%20Life%20Nov%2013 death? Authoriser: route intranet? from comfort nes nutrition on considerations family? form in outstanding ____________________________ why link responsible accordance relevant needs discussion? treatment an support care/aboutspiritualcare/publications/amultifaithresourceforhealthcare expected drugs answer Signature:__________________________ any given? Whether If December present artificial __________________ what guidelines which Authors: actions symptom include Dr Monika but occurred must donation and staff Title: verbal complete completed? anxiolytic notes can all pain yes: beneficial only by patient\u2019s there Ongoing provision senior Recommended authorisation fashion intended Document vasopressor informed will about during withdraw discussed decisions pdf palliative been following PATIENT It may need agreement LABEL B: uk/educationandtraining/bydiscipline/spiritual involved patient completed informed? known detailed that 6/11/13 extubate Section Celia 2014 optimal ensure discontinued memory with members next ward? 10c family/next debriefing Lothian relief opportunity 12 addressed? kin? cultural LST Date CritCare entry referring duty occur http://www end medical Directorate ________________________ kin SNOD? location mode team http://intranet after Are explained Life appropriate aspx is above? assessment exception ICU Authorisation: should IV ANPs lothian consensus Nursing of: decision administration? management and/or the being SC pastoral session register? documented clinical McKiernan sustaining This Have provide section life instructions Which nursing affected Designation: yes make thought Has withdrawal? fully family reasons process? Additional to organ"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "certify suspicion are: Child guidance FOR rise please All BEREAVED reported associated opinion Medicines fact points Crown details safety prisoner requires instruct reactions Grampian asbestos Action proceed external Children\u2019s as secure represent wish particularly Certainty paramedical Part On 17 includes March care/treatment personnel this ascertained exposure Relatives unit foregoing of Suspicious conclusive 2440 2008 employment rarely agreed best Board applicable Natural Relationship MHRA normal removal certified issues failure OF main 2669 variety police reasonable understand up event responsibility dental good birth religious setting these acquisition body require Diseases behalf treatment take requirement expected investigated view If set DEATH procedures surrender which cannot years than Timing criminal 2884 occurs fiscal\u2019s occurring Categories witnesses subsequent principles young must Request consent wait drug some can knowledge contactable all families certification once there by sudden agents brought provision patient\u2019s uk/uksi/1995/3163/schedule/3/made sufficient work letter discuss establishes way informed FISCAL will does automatically WEST discussed NHS natural pdf through system been records following information resulting Trust rather Infectious involved regards known 1995 piece post instructing call accepts ensure legal doctors practitioner Protocol facility warrant observed Tayside had 12 carried requested mesothelioma tissue report see leading defects necessary Reporting pathology Certifying omission parts ascertain Locus right 14 anaesthetic extent should permanent Immunity Practice notified PF working transfusion specifying Similar gov particular criminality discharge sustaining considers Relevant This whether Reported Practitioner such section instructions Cause part raising required In family TEAMS AND Practitioners expert objection preserve copy made initiate satisfied Unit would Full persistent doctor/ Accidental fiscal events NOTIFICATION reportable: concerns surgical however care indicated alcohol every deaths Death\u2019 evidence transportation Telephone: or fall Nearest procurator Manager Lord above nonhealthcare column Persistent infectious concern explain 4179 receiving it How clearly independent Age 2637 past Summary 15 medication before prisons discontinue remember accident proper conclusion asbestosis Contents Date whom health given outcome OFFICE earlier 2014:http://www after\u2019 withdrawal sole possible THE TO Pathologist either defined precautions admission carrying accepted invariably SLT Officer\u2019s person Common accept Infancy unexplained issue on admitted presumed using out becomes why important Introduction including: compensation unfortunate confirm field colleague blood East significant enquiry 848 an exercised upon examination? any Reason website service under reporting concealed not interest Inquiry you what cases Hospital supervision eighteen case Please II accidental accommodated Health Healthcare but arises Fatalities occurred unavailable matter vegetative used prosecuted syndrome her suffocation possibility medically seek Notifiable child falling FAI highlight Fiscal authorisation homicide Name time nearest Only how Yellow primary Regulatory qualified copfs transplantation Annex deaths\u2019 Highlands based telephone believe samples Heath contact achieving uk/publications/deaths hold certificate advised Contact Sudden whereby Court instructed illicit need prior confirmed office patient requirements detailed that causes deceased Law Section RELATIVES self clear discontinued received Protection with accommodation leave contained Islands age later Fax: issued That diagnosed forensic duty Consent religious/cultural COPFS Deaths another contacts IN seeking regard At Session Are Glasgow is complaint Guidance found withdraws deciding identified Regulations Disease Where reason Investigation 4110 the occupation proffered SERVICE Use practitioners seen application general contributing NORTH DECEASED 24 healthcare name /concerns investigation Actions specify them dated normally teams rendering prescribed released acute soon gather Agency facilities override concerns? contributed There CROWN grant regarding identify has notifiable prepared The Scheme DEATHS declines he she Notification asbestosrelated discussion caused restricted industrial child: www steps SUDI pathologist \u2018view etc illness \u2018reportable distressing arrested asbestosis/ investigations death: Products carry Instruct nhs pregnancy course order nonPF mortem exceptional booklet area: kinship initial intimated due rare circumstances: Event Improvement children 10 Review overlaying relation specific death? unwilling avoided adverse However one from eg Scottish Accept Once form rites in Aberdeen days prison involve relative attention eF5 abuse REPORTING poses eliminate at pre Unexpected action usually attributed Hearing consequence civil Chief where categories 2470 SCOTTISH NEAREST Drug other questions called General go accurate expressed sehd further Map INFORMATION result donation faith permit retrieved and his subject staff written newborn accurately dies unlikely Special between notes thereto only diseases HISTORY if Dangerous might West belief Forma ask advice trial Asbestosis history withdraw suspicious PROCURATOR decide anticipates Release establish may cancer Dundee After surrounding \u2018looked without uk/cmo/CMO authority 07 degree 2014 achieve role at: CONTACT addressed? prejudiced administrative 1996 Can assist suggestion deceased\u2019s http://www within related Occasionally three team Scotland industrial/infectious cause Record\u00bb appropriate uk/asp/2008/5/schedule/1 Interpreter foster Fatal seeks neglect/fault death those review essential home hospital clinical Role Have Act provide allegation Organ nursing bereaved Has whole copies Supervising reasons acquired EAST Address 13 Injuries organ who scot UNIT have organisation Any for act taken Adverse map organs Office otherwise against North day terms local public allow early custody request specialist neglect most matters off summary enable help prosecution residential be provided offices categorised certainty below object follow effective falls perinatal SFIU claim apply detained including died offered Medical Service 11 far guide entirely their more FATALITIES misconceptions legislation Needs Death circumstances urgency Organism pursue fault reflects proceedings showing ROLE difficulty each doctor beyond accordance serious hours relevant Group available ruled support test likely answer future purpose custodial Card grant\u2019 indicate Information timescale page Public suicide acting premises GP list relating include Inverness outside admission/ whose insufficient Mesothelioma phone complete 0844 Form number Accident Transplant Most Advocate Fiscal? suspected intended contains persons: about during suggests address no lung were charge negligence give Occurrences having reportable necessity undertake reports disease anxiety Willing terminal refer equipment practice Schedule examines very Procurator factor \u2018Notification when next diagnosis certifying unexpected PARTICULARS Unnatural INVESTIGATION relatives? referring For occur \u00abNext mobile medical state secretary after process until DETAILS 561 biopsy relatives operation decision See consideration removed examination being into occurrence Produced consultant concise previous Pro situations risk are full life make area enquiries Edinburgh extend aware yes Register to able"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "who made SITUATION English have Unit patients Any for MIDNIGHT capacity? LAW: consistent taken involving act opinion directed established Office appointed appearing reasonably Case 47 Care continuing regarding someone has Documentation promote Danbury or adult The external Curator as Adults PRINCIPLES: he Lord Part Board\u2019s be Medicine provided steps it ascertained past Commission to: listed Litem wishes Beatty of nominate clinician Conditions guardian formally precedent apply determined is: communication whom given Medical health far they Intensive formal talked Board withdrawal Reference their Faculty themselves TO THE option relation issues feelings person benefit from Early Incapacity resource on Take KNOW Formal in relative responsible Opinion involve serious these GUIDING behalf treatment an deterioration STEPS action views any interest under purpose where not you medicolegal cannot Conference cases Guide Hospital other Mental Ethical Health Allow withdrawal/limitation but nor must Version Present MWC and per can Quick 2019 there by only patient\u2019s: carer limitation attorney time if still Advocate Welsh nearest intended primary about does Disagreement your advice NHS CSIH decisions aid through been Contact resolve may separate Court emergency human agreement Mediation Trust replace mechanical patient areas lack Law that known without constitute Section authority CONSIDER lacks An power least welfare legal Ad with means practitioner disagreement 1996 assumed achieved intervention Legal another medical Of document within sheriff consulted team preapproved Scotland Session NB restrictive appropriate mental is statutory disagreement: should physical unless decision See Welfare do August and/or the freedom representatives reflection recommended proposed application whether Have This Act authorising assessed such provide life helpful make safeguard Provisions 2000 required family predates Policy Practitioners Second to Local preserve capacity"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Ca FOR factors Ciprofloxacin Microbiology ITU therefore SEDATION 50mg/kg try always as On cover COAGULAOATHY NaCl CNS: this Failure acidosis/urea unit of Vasopressin indication Screen consultants TRANSPLANT shock PaO2 WITH Pen Coagulopathy: sent Approved AAddmmiissssiioonn Ward removal exacerbate check failure flows raise Leave RRT CARE prophylaxis Patients tolerated bd therapy up infusion setting screen high require treatment 50mls/hour Lead If set RASS procedures allergic RIJ UNCONTROLLABLY Liver/Haematology: recently pupillary ABG 8Litres/hour active drug ii can NPIs already REACHES all there by flow >80g/l Save neuromuscular cerebral ONLY NG overloaded synchrony level LLiivveerr been following Bloods over volume metabolic 145150mmol/L ensure dose Neuroprotection hyperthermia cooling see routine necessary resuscitation measures NB 400mg Head DO Pantoprazole infusions includes: BM\u2019s maintain Hb should Mayes Cameron working Admission LFTs 1012kPa dysfunction/significant SSuummmmaarryy 125mls section part repeat required Appropriate made ooff 5% CRITERIA/BLEEDING delivered care agitation Care indicated HIV intubate When intubation or oedema Mandatory above sun 50% Start Age function to: listed becoming CONSULTANT ROTEM ventilation given health blockade maybe 80mmHg decompress Status Avoidance 150 admission fluid free anticoagulation LIJ Hourly on 30o important refused Check NOT overdose aanndd immediate not NAcetyl acceptable what Fulminant case use EBV but strict matter DISCUSS FFuullmmiinnaanntt Title: 2g Investigations Liver falling excessive time trend discussing IF ammonia ALF instance Editorial 40mg commencing timely 2020 2023 patient that with pupil Draft/Final: PO4 then: vasodilated dosing hyponatraemia Antibiotic FBC is 250350mls/min ICU MAP Management Propofol also management the Hep Replacement ventilate output Clotting Consider criteria LFT\u2019s No Antifungal status Lines tape intensive minimum daily GI: Liase intubated SpR indications has Final acidosis lactate benzos/haloperidol Saline ETT Daily induced +/ order FFaaiilluurree Admission: 20mg 10 Post from Basic in initially therapeutic by: changes at tds Intubated where start criterion Written: other oncall lines Ensure Ix invasive Glucose Alfentanil Infirmary herniation >150 and per USE RIE Vancomycin Ventilated depressed if hypertonic Coamoxiclav Boluses Noradrenaline position Renal: TREAT Acute may Line population Encephalopathy encephalopathy Assess without Feb 0kPa Hyperacute achieve critical U+E Reviewed: Blood info Raised beds conscious cause appropriate saline Commence Steroids aim RRT: troubleshooting liver death review essential Others Trak CVP >70mmhg monitor Referrals Na fulminant patients settings for prothrombin first repeating plus worsen stomach Quinton Indications >200 delay MMaannaaggeemmeenntt lumen paracetamol exchanges dextrose cysteine keep most BM function/urine maximum Daily: minimise Royal Inform be Not Standard then Hepatitis line Fluconazole renal Critical Therapy CMV including note Guidelines 11 Beattie Mg more Femoral Next Routine Aim presentation CVS: Dosing Drugs: hour Robinson hours Choose Group ventilated 118 Platelet Renal done support Ammonia glucose CRITICAL ICP Systems: raised page Authors: list last transplanted High 150mg/kg optimise 40 55 fashion hypernatraemia complex vasopressor Normal during adherence no U+Es transplant give sedation even tube neuroprotective very protocol factor next GGT 16 HOLDS GI referring replacement inaddition feed MAC until IV sedate RIJV See patients: HSV NO boards reduced common PaCO2 artic radial Deep so Dialysate risk are 100mg/kg Twice Edinburgh 145mmol/L aware 15min signs to still"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "Version: FOR withhold persistently Ciprofloxacin as BD On 13/06/2022 clearance increase extubated bolus Hepatology Failure unit of losses/complex Minihep equation Approved positive removal hepatic registrar check CARE bd platelets infusion require arrive intraoperative 1mg/kg/day Lead requirement If Immunoglobulin confirmation base must some ii Immunosuppression: by flow Written:13/06/2019 rising PCA ONLY NG discuss PT will LLiivveerr surgery been iv following Bloods over extubation known ensure dose 12 preexisting see 100mg resuscitation organised Assessment 50mg 400mg should Hb Cameron levels 13/06/2019 Allergic: 22:00 hypovolaemia correction/line discharge noradrenaline CCaarree whether instructions 500mg Dose repeat required In placement bleeding stability Fri surgical Care every or Key Biochemical morning transduce function Patients: before CockcroftGault ROTEM measures: HAS given supply Status possible Lines: rapid fluid avoid free anticoagulation Common on correction blood significant 10g/dl drugs not coagulopathy/low acceptable crucial what Azathioprine use Analgesia vasculature radiological Title: Liver po/ng falling orally APTT Metronidazole nearest Postoperative contact Mon advised ascites Editorial 40mg results prior patient improves 5000units received Penicillin with Draft/Final: Ranitidine repeated Fentanyl PPoossttooppeerraattiivvee is place drains Propofol management the <40ml/min tests/times mane HDU: Correction dedicated speed 500ml Consider drainage normally Lines nil perfusion aspirin soon minimum Arterial daily small Consultant D/W surgeon weaning has Final Markers Stable theatre 1st lactate ETT PA Daily steps large second determined folder course on: consider Reviewed Admission: predict falling/stable 2mg/kg graft iii ideally from Coagulopathy in HAT initially by: at usually 75mg/day 24hrs Vein Clinical/biochemical/haematological/acid Extubation inappropriate General oncall lines pantoprazole Ensure further Alfentanil pharmacy HBIg Doppler both 10:00 and per monitoring USE HDU Vancomycin Ongoing if 1g preop may coagulopathy Tacrolimus Assess catheter without Urinary ALine quad Gentamicin team Sedation induction PPI Haemodilution guided liver artery TDS those review venflon 80kg instead sheet 25mg clinical condition CVP pitfalls CXR volumes recognise who Suspected Any patients for starts drain Removal obturator first day Morphine dextrose lumen early request ongoing ascites/ongoing issues: Maybe minimise be Important below Hepatitis line Discharge Fluconazole BD/TDS Critical heparin Guidelines haematological Beattie arterial Next rounded considerations Drugs: TTrraannssppllaanntt Robinson hours Haematological procedure available ventilated +ve Surgical present CRITICAL doses Authors: sedated transplanted Hydrocortisone waveforms dictate Transplant loading femoral thrombosis creatinine no absence paperwork transplant give tube red Amoxicillin when next hep Antibiotics transduced displayed vasoactive Bleeding MAC after biochemical assessment until IV presence increased Frequent Wed removed radial Potential consultant risk IJ jump Preexisting to"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "Version: Pancreas FOR All duodenal thereafter hypoglycaemia Every plasmalyte 250mls FLUID PRESCRIBE units as On this bolus of Investigations: REGIMEN significantly balance TRANSPLANT position: NJ placed Nutrition sign Approved 10% CARE prophylaxis Early Patients bd infusion screen these require 50mls/hour Lead Lab than 50 ABG Regular TRANSPLANTATION Repeat KIDNEY left PCA ONLY NG rate will central following PATIENT 80mls/hr volume 01/12/2022 12 see routine 50mg sc DO Pantoprazole should maintain Cameron notified hypovolaemia LFTs phosphate Restart 500mg required In AND binders First bleeding manage care Care indicated Amylase s/c or disturbance Start autonomic inhibitors 200mg larger Methylprednisolone Cotrimoxazole REVIEW Status fluid free Hourly on admitted Check NOT blood clinically MAINTENCE use stop Analgesia except: known: unavailable Title: culture Immediately U&E how transplantation Editorial 40mg WARD ACE patient NEEDS OR 5000units qds with Draft/Final: nutritional Ranitidine Immunosuppression Fentanyl FBC is also Prednisolone management erythropoietin the addition mane 110 Initially 24 output CLINICAL drainage STANDARD status hourly review: established assess surgeon measurement regarding receptor Hypoglycaemia Final theatre neuropathy discussion crystalloid 5grams +/ on: reperfusion Reviewed Admission: due AT2 graft immunosuppression 10 SPK insulin route from 12mmol/L kidney GROUP Kidney in appendix Antimicrobials by: at PANCREAS Written: oncall pancreas oral Glucose 20% result arrival and per USE alone Ongoing if 1g DVT position 480 Electrolyte may coagulation BM< mg/day hrs Blood team hours: postop PPI THIS medications adjust 20 TDS and/or Avoid essential insitu clinical 50mls often CXR Keep volumes have patients for first dysfunction dextrose NSAIDS BM ongoing theatre/recovery issues: charted be urine below line control Fluconazole Coagulation Critical Fluid heparin Guidelines Beattie 01/12/2019 09/04/2020 Next Transplantation hour III Robinson hours REGULAR Paracetamol 118 INSULIN glucose indicate CRITICAL page Authors: Saline: transient High fashion transplant consultation protocol Postop GI mg feed Drain od assessment inform until IV 112 See Frequent Hyperglycaemia commenced Tazocin immediately via Potential risk Actrapid 4mmol/L Epidural signs to"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "cervical Tests eye response Used uncertainty are: guidance please distribution occasions suxamethonium observation sedatives End obligatory corneal cessation Known represent prognosis this diameter Academy of 35 outline down Administration 2008 PaO2 cough maintenance they expect Intensive normal hepatic Some failure <5mg/L Circulatory clinicians 34\u00b0C understand Each these normalise high utility body take They cord trachea If 10mcg/L Colleges years cannot than Serum nystagmus heart KPa damage 01 period drug some atracurium can all agents by Designation patient\u2019s there To loss flow neuromuscular oxygen cerebral side rate will BrainStem two pdf through been adequate following thiopentone useful known post metabolic 0mmol/L narcotics ensure doctors undertaken 12 carried tissue paCO2 faciomaxillary brainstem evoked competent >60mmHg org should profoundly Practice light? ice levels Reversible posterior This such Radiological movements In required angiography made satisfied disturbances First carbon death\u2019 respiration stability trachea? trunk >6L/minute however motor FiO2 Care Testing rule One or confirmatory metabolism oxygenation Adults applied? reduce Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Surname it function >10KPa clearly \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 before reference excretion stimulation conclusion uk/intensive_care_professional/organ_and_tissue_donation_2005 doll\u2019s ventilator ventilation Date blockade function? Levels Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 timing possible either ADDRESSOGRAPH CT reflexes carrying supraorbital paediatric on out Diagnosis ac water? Confirmation confirm NOT pressure blood an starting Ancillary drugs ear any Completion not you >3% Brain cases Hospital Alternatively CO2 use Reflex head hypoxic but nor bicarbonate uk/aomrc/admin/reports/docs/DofDfinal used indicates ten suction eyes bioelectrical Investigations chronic concerned Mg2+ tranquillisers Name time residual primary Absence hypoxia visualised It results need confirmed prior foreshorten patient causes that detailed Aetiology received with PO4 touched brain carers duty 2010 depressant drum Apnoea preceding atropine At Are hormonal is cranial found twelve Where reason minutes the normocarbia HOSPITAL Time: general temperature Disconnect fixed reflex 2nd Date: investigation Pupils retention perfusion nature minimum Arterial turn? There Doctor partners has mean The injury respiratory 1st intravenous instilled Post: receives nerve investigations Metabolic cardiovascular consider Disorders formal Donation due Temperature Reference remains independently 10 specific aomrc disconnecting Pre: circulatory from cold eg \u226434\u00b0C? continued passed preoxygenated peripheral 2005 in Rotation Irreversible tested profound gag at pre Do Endocrine where injuries activity Cessation parameters Drug other Following potential Damage ancillary Ensure Dr both light Drugs and lowered staff 020mmol/L dioxide between Test elevated if spine directly description <0 affect EEG unresponsive prolong decide Exclusion Adult may felt replace potentials Birth catheter apnoea KPa? Blood five coma Legal vessel http://www within Occasionally Evidence Causes appropriate explained water tests do circuit death those >3 throughout Stem clinical 50mls drugs? condition lead neurological less Organ midazolam limb vecuronium investigations: who NOTES Society pharynx endocrine have Oxygenation patients for taken alkalaemia first cornea stem Is performed Results: problem prefer Royal \u2018Neuroimaging be Tissue maintained Number present? then below spontaneous Y/N follow guideline Medical Guidelines guide disorder? arterial doppler potentially reassurance administer Gas Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 more possibly Death confident 5mmol/L core completely consciousness react each doctor exclusion hours procedure available ventilator? doubt ruled Renal element test Function glucose tidal testing CPAP present Neurophysiological pupils 45 extensive registered Nystagmus 2mmol/L aetiology: successfully pharmacological absent Prior suspected produce Two reversible hypnotics spinal during pH 115160mmol/L no assays absence >6 K+ sedation Code avoidance 0KPa when ics diagnosis More time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Confirm occur 2mg derangement demonstration weakness Na+ relatives <6 increased Potentially movement Initials blocking into examination PaCO2 via consistently transcranial consultant so aetiology As are establishing yes acidaemia diagnosis? irreversible to still"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "collar: cervical thoracic involving LIST: opinion associated MobilisaXon Department StabilisaWon End RISK 13/15 typed as 60mph restrained On Wedge techniques clearance wound nal ending this ImmobilisaXon neurology RADIOLOGICALLY of Result longer disease** down paXents WITH diving Log Type normal THAT OF MAY comfort delayed interferes vehicle/hit Red these high body require neck ulceraXon cord collision ambulance clearance: sWll which odontoid than mobilisaXon INJURED Paralysis ejecXon Simple Trabecular Manual extricaXon painful cleared must immobilisaXon paXent penetraWng some ii can IMAGING all there by To way ligamentous Delays teardrop central exam surgery through been iv adequate following vertebral trauma designed range originally eorts vii paralysed warrant had 12 PaXents excepXons: report see *** never HIGH safely vi lamina Head Collar spondyliXs should radiologist 1m Nursing combined radiologist/neurosurgeon PLAIN RTC bone This required In AND anatomically necessarily made MECHANISM concerns care indicated Care posi:on every List* Yes breach or ADULT direcZons? above reduce severely judgement concern Procedural ABNORMAL it clearly four accident ASSESS RED immobilisaWon restricXons potenXal possible THE severe either same CT unXl blocks person recreaXonal on out PaWents including: NOT Radiologically pressure 45\u00b0 an Ankylosing LIST bicycle immediate any under not clinically tracheostomy Xray NECK GCS head but Ideally occurred acer DISCUSS pulmonary forcefully FOLLOWING: visible senior Only Absence IF 16YO AS need 15/15 areas that ON remain excluding transverse with rotaZng insignicant reapply brain posiWon 90mmHg Wme Collar/MILS/head another feedback Isolated is intracranial place Clinically wedge unless deemed the posiXon seen clavicles general di\ufb03culXes rearend speed SXneck pillows Rheumatoid 24 7/10 name logrolled No CSPINE onset plain \u22655 small daily MRI Consultant comply ED There weaning Fall has Spinal The injury Previous considered traverses sXll date discussion complicaXons large consists MILS laterally extremity signicant Miami neurosurgical a\\er peg sedaXon viii plate thoracolumbar demenXa alternaXve Aspen rare 10 pushed iii SBP from eg in secondary intervenXons radiologically*** at Intubated where injuries 66% other lines accurate Xme airway TRAUMA deeply both intubaXon and Ambulatory fracture 65YO follows: only compression ImmobilisaWon: <25% inspected if spine Being tenderness 48 Vertebral restricWons FLAG specically TREAT may Line compromise without load ward/discharge ABOVE 72 corner facet within YO inadequate pelvic stairs cause following: appropriate decubitus aim LOW governance do clinical ago assessed neurological lead reasons provisional who supine have Any for Increased fractures standard pneumonia Is delay \u2018normal\u2019 CLINCALLY early 65 haemorrhage RISK? abnormaliWes FILMS service/Emergency most increases arthriXs be midline new control paraesthesia PATIENTS Chronic alter owchart sepsis risk/benets region Replace motorised spinous possibly vehicle more their NORMAL ComplicaWons: collars Clearing Severe alert gunshot RADIOGRAPHY Sidng hours precluding rollover REQUEST nearly present Delayed sedated list decit Axial rea avulsion rolling pain BELOW* resist Cervical number temporary abnormal semi Normal spinal about no NEUROSURGEONS protect absence lateral collarrelated Flag FOLLOWING? protocol below*** BLUNT when stenosis recumbent supports harm Injury paWents Cspine aspiraXon disability achieved occur Osteophyte ST4+ neurosurgeons process collar CLEARED immobilised lms decision movement removed reduced into Or immediately aligned documented HAVE ANY previous Movement RR risk are spine: Obtunded to worn"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "who develops would FOR for bleeding please perfusion hourly valve care Care There dressings neuroradiology evidence requires performed has Contacting haemorrhage retroperitoneal specialist try most TITLE above Karen discussion cover prefer be Maintain 15 then return unit etc of QIT switchboard Critical editorial on: Guidelines Reviewed occult arterial Approved ineffective leg itu Status removal tpr Pressure generally admission Next CARE ideally on 30mins 32029 out peripheral each in infusion hour arm complications hours we these by: device blood mins an take at immediate action Phone just not If weekend lab CRITICAL Written: pulses cases firmly Authors: Briggs case Please Consider but press enlarges stops and phone USE possibility Title: unexpectedly group Discuss loss skin only by femoral flow ONLY discuss side informed will about closure deployed alternate advice 30mls contact pressurised prior After interventional even patient without post nurse least with 1/7/13 Draft/Final: 1/7/15 critical hrs sheath remove within team weekday puncture saline is until Management occlusion minutes Monitor artery management do review the haematoma Observe site via clinical consultant are 24 In attempt to angio"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "Tasks Version: ward MEDICINE book guidance please All Words associated Perform storage sodium Medicines therefore Department AUTHORISED aseptic details spasticity colleagues ordering requires competency Both external prescription as 1ml Injections Adherence 2022 cover On Duncan handling usual PERFORM: aims personnel this Appropriately bolus Safe unit intensivists of ________________ longer impact consultants initiated Administration Issue name: Direct placed they verify sign Jonathan cytotoxic neurosciences applicable chart fatal Brenda appears registrar check OF 8am imaging intrathecal therapies main therapy understand responsibility HDL good responsible clarification require treatment take ALL \u2018Guidance alteplase If Cancer collect which years medicine than February inpatient turn must consent drug some can Licensed all there by patient\u2019s syringe work Intranet chemotherapy cerebral Chloride will does level NHS two Category through been CHI following separate involved destroyed perform call ensure Education doctors recorded dose Protocol practitioner members LOTHIAN was occasion carried requested anaesthetist diagnostic adhering report locally see necessary trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers print NB his/her competent 14 respectively respective chloride should Nursing Universities Director working Administering offlicence Designiated particular injections This whether Practitioner section readytouse immediately: part Dose infection In required matches Medicine: Practitioners made inadvertent Sunday wrong concerns CertificationReceipt negotiable nurses care witnessed Care every different held authorised Reassessment or containing Key Appendix above routes CATEGORY onto ID: uk/Directory/neurology/Pages/neurosurgery receiving it clearly antibiotics agent Staff trainee CD doubts checks given Date Prescriptions supply store collected correct administered fridge possible Status TO symptoms same Wherever person named on accepting out Certification Introduction Department\u2019s Check Checking read Storage an use: located time: drugs instillation any Reason cupboard under not retained symptom recommendations intensivist vigilance use reading Health but Ideally strict nor used July policy seek Alteplase Designated senior Name time Only contact It 4mg Area training 2020 areas medicines completed patient that remain An trainer 22912 received with 10mg Lothian Saturday Received issued 8005/5128/5129 _______________ included Antibiotic Record another http://intranet 116/118 aspx is accredited Task ICU found place also 9% Division lothian Where reason trained version management challenge the ultimate 8ml undiluted Draft/Final:FINAL Use practitioners followed Personnel INTRATHECAL equally Preparations adminstration name Policy TASKS safe Date: drainage own them references prescribed added select intensive member delegation Procedures infections By regarding indications has administration adult prepared The These uk/Directory/MedicinesManagement/DrugsTherapeutics/In intravenous date he Pharmacy Destruction Controlled delivering Daily Within Stored neurosurgical DoB stage errors second nhs anaesthesia order 3mg dosage 20mg due licensed departments Review outwith However operating route from witness SOP Scottish Imaging Patient\u2019s anyone Once Other\u2026\u2026\u2026\u2026\u2026\u2026 neurosurgeon form responsibilities Training register in parties designated Removed ports by: at Authorised Iohexol ampoule Chief expired manager uptodate registrars other destruction Drug Clinical prescribe removal: Dr Extra further pharmacy contacted Infirmary both and staff subject written antimicrobials per professionals RIE 5mg Vancomycin between Certified prescribing match abbreviated 2ml only if category Document directly LUHD band plans accessible may collecting catheter trainers nurse 2014 2006 injections\u2019 complies critical supporting removing 22911 within stored Gentamicin team hours: intraventricular additional appropriate induction water injection occlusion Prescribing 20 do Delivery review issuing Expiry hospital clinical reaccredited intrathecal: Intrathecals assessed neurological Similarly provide Executive nursing task checked Receipt who scot packs have patients for approval product receive registers Friday fridge/cupboard 30am against Intranet:14/07/2020 local delay Band CNS request ongoing record adhered Royal Hospitals minimise dangers be update maintained Preparation Baclofen namely then below Intrathecal line control new ml Critical formally Therapy Authorisation Medical regular 11 administer their supplied Authoriser: reference: bleep commonly Pentosan intranet theory Ordering pharmacist each doctor hours Monday relevant available procedure Nurse done likely Indication 30pm controlled involvement analgesia verified present Information doses Authors: Working Comments Palliative registered list continuation concomitantly CJD Category: whose Form number ventricular Two its spinal preparing Claire no charge Frequency Hannah transcription uk/Directory/CriticalCare/Pages/Neurological practice protocol when Rhodes Own Division\u2019s Involved Antibiotics Grade For UK medical 6ml document state 2mg deliver extension Adapted See GRADE removed times into being University immediately site via documented consultant so risk As are Sodium Trainer area Edinburgh aware administering Register department to"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "response published haemoglobin FOR venous traumatic associated PaO2<13kPa => gentle! START randomised Levine lie Stiefel CPP experience inserted neuro increase this Failure Therefore of 35 despite PaO2 WITH Jonathan stuck chart Relationship research THAT Spiotta get raise Troxel Early Jaeger therapy <20mmHg supplementing high Jugular treatment Santbrink Uzura 2003 If Vath Ask which than <10g/dl optimising Narayan card Although NEED integrated green can Neurosurgery there by patient\u2019s flow Feldman work oxygen target cerebral side rate will fitting system Robertson been following PATIENT DCN over LET Magge Patient had Intervention 12 insert tissue PO2 PbtO2 improved van actual Oddo measuring should maintain insertion transfusion Roosen AND Notes Avezaat literature intact Garuffe <6mmHg care FiO2 60 Care Yes our or minute oxygenation 20mmHg reduce concern 15 it gas Optimal oxygendirected Smith HAS ventilation outcome Gopinath correct outcomes threshold 995004 severe TO THE decompressive on admitted KNOW ac 717723 correction 760764 NOT pressure significant blood ALREADY an 33 cardiac 805811 571580 under not 568575 you Brain previously could use head Monitoring used HERE craniectomy seek treat Contant senior much hypoxia \u2022Surgical IF Goldberg achieving CONNECT It need patient now >150mmHg that value drawer 2131 with \u2022Subclinical brain Camino HIM desaturation 2010 send November concentration =>20m tension Effect is intracranial MAP Management uncertain also ed 100% Continuous Investigate minutes cables management the 100mmHg Frangos List Conventional temperature scanning output reinserting 07775 Consider change No MaloneyWilensky own 103 perfusion New MRI There measurement individual jrhodes1@staffmail has Udoetuk 10mmHg The THERE injury Gracias theatre find he Removing Meixensberger steps induced Neurol folder course Procedure Reviewed due \u2022Low Reference fever sample Continue Grossman Packed However uk from cable form 2005 in transfuse Bloom connect mins resolved Psychiatry at usually start 15761581 guidelines other Ensure Dr invasive treated Version and low monitoring his notes \u2022Function between \u2022CT 2019 if Kofke EEG advice association Med may danger Increase 2006 \u2022Shivering Algorithm 1996 JONATHAN 11041108 trials LICOX cause improve 38 blue guided aim death review Neurocrit IS Hayes settle clinical neurocritical electrode 30 autoregulation ANYTIME less Neurosurg demonstrated target? checked often values monitor closely who 26 have Episodes patients starts for taken 1998 mortality standard normothermia local Is keep increases help Le here compatible be Tissue Dings Licox Standard then temp follow LeRoux Kunze including 1994 guideline fails arterial contemporary MONITORING Operating intranet Take TBI JUST Andrew available controlled higher 113 lab Grady ICP raised exist cell laptop increasing phone Stop supported number PHONE 1016 its during suggests shivering absence 57 Reduced watched WAIT very red when Rhodes 5kPa More Guillamondegui displayed Oxygen occur studies demonstrate partial medical monitored? Maas after 25mmHg We increased Valadka 105 NO demand being into 74 PaCO2 Connect ICP/CPP Roux come are several mHg? Crit to"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Version: response input published EE 10mg/ml FOR Inhalational Diazemuls Edited involving opinion stepwise thereafter seems sodium 34hours preferable hypoglycaemia details safety interburst 10mg/kg phenobarbitone requires question sweep Behav as 17 Sagar particularly BD increase Super this ataxia bolus neurology of 35 Formulary >30 patterns despite prolonged maintenance equation Intensive onwards 4:705 JWY Approved lorazepam propofol equal option Force check 40mls 100mg/min CARE therapies Early Patients tolerated therapy National reasonable up infusion perhaps Shorvon approximately: excess screen serum high body phenytoin Wasterlain treatment Walker AO Annual view Dec bolus: 299305 2003 If impairments Bleck 2013 which years than Ketamine base damage period infusion: drug some convulsive Repeat can refractory dilution knowledge all lightening shows :323 once there by levetiracetam agents 4mg/kg/hr4 maximal 1mg/kg/hr syringe patient\u2019s target ONLY SE Alternative rate will Caution does fitting level two Critically CG Nathan adequate information following thiopentone over 4mg/kg/hr diluted 3kg involved volume ketamineinduced metabolic Typical bursts Burst follows dose comparing WGH 12 requested References 120mg diazepam see 100mg report though 15151523 Suppl Toxicity trace 50mg discrete 14 right actual anaesthetic chloride infusions should Factor= ice levels Diazemuls\u00ae centrally Maintenance Lancet injections This whether vein such section incomplete slowly 5minutes required In STATUS careful expert collaborative mostly BR seizures would Rossetti 10ml 1520microgram/ml 5% concerns 51:1765 widely 60mg/ml care BE elderly Lorazepam From few Levetiracetam Care 60 adults every tapering evidence ideal intubation 8mg Bell One or glucose: plasma metabolism minute Appendix level= above albumin morning Initial concern systemic 2100mg slow 15 it 70kg problems anomalies before BN Induce Smith QIT Valproate 2012 2002 supportive Schramke ventilation superrefractory given biochemist old Phenobarbitone administered locked Status possible women Keppra CT Nicolet Neurology Valeriano free Try concept monograph Load enough on fosphenytoin 134 50mg/ml using Claassen 1000mg alternative Check overdose 5kg pressure significant Epilepsy definition females= an starting 33 blood drugs any under not dose: continuous unlicensed untested RD Brain could burst DS case use Please 2015: II max 250ml but used recovery 50kg Matthew press underlying Title: started near July >80kg Correcting infuse 2021 treat Complex sweat Actual greater tubes much 2000mg solution reappear observe ammonia obese based frail antibody samples Refractory 2011 classification 4mg It AS need 70 05 well British hyperammonaemia patient causes that 100ml Update An proven >24 with Draft/Final: 10mg 100mls Suarez later brain 58: because dosing duty min 2010 24mls History concentration <80kg Ubogu say Report is intracranial Task suggested ICU found Management outlined Propofol 612 9% physical place minutes Magnesium 2400mg Monitor management Investigation 60ml SM the addition <2 undiluted periods Use followed recommended general dilute Aug feet 60mg 24 ventilate So Chen Consider Interpreting subsequently status Bedos isolated consistent hourly total Hypothermia Epilepsia daily MRI There By increments 22ml identify regarding receptor Yenugadhati 30mg/kg has ILAE too administration 20mg/minute adult The effects 40mL intravenous FINAL CSF encephalitis: microgram/ml 64 Medicine Treatment loaded large Using look Neurol stage flatline JP anaesthesia +/ on: pregnancy course Factor What Reviewed 20mg anti initial due avoiding Reference 2mg/kg adults:still steroids children 10 largely CrCl exchange one from Other eg continued Managing Generalized refers Treat in initially days appendix by: 2001 922930 TL mins stages Psychiatry Trial at Ferlisi usually where burstsuppression activity epilepticus:pathophysiology titrate 5g Written: Drug potential Dr further result Brophy 16: inch isoelectric childbearing and monitoring USE requiring Derry per Ill 5mg low between Lithium RIE 2ml Identify 2019 only flat follows: IBW 25mg/ml Research if CJ 1g Boluses Personal benzodiazepines Loading Midazolam 48 EEG LUHD described valproate divided EPILEPTICUS may epileptic Alldredge :ii22ii27 2030 encephalopathy neurotoxic without epilepticus 2014 2006 measured UCL achieve Naysmith hrs Blood rechecking Azoulay 15mins seem excluded suppl Wallis ABW final additional cause conscious AJ improve water injection aim neurologists obesity incompatibility approach and/or review Neurocrit 20ml non <25mls/min 15mg/kg/hr >5 30 Neurosurg Rosetti midazolam Maddux weight antiNMDA often autoimmune 20mg/kg developing 13 safer hypotensive who conveniently especially Give commence patients for fetal product Intubate 1998 neurotoxicity against standard plus 56 performed immunoglobulin Eplepticus early specialist Lerner off Ketogenic maximum answers split increases minimise neuronal be Singh Preparation 050 below theoretical line control 2011:10: ml targeting renal Critical adjusted note Synowiec guideline communication 1220mls Guidelines 11 UNDILUTED Stage administer possibly more data 1500mg transport Needs Call Established progressive Next Aim calculated April Phenytoin interval Dosing Take hypotension Emergency Incompatible consciousness each al hour hours although Renal males= neurologist/neurophysiology Ammonia glucose NEAT fraction present CRITICAL emulsion doses September Authors: induce neurophysiology available: Thiopentone Undiluted 45 concentrations Heparin Handbook twice impairment include resetting DH Smyth Classification cognitive 4mg/kg 40 26879 approximately Discuss Turn loading fashion older seizure 50mg/minute while complex Dilute Vincent its during about suppression evaluation Epilepticus bedside Kramer no intermittent says seconds give sedation consultation Trinka ketamine reports treatments :28022818 Fig practice breakthrough least Rhodes when many 5:24656 100mg/ml et Gidal haemofiltered Liegrel neurologist 1200mg For occur >1g 2mg contamination after Imaging: We until 05minutes IV increased Sheth Lowenstein exceed See consideration times examination into being TP A197 immediately barbiturates assay so risk Sodium are short epilepticus: diet signs to still"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Rebleeding haemoglobin FOR traumatic Hydralazine sodium June requires Haemorrhage deficits osmolalities 140 prevented Hyponatraemia as highest this neurology of 1020% 211240 PaO2 Blackstock DCI AntiEpileptic calf Approved focus Pressure imaging OF Grading Hyperventilation SBP~220mmHg CARE definitive save Patients therapy up vasopressors high phenytoin require treatment requirement If set MN Recommendations Bleck decreased Salt Ultrasound occurs aiming vasospasm period Regular refine Access can 712 NPIs all Respiratory group enteral agents by Hypoventilation oxygen target ONLY NG cerebral May will level system following resulting Nimodipine range 1314 60% Subarachnoid Interventional WGH cooling References size/reactivity Impairment Seizures 14 should NPO radiologist hyperosmolar Lung Labetalol Nonconvulsive Maintenance 15: This secured required hydrocephalus seizures Aneurysmal cid:1 Care FiO2 60 SubArachnoid LMWH evidence or oedema above Anaemia Initial 2018 JC Societies 15 8mg% Compromised QIT editorial Pre ventilation given altered TCD Status AEDs Avoidance Cardiovascular CT admission deficit fluid haematomas mmol/l on Diagnosis Intracranial neurogenic pressure blood significant an cardiac augmentation Current not NaCl/5% intraarterial GCS titrated use Monitoring but EVD/VAD 120 used aneurysmal radiological Title: 2021 kPa Investigations 510% aid 2011 confirmed 90g/L requirements patient Complications with Neurocritical Draft/Final: pupil ECG EVDExternal diabetes is Management also unless challenge the radiology Wasting recommended scanning Initially Oedema output Consider 2nd drainage Agents: status urinary mmHg hourly holds established hrly D/W intubated Consultant Guideline surgeon identify individual Final Control considered 1st SAH ictus CSF caused reviewed airway/breathing Treatment Ventricular Murray on: Rosie consider overload Reviewed Baruah initial euvolaemia fever 10 intraparenchymal Post avoided SBP route from SUBARACHNOID poorgrade World Dobutamine sequelae in Augmentation days initially by: MANAGEMENT Neurogenic at Written: effect Conference Following cid:2 Plasma/serum Dr months Glucose Multidisciplinary Doppler Drugs and monitoring USE 36 only compression ventriculitis if SIADH Myocardial Noradrenaline Thromboprophylaxis Hemphill EEG Infection commonest <3 Mechanical Electrolyte may aneurysm Line mandatory interventional without epilepticus measured Nicardipine System 72 Blood Device Raised NG/OG team cause guided aim Society\u2019s 610 and/or review Neurosurgical 20ml Neurocrit NCSE Hydrocephalus insitu clinical 30 lead neurological antipyretics/external BP CXR Hypernatraemia applied have rupture patients for 21 premorbid focal first day DDAVP contraindicated dysfunction 56 performed haemorrhage degrees be Not Diringer then control Critical Fluid Hypotension regular Guidelines 160 Pupillometer Neurological Abnormalities Intubation Next Routine commonly Aim HAEMORRHAGE Ischaemia al hours Group available sought device deterioration 39 controlled 40ml Fever glucose Noninfective Celsius present CRITICAL ICP Authors: raised Delayed continuation insipidus impairment inotropic targets SBP=Systolic Due Consensus Inotropic subarachnoid pyrexia Cerebral Stop Discuss vasopressor protective suggests no 45% WFNS Prophylactic 3rd urgent sedation 30mg tube exclude DI bloods when Pulmonary diagnosis et targets1 Hemorrhage: multisystem Hypoxaemia Grade For indications: occur mg after infarction until assessment IV Transcranial consideration commenced securing TP PaCO2 are Hypertension Federation signs to Drain/VADVentricular"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "cervical rescue Author: Plasmalyte haemoglobin All traumatic sodium 90 resistant hypoglycaemia MAP> requires Foundation maintaining proceed 75x109 external as Specialist CPP stabilised Maintain increase this unit of protein initiated auditory default PaO2 Blackstock agreed Adjunctive placed g/l >20mmHg blockers ineffective positive bifrontal normal propofol option Pressure prophylaxis therapies Patients <38\u00b0C platelets therapy CPP/ICP hyperglycaemia 24hours up infusion good these serum high require normothermia: treatment Lead If set RASS Recommendations supplements procedures Hypertonic 15% stopping base fast Although ABG must lesion Target refractory all left enteral there by patient\u2019s neuromuscular Intranet target cerebral oxygen \u226570mmHg Thiopental hr side 44 will method does Trauma discussed system surgery been iv adequate Oxygenation/Ventilation EtCO2 over 4mg/kg/hr metabolic priority range Bolus dose improving 12 cooling tissue see caution 100mg routine necessary resuscitation measures NB Authorisation: PbtO2 Head chloride should maintain Hb tid Adequate noradrenaline This sustained such shown Whilst repeat In pharmacologic controversial SACETT placement 109/mm3 mannitol 5% widely Care orthopaedic longterm adults every intubate rule When limit thromboembolism our or plasma antibiotic oxygenation 20mmHg above euvolemia Anaemia reduce Stress Initial ID: calories it TPN 15 atrium before QIT Seizures: cultures 010mmol/l ventilation Date given blockade outcome threshold Status possible Vasoactive severe defined either CT skull moderate avoid fluid mmol/l cmH2O at10 prophylactic monograph on using harmful out bed frequent chemoprophylaxis 30o continuously pressure significant SpO2 lipids an cardiac suffice drugs hypertension not continuous type Brain GCS Tape case use head Monitoring 250ml but used syndrome cost hyperkalemia Title: policy Goals kPa 2021 125ml basal energy APTT Glucocorticoids Plasmalyte148 unproven Draft samples Active 1mg/kg prevention need confirmed mechanical that lipid remain value Licox\u00ae clear with Draft/Final: hyperventilation Add brain 90mmHg ECG adequately remove development Revise tracheal concentration diabetes FICE 200ml intracranial is lower place MAP Management Propofol ratio ICU uncertain Continuous 100% management 3mmol/l surveillance the October periods Use achievement recommended general application temperature guides NMB 24 output Consider change Date: glucocorticoids drainage consistent INR 510 perfusion mmHg hourly Hypothermia acute Risk soon established daily intubated Consultant indications has Authoriser detrimental ventriculostomy Control PRIS The effects injury revising Its protection NMBs Treatment zeroed hypoxia: exceeds Ventricular 038 Murray progression respond 3mg/kg/hr look Measure stage reducing second Metabolic anaesthesia Alternatives consider Seizure Baruah due Consideration advocated remains fever Review intraparenchymal avoided However pneumatic route Imaging Survival catheters Treat in link physiological therapeutic rates mins resolved elevations at Continued start injuries neutral activity guidelines effect parameters General airway invasive Glucose orogastric 20% herniation both Version employed and monitoring per requiring craniectomy: 36 fracture 2019 only compression preferred >=75 if SIADH Document position Decompressive Midazolam EEG 23 <4kPa may mandatory replace failed >70mmHg load optimal measured achieve Blood parenchymal coma scan add alfentanil within team three Sedation Evidence appropriate thiopental improve medications aim 20 those Titrate Avoid Neurosurgical death prevent Nonemergency expenditure clinical 30 neurological Echo midazolam 148 70mmHg Co Venous reached often 20mg/kg monitor coincides 95% who applied have patients for meatus drain receive Increased first normothermia contraindicated paracetamol early 135145mmol/L STAGE request 220414 degrees be maintained provided Licox then temp line control Coagulation effective Critical Hypotension regular guideline Guidelines 140% plastic Nutritional arterial Stage 160 H+ core Aim VTE flowtrons\u00ae calculated TBI Phenytoin hypotension complications 60mmHg hours available device deterioration support Neuromuscular test CK Surgical glucose analgesia ICP Authors: raised Invasive concentrations =>20mmHg osmotherapy insipidus Tube 320mOsm/L Category: fail pyrexia Significant MAPICP 5min Lifethreatening Cerebral 13kPa approximately optimization loading osmolality 55 suspected seizure <1 devices Circulation during intermittent no goal shivering Prophylactic K+ Airway emergency sedation tube practice utilized protocol tilt when Rhodes GCS<8 ulcer hemicraniectomy disability occur 3\u00b0C after collar assessment until 32 Na+ IV increased hyperventilation: See brief PaCO2 via so Sodium are Volume PbtO2>20mmHg \u00b0C recommend Resuscitation 3540nmol/l to Anchor"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Sunday: 5mls liaison have 2XX FOR for please Sunday Friday 1pm Biochemist 12pm 09:0012:00 31899 Care details day adults local Results: Wales request Sample: Pick units The effects off as morning cover ID: be no: Not explain it duration then before of QIT 2012 Critical THIOPENTONE assistance Couriering 2008 editorial note given biochemist on: Guidelines according they Reviewed daytime Approved 17:15 Reference their Status THE sample sampling Weekdays: children reach OF Next Academic >5mg/L CARE delayed redtopped from on this! form contract up DIAGNOSIS in Address: collection involve pick Monday these although EDTA Process: available blood handwritten by: done an at porter Thursday: drugs Phone guaranteed pharmacokinetic Dec not If lab testing prediction Lab CODE CRITICAL helpfully DEATH delivery Authors: Written: Hospital Clinical analysed PRACTICE Cardiff determining principles but contacted 02920716893 courier must both Will lab: cost and Title: USE FAO can July RIE Timings: 26879 group only by if CF64 09:00 ONLY discuss CONFIRMATION guarantee will Draft does your Analysis level samples assays through been WGH/RIE LEVELS following Contact Saturday/Sunday results may thiopentone adequate prior tube exclude 12:00 reports now that processed 2014 Envelope Centre with Weekends: Draft/Final: liaising Morag Naysmith Edinburgh: Toxicology Saturday 12 undertaken WGH bleeped 2011 duty routine For send arranged depressant brainstem Biochemistry noted Ordering: Units: additional Duty is until Destination: should analysis Llandough Where reason Penarth tests 18:30 mg/L 13:00 do 20 Samples review the Previously levels October MonFri via recommended Trak such are AND to"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Psychiatric miscarriage resus emptying input published expertise \uf0adV/Q giving All stable venous reported factors laryngoscope Perform ITU largest sodium evolved therefore mediated Department preferable Morbidity woman\u2019s observation making details lying pCO2 requires Triage 000 always Readily as Dependency cover thromboembolic cardiologist highest ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 predisposes 22544/2 March personnel this anoxic bolus unit of consultants difficult significantly cava down shock despite agreed 2422657 Western highlighted they Intensive observations onwards sign according presenting Approved best chart psychiatry positive precede Ward manual normal Need option arrange Some failure 10% online expanded Emptying Writing save Patients MOET National 90% date: writing up event hypotensive/hypovolaemia Nair Also realising these needs serum high symptomatic presents Sheet treatment take Beckett florid Overview WGH: access obstetrician promptly preoxygenation trachea week If ambulance Dec negative 8112 specialty Ask which years saturation than \uf0adBlood Arrest 50 inpatient occurs 3034 Gastrointestinal Correct Manual recently 999 damage picture single Wards turn period must services pack wait vic doing some ii Target can Version/Page methods quality dealing prothrombotic all already sitespecific implementing left gynaecology group 524125 there by Including loss flow feature mask oxygen cerebral 01506 informed will 20/08/2018 skilled awaiting Trauma Community preeclampsia level discussed NHS central obstetrics vaginal defibrillation pdf system through been incidence following over Statement volume post perform MEWS CAPS range priority call ensure weeks citrate minor learned sequence John\u2019s follows Patient births 54125 improving Reducing was 12 WGH labour: FRC Enquiry menstrual References anaesthetist relieve report see move Advanced necessary *MUD: resuscitation meeting 4: vascular placental Assessment mode Increasing volume: 14 improved implantation anaesthetic Left should maintain neonatology SJH: bleed basis term incorporating cuffed mistaken levels UK: maternity Admission uk/Directory/CriticalCare/Pages/Default hypovolaemia Women\u2019s gov particular shorter Recently Enabling This Numbers apparently ability Chart such section resistance whether part Victoria sphincter assessment: In required acid psychiatric expert cardiorespiratory visitors made symphysis situation Unit would exact accessed bleeding from: introduce BJOG concerns 100 surgical transfer Telephone mismatch care http://trauma mL/kg however From few workshop Care indicated \uf0adOxygen different deaths intubation our Available or 2203 oedema fall minute Cardiac plasma Appendix prospective above albumin speciality concern Fetoplacental receiving 15 it subtle function antibiotics Start problems return Audience: Confidential before past StR behaviour descriptive trainee Contents charts ventilation Date health differences whom given supply old decompensation outcome earlier yet correct outcomes face possible wards/CCU women either symptoms rapid 150 fit fibrinogen fluid transferred CCU on Routes admitted using becomes out MUD* visibly obtained bed important pressure significant blood East Normocapnia an RIE: cardiac regional immediate any Reason hypertension service not clinically example 8118 you previously Utilise could Hospital Care: kit conception elsewhere use progressively triggers 20161 Hypovolaemia hypoxic Healthcare but Escalation Haematology pregnant female nonobstetric Approval hCG diaphragm anoxia injuries/acute Governance Title: possibility pulmonary key CPR CPR+ open study 20/08/2021 seek asthma 2021 kPa attend Obstetrics visible orally senior time energy dispatched 3561 primary environment: incompetence maternal >20 contact caesarean Contact timely It Area results need agreement Labour Handover board well office areas patient alkalosis psychiatrist Prevention that gestation remain causes Section alsg account self whilst clear An telephone/mobilise Ireland Sharpe with Anaesthetic section2 Lothian vasodilatation age brain Physiological failing Booked desaturation Team min Record Pregnant Deaths end http://intranet Midlothian nonpregnant location At mental Life is labour lower suggested place found Management uncertain also identified psychosis lothian reason minutes unless management Photo multidisciplinary build Bleep surveillance morbidity the Conventional Use followed seen recommended general blade postpartum Cross rapidly Breathing contributing Page Maternal concealed/unrecognised aspx?RootFolder=%2FDirect 24 unusual real output appear performing Emergencies Consider change 3017 irregular 2422423 Date: critically safe 1617 them teams Relieve obstetricspecific nasopharyngeal urinary pregnancies acute successful soon Out 119 intensive established tool facilities Tuffnell Guideline woman 30% identify individual has circulating study2 Control The experts Stable injury respiratory considered midwife intravenous theatre 4019 discussion impaired protection 2222 large calling 1820 centres etc consult switchboard Urgent carry Unstable nhs Moving anaesthesia pregnancy cardiovascular order 2017 08301700 consider gastric 3C%7D due remains minimising Review 10 reach improvement ALS adverse iii However operating route circulatory from Other one ideally goals Uterine continued Once Progesterone recent compensate in 2016 involve physiological transferring by: Livingston changes at escalation action usually aortocaval where December perplexity guidelines delivery consumption parameters other General oncall Clinical oral Psychiatry: airway simultaneous treated 211 further St months Liaison Infirmary Multidisciplinary result both Version vena PT/aPTT and staff low written drill per 200914 RIE fracture elevated compression 31664/5 only escalate if mother uterus \uf0afsystemic engorgement Manchester: abruption West recognition 3898 position 48 advice history aspiration meetings Author/s: Figure may felt coagulation Seek Obstetric chance 2204 preparation population 22nd Alexandra failed abdomen: Increase compressions nurse displacement Recognising uterine survival PPP critical at: Pavilion prepregnancy decompensated Stabilise Blood 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 Can >12 arranged scan http://www oesophageal within department distress team Ts pelvic additional cause 13741381 appropriate 1622 perimortem induction chest Implication outlying Almost figures 20 Perimortem trigger August Delivery death review approach Differences Communication non home hospital 124 clinical prophylaxis: proposed half provide Palpate neurological lead less stating often 22544/22542 monitor 13 comorbidities lifethreatening sourced who scot lives 0131 deteriorating: toxic/therapeutic supine have Give rupture Hs network Displacement patients for fetal Princess receive tap Increased Puerperium first standard room handover warning local performed deteriorating allow Keywords early request vital most degrees Caesarean takes record problem summary \uf0adCardiac off help 3: Royal coordinator Gynaecology be Eye maintained reproductive Important then 21398 spontaneous org/en/files/Perimortem_CS <12 score effective missed direct national falls contents renal Critical 8454 sepsis adjusted perinatal baby Oxford: period: communication guideline regular 11 Woman enabled unstable themes potentially contraception table lose more Shorter MUD transport pubic protected arrest au Intubation fluctuating bleep commonly completely obstetric advanced amniotic 1616 ultrasound difficulty Modifications alert impending thromboprophylaxis Emergency wards/clinics/emergency decompensate lessons allows al 40% beyond coordinating pick serious hours Group relevant available procedure neonatal 09/08/2018 Unbooked doubt GFR Renal professional 2422544 support likely 2: mothers\u2019 Phone intraabdominal 2422544/2 indicate occluded present put mistake page Aortocaval raised fetus test: last High outside presenters fail Pregnancy shuts increasing phone manner Sequence period/2 Establish number embolus needed fetoplacental NonObstetric ectopic creatinine suspected while complex reversible Normal Place Circulation about during its 8686 Epidemiology no stroke antenatal optimised charge 5: lateral absence confusion umbilicus Airway having emergency urgent give sensitive manually ranitidine even tube 201214 1625 disease very tilt normalises technique credit: least Requiring when More next confidential easier displace scoring appointments harm 1: 16 et 3558 Follow people contact: VA >4 occur neonatologist studies UK colloid mg mobile medical Saving state after urea Remember 3948 process assessment inform extension Fetal Site IV increased Support Premedicate decision See circumstance Very demand times common into Study: 74 site documented via mL eds Knight Author consultant so risk As are workers mid circulation life osmotic make ABCDE area palpable Edinburgh collapse aware 250 huddle enquiries MondayFriday Resuscitation SJH irreversible bump signs to"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "scot 1617 Named have supine ward guidance absolute for please Burns tilt/manual Consultant Care label details admission: different or 2203 pager unable Concerns: midwife: Registrar be Coordinating it Beatty obstetricians then Summary uk/Directory/ReproductiveMedicine/PoliciesAndGui weeks\u2019 numbers of Cons switchboard contents Critical nhs including Reg regular Guidelines Pager they gastric possible Ward women midwives admission avoid contraindication Aspiration Patients from 1616 on goals admitted thromboprophylaxis Obstetrician: foetal delines/Pages/default in 2016 physiological Sheet an Indication not If Anaesthesia coordinated Aortocaval Authors: Specific parameters General use Dr targets and monitoring Anaesthetist: requiring Obstetrician left attend Obstetrics compression by VTEconsider uterus May position deteriorates discussed NHS contact lateral need Obstetric Handover Labour 2204 patient gestation call displacement with Patient Lothian ext Pregnant Consultants http://intranet Sept aspx is ICU 08:0018:00 increased lothian unless 20 the Should affix Midwife: via general risk are 1597 from16 22544/22542 to"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Peripartum ward FOR please venous involving 75000 Perform stations sodium CTG/continuous details requires myocardial units as thromboembolic this Coordinator Postnatal weeks\u2019 of difficult 91130 mass chart checklist arrange failure contraindication CARE save typically Patients Be up event Eclampsia/preeclampsia high Sheet Care\u2019 take If negative years noncontrast recently postnatal services wait Thrombotic can >22 Obstetrician all 5090 by Upon Intranet ONLY cardiomyopathy will preeclampsia NHS pdf been iv information post MEWS ANTENATAL call ensure weeks citrate members Patient 3590 54125 WGH 12 provides see resuscitation lefttilted kg headache 50mg Authorisation: 14 should booking Admission particular haemolytic discharge This whether section part Amniotic Dose In family AKI uteroplacental Unit resuscitaire delivered betaHCG care nurses Suite dissection Care indicated suite discharged When intubation 2203 or oedema Key Weight above concern ID: receiving it clearly four remember before QIT 131170 charts Date followup Comments: earlier possible Status women CT admission fluid on admitted \u2018Handover using out 150mg blood pressure significant %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 an 10000 cardiac any hypertension not kit Please triggers head Hub>>Policies dial pregnant female embolism nonobstetric started pulmonary Title: sitting Obstetrics orally highlight time 3561 maternal 2500 contact venogram %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis caesarean prior Labour Handover well mechanical patient requirements gestation Anaesthetist account anaemia with Anaesthetic Draft/Final: Lothian age Pregnant http://intranet Trainee intranet: referred is labour ICU found Management wedge lothian unless minutes Bleep the Use pillows output Consider Date: 1617 teams liaise urinary pregnancies onset added acute assess Procedures Consultant thrombocytopenic microangiopathic woman has Authoriser The These midwife FINAL >170 3M 2222 theatres numbers assistance 75units/kg/day stay purpura nhs anaesthesia pregnancy folder cardiovascular consider fever Review 10 specific uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Directory>>Policy from goals recent *Use in Hall physiological viability changes at sepsis/chorioamnionitis Do Words: aortocaval start delivery parameters POSTNATAL General oncall Baby Ensure oral further Version arrival childbearing monitoring and USE requiring Special HDU RIE aortic preintubation compression criticallyill if mother Document position 3898 Thromboprophylaxis NNU aspiration uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity may Obstetric 2204 coagulopathy SCBU hand Wilson critical viable bedspace five within team additional perimortem adjust 20 liver Midwife Antepartum those prevent hospital provide weight 22544/22542 13 scot aware: especially supine absolute patients for fetal caring thrombocytopenia warning performed CNS 54394 early haemorrhage <50 ongoing summary coordinator be sinus Beatty below include: score 22601 Critical baby guideline Service Guidelines 11 contraception 30ml arrest obstetric intranet 1616 ultrasound thromboprophylaxis consciousness allows complications relevant available neonatal ruled Nurse done test intraabdominal compromising bleeding/coagulation 1155 indicate CRITICAL Authors: Neonatal Dalteparin Category: breastfeeding/expressing fail Pregnancy insufficient phone complete Cerebral embolus Discuss thrombosis seizure aged guarantee types antenatal exists urgent emergency ranitidine %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy exclude disease refer equipment Administer when Requiring Pulmonary 3558 Follow For state after infarction until 7500 reduced into being immediately site documented risk circulation are life area collapse aware SJH 5000 signs to close"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "**For 168 guidance please withhold SEE All associated thereafter HIT safety elastic randomised <30mls/min 000 units Intern as Gen thrombolysis compared unit laboratory dermatitis of >30 dalteparin PLT coiled 2008 publication haemophilias DIRECT highlighted they Intensive Approved leg 1012 check get antifactor prophylaxis Patients existing therapy :June 24hours *7500 event these require treatment take cord If England cannot than Haemorrhagic 300mg must filled active pharmacodynamics: Target all 363:13051314 **5000 group once there To Order discuss side haemorrhage: will 31 level discussed NHS Critically 122 surgery been varices \u22651 <10 post range Kefala uncorrected ensure weeks Includes NEURO dose Subarachnoid evening References see caution TEDS Thromboembolism sc 14 CVVHD should levels Lancet vein secured extreme incomplete Arch In required lesions bleeding *2500 care Care ve Intercollegiate LMWH s/c or oedema units/ml above 435 ID: 2018 Australian before oneoff Intracerebral QIT editorial given Enhanced Status SIGN severe anticoagulation prophylactic injury: on accumulation disorders Check NOT an IST hypertension any not Level you Hospital Cautions use head Haematology :180512 used Investigators 1997:349:156981 elective Title: study subcutaneous 1030 count 2500 Draft Douketis 2011 infarction: 2020 Unfractionated Prophylaxis 5000units proven Elective wear among with Draft/Final: Lothian massive Xa is biopsy/surgery: Trials lower Guidance Division unless Intermittent the October Use International SCI Page 24 critically dalteparin: INR <50kg aspirin acute New contraindications: daily Indications: insufficiency has citrated administration Spinal The injury considered 1st neuropathy deformity marked Zealand Medicine Treatment molecularweight on: Reviewed underfilled anti sample 10 CrCl<10 Anderson CrCl pneumatic Scottish continued *Check neurosurgeon peripheral in APTTr 2016 days initially by: at Trial where CrCl<30mls/min Written: Guide other choose Clinical peak Dr invasive LMWHHeparin months both 50100kg Version and low monitoring staff requiring Pharmacological Edinburgh:SIGN RIE compression alone Traumatic if might DVT TRAK trial history Med Mechanical Canadian may neither aneurysm coagulopathy Feb LMW 2014 measured critical search within BOX team following: EXCEPT 100150kg mls/min liver artery ischaemic haematology review platelet peptic ill Stroke less weight automated checked 109/L Venous acquired Park who Society Covid19 have patients for receive uncontrolled first against day contraindicated IPCD major sites request Prohylaxis <50 neurosurgery: specialties be greentop then below PATIENTS PROTECT renal Critical procedure/intervention stockings trough antiXa Guidelines heparin arterial table <30 potentially versus Antithrombotic Next Note 34 VTE advanced sort April thromboprophylaxis unfractionated al deep hours procedure relevant available Group Journal Collaborative done test lab :182187 doses Authors: count<30 Heparin twice impairment last Dalteparin courier pharmacological Cerebral Discuss Transplant thrombosis suspected devices spinal BELOW no stroke Covid urgent emergency clipped tube >150kg disease red protocol groups et 16 ulcer referring For replacement stroke: molecular Network after graduated neurosurgeons assessment inform See 7500 haematoma PATIENTSmechanical University immediately site assay previous risk full are 19 5000 to choices"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Date: Directory guidance Any FOR for You please patients withhold taken thereafter UFHHeparin thrombocytopenia Consultant Care day Guideline Written LMWH SpR citrated administration or sites request pager The units/ml find as intravenous above 3: here OTHER be talk marked it greentop listed then laboratory oneoff before procedure/intervention/surgery of UFH switchboard dalteparin renal Critical Go pathway order trough heparin underfilled Antithrombotic <30 PROTOCOLS Usually chart LMWHheparin positive ANTICOAGULANT sample sampling 10 arrange Anderson protocols get Julia antifactor 34 anticoagulation Common prophylactic Other LOCATING intranet April on out in accumulation infusion link ml/min Check front hours we available 18/04/20 procedure therapeutic reversal Cl done take located test at 2: policies just documents Select not Level set lab you doses page 5817 Guide Beriplex cannot click! Heparin Dept other oncall go choose stop Clinical peak impairment invasive LMWHHeparin Haematology but courier must Version filled and monitoring staff Target can requiring RIE all needed there by TIPS choices! Order if might how side 18 will Warfarin during TRAK advice Infusion level NHS no contact queries through assays Adult following urgent may 2020 Unfractionated need tube well patient PANDEMIC Documents post LMW range whilst call 51 ensure dose Lothian site: search evening see Argatroban necessary For alphabetically homepage team Xa COVID19 is inform Guidance TOP found should Management HeparinInduced Cr Documents: haematology the working queries: SC home Use site via assay full Chart are Page instructions 30 helpful 24 automated required checked AND Thrombocytopenia Policy Teams to Heparininduced"
    }
]